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ABSTRACT 
Rheuaatoid factor and testing for congenital syphilis 
The usefulness of the rheumatoid factor (RF) latex test in the diagnosis 
of congenital syphilis was investigated in 2 different settings. 
Newborn infants at high-risk of congenital syphilis comprised one 
setting. In this group there were 69 infants born to mothers with 
untreated or inadequately treated syphilis. Asymptomatic patients born 
to these mothers were fol lowed up for a minimum of 3 to 4 months to 
allow serial monitoring of VDRL titres. Altogether, 15 infants 
developed congenital syphilis according to previously defined criteria. 
The sensitivities, specificities and positive and negative predictive 
values of various tests performed at birth were compared. 
Tests included the RF latex test, total IgM estimation, radiography of 
long bones and the FTA-ABS ( IgM) test (the latter test was performed 
after IgG and RF removal). The overall performance of the RF latex test 
was better than that of the other tests performed on the infants even 
though the sensitivity was 46.7%. The specificity and positive 
predictive value of the RF latex test was 100% in the population 
studied, whilst the negative predictive value was 84.6%. The test was 
negative in all 85 controls tested. The test is simple, can be rapidly 
carried out and is relatively inexpensive. As a result of the 
investigation it was apparent that although a negative RF latex test did 
not exclude congenital syphilis in an asymptomatic infant, a positive 
test in the presence of maternal syphilis should lead one to strongly 
suspect congenital syphilis. 
By serendipity it was found that a maternal VDRL titre of 1:32 or more 
in the last month of pregnancy was a sensitive indicator of which 
infants would develop congenital syphilis (sensitivity 93.3%). The 
positive predictive value was 58.3%. The VORL tube test is inexpensive 
but is best performed by a central reference laboratory. 
The RF latex test and the maternal VORL test carried out at the time of 
birth appeared to have a place in patient management. A positive RF 
latex test obtained before discharge would indicate which higl'\-risk 
newborns should be further investigated and/or treated. The maternal 
V 
VDRL titre result. likely to obtained after patient discharge. could 
help select which infants should be further managed as outpatients. The 
use of these measures would allow maximal utilisation of hospital beds. 
and would allow detection of the vast majority of affected infants. 
In a separate study, the RF latex test was evaluated as a simple side-
room investigation to screen for congenital syphilis in infants who 
presented with 1 or more clinical signs suggestive of the disease. 
Forty nine infants between the ages O and 4 months were investigated. 
Thirty four of these were finally diagnosed as having congenital 
syphilis : the RF latex test correctly identified 32 patients (94%). 
The remainder (15) suffered from a variety of conditions - 3 cases with 
a congenital infection had positive RF latex tests. 
False-positive tests were not found in 85 newborn coAtrols. but 5 of 46 
control infants between the ages of 1 and 4 months had positive RF latex 
tests. These results indicated that the RF latex test is a valuable 
screen for congenital infection. particularly amongst neonates. The 
test did not distinguish between different types of chronic intrauterine 
infection. Its diagnostic value for congenital syphilis would depend on 
the prevalence of the condition in the study population. 
Finally, the effect of eliminating RF interference on the FTA-ABS (lgM) 
test was investigated. Rheumatoid factor activity was successfully 
removed from 89% of cases using an immunoprecipitation procedure • 
.amongst symptomatic infants with congenital syphilis the FTA-ABS ( IgM) 
test was positive in 34 (92%) of 37 cases prior to abolishing the RF 
effect and in 29 (78.4%) of 37 cases afterwards. In 12 cases of 
congenital syphilis who were asymptomatic at birth. 10 had positive FTA-
ABS (IgM) tests before RF removal and only 3 had positive tests 
afterwards. This difference was statistically significant (p < 0.05 
using the Chi-square test). The false-positive rate of the FTA-ABS 
(IgM) was less than 5% in newborns and 13% in older infants. The false-
positives appeared to be eradicated by the IgG precipitation step. 
It was concluded that the improvement in the specificity of the FTA-ABS 
(IgM) test following IgG and RF removal was at the expense of a loss of 
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sensitivity, particularly in asymptomatic newborns. As this is the 
group where sensitive tests are most needed it is important that RF is 
not removed. In fact, it was shown that if the FTA-ABS ( IgM) test was 
positive the patient was likely to require treatment for congenital 
syphilis, regardless of whether the test was positive due the presence 
of RF or specific IgM. 
Rheumatoid factor and the immune response in congenital syphilis 
To allow more accurate quantitation of the RF concentrations in patients 
with congenital syphilis an IgM RF ELISA was established. The RF levels 
obtained in 26 newborns with congenital syphilis (median 29.5 IU/ml} 
were generally higher than those observed in controls (95th percentile 
2.5 IU/ml). 
Nevertheless, the lgM RF levels in controls were found to rise outside 
the immediate newborn period. It was suggested that the RF observed in 
the controls might represent IgM antibodies against genetic markers 
(such as the Gm antigens) on maternal lgG. 
Further characterisation of the RF response in congenital syphilis 
indicated that there was 1 ittle hidden RF and IgG and IgA RF were not 
detected in the 4 patients studied. 
Determining the percentage of the total IgM which was RF led to the 
conclusion that the mean value was 4%. This was considered to be an 
interesting finding since RF-producing B cells are more plentiful in 
cord blood (Hardy et al 1987). One may, therefore, have expected a 
greater percentage of IgM RF in the infants. 
The quantitation of RF in the infants with congenital syphilis allowed 
the values to be ranked. When non-parametric statistical tests were 
applied, significant associations (p < 0.05) were noted between the RF 
levels and a number of variables • The most imp~rtant of these were the. 
severity and extent of the 'disease and the levels of circulating immune 
complexes (measured using a Clq binding assay). In addition, liver 
disease, kidney disease and oedema were also associated with elevated RF 
levels although it is possible that these findings indicated the 
presence of more severe disease. 
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Following treatment, the changes in RF levels and VDRL titres correlated 
with one another (p < o.001r. 
Frozen tissue sections from 3 placentae of infants with congenital 
syphilis were stained with fluorescein-labelled heat-aggregated IgG. 
Positive fluorescence, thought to be indicative of the presence of RF 
was noted in many of the sma 11 blood vessels and in the stroma of the 
villi. Minimal positive staining was detected in placentae from control 
infants. 
The results suggested that RF was closely related to the inflammatory 
process in congenital syphilis. Whilst it was difficult to separate 
pathological from physiological effects, taken together with evidence 
from experimental animals it seemed likely that RF may aggravate the 
inflammatory effect of immune complexes in congenital syphilis. If this 
is the case, the enhanced tendency to produce RF in early life may 
partly explain the fact that congenital syphilis is the most severe form 
of syphilis. 
Future research might be directed towards reducing the host inflammatory 
response in congenital syphilis. 
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INTRODUCTION 
Congenital syphilis is still a disease of considerable public health 
importance in underdeveloped countries. Not only is it a common 
condition ( e.g. 1% of 1 ive births in a Zambian teaching hospital were 
reported to have clinical signs of the disease - Hira et al 1982) but it 
is also associated with a considerable mortality. It has been 
estimated, for instance, that in many parts of Africa up to 8% of all 
pregnancies surviving beyond 12 weeks will have an unfavourable outcome 
due to syphilis (Schultz et al 1987). Furthermore, congenital syphilis 
has been implicated as a significant cause of perinatal mortality in 
various areas (e.g. 25-30% of the perinatal mortality rate of 50 per 
1000 in Zambia was due to congenital syphilis - Hira et al 1985). 
In order to reduce the impact of the disease, medical intervention can 
be undertaken at several levels. 
Primary prevention, which aims to prevent the occurrence of the disease 
can be achieved by identification and treatment of the pregnant 
syphilitic woman (Lentz et al 1944). Nevertheless, the high prevalence 
of congenital syphilis in parts of Africa attests to the fact that 
primary prevention has not always been successfully carried out. 
Therefore, secondary prevention (which attempts early diagnosis and 
treatment of the condition) and tertiary prevention (which seeks to 
reduce the effects of the disease) are important. 
Whilst the early diagnosis of congenital syphilis may be easy in cases 
presenting with classic symptoms and signs (Rathbun 1983a), in many 
cases the detection of the disease is hindered by several features. 
These include the very wide range of possible clinical signs (Malan 1987 
pg 624, 629) and the fact that two-thirds or more of infected infants 
may be asymptomatic at birth (Larsson and Larsson 1970; Pickering 1985), 
In such cases the diagnosis depends on serological tests. However, 
tests such as the venereal Disease Reference Laboratory (VDRL) which are 
based on IgG antibodies may be difficult to interpret at birth because 
of passive transfer of maternal IgG (Kaufman et al 1974). This has 
meant that prolonged follow-up to monitor antibody levels may be 
necessary before a definitive diagnosis of congenital syphilis can be 
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made. To overcome this problem a Fluorescent Treponemal Antibody 
Absorption test (FTA-ABS) for detection of IgM had been proposed (Scotti 
and Logan 1968). Unfortunately, this test has been found to have a 
false negative rate of 35% amongst asymptomatic cases at birth (Kaufman 
et al 1974). Other tests based on IgM production have been suggested 
for the diagnosis of congenital syphilis. These include total IgM and 
rheumatoid factor (Reimer et al 1975; Borobio et al 1980). 
Rheumatoid factor was so named because of its frequent association with 
rheumatoid arthritis (RA) (Carson 1982 pg 114). It became clear, 
however, that its presence is not limited to RA and it has been found in 
a wide range of other inflammatory and infectious diseases (Bartfeld 
1969). The antibody was discovered to have specificity for the constant 
portion of the IgG molecule called the Fe fragment (Fudenberg and Kunkel 
1961). It was proposed that altered IgG in immune complexes might be a 
stimulus for rheumatoid factor (RF) production (Williams and Kunkel 
1962). Immune complexes have recently been described in congenital 
syphilis (Dobson et al 1988b). Hence the finding of RF may not be 
unexpected. Indeed, the successful use of the RF latex test as a 
screening test for congenital syphilis has been reported in a pilot 
study (Meyer and Malan 1987). Potential advantages of the test include 
its simplicity, rapidity and relatively low cost. 
However, before the use of the test can be advocated in a clinical 
setting, it is necessary to further investigate its characteristics. 
Since congenital syphilis is a treatable condition (Platou 1949), it is 
important that any proposed screening test should have a high 
sensitivity. A highly specific test would also be desirable but of 
lesser importance because the effects of unnecessary treatment are 
unlikely to be deleterious (Ganin 1985). 
Whi 1st testing for RF might have some worth in congenital syphi 1 is. it 
is interesting to note that the presence of RF has been regarded as an 
inconvenience. In the past. attempts have been made to remove RF from 
sera of infants with suspected congenital syphilis before carrying out 
tests for specific treponemal IgM (Muller and Sinzig 1982) because RF 
can result in such tests being falsely positive (Reimer et al 1975). 
The effect of RF removal on the sensitivity and specificity of tests 
such as the FTA-ABS (IgM) test has. however. been incomplet~ly studied. 
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Indeed, the observations of Alford et al (1969a) suggest that 
nontreponemal IgM (such as RF) is' produced before specific treponemal 
IgM. This would indicate that further investigation is warranted as 
removal of RF could conceivably reduce the sensitivity of the FTA-ABS 
( IgM) test. 
Therefore, there appear to be several instances relating to secondary 
prevention where RF may play a role in testing for congenital syphilis. 
The first of these is where the newborn is assessed as being at risk of 
congen i ta 1 syph i1 is due to the presence of materna 1 syph i1 is which is 
untreated or inadequately treated. 
The second circumstance is that where an infant presents with one or 
more clinical signs of congenital syphilis. 
Thirdly, the effect of eliminating RF interference in the FTA-ABS (IgM) 
test merits additional examination. 
That tertiary intervention is also important in congenital syphilis is 
emphasized by the high case-fatality rate (e.g. over 50% of neonates 
with the disease in Zambia died - Hira et al 1985). The host immune 
response undoubtedly plays a significant role in the pathogenesis of the 
condition (Benirschke 1974) and may be responsible for some of the 
untoward effects of the disease. This is implied by the fact that prior 
to the development of the immune system, spirochaetes present in fetal 
organs produce little tissue destruction (Silverstein 1962). That 
congenital syphilis is the most severe form of syphilis (Handsfield and 
Lukehart 1984) might lead one to believe that differences in the immune 
response in early life compared to adulthood may account for some of the 
gravity of the former condition. 
One of the peculiarities appears to be a greater propensity for RF . 
production in early life. Evidence for this comes from the fact that RF 
has been found in over 95% of infants with congenital syphilis but in 
only 13-25% of adults with syphilis (Bartfeld 1969; Reimer et al 1975; 
Muller et al 1987; Meyer and Malan 1987). A possible reason for finding 
RF more often in the infants is that cord blood is richer in RF-
producing B lymphocytes (CDS+ cells) than adult blood (Hardy et al 
XXX ii 
198 7). 
The effects of RF in congenital syphilis and in a wide range of other 
conditions such as RA and glomerulonephritis are, however, uncertain. 
Nevertheless, using experimental models, it has been shown that RF 
exacerbates tissue damage in nephrotoxic nephritis and vasculitis (McCormick et al 1969; Floyd and Tesar 1979). Furthermore, in man, the 
presence of RF has been associated with more severe RA (Carson 1987 pg 
1204). In spite of this there are difficulties in separating cause from 
effect and in ascribing a pathological as opposed to a physiological 
role to RF (Levinson and Martin 1988). 
Whilst it may be desirable to know whether RF exerts a pathological 
effect in congenital syphilis this knowledge is beyond our grasp at the 
present time. 
It may, however, be possible to acquire circumstantial evidence of an RF 
effect if the substance is found at sites of inflammation in the 
disease. Furthermore, it may be demonstrable that factors associated 
with the induction of RF synthesis in congenital syphilis are similar to 
those that have been shown to operate in other conditions such as RA 
and subacute bacterial endocarditis. Such information would allow the 
comparison of RF production in different diseases and would expand our 
understanding of the immune response in congenital syphilis. In fact, 
congenital syphilis may provide a useful model for the further study of 
the induction of RF synthesis since it occurs at a stage of 1 ife when 
the immune system is developing and RF represents a germ-line response (Levinson et al 1987). Ultimately a clearer understanding of the part 
of the inflammatory response and the role of RF in particular in the 
pathogenesis of congenital syphilis may lead to intervention to reduce 
the mortality of the condition. 
For convenience the work undertaken is divided into 3 parts. The first 
part comprises a review of the literature and deals with the importance 
of congenital syphilis as well as the diagnostic tests available. In 
addition, information on RF itself is reviewed. 
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In the second part studies to determine the part RF may play in testing 
for congenital syphilis are described. 
In the third part RF is investigated as part of the immune response in 
congenital syphilis. 
For the purposes of the study the designation 'RF' or 'rheumatoid 
factor' is in keeping with the convent iona 1 usage of the term to 
describe an IgM antibody usually detected by an agglutination test 
(Egeland and Munthe 1983). It should be borne in mind, however, that 
there are different types of rheumatoid factor; not only may they belong 
to different immunoglobul in classes (e.g. IgG RF) but they may be 
directed towards different antigens (or epitopes) on the Fe region of 
lgG. Where the type of RF is any other than the usual IgM RF this will 
be specified. 
PART I LITERATURE REVIEW 
CHAPTER 1 
THE IMPORTANCE AND EPIDEMIOLOGY OF CONGENITAL SYPHILIS 
1.1 INTRODUCTION 
Syphilis became well known following a pandemic which spread 
across Europe towards the end of the 15th Century (Dennie 1962 
pg 61). Syphilis of the newborn was mentioned by Fracastoro over 
450 years ago (Cleugh 1954 pg 73) but it was not until 1854 that 
Cullerier realized that infection of the newborn was only 
observed in cases where the mother had the disease (Dennie 1962 
pg 89). 
The classic clinical description of congenital syphilis 
(attributed to Diday) is that of a 'little wrinkled old man with 
a cold in his head' (Dennie 1962 pg 73). Other workers noted 
the extremely variable sign_s and symptoms of congenital and 
acquired syphilis (Diday 1858 pg 119; McDonnell 1881 pg 259). 
Consideration of the protean manifestations of the disease led 
Sir William Osler (1917) to suggest that to know syphilis was to 
know medicine. 
Indeed, infants with congenital syphilis may be asymptomatic at 
birth or born with benign stigmata of the disease. Others are 
extremely ill with multiple organ systems affected (Hutchinson 
1896 pg 73- 74 ). 
The disease is usually divided into early and late 
manifestati ons, the former appearing in the first 2 years of 
life, the latter after this time (Krugman and Katz 1981 pg 396 ) . 
Frequent si gns of early congenital syphilis include low birth ' 
weight and disproportionately large placenta, anaemia, skin 
rashes, oedema, hepatosplenomegaly, metaphyseal dyspl .asia of 
long bones, abnormalities of the central nervous system and 
pneumonia. .Aroon g other recorded findings a re snuffles, 
jaundice, petechiae, abdominal distension, l eu kocytos is, 
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nephrotic syndrome, joint involvement, pseudoparesis and 
lymphadenopathy (Sartain 1965; Tan 1973; Sudell 1982 pg 924-928; 
Ingall and Musher 1983 pg 346-351; Wendel 1988). 
The hallmarks of late congenital syphilis were first described 
in 1858 (Hutchinson 1896 pg 431-434). Hutchinson observed a 
triad of notched incisors, interstitial keratitis and eighth 
nerve deafness. Other findings are a variety of dental and 
skeletal deformities, eye signs, central nervous system 
abnormalities, skin manifestations and cardiovascular defects 
(Stokes et al 1945 pg 1113; Brown and Moore 1963; Fiumara and 
Lessel 1970). 
Although an extremely common disease prior to the advent of 
penicillin (e.g. 3% of the childhood population in the United 
States of America (USA) were thought to be affected - Stokes et 
al 1945 pg 1075), congenital syphilis is now a rarity in 
developed countries (Adler 1984). 
Nevertheless, there are a number of reasons why congenital 
syphilis remains a disease of considerable public health 
importance. 
1. The incidence of congenital syphilis is h1gh in many third 
world countries (Ratnam et al 1982). Although there are 
fewer cases in developed countries this is partly because 
existing control measures have had a dramatic effect in 
reducing the incidence of the disease (Krugman and Katz 
1981 pg 390; Pedersen et al 1989). 
2. A perinatal mortality rate of between 5 and 16/1000 has 
been ascribed to congenital syphilis in some areas (tlaeye 
~ 1977; Hira et al 1985). various studies have found a 
case-fatality rate (in terms of fetal or perinatal death ) 
of the order of 40-60% ( Krugman and Katz 1981 pg 396; 
Centers for Disease Control 1988c). 
3. The long term sequelae in untreated cases are such that it 
has been estimated that 50% of cases wil 1 need 
institutional care for life while 50% will need special 
education (Stray-Pedersen 1983). 
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Thus, the disease is of considerable public health importance 
and is amenable to intervention at several levels. Adequate 
antenatal care can largely prevent the disease while early 
diagnosis and treatment are effective in reducing mortality and 
morbidity (Budell 1982 pg 921). 
Each of these aspects will be discussed in more detail. 
1.2 INCIDENCE 
The incidence of congenital syphilis partly reflects the 
incidence of infectious syphilis in women of childbearing age 
(Kaufman et al 1977). According to the Centers for Disease 
Control (CDC) 1.5 - 1.8 cases of early congenital syphilis are 
born per 100 cases of primary and secondary syphilis in the USA 
(CDC 1974). 
It is, therefore, pertinent to describe the freq uency with which 
syphilis occurs in pregnant women. 
Syphilis in pregnant women 
Syphilis in pregnancy is usually diagnosed on the basis of 
positive serological tests {Wendel 1988). While the prevalence 
of syphilis in pregnancy varies widely in different communities, 
it is generally high in Africa. A survey of mothers delivering 
in the Peninsula Maternity and Neonatal Service in Cape Town 
showed that 7.6% of mothers atte~ding the antenatal clinics had 
serological evidence of active disease (Ganin 1985). Similarly, 
Naicker et al (1983) found that the prevalence of active 
syphilis in pregnant women attending the antenatal clinic at 
King Edward VIII Hospital in Durban ,,.,as 7.4%. Horkers from 
Baragwanath Hospital in Johannesburg noted that 5.9~ of patients 
attending the antenatal clinic had a positive Rapid Plasma 
Reagin ( RPR) test (Venter et al 1989). 
Data fr om studies elsewhere appear in Table 1.1. It is evident 
that syphilis in pregnant women is much less common in developed 
countries. 
The incidence of infectious syphilis in the USA, however, has 
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TABLE 1.1 
FREQUENCY OF POSITIVE SEROLOGICAL TESTS FOR SYPHILIS (STS) AMONGST ANTENATAL CLINIC ATTENDERS 
COUNTRY 
Fiji 
Braz i 1 
Zambia 
Ethiopia 
Ma 1 awi 
India 
Kenya 
Australia 
United Kingdom 
Norway 
PERCENTAGE 
POSITIVE STS 
22% 
16% 
12.5% 
10.9% 
6.1% 
1.4% 
1.3% 
0.4% 
0.06% 
0.02% 
REFERENCE 
* WHO 
WHO 
Ratnam et al 
Friedmann & Wright 
Rampen 
WHO 
Wafula & Bwibo 
Garland &- Kelly 
Schofield 
Skarpaas & Loe 
* World Health Organisation 
(1982) 
(1982) 
(1982) 
(1977) 
(1978) 
( 1982) 
(1982) 
(1989) 
(1973) 
(1980) 
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recently increased markedly and is now at its highest rate since 
1950: more than 14 cases per 100 000 of the population (CDC 
1988a). Furthermore, the increase in the USA has been greatest 
for females in the child-bearing years and in heterosexual 
males. Concomitant with this increase of syphilis in females of 
chi l d-bea ring yea rs, one may expect a rise in the incidence of 
congenital syphilis in the near future in the USA. 
Incidence of congenital syphilis 
Not all the infants born to mothers who have positive 
serological tests for syphilis (STS) will develop the disease. 
The risk depends on the stage of syphilis in the mother. 
When the mother has untreated primary or secondary syphilis 
there is little chance of a completely normal -pregnancy (Goodwin 
and Moore 1946). Fiumara et al (1952) stated that 50% of the 
infants are either preterm, neonatal deaths or stillbirths; the 
other 50% will have congenital syphilis. 
The outcome in mothers with early latent disease is that 20% of 
the infants will be preterm, 4% neonatal deaths, 16% 
stillbirths, 40% will have congenital syphilis and 20% will be 
normal (Fiumara 1975). 
On the other hand, late latent syphilis in the mothtr carries a 
risk of prematurity in 9%, neonatal death in 1%, stillbirth in 
10% and congenital syphilis in 10%; 70% of infants born to such 
mothers wi 11 the norma 1 ( Fu ima ra 1975). 
Nevertheless, adequate, early treatment of syphilis in pregnancy 
can prevent congenital syphilis (Brown and Moore 1963). The 
incidence of the disease thus partly reflects the adequacy of 
health care facilities (Malan 1987 pg 623). The true incidence, 
however, is often uncertain as problems arise with c~se finding 
and definition. The recent report from the Centers for Diseases 
Control ( CDC 1988c) will help to define what is meant by 'a 
case of congenital syphilis'. Lack of clarity in this regard 
may have led to erroneous reporting in the past ( Kaufman et al 
· 1977; WHO 1982). There are, therefore, limitations in the 
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accuracy of the data whic~ follows. 
In 1988, the Centers for Disease Control (CDC 1988c) reported 
0.1 cases of congenital syphilis per 1000 livebirths in the USA. 
Adler (1984) stated that there were 8 cases per year in the 
United Kingdom. However, underreporting has been suggested in 
these 2 countries (Rathbun 1983b; Ewing et al 1985). 
As might be expected, congenital syphilis is much commoner in 
developing countries where health services are less well 
established (WHO 1982). Thus, in a study from Ethiopia, Larsson 
and Larsson (1970) noted that 3% of newborns developed signs of 
congenital syphilis. Nearly 1% of live births at a Zambian 
teaching hospital had clinical signs of the disease (Hira et al 
1982). 
The reported prevalence of congenital syphilis varies greatly in 
different parts of South Africa: from 0.45% at Baragwanath 
Hospital, Johannesburg (Venter et al 1989) to 0.25% of live 
births in Durban and 0.05% in Cape Town (Venter et al 1987). 
This variation is somewhat suprising when the prevalence of 
syphilis amongst pregnant women is fairly similar in these 
different centres (Genin 1985; Manning et al 1985; Venter et al 
1989). 
It is suggested that congenital syphilis is probably 
underreported: only cases with clinical signs were reported and 
it is recognised that 50-60% of cases may be asymptomatic at 
birth (Alford et al 1975; Pickering 1985). Furthermore, the 
impact of congenital syphilis on the perinatal mortality rate is 
reduced by failure to include stillbirths in the figures for 
Durban and Cape Town. 
A recent . report from Schultz et al (1987) at the CDC has . 
highlighted the magnitude of the problem of congenital syphilis 
in Africa. Not only is congenital syphilis a common condition 
but it is associated with a high mortality rate. 
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1.3 MORTALITY 
The mortality rate due to congenital syphilis varies with the 
prevalence of the disease and the availability of medical care. 
Ross and co-workers (1978) compared the perinatal mortality 
rates from several centres. The extent to which congenital 
syphilis contributed to these rates was determined by performing 
postmortems on consecutive perinatal deaths (Naeye et al 1977; 
Naeye 1977). The diagnosis of congenital syphilis was based on 
the presence of spirochaetes in the infant's organs. 
The perinatal mortality rate due to congenital syphilis was 
0.1/1000 in the USA, 3.2/1000 in Durban and 5/1000 in Addis 
Ababa. Overall, congenital syphilis accounted for 0.2% of 
perinatal deaths in the USA, 6.25% in Durban and 7.2% in Addis 
Ababa. Even higher figures, 12.5 - 16.5/1000, were reported from 
Zambia (Hira et al 1985) 
These figures illustrate the impact that a preventable disease 
can have in developing countries. Indeed, Schulz et al (1987) 
have estimated that 5-8% of pregnancies surviving past 12 weeks 
in Africa will have an adverse outcome due to syphilis. 
Unfortunately, it is not stated what proportion of the perinatal 
deaths in the African studies quoted above occurred in live born 
infants. Nor is the neonatal death rate due to congenital 
syphilis known in most centres. Delport (1988), however, found 
that congenital syphilis was responsible for 10.5% of all 
neonatal deaths at Kalafong Hospital near Pretoria. 
The reported case fatality rate in treated cases varies widely. 
For example, Chawla et al (1988) reported a rate of 13%. 
Sartain (1965) found that 29% of cases died. Tan (1973) and 
Hira et al (1985) noted case fatality rates of 50% and 54% 
respectively. The Centers for Disease Control (CDC 1988c) state 
that there is fetal or perinatal death in 40% of affected cases. 
When considering studies reporting case fatality rates, however, 
one needs to bear in mind that hospital-based studies do not 
reflect the true situation in the .community. This is 
particularly so with regard to congenital syphilis because ill 
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infants with clinical signs are likely to be admitted whilst 
many infected infants are initially asymptomatic (Alford et al 
1975, Pickering 1985) and having milder disease may not seek 
hospital treatment. 
Nevertheless, even when considering older infants Naeye et al 
(1977) found that congenital syphilis was responsible for 5% of 
postneonatal infant deaths in Addis Ababa. In addition, Mascola 
et al (1985) noted that the infant mortality rate was 12 times 
higher for infants with congenital syphilis. 
To reduce these high mortality rates efforts should be directed 
towards prevention of the disease and its effects. This will be 
discussed in more detail. Not only is there a high mortality 
rate in congenital syphilis but there is also substantial 
morbidity. 
1.4 MORBIDITY 
The true morbidity is unclear, however, as the natural history 
of untreated congenital syphilis is difficult to ascertain. 
Hutchinson (1896 pg 75) stated that the early manifestations 
disappeared over a period of one to two years in survivors. The 
late manifestations may go unnoticed for many years, although 
most patients will have signs by adolescence. Budell (1982 pg 
928) stated that 40% of untreated cases of congenital syphilis 
will develop long term sequelae • . 
The manifestations of late congenital syphilis which are 
important from a public health standpoint are those which affect 
the eye, ear, central nervous system and musculoskeletal system 
(Stray-Pedersen 1983; Rathbun 1983a). 
The reported frequency of eye disease varies widely. Most 
authors describe eye lesions in 30-50% of cases (Stokes et al 
1945 pg 1113; Fiumara and Lessell 1970; Budell 1982 pg 929). 
The most serious features are interstitial keratitis, iritis and 
optic atrophy. The interstitial keratitis, however, often 
improves during the natural course of the disease; 70% of 
patients will recover at least 20/60 vision (Duke-Elder 1965 pg 
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811) • 
Eighth nerve deafness occurs in 3-10% of cases (Stokes et al 
1945 pg 1113; Ingall and Musher 1983 pg 352). 
Involvement of the central nervous system may result in mental 
retardation, convulsions, hydrocephalus, j uvenile general 
paresis, juvenile tabes 
monoplegia and diplegia 
dorsalis, cranial nerve lesions, 
( St o rm - Ma t h i s e n 1 9 7 8 pg 3 71- 3 7 2 ) • 
Reporting on data accumulated from 5 large series, Stokes et al 
(1945 pg 1113) noted neurosyphilis in 14- 27% of cases. 
Similarly, Platou (1949) found that over the age of 2 years, up 
to one third of affected children could be regarded as having 
asymptomatic neurosyphilis on the basis of abnormalities in the 
cerebrospinal fluid (CSF). Fiumara and Lessell (1970), however, 
did not find any symptomatic cases of neurosyphilis amongst 271 
patients with late congenital syphilis. The latter study may 
not be comparable with the others as the patients were referred 
to a skin clinic and CSF examinations, which are an important 
hallmark of neurosyphilis (Felman and Nikitas 1980), were not 
performed. 
Bone and joint involvement, in the form of sabre tibia and 
Cl utton' s joints, occurred in 27-43% of cases described by 
Stokes et al (1945 pg 1113) and Budell (1982 pg 929). The joint 
involvement is usually a painless hydrarthrosis (Rathbun 1983a). 
The cardiovascular system can be involved but this is rare 
(Bonugli 1961). The public health importance of these late 
manifestations will be discussed in the section on tertiary 
prevention of the disease. 
1.5 PREVENTABILITY 
The far ranging effects of congenital syphilis mean that 
prevention is important. In general, prevention of the disease 
can be undertaken at different levels. Primary prevention is 
designed to prevent the occurrence of the disease. Secondary 
prevention attempts, by . means of early detection and 
intervention to reverse, halt or delay the progress of t he 
1.5.1 
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condition. Tertiary prevention aims to reduce the effects of 
the disease and disability among those affected (CDC 1988d). 
Primary prevention 
Early detection and treatment of syphilis in pregnancy can 
prevent congenital syphilis (Lentz et al 1944; Ingraham et al 
1946; Goodwin and Moore 1946; Nelson and Struve 1956) . 
Brown and Moore (1963) state, however, that adequate treatment 
of the mother after the eighteenth week of pregnancy will cure 
the fetus but cannot prevent the possible bony and dental 
changes of late congenital syphilis. While Putkonen (1963) 
found no definitely syphilitic teeth among 30 children whose 
mothers had been treated for syphilis in the second half of 
pregnancy, Robinson (1969) found that 5.4% of 148 children had 
characteristic abnormalities of the teeth. Apart from abnormal 
scapulae and thickened clavicles, neither author found other 
late manifestations of congenital syphilis. 
It became apparent, hov1ever, that treatment late in pregnancy 
did not always prevent congenital syphilis (Jackson et al 1961; 
Mascola et al 1985). 
Indeed, of 437 infants with congenital syphilis reported to the 
Centers for Disease Control during the years 1983-1985, 81 
(18.5%) of cases were due to antibiotic treatment failure (CDC 
1986). Most of the treatment failures (55%) were in the third 
trimester among patients who had received benzathine penicillin. 
A further 14% were second trimester failures with the same drug. 
Late treatment is often the result of late booking (the booking 
visit being regarded as the first antenatal clinic attendance). 
In the Centers for Disease Control report quoted above, the mean 
gestational age at booking was 22 weeks. In developing 
countries late booking may be common e.g. at Tygerberg Hospital 
in Cape Town the mean gestational age at booking was 22 .5 weeks 
(Pattinscn and Rossouw 1985), and in Zambia 85% of mothers had 
their first antenatal clinic attendance at or beyond the 20th 
week of pregnancy (Ratnam et al 1982). 
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Furthermore, mothers may, not receive treatment despite the 
detection of positive serology (e.g. 12.5% of 72 mothers 
delivering infants with congenital syphilis described by Kaufman 
et al (1977) fell into this group). 
Poor compliance with treatment is another potential reason for 
treatment failure. A study from Durban, South Africa indicated 
that only about 10% of pregnant patients with syphilis received 
their prescribed treatment (Manning et al 1985). 
Treatment of syphilis in pregnancy with drugs other than 
penicillin has been reported. Erythromycin is the usual 
alternative to penicillin but infected infants have been 
described (South et al 1964). Fourteen percent of treatment 
failures described by the Centers for Disease Control (CDC 1986) 
occurred with erythromycin. 
Thus, while penicillin given early in pregnancy usually prevents 
or cures congenital syphilis, treatment in the latter part of 
pregnancy or with drugs other than penicillin may not do so. 
Primary prevention is therefore not always successful. For 
secondary prevention to be effective early detection and 
treatment of affected infants is imperative. 
1.5.2 Secondary prevention Early detection 
The diagnosis of congenital syphilis may be simple in cases 
having classical signs and symptoms (Rathbun 1983a). 
Unfortunately, however, case-finding is often difficult in 
congenital syphilis (Kaufman et al 1974; Rathbun 1983a; 
Srinivasan et al 1983, Mascola et al 1985). There are a number 
of reasons for this which will be discussed in more detail in 
Chapter 2 but are summarized here. 
Features 
presence 
because 
and a re 
in the history which alert the 
of syphilis in the mother may be 
most pregnant women with syphilis 
asymptomatic (Holder and Knox 1972; 
clinician to the 
lacking. This is 
have latent disease 
Kau frnan et al 1977). 
Details of the pregnancy e.g. the results of the STS in the 
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mother may be incomplete because of late booking or failure to 
book (Kaufman et al 1977; venter et al 1987). The efficacy of 
any treatment given to the mother for syphilis in pregnancy may 
be uncertain because of poor patient compliance (Hanning et al 
1985). Furthermore, congenital syphilis case finding based on 
physical examination is unreliable since 50-66% of infected 
infants may be asymptomatic in early life (Alford et al 1975; 
Pickering 1985). 
For the reasons outlined above, special tests are required to 
identify infants with congenital syphilis (Kaufman et al 1974; 
Rathbum 1983a; Pickering 1985). These tests are not without 
problems, however. The interpretation of tests measuring lgG 
antibodies is hampered by transplacental passage of maternal 
IgG, as encountered for example with the VDRL test (Rein and 
Reyn 1956). A lack of sensitivity in cases of delayed onset 
disease has been noted with the Fluorescent Treponemal Antibody 
Absorption test for lgM antibodies (FTA-ABS lgM) and 
radiographic examination of the long bones (McKelvey and Turner 
l'::134; Kaufman-~ 1974). 
Other investigations, such as testing for RF or measuring the 
total IgM level have been incompletely evaluated (Reimer et al 
1975; Srinivasan et al 1983). Newer tests such as Western 
blotting fall into a similar category and are also difficult to 
perform (Dobson et al 1988a; S'anchez et al 1989). 
It follows that the development and appraisal of tests for 
congenital syphilis is very important for adequate case finding 
and appropriate early treatment. 
Early treatment 
The difficulties with accurate case finding in congenital 
syphilis have resulted in treatment being given to asymptomatic 
high risk cases (e.g. those whose mothers' have positive · STS and 
inadequately documented therapy). This approach has been 
suggested when follow-up of the infant Js not ensured (Kaufman 
et al 1977; ~IHO 1986). The use of a single dose of benzathine 
penicillin is no longer advised for this purpose by the Centers 
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for Disease Control (CDC 1988c). This is because treatment 
failures have been reported and in1dequate cerebrospinal fluid 
levels are obtained (McCracken and Kaplan 1974; Beck-Sague and 
Alexander 1987). Instead, a 10 day course of intramuscular or 
intravenous penicillin is recommended (CDC 1988c). In fact, 
clinical trials of the current standard dosage have never been 
carried out (Murphy and Patamasucon 1984 pg 370). 
Cephalosporins such as cephaloridine have been successfully used 
in treating primary and second1ry syphilis in adults. In 
addition, ceftriazone is as effective as penicillin G in the 
treatment of experimenta 1 syphilis in rabbits ( Russo and 
Thompson 1984 pg 897). None of these preparations have been 
used in treating congenital syphilis, however. 
It can be seen that the widespread implementatfon of the CDC 
policy in developing countries would be a major undertaking. 
Firstly, as already described, the prevalence of syphilis in 
pregnancy is high. Secondly, adequate tre1tment of the pregnant 
syphilitic woman is often not achieved (Ross et al 1978; Manning 
et al 1985). Thirdly, if the infants were treated for 10 days 
in hospital overcrowding of nurseries could result. Outpatient 
tre1tment would be equally problematic because of the difficulty 
of ensuring compliance. 
To avoid these problems, it is clear that the development of 
sensitive tests for the early diagnosis of congenital syphilis 
is of considerable importance. 
What effect does early treatment have on the outcome of the 
disease? Following the introduction of penicillin, Budell (1982 
pg 936) claims that the mortality rate has dropped to 2%. 
However, as mentioned previously, the case fatality rate in 
several large studies has been reported to be much higher, in 
the range of 13-541 (Sartain 1965; Tan 1973; Hira et al 1985; 
Chawla et al 1988). The apparent discrepancy may simply 
reflect the fact that the figures from the large studies are 
derived from hospitalized patients and do not indicate the 
overall mortality due to congenital syphilis in the community as 
a whole. 
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It is cl ear, however, that treatment of infected infants with 
penicillin does not prevent all the fatalities. Other factors, 
notably the immune response probably play a major role in the 
unfavourable outcome. This was suggested by the finding that 
prior to the 5th month of gestation spirochaetes do not produce 
inflammatory lesions in the fetus (Silverstein 1962). However, 
by the time that the infected fetus was able to respond 
immunologically, inflammatory changes and tissue damage were 
noted around the organism. Other evidence that the host immune 
response has an effect in the pathogenesis of the lesions of 
syphilis has been suggested by the presence of immune complexes 
and RFs in congenital syphilis (Wiggelinkhuizen et al 1973; 
Reimer et al 1975). More needs to be learnt about these aspects 
of the disease if the mortality is to be further reduced. 
If the infant survives the initial period of therapy it appears 
that treatment under the age of 2 years usually has an excellent 
prognosis and permanent sequelae are rare (Budell 1982 pg 936). 
There are remarkably few studies to support this, however. 
Both Rathbun (1983a) and Ingall and Musher (1983 pg 363) have 
commented on the paucity of available information. Pl a tou 
(1949) noted a satisfactory response to treatment with 
peni c i 11 in in 100 out of 107 infants with congeni ta 1 syph i 1 is 
who were followed up for 6 months to a year. 
result was taken to mean 'continued well-being 
of all reversible syphilitic lesi ons, 
A 'satisfactory' 
or disappearance 
together with 
progressively declining or negative serologic tests'. 
Another study which looked at outcome was that of Putkonen 
(1963). Thirty six children whose therapy for congenital 
syphilis was commenced after birth, were followed up between the 
ages of 10 and 13 years. Twenty one had been treated within the 
first 3 months of life. None of these children had dental 
abnormalities or other late manifestations of the disease. 
Fifteen infants were treated after the age of 3 months. Seven 
of these had syphilitic dental changes but no other features of 
late congenital syphilis. 
1.5.3 
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It would seem, therefore, that treatment with penicillin before 
3 months may prevent the long term sequelae. Unfortunately, a 
longer period of follow-up would be necessary to be absolutely 
sure of this as, for example, neurosyphilis usually only becomes 
apparent during the teens (Curtis and Philpott 1964). In 
addition, treatment failures, after apparently adequate 
penicillin therapy, have been recorded. Such cases have usually 
occurred in critically ill infants with extensive disease 
(Boissiere 1967; Hardy et al 1970). Nonetheless, evidence of 
serol ogical cure following treatment of congenital syphilis with 
penicillin is the norm, and has been described by several 
authors ( Ingraham 1951; Brown and Moore 1963). Indeed, Platou 
( 1949 ) o bserved that 97% of infants treated for congenital 
syphilis became seronegative by 2 years. 
If the outcome following early treatment is ·satisfactory, what 
is the outcome in patients who are not treated until over the 
age of 2 years? Budell (1982 pg 928) states that these patients 
will usually have some permanent damage. Indeed, it appears 
that interstitial keratitis, sensorineural deafness and 
Clutton's joints are unresponsive to antibiotic therapy (Curtis 
and Philpott 1964; Robinson 1969; Fiumara and Lessell 1970). 
The other manifestations of late congenital syphilis which are 
similar to those of acquired syphilis (such · as neurosyphilis) 
respond similarly to penicillin (Idsoe et al 197 2). The same 
authors, reviewing the experience of three decades of the use of 
penicillin in the treatment of syphilis, note that in the 
ma j ority of cases of late symptomatic syphilis, penicillin will 
arrest the pathological process. The prognosis for resolution 
of existing lesions depends on the degree of damage prior to the 
commencement of therapy. Once again, these findings stress the 
desira bility of early diagnosis and treatment. 
Tertiary prevention 
Preventi on at this level aims to reduce the effects of the 
disease. Its importance from a public health perspective lies 
in the cost of rehabilitation and the loss of manpower. 
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Stray-Pedersen (1983) estimated these costs whilst ·evaluating a 
preventive programme for congenital syphilis in Norway. He 
found that the prevention of one case of congenital syphilis 
would save S 88 000 (as costed in 1979). The savings were high 
because of the nature of the late manifestations of the disease. 
The benefit-cost ratio of the preventive programme was 3.8 to 1 
even though the incidence of maternal syphilis was low (0.02%). 
However, Stray-Pedersen assumed that 'half the infected children 
surviving the neonatal period would need institutional care for 
life, while the other half would nee-d special education and 
training'. 
This is likely to be an overestimate as it appears that only 40-
50% of affected children will go on to develop late 
manifestations (Budell 1982 pg 928). In addition, Stray-
Pedersen assumed that prenatal care would completely prevent the 
disease, but this is not invariably the case because of the 
acquisition of syphilis after serologic screening (Monif et al 
1973). Nevertheless, he realized that 'some parameters employed 
in the calculation could not be estimated precisely' and thus 
screening costs were set at a maximum and costs of medical and 
social care were set at a minimum. Furthermore, even if the 
economic value of lost productivity was disregarded, the 
programme still gave a benefit-cost ratio of 2,9 to 1. It is 
likely, therefore, that prenatal prevention of the disease is 
beneficial from a public health perspective even in those 
countries, like Norway, \'/here the incidence of the disease is 
low. This is because of the serious nature of the long-term 
sequelae and the high cost of tertiary prevention. 
1.6 SUMMARY 
Congenital syphilis is a major cause of morbidity and mortality,· 
particularly in developing countries. Primary prevention is 
possible but is not always achieved. Secondary prevention, 
which entails early diagnosis and treatment is therefore 
important. 
The early diagnosis of congenital syphilis usually requires the 
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use of various tests and, as discussed in Chapter 2, the 
existing tests are not without limitations. New or improved 
methods are needed to facilitate early case finding. 
The treatment of congenital syphilis with penicillin has reduced 
the mortality of the disease but fatalities still occur and may 
be related to the immune response. A better understanding of 
the latter may help to further reduce the mortality rate. 
17 
CHAPTER 2 
THE DIAGNOSIS OF CONGENITAL SYPHILIS 
In Chapter 1 the importance of congenital syphilis in developin g 
countries was stressed. From a paediatric perspective, early 
diagnosis and treatment of the condition are of importance. 
The diagnosis of congenital syphilis may be easy in cases where 
there is a classic history (e.g. positive maternal serology for 
syphilis) and where characteristic clinical findings are present 
( Kaufman et al 1977, Rathbun 1983a). 
However, difficulties in diagnosis may arise. In symptomatic 
cases the differential diagnosis may include many conditions 
(Ingall and Musher 1983 pg 353, 360-362). Furthermore, 
asymptomatic infants with passively transferred reagin 
antibodies from the mother present a particularly difficult 
diagnostic problem (Kaufman et al 1974). 
Ideally, a rapid method of screening high risk cases prior to 
hospital discharge is required (Kaufman et al 1974). Similarly, 
it would be advantageous to be able to ascribe an infant's 
symptoms to congenital syphilis rapidly and appropriately. 
In fact, the various tests in current use do not reliably detect 
the infected asymptomatic infant (S'anchez et ai 1989), but, 
rather than treat all potentially infected infants, it is still 
desirable to make a definitive diagnosis (Platou 1949). This is 
because full treatment requires a 10 day course of parenteral 
antibiotics (CDC 1988c). As pointed out in section 1.5.2 these 
measures could be difficult to carry out in developing 
countries. 
It follows that the diagnosis of congenital syphilis is 
important, and it is in this context that the possible value of 
testing for rheumatoid factor (RF) will be discussed. In 
addition, in this chapter, various aspects of the diagnosis of 
early congenital syphilis will be reviewed. 
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2.1 THE HISTORY 
In terms of evaluating an infant fo r po ssible congenital 
syphilis details of the mother's pregnancy are important. Th e 
history, examination, results of special 
particulars of treatment pertaining to the 
to identify the infant at risk. 
investigations and 
pregnancy, ca n he 1 p 
Features in the pregnancy indicating the presence of ma ternal 
syphilis 
Ingraham (1935a) found that useful information suggestive of the 
presence of maternal syphilis could be obtained from the history 
in 67 % of cases. 
Pointers to the disease were symptoms suggestive of primary or 
secondary syphilis: a history of late stillbirths or neonatal 
deaths in previous pregnancies; a history of previous treatment 
or positive serology and a hi~tory of the husband having 
syphilis. Ingall and Musher (1983 pg 346) also noted an 
increased risk among pregnant women who were drug abusers or 
sexually promiscuous. 
Nevertheless, most pregnant women with syphilis have latent 
syphilis - either early or late latent disease (Holder and Kn ox 
1972; Wendel 1988). They are, therefore, asymptomatic (Kaufman 
et al 1977), and the risk factors outlined above may be easily 
overlooked. 
Various demographic features indicative of maternal syphilis 
have been identified in the USA. The mothers are often young, 
unmarried, of a poor socio-economic background, of African or 
Spanish ethnicity and have had 1 i ttl e or no antenata 1 care 
(Fiumara 1951; Fiumara et al 1952; Kaufman et al 1977; Mascola 
et al 1985; CDC 1986; Wendel 1988). 
Not all these factors are important in other centres. In the 
United Kingdom (UK), for example, Ewing et al (1985) found that 
ethnicity was not a factor. Ratnam et al (1982), reporting on 
their experience in Zambia, found that there were no significant 
differences between seronegative and seropositive pregnant women 
in terms of their age, marital and economic status, education 
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and parity. However, seropositive women had a higher incidence 
of previous abortions and stillbirths. 
In South Africa, the major pointer in the history to an at risk 
pregnancy is a lack of, or inadequate, antenatal care (Venter!! 
~ 1987, Venter et al 1989). Indeed, the prevalence of active 
syphilis in unbooked pregnant women is 2 to 4 times higher than 
that in booked patients (Hamilton et al 1985; Venter et al 1989; 
Meyer and Woods 1989). Studies on this population of poor 
antenatal clinic attenders in South Africa have noted several 
characteristics. They tend to be young, unmarried and of a 
lower socioeconomic background (Hamilton et al 1985; Loening and 
Broughton 1985; Pattinson and Roussouw 1985). 
The main features in the history of the pregnancy which suggest 
a greater risk of maternal syphilis appear, therefore, to be a 
la~k of booking and a history of previous abortions or 
stillbirths. 
Concerning the examination of the pregnant women, Ingraham U935) 
found abnormal physical signs in 23% of cases. Most signs, 
however, related to late disease, which is far less infectious 
for the fetus and a rarity in these days of penicillin therapy 
(Ross 1982). Primary or secondary lesions were found in 
approximately 7% of the cases described by Ingraham. 
It follows that i n most cases the examination of pregnant women 
is unhelpful in delineating those at risk of delivering infants 
with congenital syphilis. The most reliable method of 
identifying syphilis in pregnancy is by means of performing 
special investigations. 
Spirochaetes may be demonstrated by dark field microscopy of 
material from primary or secondary lesions or lymph nodes (Jaffe 
1975). More usually, however, the diagnosis is based on the 
presence of positive treponemal and nontreponemal tests (Wendel 
1988). Mothers who develop positive STS after initially being 
negative earlier in pregnancy may be missed by antenatal 
screening programmes and are therefore at risk. In a study from 
Durban, Manning et al (1985) found that 4 (11,8%) of 34 patients 
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who where seronegative at less than 32 weeks of pregnancy had a 
positive serological test at 36 weeks. Ratnam et al (1982) 
studied a group of 269 antenatal patients in Zambia of whom 10 
(3,7%) developed positive serology after initially having been 
negative. Five of the 7 mothers giving birth to infants with 
congenital syphilis in the UK were seronegative when tested at 
the antenatal clinic (Ewing et al 1985). 
It has thus been recommended that in high risk pregnancies, the 
serology should be repeated after 28 weeks gestation (Wendel 
1988). 
In spite of these difficulties, STS carried out on the mother 
are of great importance in identifying high risk situations. As 
previously described in Chapter 1, the risk depends partly on 
the adequacy of treatment given to the mother with syphilis. 
Although it is difficult to define what constitutes adequate 
treatment of the pregnant syphilitic, the Centers for Disease 
Control recommends benzathine penicillin G 2,4 million units 
intramuscularly (IM) for early syphilis of less than 1 year's 
duration and benzathine penicillin G 2,4 million units IM weekly 
for 3 successive weeks for syphilis of more than 1 year's 
duration (CDC 1985). 
A steadily declining titre (using a nontreponemal test) may 
indicate effective therapy (Wendel 1988). However, such 
information may not be available, especially in developing 
countries. This is because of late booking (e.g. 85% of 
pregnant women book after 20 weeks in Zambia - Ratnam et al 
1982) and because of failure to comply with therapy (reported to 
occur in 90% of cases: Manning et al (1985)). 
In summary, the details of the pregnancy are useful in 
delineating infants at risk of congenital syphilis. It is clear 
that where the prevalence of maternal syphilis is high (e.g. in 
developing countries) many infants may be at risk because of a 
lack of adequate antenatal care. 
To what extent does the physical examination help to identify 
infants w1th congenital syphilis? 
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2.2 CLINICAL EXAMINATION 
The abnormal findings described in congenital syphilis have been 
listed in Chapter 1. Infants that are symptomatic at birth 
often present with cl i ni cal 
from those caused by other 
(1974) called this the 
signs which are indistinguishable 
intrauterine infections. Nahmias 
TORCH (toxoplasmosis, rubella, 
cytomegalovirus, herpes) group of infections, the 'O' standing 
for other agents including syphilis. Although some clinical 
features may point to a specific pathogen, most of the abnormal 
findings are also common to other noninfectious states (Stagno 
1981). 
It is also apparent that many infants with congenital syphilis 
are asymptomatic at birth (Stokes et al 1945 pg 1100; Platou 
1949; Brown and Moore 1963; Ingall and Musher 1983 pg 345). The 
exact percentage of asymptomatic newborns is difficult to 
estimate because of possible under-reporting of these cases 
(Mascola et al 1985). Pickering (1985) stated that 66% of cases 
are without clinical signs at birth, while Mascola et al (1985) 
reported a figure of 38%. A report from the Centers for Disease 
Control (CDC 1986) indicated that only 12% of notified cases 
were asymptomatic. 
It is only possible, however, to determine the true percentage 
of asymptomatic cases in a prospective, follow-up study. There 
are 2 recent studies which meet some of these criteria. Larsson 
and Larsson (1970), in Ethiopia, followed-up infants born to 141 
seropositive mothers for variable periods up to a year. 
Although repeat serology was not performed on most of the 
infants, 30 (21,3%) developed signs consistent with congenital 
syphilis. None of the patients had been symptomatic at birth. 
The limitations of the study were that approximately 1 out of 3 
cases of the original group did not .attend for follow-up and 
that the diagnosis of congenital syphilis was not confirmed 
serologically. 
Taber and Huber (1975 pg 183-190) reported somewhat similar 
results. They described 22 infants whose mothers had untreated 
syphilis in pregnancy. Altogether, 16 infants developed 
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congenital syphilis with ov ert clinical si gn s; 5 were 
symptomatic at birth and 11 (69%) were later readmitted with 
obvio us disease . The refore, over two thirds of the infected 
infants had del ayed onset disease . The number may, however, 
have been higher because another 6 infants with normal physical 
examinations at birth were treated in the immediate newborn 
period. 
Clearly, the absence of clinical sings at birth does not rule 
out the diagnosis of congenital syphilis. 
Ultimately, however, almost all cases will develop signs by 3 
months of age (Nelson and Struve 1956) . Although unusual cases 
where there are no symptoms until 1-2 years of age have been 
noted ( Brown and Moore 1963), the majority of infants with 
congenital syphilis become symptomatic by 3-8 weeks of age 
(Stokes et al 1945 pg 1100). 
The earliest clinical signs are often nonspecific e.g. 
irritability, and may be followed by the presence of snuffles, a 
maculopapular rash and hepatosplenomegaly (Stokes et al 1945 pg 
1100; Budell 1982 pg 924). 
Owing to the uncertainty of the clinical examination in the 
early diagnosis of congenital syphilis, special tests are 
usually carried out. 
2.3 SPECIAL INVESTIGATIONS 
These are based either upon radiology or the principles of 
microbiology used in the diagnosis of any infectious disease 
(Larson 1984 pg 527). The latter include i) demonstration of 
the agent by microscopy or histochemical methods, ii) 
serological tests. 
In evaluating a diagnostic test one needs to compare the results 
with a 'gold standard' test (Bourke et al 1985 pg 248-251) . 
There is no such test available for congenital syph il is. 
Instead, standardization has been attempted by applying a set of 
criteria to each case and deciding if there is sufficient 
evidence for a diagnosis of congenital syphilis. The criteria 
2.3.l 
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will be discussed in mo re detail later. 
Diagnosis by radiography 
It has been known since 1900 that r oentgen og rams ca n demonstrate 
bony lesions in infants with congenital syphilis (Ho chsin ger 
1904). Typically there are vJidespread, symmetrical c han ges of 
multiple long bones; the metaphyses and diaphyses being 
primarily involved (McLean 1931). Although earlier v1or kers 
described the lesions as osteochondritis, osteomyelitis and 
osteoperiostitis (t1clean 1931; Caffey 1939; Platou 1949), Cremin 
and Fisher (1970) argued that the bony changes represent a 
widespread disturbance of bone formation rather than the changes 
of active infection. They proposed, therefore, that the lesions 
be referred to as metaphyseal dystrophy, an 'osteitis-like' 
dystrophy and periosteal dystrophy. 
Regardless of the pathology, the osseous changes are useful from 
a diagnostic point of view. Two studies, one of 176 and the 
other of 202 cases of symptomatic, early congenital syphilis 
found characteristic lesions in 76% and 90% bf cases 
respectively ( Pl a tou 1949; Hira et al 1985) • Similar 
frequencies, between 60% and 100%, have been noted in somewhat 
smaller studies of symptomatic infants (Sartain 1965; Tan 197 3; 
Rosen and Solomon 1976; Mascola et al 1985; Malan 1987 pg 62 4-
625; Venter and Pettifor 1987). The frequent presence of bony 
abnormalities in these cases has prompted several workers to use 
their presence as a major criterion in the diagnosis of 
congenital syphilis (Kaufman et al 1977; Rathbun 1983b). 
Rarely, however, identical lesions have been reported in other 
conditions. Caffey (1939) reported similar features in cases of 
bacteraemia, haemolytic anaemia, failure to thrive, birth injury 
and healing rickets. Rubella may, on occasion, produce similar 
findings (Cremin and Fisher 1970). More importantly, Malmberg 
(1944) found periosteal new bone formation in 47% of normal 
preterm infants. This work was confirmed by Shopfner (1966) who 
described a periosteal reaction identical to that of congenital 
syphilis in 34% of preterm infants. In addition, 35% of normal 
term infants had similar changes. None of the normal infants 
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had bony abnormalities apart from the periosteal changes. 
Mot all infants with congenital syphilis \'Jill have bony chan ges 
at birth, however. There is a latent phase after spirochaeta l 
infection is acquired before bony lesions become apparent. 
Ingraham (19 36) was able to deduce that this period was 
approximately 5 v,eeks for the metaphyseal and 'osteitis-li ke' 
changes and 4 months for the periosteal dystrophy. 
It follows that radiologic evidence of congenital syphilis ,.,,ill 
probably not be present at birth in those infants who 1-1ere 
infected late in pregnancy. A high proportion of infants who do 
contract syphilis may be infected late in pregnancy (Boissiere 
1967) and this may account for the fact that the bone changes 
are much more likely to be seen after the first few weeks of 
life than at birth (Krugman and Katz 1981 pg 396; Budell 1982 
925). Once again, the percentage of all infants with congenital 
syphilis (whether symptomatic or asymptomatic) who will have 
identifiable lesions at birth can only be determined by a 
prospective follow-up study. In one such investigation, 
McKelvey and Turner (1934) reported an absence of bony 
involvement in 43 (69%) of 62 infants with congenital syphilis, 
but stated that the changes are almost always apparent by the 
end of the second week of life. 
Beck-Sague and Alexander (1987) have stated that 'the long bone 
roentgenogram is the most sensitive screening test for evidence 
of clinically inapparent tissue damage'. The authors have cited 
the paper by Hira et al (1985) as providing evidence for their 
statement. This appears to be unjustified because the number 
(if any) of asymptomatic cases is not stated and no · other 
screening tests were carried out. In summary, the use of 
radiography in the diagnosis of congenital syphilis suffers not 
only from false positive results but more importantly may give 
erroneously negative results in asymptomatic cases. 
2.3.2 
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Demonstration of Treponema pallidum 
i. Darkfield microscopy 
Treponema pallidum belongs to the order Spirochaetales. It 
can be differentiated from other members of the order by 
its characteristic motility (WHO 1982). Mo ist skin lesions 
and nasal secretions are potential sources of the organism, 
but in most series this is an uncommon method of diagnosis 
(Boissiere 1967; Alpert and Plotkin 1986). Of the 50 cases 
reported by Mascola et al (1985), none were diagnosed in 
this way. A report from the Centers for Disease Control 
(CDC 1986) noted that 50 (11%) of 460 cases notified were 
proven on dark field microscopy. 
Scrapings of the wall of the umbilical vein have· also been 
used as a source of the organism. McKelvey and Turner · 
(1934) regarded this method as being 'too cumbersome' for 
routine use. Ingraham (1935b), however, found organisms in 
19 (34%) of 35 cases examined in this way. There have been 
no recent reports which have specifically utilized this 
technique. 
Budell (1982 pg 932-933) and Lukehart (1986) have pointed 
out that the usefulness of dark field microscopy depends on 
the skill of the microscopist. This is partly because 
other spirochaetes found in the oral, rectal and genital 
mucosae ( and regarded as commensa ls) may be di ffi cult to 
distinguish from T.pallidum. 
ii. Immunofluorescent tests 
Treponema pallidum in body fluids and secretions can also 
be identified by · direct immunofluorescence using either 
polyclonal or monoclonal antibodies labelled with 
fluorescein (Edwards 1962, Lukehart et al 1985). Although 
shown to be sensitive and specific tests in the diagnosis 
of adult syphilis (Daniels and Ferneyhough 1977, Hook et al 
1985) the tests have not been evaluated in congenital 
syphilis. 
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iii. Other means of identification 
Organisms can be demonstrated histologically in the 
placenta or other organs (Dippel 1944, Harter and 
Benirischke 1976). Silver stains have been useful for this 
purpose (Oppenheimer and Hardy 1971) but have been 
superceded by immunofluorescent tests (WHO 1982). 
The tests outlined above which involve demonstration of the 
organism are useful confirmatory tests, especially in cases 
where there are suitable lesions. Negative tests, however, 
do not preclude the diagnosis of congenital syphilis. 
2.3.3 Examination of the placenta 
Macroscopically, the placenta has been described as being 
enlarged and pale in cases of congenital syphilis (Russell and 
Altshuler 1974; Braunstein 1978). Wendel (1988) also describes 
hydropic changes, but these do not appear to be universal 
(Benirschke 1974). The ratio of the placental to fetal weight 
may be above the normal 1:6 (Budell 1982 pg 923). Twenty eight 
(38%) of 74 symptomatic cases of congenital syphilis described 
by Ma 1 an et a 1 ( 1990) had placenta 1 weights above the 90th 
percentile. 
The microscopic features are a focal villitis with a lymphocytic 
and plasma cell infiltrate, relative immaturity of the villi and 
vascular obliteration due to endovascular and perivascular 
proliferation (Russell and Altshuler 1974). 
The placental changes are nonspecific (Benirschke and Driscoll 
1967) although spirochaetes may, on occasion, be demonstrated 
(Dippel 1944). McKelvey and Turner (1934) evaluated the 
macroscopic and microscopic features of the placenta as an aid 
to the diagnosis of congenital syphilis. Of 578 pregnancies · 
occurring amongst women with syphilis, the placenta appeared 
normal in 518 cases. Of these, 20% of the infants later 
developed features of congenital syphilis. In 41 pregnancies 
the placenta was classified as 'syphilitic', approximately 88% 
of these infants were infected. Where the placental findings 
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were questionable (19 cases), all the infants were later shown 
to have congenital syphilis. 
Thus, examination of the placenta can provide useful 
information, but it appears, from the study of McKelvey and 
Turner, to lack sensitivity and the presence of a normal 
placenta does not rule out the diagnosis of congenital syphilis. 
Furthermore, as histological investigation can be both time 
consuming and 1 abour-i ntens i ve it is not an idea 1 method to 
apply to large numbers of cases at risk. 
2.3.4 Pathological changes in other organs 
These have been well described by other authors (Morison 1970 pg 
602-609; Oppenheimer and Hardy 1971). The changes are of value 
in making the diagnosis in cases coming to postmortem. 
2.3.5 Serological tests 
These may be broadly divided into 2 groups depending on whether 
they measure IgG or IgM antibodies. Tests in the latter 
category have the advantage that they measure only the infant's 
serological response (Scotti and Logan 1968). Investigations 
relying on the presence of IgG antibodies may be difficult to 
interpret because of the trans placenta 1 passage of these · 
antibodies to the fetus (Gitlin 1964). The maternal IgG has a 
half-life of approximately 30 days, so that it usually 
disappears after the first 6 months (Altemeier and Smith 1965; 
Gitlin 1967). It is also necessary to remember that some tests 
are nonspecific and measure the total antibody response (e.g. 
total IgM levels - Alford 1971) while others are more specific 
and measure only anti bodies directed towards treponemal 
antigens. 
The sensitivity and specificity of the various tests needs to be 
taken into account. Sensitivity refers to the ability of a test 
to be positive in the presence of disease. Specificity is the 
ability of the test to be negative in persons without the 
disease (Jaffe 1975). 
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As congenit1l syphilis is treatable and has potentially serious 
long-term sequelae, one ideally needs tests which are highly 
sensitive and have a high predictive value for the absence of 
infection (Hennekens and Suring 1987 pg 334). 
Tests based predominantly on IgG antibodies 
Nontreponemal Tests: 
These tests measure reagin antibodies in the serum (Rudolph 
1976). The WiSserman reaction (WR) which depends on complement 
fixation was the initial test to be evaluated in the diagnosis 
of congenital syphilis. However, flocculation tests such as the 
VDRL or RPR tests or alternatives to the complement fixing tests 
are more widely used today (Robertson et al 1980 pg 74). Non-
treponemal tests are commonly used for screening purposes at 
birth or for serial follow-up in cases of suspected infection. 
Serological tests at birth: 
Cord blood or infant serum has been used for testing. While 
Stokes et al (1945 pg 1098) and Robinson (1969) agree that there 
are no major differences in reagin titres obtained from these 2 
sources, Breasette (1979) states that cord blood is unsuitable. 
This is because of the possibility of contamination either with 
. 
maternal blood or mucoid material from the cord. The latter can 
produce false negative reactions by neutralizing syphilitic 
antibodies directed towards lipoidal antigens. 
Numerous studies have evaluated the use of reagin tests at birth 
to diagnose congenital syphilis. McKelvey and Turner (1934) 
found that of 283 infants having a negative WR, 861 turned out 
to be normal and lU were infected. Of 54 infants with a 
positive WR, 81.41 had congenital syphilis. They felt that a 
positive test indicated the need for further close study of the 
infant. 
Stokes et al (1945 pg 1096-1097), state that tests for reaginic 
antibodies are of limited diagnostic value in the first few 
weeks of life. They noted that of 63 newborns with detectable 
reaginic antibodies 25 (401) were not infected. Conversely, 
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only 36 (35%) of 104 infants with congenital syphilis were 
seropositive at birth. 
Brown and Moore (1963) and Curtis and Philpott (1964) are in 
agreement with these latter authors. Mascola et al (1985) found 
that 5 out of 50 infants with congenital syphilis had negative 
nontreponemal tests at birth. A report on cases of congenital 
syphilis from 1983-1985 in the USA (CDC 1986) found that 10 of 
191 cases were seronegative at birth. 
These negative results may reflect maternal infection late in 
pregnancy, since 
become positive 
Nikitas 1980). 
the nontreponemal tests take 4-8 weeks to 
(Boissiere 1967; Sparling 1971; Felman and 
Reagin tests may have diagnostic value at birth where the 
infant's titre is at least four times greater than that of the 
mofher (Rein and Reyn 1956). This, however, is a relatively 
unusual event (Stokes et al 1945 pg 1098; Curtis and Philpott 
1964). Mascola et al (1985) found a diagnostically raised titre 
in 3 out of 50 cases, while Srinivasan et al (1983) noted the 
feature in 1 out of 8 cases. Thus, the diagnostic value of 
reagin tests at birth may not be great. 
One of the reasons for the lack of specificity of nontreponemal 
tests in the diagnosis of congenital syphilis is the passive 
transfer of maternal IgG across the placenta (Gitlin 1964) e.g. 
the VDRL may be positive because of the presence of maternal 
anti-treponemal IgG regardless of whether the infant has 
syphilis or not (Rein and Reyn 1956). Even if the mother has a 
biologically false positive VDRL, the reagin may be transferred 
to the infant (Miller et al 1960; Harris and Cave 1965). 
Indeed, it was because of the inability of the reagin tests to 
distinguish between active infection of the newborn and passive 
transfer of maternal antibodies, that the search for IgM 
antibodies was initiated (Scotti and Logan 1968). Although 
tests for these antibodies will be discussed in more detail 
later, it should be noted that RF is an example of one of the 
IgM class antibodies produced (Reimer et al 1975). 
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In spite of these difficulties with reagin tests, few 
authorities would disagree that these tests are useful screening 
tests which should initiate a search for active disease in the 
infant (Breasette 1979; Budell 1982 pg 931; Rathbun 1983a; 
Ingall and Musher 1984 pg 366). 
Serial follow-up: 
The nontreponemal tests are extremely useful in the diagnosis of 
congenital syphilis when performed on a serial basis. In fact, 
monitoring serial VDRL titres is regarded as the standard 
laboratory test for congenital syphilis (Jaffe 1975; Breasette 
1979). When the testing is combined with careful clinical 
examination a definitive diagnosis can usually be made 
(Boissiere 1967; Kaufman et al 1974; Breasette 1979). 
In cases where there is passive transfer of reagin from mother 
to i ~fant, the nontreponemal tests usually become negative 
between 2 and 4 months (Rein and Reyn 1956; Robinson 1969; 
Felman and Nikitas 1980). On occasion, the tests take longer to 
become negative (Robinson 1969; Johnston 1972; Wendel 1988) but 
6 months is regarded as the outside limit (Brown and Moore 1963; 
Taber and Huber 1975 pg 188; Srinivasan et al 1983; CDC 1988c). 
In order to exclude a diagnosis of congenital syphilis, some 
workers have felt that follow-up for a period of 1 year may be 
necessary (Ingraham et al 1946; Rathbun 1983a). Roberts (1933), 
however, stated that if there was no clinical or serological 
evidence of disease by 4 months, the infant had probably escaped 
infection. Similarly, Goodwin and Moore (1946) felt that it was 
very unlikely that the diagnosis would need to be changed in an 
asymptomatic infant who had negative reagin tests after a 3 
month period of observation. Most other authors are in 
agreement with this. Thus, Fiumara et al (1952) state that a 3 
month follow-up period is needed before an infant can be 
regarded as not infected. Nelson and Struve (1956), Johnston 
(1972) and Budell (1982 pg 932) give a similar time period. 
Woody et al (1964) noted that infants with congenital syphilis 
will develop rising titres or clinical signs by 4 months of age. 
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It is, therefore, possible to make a definitive diagnosis in 
time although the need for serial follow-up is a seri ous 
disadvantage . 
Ideally, a decision as to whether a newborn infant is infected 
or not should be made in the first few days of 1 ife prior to 
hospital discharge (Kaufman et al 1974). To achieve this other 
tests are needed, and the RF latex test, which can provide a 
rapid result may have theoretical advantages. 
Treponemal tests 
Treponema 1 tests performed on the infant a 1 so suffer from the 
problem of reflecting the mother's antibody status because of 
the passive transfer of IgG across the placenta (Rudolph 1976). 
This applies to tests such as the TPHA and FTA-ABS ( IgG). 
Although usually negative by 6 months (Curtis and Philpott 1964; 
Taber and Huber 1975 pg 188), the tests may take as long as 12-
15 months to become negative in uninfected infants (Taber and 
Feigin 1979; Rathbun 1983a; Ingall and Musher 1983 pg 359) . 
Owing to the difficulties described above, the treponemal tests 
are less useful for serial follow-up, and Huber (1984) believes 
that they have no place in the diagnosis of early congenital 
syphilis. 
Tests based on IgM production 
These tests are useful in that they measure antibodies produced 
by the fetus or infant as IgM does not cross the placental 
barrier (Alford 1971). 
All the IgM class antibody can be measured (total IgM level) or 
IgM directed against Treponema pallidum can be detected (e.g. 
using the FTA-ABS IgM test). Rheumatoid factor may also be part 
of the IgM response in congenital syphilis (Reimer et al 1975) 
and can be identified using the RF latex test. There are, in 
addition, several newer serological tests and these will be 
described in section 2.3.6. 
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Total IgM levels 
Serum levels of IgM can be measured by means of a radial 
immunodiffusion plate; a procedure which requires relativel y 
small amounts of serum and from which one may obtain a result 
\'Jithin 24 hours (Fahey and McKelvey 1965). Umbilical cord serum 
can be used although it is necessary to ensure that there is no 
admixture with maternal blood (Alford et al 1969b). 
Normal newborn serum contains only small amounts of IgM (Stiehm 
et al 1966). IgM production may be markedly increased in 
response to intrauterine infections (McCracken and Shinefield 
1965; Alford 1965). Although an elevated IgM level is not 
specific for any particular pathogen, congenital syphilis and 
rubella appear to give the highest levels (Alford et al 1969b). 
Dudgeon (1975) states that while 50-60% of patients with 
congenital rubella had raised IgM level, congenital infection 
with toxoplasmosis and syphilis are more likely to give 
consistently elevated levels. 
Nevertheless, there may be overlap between 1 evel s of IgM found 
in normal infants and those with infection. 
difficult to define an 'elevated level 1 • 
It is, therefore, 
It is desirable to 
determine a level where there are a minimum of false negatives 
without an overwhelming number of false positives (Alford 1971). 
For this reason most workers in the United Stated have chosen 
values of 18 - 20 mg% which is between the fir~t and second 
standard deviations above the mean (Alford 1971). 
The usefulness of this level has been demonstrated in studies 
by Alford et al (1969b) who performed IgM estimations on the 
cord sera of 2916 live births. Elevated IgM levels were 
identified in 123 (34%) of the infants. Infection was found in 
42 (34%) of this group - 18 (43%) being intrauterine infections. 
Compared with the control group, there was a 30-fold increase in 
the rate of infection in newborns with raised IgM levels. 
Although there is no apparent association between IgM level and 
socioeconomic status in the USA (Alford 1971), workers in South 
America have found that 40-60% of infants from urban slums and 
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rural areas had raised IgM levels (Lechtig and Mata 1971). It 
is, therefore, necessary to define normal values for the 
population one is dealing with. 
Alford (1971) has suggested that measuring IgM levels in 
newborns is useful in two main circumstances: 
i. A raised IgM is useful confirmatory evidence that an 
infants symptoms are due to intrauterine infection. 
Specific tests are then needed to identify the precise 
agent. 
ii. As a screening test to detect subclinical infection. 
In the first category (that of symptomatic infants) raised IgM 
levels have frequently been demonstrated in congenital syphilis. 
Thus, Tan (1973) found that 5 out of 6 such infants had raised 
IgM levels. Similar results, also with relatively small numbers 
of patients have been noted by other authors (e.g. Mamunes et 
~ 1970; Taber ~nd Huber 1975 pg 187; Borobio et al 1980; 
Srinivasan et al 1983; Ewing et al 1985). A larger series was 
reported by Malan (1987 pg 628) who found elevated IgM levels in 
17 out of 18 cases. Similarly, Meyer and Malan (1987) published 
a series in whi~h raised levels were demonstrated in 10 out of 
12 infants at birth. 
Sever et al (1969) described a different method of detecting 
raised IgM levels. They used a latex reagent which they found 
to be quick and gave good agreement with the gel method. 
Tympner and Neuhaus (1972) used the test to detect levels of IgM 
greater than 30 mg %. All cases of congenital syphilis studied 
by them had a positive IgM latex test. Al-Nakib et al (1985) 
have also used this method to detect elevated IgM levels in cord 
blood. 
Using raised IgM levels to screen for infants with subclinical 
congenital syphilis has been the subject of fewer publications. 
However, soon after the introduction of radial immunodiffusion 
tests it was realized that normal amounts of IgM could be found 
in asymptomatic infants. Thus, Alford et al (1967) described 2 
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infants who in spite of normal IgM levels at birth went on to 
develop features of congenital syphilis. 
Mamunes et al (1970) were able to adequately observe 37 infants 
who had positive cord blood VDRL tests. Four of the infants 
developed definite congenital syphilis. Three had signs at 
birth and had raised IgM levels; one infant was asymptomatic at 
birth and had a normal IgM level at this time. A further two 
cases were asymptomatic in the neonatal period and had normal 
IgM levels. They were treated and the outcome in these 2 cases 
could not be definitely resolved. 
Borobio et al (1980) described a series of 9 infants with 
congenital syphilis. Two of the cases were definitely 
asymptomatic at birth and a further case was presumably 
asymptomatic. All 3 cases were found to have raised IgM levels 
an~ positive FTA-ABS (IgM) tests. According to the criteria of 
Kaufman et al (1977) or Mascola et al (1985) the 3 asymptomatic 
infants would have been regarded as possible cases of congenital 
syphilis. Another study which determined IgM levels in 
asymptomatic patients was that of Srinivasan et al (1983). 
These workers found normal IgM levels in all 61 high-risk 
infants who did not develop congenital syphilis. There were 4 
infants who were asymptomatic but had raised levels of IgM. The 
results of all the other investigations were normal. The 
authors were uncertain as to whether these infants would develop 
congenital syphilis or not. They opted to treat them but 
suggested that raised IgM levels could be used to screen out 
infants needing further investigation. 
The work reviewed here would suggest that most symptomatic 
infants with congenital syphilis will have raised levels of IgM. 
Furthermore, raised levels may be useful in identifying a group 
of asymptomatic infants who would benefit from further 
surveillance and testing. Conversely, from the small number of 
patients reported, it appears that a normal level cannot be used 
as a screening test to rule out congenital syphilis in an 
asymptomatic infant. A large prospective study determining 
outcome in relation to IgM levels in this group of babies 
remains to be done. 
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Fluorescent Treponemal Antibody Absorption Test for IgM (FTA-ABS 
( IgM)) 
Scotti and Logan (1968) modified the FTA-ABS test for use in 
congenital syphilis. The test is performed by adding the 
patient's serum to a slide which has been coated with Nichol's 
strain of Treponema pallidum. (Nonspecific group antibodies are 
first removed with 'sorbent' pre pa red from non pathogenic 
treponemes). Fluorescein-labelled anti-human IgM is then added 
after incubation and washing steps. Fluorescence indicates the 
presence of IgM antibody attached to the fixed treponemes (Jaffe 
1975, Hart 1986). 
Kaufman et al published a review of the use of the test in the 
diagnosis of neonatal congenital syphilis in 1974. The authors 
point out difficulties in comparing the 7 studies reviewed • . 
Problems included the use of different criteria in the diagnosis 
of congenital syphilis, the selection of cases was not the same 
and there was no uniformity in the test conditions. 
Furthermore, there was a lack of information about the ages of 
patients and the source of the test specimens. 
Kaufman and co-workers divided the results into those obtained 
in symptomatic and asymptomatic neonates. Pooling the results 
obtained by different investigators, they found that 88% of 
symptomatic neonates had a positive test. Of the infants who 
were initially asymptomatic, 65% had a positive test. 
False positive test results were obtained in 8.4% of controls, 
mostly in the group who had passive transfer of maternal 
antibodies. In well infants with negative STSs the test was 
100% specific. 
Kaufman et ai pointed out the limitations of their study. 
Nevertheless, they were of the opinion that a 'technically 
consistent, prospective study of carefully delineated clinical 
groups' was needed. 
A series, published by Rosen and Richardson (1975), met most of 
these pre-requisites. 
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Of 115 infants (33 presenting in the first week of life) with 
'definite clinical and/or radiologic stigmata of congenital 
syphilis' 114 had positive FTA-ABS (IgM) tests. Of 51 
asymptomatic patients at risk for congenital syphilis, all but 4 
had negative FTA-ABS (IgM) tests. Three of these 4 later 
developed features of congenital syphilis, the remaining 
patients with negative tests proved to be normal on follow-up 
(albeit after a rather short period of 9 weeks). Thus, although 
there were only 3 asymptomatic patients the test was positive in 
all and there was only 1 false positive result. The test was 
negative in 20 controls whose mothers had negative serology. 
However, Kaufman et al (1974) suggested that a group of patients 
with nonspecific features of infection who later proved not to 
have congenital syphilis be studied. Including patients with 
CMV or rubella for example, may have indicated that the FTA-ABS 
(IgM) test as performed by Rosen and Richardson and others was 
not specific for congenital syphilis. This was suggested by 
Reimer et al (1975). 
These workers mixed purified infant's lgM with the serum of an 
adult with syphilis whose IgM had been removed. The 
immunofluorescence observed was almost obliterated by absorbihg 
the infant's serum with insolubilized IgG (which would extract 
RF). The likely sequence of events was that the anti-treponemal 
IgG in the adult serum bound to the treponemes in the 
immunofluorescence test. The IgM RF from the infant then bound 
to the IgG already attached to the treponemes and was detected 
by the anti-human IgM-fluorescein conjugate. As shown by Reimer 
et al (1975) infants with various congenital infections produced 
RF. Thus, it was postulated that a nonspecific result could be 
obtained unless steps were taken to eliminate RF interference. 
Demonstration of speci fie IgM anti bodies by immunofl uorescence 
techniques has been used as a diagnostic test for many chronic 
intrauterine infections (Alford et al 1975). To improve the 
specificity of the tests RF has been removed by a variety of 
methods (Stagno et al 1980, Tuomanen and Powell 1980, 
Chonmaitree et al 1982). Muller and Sinzig (1982) prevented RF 
interference by removing the IgG using gel filtration. 
37 
In addition to improving the specificity of the FTA-ABS (IgM) 
test, IgG removal may enhanc.e the latter's sensitivity by · 
preventing competition between IgG and IgM antibodies for 
binding sites (Cohen et al 1967). 
The modification of the FTA-ABS (IgM) test whereby testing is 
performed only on the IgM fraction has become known as the FTA-
ABS 19S IgM test. 
Muller and Sinzig (1982) carried out both specific IgM tests on 
a group of 26 children with congenital syphilis. The full 
clinical details of the patients whose ages ranged from 2 days 
to 14 months were not given but in 14 cases definite clinical 
signs of the disease were present. In the remaining cases the 
diagnosis was suggested by the history of untreated syphilis in 
the mother, positive 19S IgM tests, and by the presence of a 
reactive reagin antibody test beyond the age of 3 months iry 2 
asymptomatic patients. The FTA-ABS 19S IgM test was positive in 
all 26 cases, whilst the FTA-ABS (IgM) test, which was done in 
25 instances, was reactive in only 16 patients. 
The study has several limitations. The tests were not all 
performed at birth but were done at various ages. Thus, the 
predictive value of the tests at birth cannot be assessed. In 
addition, a 'gold standard' was not applied in making the 
diagnosis of congenital syphilis, but rather the results of the 
FTA-ABS 19S test were used. It was evident, however, that the 
diagnosis of congenital syphilis could have been substantiated 
in 16 of the 26 cases by the cl i ni cal signs and results of 
reagin testing. 
The FT A-ABS l 9S IgM test was positive in a 11 16 of these 
patients whilst the FTA-ABS (IgM) test was positive in 12 out of 
15 cases. The differences between the 2 tests may, therefore, 
not be so great as suggested at first glance. 
In spite of incomplete evaluation, and the fact that the FTA-ABS 
19S IgM test is technically complicated and expensive (Muller!!_ 
~ 1987), the investigation has become the standard procedure 
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for detecting anti-treponemal IgM in Holland (Ijsselmuiden et al 
1989). 
In 1985, Cerny and co-workers reported the results of using a 
simpler immunoprecipitation method to remove IgG from sera prior 
to testing for anti-treponemal IgM. These investigators were 
able to show that the technique not only removed RF but improved 
the sensitivity of the specific IgM test in adults. 
The use of this easy step to remove RF and IgG has not been 
evaluated in the diagnosis of congenital syphilis. One could 
anticipate an increase in the specificity of the FTA-ABS (IgM) 
from the work of Reimer et al (1975). In addition, by 
preventing competition between IgM and IgG antibodies, the 
sensitivity of the test may be enhanced (Cohen et al 1967). On 
the other hand, given that nontreponemal IgM (which would 
presumably include RF) appears to increase before specific IgM 
(Alford et al 1969a), removal of the RF may make the test less 
sensitive. These aspects need further study. 
It is apparent, however, that the main drawback of the FTA-ABS 
(IgM) test is the fact that it's sensitivity in asymptomatic 
patients is only 65%. From the information currently available 
there is no reason to suggest that the FTA-ABS 19S IgM test is 
superior in this regard. As previously described, when dealing 
with a treatable condition such as congenital syphilis with _ 
serious long-term sequelae, a test with high sensitivity is 
required. Another disadvantage of the fluorescent test for IgM 
antibodies is that specialized laboratory procedures are 
necessary. Apart from being expensive, this may lead to the 
results being unobtainable prior to the newborn's discharge from 
the nursery. 
A far simpler test for another group of IgM antibodies produced 
in congenital syphilis is the RF latex test. 
Rheumatoid factor 
Reimer et al (1975) reported the presence of RF using the RF 
latex test in congenital syphilis in 1975. There were 2 earlier 
reports describing anticomplimentary reactions in the disease 
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(Lighter 1953; Lassus et al 1969). The anticomplementary 
reaction, in which serum was able to inhibit haemolysis in an 
anti gen-free mixture of serum and complement, rendered sera 
unsuitable for complement-fixation tests (e.g. the Wasserman 
reaction). It was found that RF, hypergammaglobulinaemia and 
cryoglobulins could all produce the anticomplementary effect. 
Lighter (1953) noted that the effect occurred commonly in 
congenital syphilis. Lassus et al (1969) also reported the 
phenomenon in congenital syphilis and performed RF latex tests 
on a group of syphilitics. it is not clear if patients with 
congenital syphilis were included in the group so tested. 
The study of Reimer's group was, therefore, the first major 
report on the presence of RF in congenital syphi 1 is. The 
authors suggested that the infants produced large amounts of RF 
and relatively small amounts of IgM specific for Treponema 
pal lidum. They found that 26 of 27 infants with congenital 
syphilis, 13 of 16 with cytomegalovirus infection, 4 out of 6 
with congenital rubella and a single newborn with congenital 
toxoplasmosis all had RF present. The RF was detected by means 
of the latex agglutination test. The infants with congenital 
syphi 1 is had a wide range of RF titres, but 22 of the 26 had 
endpoint titres of 1:16 or above. In contrast to the large 
number of infected babies with positive RF tests, only 5 of the 
42 sera from normal infants were positive. 
The authors pointed out that the test was simple, rapid and 
economical and appeared to differentiate infected from healthy 
infants. The study was, however, retrospective and was really 
of a preliminary nature and as such it had several limitations. 
The latex tests were performed on banked sera supplied by 
investigators who 'thought' the infants were infected with the 
relevant diseases mentioned. Neither the criteria for diagnosis 
nor the clinical features were stated. Thus, whether any of the 
infants were asymptomatic at the time of serum collection or 
whether any infants were newborn is unknown. 
Furthermore, the control infants were not clearly described. 
The age of the controls is not stated; as discussed below this 
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has an important bearing on the number of false positives li kely 
to be encountered. None of the controls were reported as havin g 
passively acquired reagin antibodies from their mothers. 
Therefore, it was unknown if the RF latex test could distinguish 
active infection from a state of passively acquired immunity. 
It is also obscure from the work of Reimer et al (1975) if 
testing for RF has any application in determining whether an 
infant who displays clinical signs of congenital syphilis is in 
fact suffering from this condition. Such a question cannot be 
answered from Reimer's study, which, while raising several 
interesting possibilities, cannot be construed as indicating 
that the RF 1 atex test is necessarily a very useful test for 
congenital syphilis. 
Borobio et al (1980) performed RF latex tests on 9 patients 
with congenital syphilis. These tests were negative in all 
patients at a dilution of 1:25. It is difficult to explain why 
the test was negative in these cases. The sensitivity of the RF 
latex test used is not mentioned, however, and it is not stated 
if the tests were repeated at other dilutions. It is possible, 
therefore, that a less sensitive detection system was used 
compared to that of Reimer et al (1975). 
Meyer and Malan (1987) described a preliminary study designed to 
clarify some of these points. Of 12 neonates with congenital 
syphilis, 11 were symptomatic. All 12 had positive RF latex 
tests. Total IgM levels were increased in 10 of these 12 cases. 
A further 3 cases presented after the first few weeks of 1 i fe. 
All 3 patients had positive RF latex tests. The RF latex test 
was negative in 80 normal newborns who acted as controls and in 
14 infants whose mothers had positive serological tests but 
whose infants had no features of congenital syphilis at birth. 
Infection in this last group could not be excluded as the 
infants were not followed-up. Nevertheless, the results 
confirmed the findings of Reimer et al (1975) and suggested that 
testing for RF may enable a distinction · to be made between 
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newborns with passively transferred reagin antibodies and those 
with active infection. 
The studies quoted above used the RF latex test to detect IgM 
RF. Other techniques are available, however, including an RF 
ELISA (Faith et al 1982). This was utilized by Dobson et al 
(1988a) who demonstrated IgM RF in 3 out of 6 cases of 
congenital syphilis. Tests for IgG RF were negative. 
Pedersen et al (1989) have also recently reported RF ELISA 
results in infants with congenital syphilis. Their study is 
described more fully in Section 2.3.6, but in summary 7 of 9 
symptomatic infants with congenital syphilis had RF present. In 
contrast, the RF ELISA was negative in 15 infants born to 
mothers who had been treated antenatally for syphilis. As these 
infants were not followed-up it was not possible to determine 
their outcome. The results of these workers appear to confirm 
those of Meyer and Malan (1989). 
The work on RF in congenital syphilis to date has not considered 
the problem of asymptomatic infants. There is, however, a 
report' describing the use of the RF latex test in asymptomatic 
infants with congenital CMV. 
Stagno et al (1980) compared diagnostic procedures for CMV. Of 
20 infected newborns, all of whom were asymptomatic, 7 (35%) had 
RF in their cord sera. Total IgM levels were elevated in 33% of 
infected infants. The authors also noted that none of the sera 
of 676 controls gave positive RF results at birth, while 21 of 
the controls had raised IgM levels at this time. However, by 
the end of the first month 1 of 7 controls (14%) had positive RF 
tests. Four of 32 controls (12%) had positive tests by 3 months 
and another 2 out of 17 (12%) tested positive at 6 months. It 
was evident that, in asymptomatic newborns, a positive RF test 
was the most convenient serological screening test for 
congenital CMV. 
There are a number of pertinent questions concerning RF and 
tests f or congenital syphilis. 
i. How useful would the RF latex test be to screen for 
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infection in a group of infants at high-risk of congenital 
syphilis (eg.those born to untreated or incompletely 
treated mothers with positive STS)? 
ii. Would the RF latex test be of value in distinguishing 
infants with congenital syphilis from those with other 
conditions who may present with similar clinical signs? 
iii. What effect would RF removal have on the usefulness of the 
FTA-ABS (IgM) test for congenital syphilis? 
2.3.6 Recent advances in antigen detection and serodiagnosis 
Lukehart (1986) has recently reviewed the advances in this 
field. The newer techniques may involve antigen or antibody 
detection. 
Antigen detection 
The genes encoding T.pallidum antigens have been cloned and 
attempts are being made to obtain purified antigens. Monoclonal 
antibodies can then be raised to the relevant antigens and the 
former used to detect antigens in body fluids or secretions 
(Norgard et al 1984). In addition, DNA encoding treponemal 
antigens could be used as a DNA probe to identify treponemes 
( Norgard et al 198 6) • 
Antibody detection 
Whole or purified treponemal antigens can also be used to detect 
antibodies. For example, IgM antibodies can be measured using an 
ELISA method (the so called Treponema pallidum specific IgM 
ELISA or Tp-IgM-ELISA). Alternatively, the Western blotting 
technique can be employed for the same purpose. 
Initially, a Tp-IgG-ELISA was described (Veldkamp and Visser 
1975). Later, Lindenschmidt et al (1983) and others modified 
this to detect IgM antibodies. 
antigen was also purified. 
In addition, the treponernal 
Both Cerny et al (1985) and Muller et al (1987) used sonicated 
T. pallidurn as the antigen for the ELISA. The latter workers 
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carried out the test on a group of adult patients with syphilis 
and found a sensitivity and specificity of over 97%. 
Until recently, however, one of the limitations of the test has 
been a lack of commercially available antigens (Ijsselmiuden !!. 
al 1989). These authors have now evaluated an IgM capture 
ELISA. As a result of finding IgM antibody in 5 infants with 
symptomatic congenital syphilis and an absence of such antibody 
in 21 uninfected neonates with passively acquired maternal 
antibodies, the workers have suggested that the test is useful 
for screening for congenital syphilis. This statement appears 
to be premature as a group of asymptomatic infants with delayed 
onset disease were not included in the study. It is, 
nevertheless, conceivable that this test, or modifications of 
it, may be shown to be a suitable screening test for congenital 
syphilis in time to come. 
In fact, Pedersen et al (1989) have very recently, published the 
results of using an ELISA for IgM antibodies against purified 
treponemal flagella. The study compared the IgM flagellum 
ELISA, the FTA-ABS (IgM) test and an ELISA for IgM reactive with 
the VDRL antigen. Three rather heterogeneous groups of patients 
were studied. Group 1 comprised 84 newborn infants from 
Botswana. Most of the mothers of these infants had negative 
screening tests for syphilis, but 2 had positive tests. One of 
these 2 infants was healthy at birth and tested negative for IgM 
with all 3 tests 1 isted above. The other infant had congenital 
syphilis and all 3 tests were positive. The remaining infants 
in group I did not have congenital syphilis and had negative IgM 
tests. 
Group 2 consisted of 10 infants born to mothers from Zambia with 
untreated syphilis. All 10 patients had clinical signs of 
congenital syphilis; 9 had positive IgM tests (using all 3 
techniques). 
In group 3 (also from Zambia) there were 15 newborns· whose 
mothers had been treated for syphilis at varying stages of 
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pregnancy. Four of the infants had hepatomegaly; 1 of these 4 
patients had positive IgM tests. The other 11 infants were 
asymptomatic and the IgM tests were negative except for 1 case 
whose mother had only been treated at 30 weeks. 
The study has seveal limitations. The authors do not state what 
their 'gold standard' for the diagnosis of congenital syphilis 
is. They do not appear to have used a set of criteria for this. 
Hence, for example, it is not clear whether they regarded the 4 
infants with hepatomegaly as having the disease or not. A 
similar lack of clarity exists with regard to the asymptomatic 
patients. There was 1 such patient in group 1 whose mother had 
untreated spyphilis. As this case was not followed-up the 
significance of the negative IgM tests could not be determined. 
Any of the asymptomatic patients in group 3 may or may not have 
been infected. 
What points can be made from the study? Al 1 3 IgM tests were 
able to detect symptomatic congenital syphilis. The tests had 
equal sensitivity in this regard. The VDRL IgM ELISA has 
potential advantages over the FTA-ABS (IgM) and flagellum ELISA 
in 1ts simplicity and the fact that the quantitative results of 
an ELISA are likely to be easier to assess than those of the 
rather subjective fluorescent antibody tests (Griffiths et al 
1982). On the other hand, it could be argued that the FTA-ABS 
(IgM) test has been in use for many years and its limitations 
are known ( Kaufman et al 1974). 
The study is of little value in determining the usefulness of 
the tests in asymptomatic but infected infants - the very group 
where sensitive tests are needed (Kaufman et al 1974). In 
addition, if the 4 infants in group 3 who had hepatomegaly are 
regarded as having congenital syphilis, the IgM tests would have 
been falsely negative in ' 3 out of the 4 cases. Perhaps the 
authors would have produced a simpler paper by considering only 
2 groups - those who definitely did not have congenital syphilis 
(by virt ue of being asymptomatic and having mothers with 
negative STS) and those who definitely had the disease (by 
I 
criteria other than the IgM tests under review). 
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Western blotting has been used by Dobson et al (1988a) to 
demonstrate the IgM response to treponemal antigens. The 
workers were able to show that the sera of all 6 infants with 
congenital syphilis demonstrated reactivity against 47 and 37 
kilodalton (kOa) antigens, whilst these findings were absent in 
13 control sera. 
S'anchez et al (1989) extended the observations to 12 
symptomatic infants with congenital syphilis, 9 asymptomatic 
infants with uncertain infection and 18 well infants of mothers 
previously treated for syphilis. Each of the symptomatic 
infants had IgM antibodies directed against the 47kDa antigen. 
In addition, 2 of the asymptomatic infants showed a similar 
pattern of reactivity. A lack of response to the same antigens 
was noted in 13 control sera. The remainder of the infants did 
not show a response to the 47k0a antigen. 
The findings of Dobson's and S'anchez's groups are important but 
these new approaches have not yet been shown to be of value in 
asymptomatic infants with delayed onset congenital syphilis. It 
is not known if the 2 asymptomatic infants with IgM reactivity 
to the 47kDa antigen described by S1 anchez et al (1989) were 
actually infected as they were treated with penicillin. 
Furthermore. the final outcome of the other 7 infants in the 
group with uncertain disease is not stated. 
It fo 11 ows that much work st i 11 needs to be done in order to 
evaluate the Western blotting technique fully. 
2.3.7 Cerebrospinal fluid (CSF) exaaination 
Platou (1949) described CSF 'abnormalities' in 63,6% of 172 
cases of early congenital syphilis. Most authorities agree that 
elevations in white cell count, raised protein concentrations, 
the presence of spirochaetes and a positive VDRL may be found in 
congenital neurosyphilis (Rathbun 1983a). However. the values 
regarded by Platou as abnormal (5 or more cells per mm 3 and 
protein above 45 mg %) would now be considered normal in 
newborns (Naidoo 1968, Sarff et a 1 1976). Another potential 
problem is passive transfer of antibody of maternal origin from 
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blood to CSF in infants. Thorley et al (1975) demonstrated that 
this occurs with diphtheria and tetanus antibodies. The extent 
to which this affects VDRL results in the CSF in congenital 
syphilis is un known. 
Srinivasan et al (1983) evaluated the role of CSF examinations 
in the diagnosis of congenital syphilis. All 61 infants who 
were asymptomatic at birth (but at high-risk of developing 
congenital syphilis) had normal CSF tests. They were treated 
with benzathine penicillin (which is unli kely to produce 
adequate CSF levels - McCracken and Kaplan 1974) and the 25 who 
returned for follow-up were clinically normal. Of eight infants 
with clinical disease or raised IgM levels, two had abnormal CSF 
tests. All nine infants presenting with congenital syphilis in 
the postneonatal period had normal CSF findings. The authors 
noted that neurosyphilis appeared to be uncommon and that 
asymptomatic infants were unlikely to have CNS involvement as 
detected by lumbar puncture. 
Recently, Mascola et al (1985) noted that 18 (53%) of 34 infants 
with congenital syphilis had a positive VDRL test of the CSF. 
Similarly, Hira et al (1985) found that 44% of newborns with the 
disease had an abnormal CSF. A publication from the Centers for 
Disease Control (CDC 1986) suggests a different picture. Of 460 
patients with suspected congenital syphilis under 1 year of age, 
241 (53%) were regarded as definite o,r probable cases. 
Altogether, 34 infants had clinically significant CNS 
involvement, but only 5 had CSF serological evidence of 
neurosyphilis. Unfortunately, the total number of infants who 
had CSF examinations is not stated. 
A recent publication from the Centers for Disease Control (CDC 
1988c) on congenital syphilis, states that the role of CSF 
examination in the diagnosis is debatable. As the most recent 
treatment protocols from the Centers . for Disease Control (CDC 
1988c) advise treatment of all infants with a regimen effective 
for neurosyphilis, no change in antibiotic policy could be 
expected from performing a lumbar puncture. It is uncertain 
whether there would be a change in the prognosis. 
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It is also noteworthy that the performance of a spinal tap may 
have a high failure rate (e.g. the procedure was unsuccessful in 
64/142 of 45% of the cases described by Hira et al 1985). 
2.3.8 Other investigations 
Other laboratory investigations may suggest 
proposed diagnosis of congenital syphilis. 
been reviewed by Ingall and Musher (1983 pg 
or lend support 
These findings 
347-348). 
to a 
have 
The ful 1 blood count may demonstrate anaemia with or without 
features of haemolysis, leucocytosis, leucopaenia or 
thrombocytopenia. 
The blood chemistry may ind1cate hyperbilirubinaemia (either 
conjugated or unconjugated), hypoalbuminaemia and/or raised 
liver enzymes (e.g. alanine aminotransferase). 
Urinary abnormalities including proteinuria may be present. 
The wide range of abnormal laboratory findings described serves 
to stress the protean manifestations of the disease. In 
general, however, the tests are of an ancillary nature and none 
are so consistently associated with congenital syphilis as to be 
of value as screening tests. 
2.4 DIAGNOSTIC CRITERIA FOR CONGENITAL SYPHILIS 
2.4.1 
The problem of a lack of a 'gold standard' test in the diagnosis 
of congenital syphilis has already been outlined. 
It will be recalled from Section 2.3.5 that for practical 
purposes a diagnosis of congenital syphilis can be excluded if 
the VDR L titre has declined to zero and there are no clinical 
signs by 3- 4 months. 
Several groups have described sets of criteria by which the 
diagnosis can be 'ruled in'. 
Criteria of Kaufman et al 1977 
Kaufman and co-workers ( 1977) developed a set of criteria for 
the dia gnosis of neonatal and early congenital syphilis. The 
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criteria are shown in Table 2.1 and include clinical, 
serological and epidemio)ogical data. While useful for 
assigning disease status, some points require clarification and 
there are difficulties with the 'probable' cases. 
i. 
ii. 
From the list of criteria it appears that the diagnosis of 
probable congenital syphilis can be made on the basis of 
one major and one minor clinical feature. This 
interpretation of the criteria is correct if the STS are 
positive. The diagnosis is stated as being unlikely in the 
absence of positive STS, and in their 'Discussion', the 
authors note that 'upon initial examination the ideal test 
should be at least a quantitative VDRL test'. If the 
proviso of initial serological testing is ignored the 
criteria \'lould be non-specific as findings such as 
radiographic changes in the long bones and 
hepatosplenomegaly have been noted in symptomatic infants 
with congenital CMV (Mahboubi 1981; Stagno et al 1984 pg 
109) • 
The VDRL usually reverts to nonreactive 
infants by 4 months (serologic criterion 
in uninfected 
D). Several 
authors have noted that 6 months may be the outside limit 
( Brown and More 1963; Taber and Huber 1975; Srinivasan et 
~ 1983; CDC 1988c). 
iii. The use of a reactive FTA-ABS (IgM) test along with 2 minor 
criteria needs clarification. Reimer et al (1975 ) 
suggested that a positive test may be obtained in the 
presence of RF. Infants with intrauterine infections other 
than congenital syphilis (e.g. toxoplasmosis, 
cytomegalovirus) may produce RF and have 2 of the minor 
clinical criteria (e.g. hepatosplenomegaly and central 
nerv ou s system signs ) . Thus, one needs to specify that 
interference from RF is removed prior to the FTA-ABS( IgM) 
test. 
iv. The presence of a reactive FTA-ABS (IgG) test and one major 
clini ca l criterion may also be relatively nonspecific in 
certain populations. For example, in many parts of South 
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Africa approximately 6-8% of antenatal clinic attenders 
have positive serology for syphilis U~aicker et al 1983; 
Gonin 1985) The FTA-ABS (IgG) may be positive in the 
infant because of passive transfer of IgG antibodies 
(Curtis and Philpot 1964). In a population where syphilis 
is prevalent it is conceivable that periostitis, itself a 
nonspecific feature (Shopfner 1966), may be present in 
infants of adequately treated mothers. 
2.4.2 Criteria of Rathbun (Rathbun 1983b) 
Rathbun published a modified set of criteria in 1983 (Table 
2.2). To the clinical criteria of Kaufman et al (1977) were 
added a positive reag in test of the cerebrospi na l fluid and 
bullous lesions or a palmar/plantar rash. Pneumonitis, 
oedema/ascites, placental abnormalities and intrauterine growth 
retardation were added to the minor clinical criteria. These 
findings are nonspecific (Benirischke and Discoll 1967 pg 269-
270; Malan 1987 pg 627) and the value of intrauterine growth 
retardation is particularly doubtful for several reasons. 
Firstly, in some communities it is extremely common and without 
obvious cause (e.g. nearly 6% amongst Cape Coloureds in Cape 
Town - Malan et al 1967). Secondly, Naeye (1971) has shown that 
congenital syphilis has little effect on fetal growth. 
The serological criteria have been modified to include the 
development of a positive treponemal antibody test after birth. 
This would presumably include the FTA-ABS (IgM) test and would 
be subject to the same limitations as previously discussed. The 
presence of a positive treponemal antibody test after 1 year of 
age has also been included. The limitations of this are that 
the treponemal tests may remain positive for up to 15 months in 
uninfected cases (Taber and Feigin 1979; Rathbun 1983a). 
The epide!lliologic criteria have also been expanded to include 
untreated early syphilis in the mother within 4 weeks of 
delivery. Unfortunately, the duration of maternal infec.tion is 
often unknown (Ingraham 1936). This is a serious disadvantage 
as it means that one of the major criteri~ will rarely be met. 
2.4.3 
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Under the heading 'minor epidemiologic criteria', Rathbun has 
included 'Mother an untreated contact to lesion syphilis during 
pregnancy•. Presumably this is added to cover the lag period 
of 4-8 weeks after infection during which the mother's serology 
may be negative (Felman and Nikitas 1980). 
Criteria of Hira et al (1985) 
These authors have also published guidelines for the diagnosis 
of congenital syphilis (see Appendix 1, Table A.1.1). 
In general, the format is similar to that of Kaufman et al 
1977), although there are some changes. The radiological 
features have been moved to the section of minor clinical 
criteria. This seems reasonable in view of the large numbner of 
false positives (35%) obtained in normal infants (Shopfner 1966) 
In addition, the 'haemolytic anaemia' listed by Kaufman et al as 
a minor clinical criterion has been replaced with jaundice and 
anaemia (listed as 2 separate criteria). Again, this has some 
merit as the anaemia of congenital syphilis is not always 
haemolytic (Sartain 1965). 
On the other hand, jaundice is common amongst newborns without 
congenital syphilis and, as suggested by Ingall and Musher (1983 
pg 347) it is when the jaundice persists or appears after the 
first week that the diagnosis should be considered. 
One of the major criticisms of the criteria of (Hira et al 1985) 
is that the probable and possfble cases are identical with 
respect to the clinical signs. This makes it pointless to call 
the radiologic changes 1 minor 1 rather than •major•. The authors 
have suggested that in Zambia the minor clinical criteria are 
much commoner in syphilitic infants than noninfected controls 
and hence have been given the same weight as the major clincal 
criteria. This finding cannot necessarily be extrapolated to 
other communities where congenital syphilis is less prevalent. 
It wou 1 d seem that the c ri teri a have no rea 1 advantage over 
those of Kaufman et al although they could serve to alert 
workers in Zambia to the possibility of congenital syphilis. 
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2.4.4 Criteria of Mascola et al (1985) 
Mascola et al (1985) published a very similar set of criteria to 
those of Kaufman et al (see Appendix A.I, Table A.1.2). The 
only change was in the category of 'possible' congenital 
syphilis where serological criterion A or B with only one minor 
criterion was added. Although Kaufman did not explicitly state 
this, fo~ practical purposes the criteria are the same in these 
2 papers. 
2.4.5 Criteria outlined by the Centers for Disease Control 
More recent 1 y, the Centers for Disease Contro 1 ( CDC 1988c) have 
suggested a different set of diagnostic classifications for 
congenital syphilis (Table 2.3). 
Cases formerly known as 'probable' or 'possible' are now 
regarded as 'compatible'. This may be useful in deciding who 
needs treatment. Clinically and prognostically, however, it 
does not distinguish for example an infant who has gross signs 
of disease from one who is completely well but whose mother had 
only 2 doses of benzathine penicillin. 
Stillborn infants with a reactive STS are also placed in the 
'compatible' category. This may be useful for surveillance but 
from a clinical point of view may give one a false sense of 
security about the diagnosis. Some authors have regarded 
infection as 'proven' only when spirochaetes have been 
demonstrated in the infant or placenta (Dippel 1944; Naeye 
1977). Once again, where maternal syphilis is prevalent, an 
adequately treated mother could have a stillborn infant with a 
positive STS who died from an unrelated cause. 
It is apparent that none of the proposed criteria are perfect. 
The more recently suggested guidelines do not appear to have any 
significant advantages over those of Kaufman et al (1977). 
Those of Rathbun (1983) may be too broad for a developing 
country where intrauterine growth retardation and incomplete 
maternal therapy are common. The resultant groups of patients 
obtained with the criteria of Kaufman and co-workers (i.e. 
definite, probable, possible .• unlikely) appear to be more clear-
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cut than those obtained with the Centers for Disease Control 
criteria (confirmed, compatible, unlikely). 
The Centers for Disease Control criteria also have implications 
for treatment which need to be considered in a developing 
country such as South Africa. As previously mentioned, 5-8% of 
antenatal clinic attenders have. positive serology for syphilis. 
According to Manning et al (1985) 90% of pregnant women with 
syphilis at King Edward VIII Hospital in Durban did not receive 
the therapy as prescribed. These women would be regarded as not 
having received adequate treatment. The Centers for Disease 
Control would recommend treating all the infants of these 
mothers with a 10 day course of parenteral penicillin. In the 
light of the load on the health care system, this would probably 
not be feasible. 
Rather than treat all cases various authors (.e.g. Stokes et al 
1945 pg 1097-1099; Kaufman et al 1977; Ingal 1 and Musher 1983 pg 
366) have suggested a period of follow-up and surveillance 
(usually lasting 3-4 months). Again, this poses a problem when 
one considers the numbers involved. 
For the purposes of this study consistent criteria for the 
diagnosis of congenita 1 syphilis were considered to be 
essential. The guidelines of Kaufman et al (1977) were followed 
with the exception that 6 months was taken as the 1 imit for 
nontreponemal tests to revert to negative. 
2.5 SUMMARY 
The history of the pregnancy and the results of the STS for 
syphilis performed on the mother and/or baby may indicate that 
the infant is at risk for, congenital syphilis. 
In this situation, the demonstration of T.pallidum is the method 
of choice for definitive diagnosis of congenital syphilis, but 
is not often possible. 
Clinical and radiological changes and a positive FTA-ABS (IgM) 
test are helpful if present but their absence does not exclude 
the dia gnosis. In practice, monitoring serial VDRL titres 
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combined with clinical surveillance is often the most certain 
method of diagnosis. Idea~ly, one would like a test (or tests ) 
which could be done prior to the infant•s discharge and 
following which definite decisions as to whether the infant is 
infected or not could be made. Work from A 1 ford et al ( 1969a) 
suggests that nontreponemal IgM may be produced before disease-
specific IgM and Reimer et al (1975) have noted production of 
relatively large amounts of RF and small amounts of specific 
IgM. Thus, testing for RF to identify infected infants appears 
to be worth further evaluation. Likewise, the use of elevated 
IgM levels as a test for congenital syphilis has not been 
extensively studied and no large prospective study has been 
reported. 
Furthermore, the clinical findings in infants with congenital 
infection may be similar to those produced by other conditions. 
Would testing for RF help clarify which infants have congenital 
syphilis and those who do not? 
Finally, the specificity of the FTA-ABS (IgM) has been in doubt 
following the work of Reimer et al (1975). Methods now exist 
for the rapid removal of RF. What effect would this have on the 
usefulness of FTA-ABS (IgM) test? 
These questions merit further investigation. 
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TABLE 2.3 
DIAGNOSTIC CLASSIFICATIONS OF CONGENITAL SYPHILIS - CENTERS FOR DISEASE CONTROL (CDC 1988c) 
Confirmed case 
Identification of T.pallidum by dark field microscopy, fluorescent 
antibody, or other specific stains in specimens from lesions, 
autopsy material, placenta, or umbilical cord. 
Compatible (formerly, "probable" or "possible•) case 
a reactive STS in a stillborn infant 
OR 
a reactive STS in an infant whose mother had syphilis during pregnancy and was not adequately treated, regardless of symptoms in 
the infant 
OR 
a reactive Venereal Disease Research Laboratory (VDRL) test of 
cerebrospinal fluid 
OR 
a reactive STS in an infant with any of the following signs: 
snuffles, condyloma lata, osteitis, periostitis or osteochondritis, 
ascites, skin and mucous membrane lesions, hepatitis, hepatomegaly, 
splenomegaly, nephrosis, nephritis, or hemolytic anemia 
OR 
fourfold or greater rise in titres of nontreponemal tests (VDRL or 
rapid plasma reagi n ( RPR)) and a confirmed fluorescent treponema l 
antibody absorption (FTA-ABS) or microhemagglutination assay for 
antibody to T.pallidum· (MHA-TP) over a 3-month period 
OR 
a reactive treponemal test or nontreponemal test that does not 
revert to nonreactive in 6 months 
Unlikely case 
nonreactive STS 
OR 
treponemal tests revert to nonreactive within 6 months 
OR 
no symptoms in live-born infant whose mother, treated for syphilis during pregnancy, had a fourfold or greater fall in titer and the infant's STS is also fourfold or lower than the maternal titer was 
at the time of treatment 
57 
CHAPTER 3 
RHEUMATOID FACTOR AND THE It91UNE RESPONSE 
3.1 INTRODUCTION 
As described in Chapter 2, preliminary studies indicate that a 
significant percentage of infants with congenital syphilis have 
RF in their sera (Reimer et al 1975; Meyer and Malan 1987). This 
raises the question of what part RF plays in the immune response 
in congenital syphilis. 
It is apparent that the host's inflammatory reaction is 
important in the development of the lesions of congenital 
syphilis (Benirschke 1974). Furthermore, congenital syphilis is 
the most severe form of syphilis (Handsfield and Lukehart 1984), 
with a high case fatality rate (see Section 1.2). It is of 
interest to note that the finding of RF in acquired syphilis is 
less common than in the congenital disease (Bartfeld 1969; 
Reimer et al 1975; MUller et al 1987; Meyer and Malan 1987). 
This difference may simply reflect the fact that there are more 
RF-producing cells in early life (Hardy et al 1987), and be 
unrelated to the severity of the disease. Higher concentrations 
of RF have, however, been associated with a more serious outcome 
in patients with e.g. rheumatoid arthritis (RA) (Gordon et al 
1973). 
To date, the role, if any, of RF in the pathogenesis of 
congenital syphilis has not been explored. There is, however, a 
large amount of literature describing the effects of RF in 
adults and experimental animals. 
A summary of this literature is presented as a background 
against which further research on RF in congenital syphilis was 
undertaken. 
3.2 HISTORY OF THE DISCOVERY OF RHEUMATOID FACTOR 
Rheumatoid factors are antibodies reactive against a portion of 
immunoglobul in G and are so named because of their frequent 
association with RA (Davis 1979 pg 77; Carson 1982 pg 114). 
58 
Meyer in 1922 described the agglutination of red blood cells 
which had been 'sensitized' (or coated) with antibody. Serum 
from 8-10 patients (one of whom had cirrhosis and another with 
chronic bronchitis) resulted in erythrocyte agglutination. In 
retrospect this phenomenon was almost certainly due to RF. 
Cecil et al (1930) found that serum from patients with RA 
agglutinated certain streptococci. This reaction was thought to 
lend support to the idea that streptococci were important in the 
pathogenesis of RA, although Wallis (1946a) doubted this. He 
showed that agglutination was not 1 imited to streptocci but 
could also be obtained with pneumococci (Wallis 1946b). Lamont-
Havers ( 1955) correctly surmised that a component of norma 1 
serum (later found to be IgG) attached to the bacteria and the 
agglutination was completed by a 'specific rheumatoid arthritis 
factor' from the serum of patients with RA. 
Waa 1 er a 1 so performed some of the early work on RF. He 
presented his work on the 'agglutinating activating (AA)' factor 
at a congress in 1939 and published his work in 1940. He found 
that sensitized sheep red blood cells were agglutinated with 
serum from a patient with RA. ( Interestingly, the patient was 
initially thought to have syphilis). 
Similar observations were made by Rose, Ragan, Pearce and Lipman 
(1948). Pearce who had RA was working on rickettsial disease. 
She contracted rickettsial pox and her serum was found to 
agglutinate sensitized sheep red cells. Rose suggested that the 
agglutination might be due to the RA. He found that the same 
reaction occurred in other patients with RA and the work was 
published without reference to Waaler's findings. Ragan (1961) 
later noted that Lipman had heard Waaler's earlier report at a 
microbiology congress. Hence, the sensitized sheep cell 
agglutination test has been known as the Waaler-Rose test and, 
in 1949, Pike et al called the factor responsible for the 
agglutination reaction 'rheumatoid factor'. 
Modifications of the original Waaler-Rose test for RF were 
proposed by Heller et al (1949). 
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Heller et al later reported (1954) that the Waaler-Rose test was 
inhibited by prior treatment of the serum with Cohn Fraction I I , 
.suggesting that the RF was bound by gammaglobulin. Li kewise, 
Cohn Fraction II together with tannic acid was successfully used 
to sensitize sheep red cells in place of the rabbit antibodies. 
This was called the FI! tanned sheep cell agglutination test. 
Singer and Plotz (1956) then successfully utilized the latex 
test system to demonstrate RF. Cohn Fraction II was used to 
coat latex particles which acted as an indicator instead of red 
cells. Modifications of the original method were proposed by 
Rheins et al (1957) and the test is still widely used today. 
Epstein et al (1956) showed that an indicator system was not 
always necessary - the serum of patients with RA could react 
directly with Cohn Fraction II to form a precipitate. 
A review of the literature indicates that while a large number 
of tests have become available to detect RF, the interpretation 
of test results has lagged far behind (Williams 1983). 
Nevertheless, work was carried out on the immunological 
reactions involved in the various tests and in the structure of 
RF itself. 
Franklin et al (1957) showed that RF was a gammaglobulin of the 
19S type. These workers also showed that RF in the serum was 
present in a complex which could be separated intp 19S and 7S 
components by ultracentrifugation. 
Mellors et al (1959) then found that the presence of RF was not 
limited to the serum. These authors used aggregated 
gammaglobulin labelled with fluorescein as a marker for RF. 
They demonstrated that plasma cells in the synovium of patients 
with RA were actively producing RF. This suggested that RF was 
not merely an immunological curiosity but was in some way linked 
to the joint pathology. Active research into the structure, 
biological activity and measurement of RF has continued with the 
publication of some 3000 articles on the subject since the 
publication of Rose and co-workers in 1948 (Fraser 1988). 
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3.3 CONDITIONS ASSOCIATED WITH THE PRESENCE OF RHEUMATOID FACTOR 
The presence of RF was thought to be specific for RA with some 
'uncommon exceptions' (Ziff 1957). Singer (1961) questioned 
\'ihether RF was part of the immunological reaction present in RA 
and allied conditions or whether it was part of a more 
nonspecific 'host reaction'. The latter possibility seems more 
likely in view of the fact that RF has been found in a large 
number of unrelated conditions, some of which are shown in Table 
3 .1. 
Rheumatoid factor has also been found in normal individuals and 
is more common with increasing age (Mikkelson~ 1967; Hooper 
~ 1972, Landau and Plavnic 1982 pg 179-182). 
It has, therefore, been necessary to define a level of RF to 
distinguish 'seronegative' from 'seropositive' patients. 
TABLE 3.1 
DISORDERS ASSOCIATED WITH THE PRESENCE OF RHEUMATOID FACTOR 
Connective tissue diseases: rheumatoid arthritis, systemic 
lupus erythematosis, sclerodema, Sjogren's syndrome 
Infectious diseases: 
Viral infectious mononucleosis, influenza, infectious 
hepatitis 
Bacteria 1 syphilis, tuberculosis, leprosy, brucellosis, 
subacute bacterial endocarditis 
Parasitic - malaria, kala-azar, trichinosis, toxoplasmosis 
Neoplastic conditions: Leukaemia, myeloma, various malignancies 
Other Conditions: Cirrhosis, asthma, sarcoidosis, myocardial 
infarction, psychiatric disturbances, rheumatic fever 
(Data from de Forest et al 1956; Epstein et al 1957; 
Rothermich and Philips 1957; Ziff 1957; Dresner and Trombly 
1959; Peltier and Christian 1959; Bartfeld 1969; Hooper et al 
1972; Reimer et al 1975; Carson 1982 pg 116-117) 
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3.4 STRUCTURE AND SPECIFICITIES OF RHEUMATOID FACTORS 
In as much as the conditions associated with RF have proved t o 
be diverse, so RFs of different structure and specificities have 
been described. 
Rheumatoid factor activity has been demonstrated among 
immunoglobulin classes M, G, A and E (Carson 1982 pg 116). 
IgM RF 
IgM RF has a pentameric structure similar to other 19S 
antibodies. However, monomeric IgM RF has also been described 
(Theofilopoulos et al 1974). 
The valency of IgM RF is 5, although it would be expected to be 
10 as each IgM subunit has a valency of 2. It may be that 
steric hindrances prevent further IgG molecules from binding. 
In order to characterize RF make-up further, the idiotypes (or 
antigenic determinants of the antibodies) have been extensively 
studied. Chen et al (1988) have recently reviewed this subject. 
They noted the heterogeneity of RFs in terms of idiotypic 
structure and suggested that several V (variable region) genes 
were involved in RF production. 
IgG RF 
The structure of IgG RF is similar to that of other IgG 
molecules although in the serum and synovial fluid IgG RF tends 
to exist in . a complexed form. This is because IgG RF has a 
valency of 2 and has an antibody specificity to antigens in the 
Fe region of IgG. Thus, dimers or larger polymers of IgG RF may 
be formed (Pope et al 1974). 
IgA RF 
This usually exists in the form of dimers and has been found in 
sera from patients with RA, Sjogrens syndrome and systemic 
lupus erythematosis (Dunne et al 1979) 
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Specificity of rheumatoid factor 
Polyclonal RFs have been shown t o have spec i f i city fo r ant i genic 
det erminants ( epi t opes ) on the Fe re gion of Ig G ( Fu denbe rg and 
Kun kel 1961; Fran kl in and Fuden berg 1965) . The epitopes have 
been locali zed to the second and third domains (CH 2 and CH 3) of the constant region of IgG. Interestingly, this is the same 
section of IgG to which staphylococcal protein A binds (Manni k 
and Nardella 1985). 
The most important of the antigenic determinants is possibly the 
Ga antigen found in IgG subclasses, 1, 2 and 4 (Allen and Kun kel 
1966; Hol borow and Swannell 1983 pg 247). Rheumatoid factors 
react poorly with IgG subclass 3 (Natvig et al 1972). Some RFs 
show specificity toward the genetic marker Gm, found in the Fe 
fragment of IgG (Gaarder and Natvig 1970). Binding can be more 
pronounced toward human IgG (autologous or isologous) or may be · 
heterologous against animal IgG (Carson 1981 pg 684). 
Binding of RFs to IgG in immune complexes has been shown to be 
greater than binding to native IgG (Coulie and Van Snick 1985). 
Rheumatoid factors may al so react with various non-
immunoglobulin antigens e.g. deoxyribonucleic acid (DNA) and 
nucleosomes (Williams 1979). 
The association constants (or affinities) of RFs for their 
antigens are low in comparison to other antigen-antibody 
reactions (Williams 1979; Carson 1982 pg 123). The RF-IgG 
complexes are thus easily dissociated (Allen and Kunkel 1966). 
3.5 INDUCTION OF RHEUMATOID FACTOR SYNTHESIS 
It has already been m~ntioned that widely different diseases 
give rise to RF. It is not surprising, therefore, to find that 
there are several known stimuli for RF production. 
These stimuli have been reviewed by Egeland and Munthe (1983), 
Carson (1985 pg 669-672) and Chen et al (1988). 
3.5.1 
3.5.2 
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Polyclonal B cell activators 
Rheumatoid 
lymphocytes. 
fact or s are i mmu nogl obul ins produced by B-
It follows that non-specific activation of 
different B-cell clones can result in RF formation. Kno1tm 
polyclonal stimuli such as hyperimmunization, tetanus to xoid, 
components of bacterial cell walls (e . g. lipopolysaccharide ) , 
pokeweed mitogen and Ebstein Barr virus have been studied for 
their RF-inducing capabilities. Work done in vitro and in vivo 
with laboratory animals and in vitro using human peripheral 
mononuclear cells from normal individuals, has shown that all 
these stimuli can result in RF production (Bokisch et al 1972; 
Slaughter et al 1978; Koopman and Schrohenloher 1980; Olsen et 
~ 1982; Dziarski 1982; ~·Jelch et al 1983; Nemazee and Sato 1983; 
Coulie and Van Snick 1983) . Coulie and Van Snick (1983) found 
that immunization with a variety of protein antigens could lead 
to RF synthesis in mice. In vitro RF production by spleen cells 
was not seen if the animal had only received a pr1mary injection 
before sacrifice. The RF response was only observed as part of 
the secondary response in immune animals. The in vitro presence 
of RF was found to be short-lived; RF production was first 
demonstrated on day 2, it peaked on day 3 and ended on day 4. 
Interestingly, serum RF levels were not increased in the mice, 
possibly because of RF consumption by the immune complexes. 
Nemaz ee and Sato (1983) noted that the RF response in mice ended 
when the foreign antigen had been cleared. Most of the RF 
produced was IgM and there was little immunoglobulin class 
switching. As pointed out by the authors, this pattern is 
similar to that found when 8-cells produce immunoglobulin 
independently of T-cells. 
I11111une complexes 
Immune complexes have been found in a wide range of diseases. 
In some circumstances, these complexes lead to induction of RF 
production. Evidence for this has been obtained in animal 
models. Thus, Abruzzo and Christian (1961) found that rabbits 
repeatedly immunized intravenously with killed bacteria 
(Escherichia coli and Bacillus subtilis) produced RF-li ke 
substances. The authors were of the opinion that the prolonged 
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immunization resulted in immune complex formation which in turn 
stimulated RF production. There was little direct evidence for 
this postulate, however, as immune complexes were not measured. 
Williams and Kunkel (1963) described a similar response in 
rabbits immunized with horse spleen f~rritin. Higher levels of 
RF could be obtained by injecting complexes containing ferritin 
and antibody to ferritin. The RF antibodies were shown to have 
definite specificity for individual rabbit gammaglobulins. This 
may indicate that the antibody response was not polyclonal. It 
was also noted that immunization with autologous gammaglobulin 
that had been enzymatically split with papain, resulted in 
greater RF synthesis than using unsplit gammaglobulin. The 
authors used this evidence to suggest that altered gammaglobulin 
in immune complexes may act as an antigen for the formation of 
RF. This postulate is still held today (e.g. Nemazee and Sato 
1982) • 
Nemazee and Sato (1983), working with mice, were also able to 
show that RF was produced in response to immunization. They 
found it was necessary to give more than one injection of the 
antigen. The antigen used .,.,as keyhole limpet haemocyanin and 
the absence of RF induction following direct antigen exposure 
was thought to be unlike that seen with polyclonal 8-cell 
activators. It was hypothesized that the RF response depended 
on the prior formation of immune complexes. 
definite suJ:)port for this. Nemazee 
Again there was no 
publi5hed further 
observations in 1985. Injecting mice with antigen 
intraperitoneally and preformed antibody intravenously resulted 
in a brisk RF response (as determined using a plaque-forming 
assay for RF with spleen cells). Antigen or antibody alone did 
not produce this effect. The RF formed had the same IgG 
subclass specificity as that contained in the immune complex 
giving rise to it. Thus, complexes containing IgG1 led to anti-
IgG1 production. Likewise, complexes with IgG2a antigen 
resulted in the RF being anti-IgG2a specific. These findings 
extended those of Williams and Kunkel (1963) and strongly 
suggested that immune complexes acted on their own and not as 
polyclonal B-stimulators to cause RF manufacture. If the latter 
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were the stimulus for RF synthesis one would not expect subclass 
specificity to be present. 
Coulie and Van Snick (1985) reached similar conclusions to those 
of Nemazee ( 1985). Preformed immune com pl exes were given to 
irradiated mice. The mice received syngeneic spleen cells from 
donor mice that had been primed with exposure to the antigen 
present in the immune complexes. A considerable RF response 
ensued. Neither antigen nor antibody alone caused this 
reaction. The specificity of the RF produced could be 
demonstrated. The authors were also able to show that the 
antigen-antibody ratio in the immune complex was important in 
determining the effectiveness of the stimulus. Complexes formed 
in the presence of large antigen excess were shown to be poor RF 
inducers. Although no reason for this was suggested, it was 
shown that RF was only produced if there were Fe antibody 
fragments in the complexes. Perhaps the complexes formed in 
marked antigen excess had fewer Fe regions exposed. 
The experiments performed by Coul ie and Van Snick (1985) and 
Nemazee (1985) were also useful in elucidating the lymphocyte 
interactions involved in RF formation in mice. Coulie and Van 
Snick showed that if T-cells were removed from the donor spleen 
cells given to irradiated mice there was no RF response. 
Nemazee, using genetically athymic mice, also showed a lack of 
RF production in the absence of thymus-derived lymphocytes. 
Further evidence indicating the need for T-cells came from 
Nemazee's work (1985) using CBA/N mice with the xid genetic 
defect. These mice, which respond poorly to T-independent 
antigens, were able to make RF following immune complex 
administration. This suggested that immune complexes stimulated 
RF-producing cells in the absence of T-cell help. 
It was apparent that not all stimuli leading to RF formation 
were T-cell-dependent as athymic mice given lipopolysaccharide, 
a polyclonal B-cell stimulator, made RF. Nemazee (1985), 
therefore noted that there were at least two independent 
mechanisms for RF synthesis in mice, one involving immune 
complexes, the other polyclonal B-cell stimuli. 
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The relevance of these findings to human disease is uncertain. 
In vitro experiments, however, using mononuclear cells from 
human peripheral blood have demonstrated RF production. Pisko 
et al (1982) used heat-aggregated IgG (HaigG) to simulate immune 
complexes. Normal human peripheral mononuclear cells were able 
to make RF after exposure to high levels of HaigG. The response 
was a polyclonal B-cell one, however, as non-RF IgM was also 
produced. A much more specific RF response was obtained using 
amounts of HaigG 1-10 000 times lower (Tao et al 1984). In this 
system, mononuclear cells from patients with RA produced RF 
without an associated rise in other types of IgM •. The stimulus 
was not effective in lymphocytes from normal individuals. These 
experiments indicated that lymphocytes from normal individuals 
could make RF in response to simulated immune complexes and that 
lymphocytes from RA patients had been specifically primed to 
produce RF. 
Evidence that immune complexes may give rise to RF antibodies in 
vivo comes from work in patients with subacute bacterial 
endocarditis. Thus, Carson et al (1978) found that on average, 
the levels of immune complexes peaked 9 days before the zenith 
of RF levels. 
3.5.3 Antibodies mimicking the Fe portion of lgG 
Molecular mimicry may be an important mechanism in the 
generation of certain diseases. The antigenic determinants (or 
epitopes) of a foreign _ substance may also be present in host 
tissue. The immune response directed towards the foreign 
antigen then reacts with the same epitopes in the host. In this 
way an autoimmune response to self-antigens may be invoked 
(reviewed by Zwillich and Lipsky 1987). 
Interestingly, various bacterial and viral antigens bind 
specifically with human IgG. 
These antigens include staphylococcal protein A, streptococcal 
Fe receptor and viral capsid (Reis et al 1984; Mardella et al 
1985; Inman et al 1987). Mouritsen (1986) has suggested that 
antibody to these antigens may mimic the Fe portion of IgG. 
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Anti-idiotypic antibody could then bind to the initial antibody 
as well as to the Fe epi tope of IgG. 
antibody would in fact be RF. 
This anti-idiotypic 
3.5.4 Cross-reactivity between the Fe region of lgG and other 
antigens. 
Cross reactivity with IgG has been demonstrated for example with 
nuclear antigens (Darwin~ 1986), DNA-histone (Agnello~ 
1980) and cystoskeletal components (Rubin et al 1984). 
Rheumatoid factor is also able to cross react with these 
antigens, suggesting that they may trigger RF production. 
3.5.5 Altered control mechanisms 
Rheumatoid factor production has been shown to be subject to 
control by various means including suppressor T-cells and anti-
idiotypic antibodies (Koopman 1981; Koopman et al 1983; Fong et 
!!_ 1984; Abe et al 1984; Takeuchi et al 1985). It has been 
proposed that alterations in these components may be responsible 
for excessive RF synthesis, particularly in disease (Olsen and 
Jasin 1985). Recently prostaglandin E2 has also been shown to 
exert a controlling role on in vitro RF production (Alvarellos 
et al 1988). 
3.6 CELLULAR PRODUCTION OF RHEUMATOID FACTOR 
Although in vitro experiments have shown that circulating 
mononuclear cells can make RF, these cells are not the major 
source of RF in RA (Egeland and Munthe 1983). 
In patients with RA, cells in the synovial tissue, bone marrow, 
lymph nodes and spleen appear to be the main sites of RF 
production (Mellors et al 1959; Munthe and Natvig 1972; Vaughan 
et al 1976; Fehr et al 1981). The same localities may be active 
in other diseases associated with the presence of RF (Egeland 
and Munthe 1983), although there are few studies on this. 
Until recently 1 ittle has been written about the B-cel 1 subsets 
giving rise to RF although it has several important functions 
and is present in many di~ease states. Hardy et al (1987) 
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were able to show that B-cells which were CDS positive (Leu-1) 
were responsible for RF production. These cells comprised 20-
30% of B cells in adults and 75% of B-cells in cord blood. It 
has also been shown that there is an expansion of this B-cell 
population in patients with RA (Plater-Zyberk et al 1985). 
3.7 PHYSIOLOGICAL ROLE 
The wide range of stimuli giving rise to RF led several 
authorities to the conclusion that RF plays a role in the normal 
immune response. The possible physiological effects of RF are 
discussed below. 
3.7.1. Clearance of i11111une complexes 
Immune complex handling by the body appears to be a complex 
process. Nevertheless, a model has been proposed whereby some 
immune complexes attach to erythrocytes. This prevents tissue 
binding and damage (reviewed by Kimberly 1987). Clearance of 
immune complexes from the circulation normally occurs when the 
complexes are stripped from the erythrocytes by the mononuclear 
phagocyte system (reviewed by Mannik 1982). 
Van Snick et al (1978) performed comprehensive in vitro studies 
on the effect of RF en immune complex uptake by macrophages. 
The macrophages were derived from mouse peritoneal cavity, mouse 
lung and human mononuclear blood cells. The effect of purified 
IgM RF on removal of immune complexes was studied. The 
complexes were formed either with transferrin and anti-
transferrin antibodies or HaigG. To monitor the fate of the 
immune complexes, the antigens were radiolabel led with 125 1. 
Uptake of immune complexes was assessed by measuring the 
radioactivity associated with purified macrophages together with 
the radioactivity present in the supernatant culture fluids. 
The latter was thought to indicate processing of immune 
comple xes by the cells and release of degradation pro4ucts. 
It was found that: 
i. IgM RF resulted in il 20-fold increase in uptake or 
processing of the HaigG by macrophages. 
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ii. RF was responsible for a rise in the uptake of antigen-
antibody complexes by phagocytes. The ratio of antigen to 
antibody in the complexes influenced the RF effect. A 
maximal stimulation was obtained when the antigen 
concentration was 10 times greater than that of the 
antibody. 
iii. Complement appeared to produce a separate effect to that of 
RF and could even abolish the latter's opsonic potential. 
The complement effects are discussed elsewhere. 
The in vivo effect of RF was assessed by Van Snick and co-
workers by injecting radiolabelled antigen-antibody complexes 
into the peritoneal cavity of mice. It was found that addition 
of IgM RF to the complexes formed in 10 times anti gen excess, 
resulted in a 14-fold increase in the radioactivity of cells 
obtained by washing the peritoneal cavity. 
Van Snick et al (1978) found that different RFs varied in their 
effects on immune complex uptake. 
Hogben and Devey (1986) confirmed some of the in vivo findings 
of Van Snick et al (1978) using the mouse as an experimental 
animal. Rheumatoid factor was produced in the mice by 
intraperitoneal innoculation of bacterial lipopolysaccharide 
(LPS). Preformed immune complexes consisting of radiolabelled 
human serum albumin and antibodies to it were injected into the 
animals. Varying antigen-antibody ratios were used and immune 
complex clearance from the circulation measured. Findings were: 
i. Immune complexes formed in antibody excess (shown to be 
large complexes) were cleared more rapidly in mice with 
LPS-induced RF. 
ii. Immune complexes formed in antigen excess were cleared more 
slowly in mice with RF and in controls. Although complexes 
with 2 to 5 times antigen excess were removed more quickly 
in the presence of RF, complexes with 10 times antigen 
excess disappeared more slowly in the mice with RF than 
those without. 
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These last results differed fr om th ose of Van Sni ck e t al (1978) 
but the antigen-a nti bo dy comp le xes were different. Al so Van 
Snic k's group used heterol ogous RF and clea r ance of compl exes 
fr om the peritoneal cavity may not be t he same as t hat f rom t he 
circulation. Hogben and Devey ( 1986) also point out that LPS 
can affect phagocytic function apart fr om its acti on on RF. 
Nevertheless, the in vivo findings of the latter authors ap pea r 
to correlate with some of the in vitro effects observed by Va n 
Snic k et al (1978). Thus, larger complexes formed in slight 
anti gen excess were removed more quic kly in the presence of RF 
in both studies. The differential effect seen in vi v.Q on 
clearance of small complexes formed in antigen excess may be 
explained by complement interactions. Presumably less 
complement vmuld hav:e been available in the peritoneal cavity 
than in the serum. 
fully elsewhere. 
This complement effect is discussed more 
Further work on the effect of RF on immune complex clearance was 
carried out in rabbits. Adding IgM RF to immune comple xes 
formed from antibody and double stranded DNA increased the 
clearance rate in rabbits (Taylor et al 1986). This effect may 
have been partly due to the action of RF in improving binding of 
immune complexes to rabbit platelets. This complement-dependent 
process is similar to the one which occurs in man when immune 
complexes bind to erythrocyte receptors (Cornacoff e~ 1983). 
The latter reaction is also enhanced by IgM RF (Taylor et al 
1986). In man, the immune complexes are then removed by 
phagocytes, mainly in the liver (Mannik 1982). This stripping 
could be aided by RF which can increase the uptake of immune 
complexes by macrophages in vitro (Van Snick et al 1978). 
3.7.2 Resistance to infection 
Another reason for finding RF in diverse situations may be that 
it aids the host defence mechanism in its response to foreign 
antigens. For example, RF may stabilize weak antigen-antibody 
interactions and this would enable it to serve as a first line 
defence system until sufficient antigen-specific antibody is 
produced (vlelch et al 1983). 
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This 'amplifying' or 'enhancing' effect of RF has als o be en 
described by other authors Olemazee and Sato 1982 ; Nemazee and 
Sato 1983; Coulie and Van Snick 1983). Nemazee and Sato (1982) 
suggest that enhancing antibodies (like RF) may improve 
complement fixation by immune complexes and thus trigger 
cytolysis of cellular antigens. It is also conceivable that 
anti gen recognition may be improved by greater 
antigen to the surface immunoglobulin of B-cells. 
binding of 
Specific examples of the RF effect on infections have been 
described. Notkins (1971) showed that RF attached to infectious 
virus-antibody complexes was not able to neutralize the virus 
but made the complexes more susceptible to neutralisation by 
complement. 
Almeida and Griffith (1980) found that when there was little 
sp~cific antibody to a virus, RF could cause lightly coated 
virus particles to be linked together. This may aid their 
removal. Similarly, RF may enhance the clearance of plasmodia 
(Green and Packer 1984). IgM RF has also been shown to protect 
suckling rat pups from Trypanosoma lewisi infection. The RF 
which was transferred in colostrum, amplified the effect of 
specific IgG against the organisms (Clarkson~ 1981). 
3.7.3 Regulatory function 
It has been suggested that RF may have a regulatory role in the 
immune system. The Fab fragment of RF is directed against IgG 
and Chen et al (1988) have proposed that RF may serve as a 
precursor of anti-idiotypic antibodies. These latter antibodies 
may bring immune responses against anti gens to an end and in 
this way have a regulatory effect (Burdette and Schwartz 1987). 
Furthermore RF could assist clearance of idiotypic-anti-
idiotypic complexes (Morgan et al 1979; Fong et al 1985). 
It has been shown that new antigens are expressed when antigen-
antibody complexes form. Antigenic sites on the Fe fragment may 
be revealed in this way. As RF is an antibody directed against 
Fe fragments and helps to clear immune complexes, it may exert 
an indirect modulating effect (Nemazee and Sato 1982). Finally, 
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it has been postulated that B-cells containing RF actually ta ke 
up immune com pl exes, process the anti gen and present it t o 
regulatory T-cells (Chen et al 1988), although there is, as yet, 
little direct evidence to support this. 
3.7.4 Complement activation 
There are contradictory reports regarding the relationship 
between complement and RF, both of which bind to immune 
complexes (Davis and Bollet 1964). It was shown that IgM RF was 
able to fix and activate complement under certain conditions, 
e.g. when bound to IgG coated-erythrocytes (Zwaifler and Schur 
1968; Tanimoto et al 1975; Taylor-Upsahl et al 1977). In these 
experiments it was found to be necessary to render the IgG used 
for coating incapable of its own complement activation by 
reduction and alkylation. 
The interaction between IgM RF, immune complexes and complement 
activation is also controversial. Tesar and Schmid (1970), for 
example, found that RF increased complement activation by 
soluble immune complexes and complexes formed in antigen excess. 
Doekes et al (1985) and Shingu et al (1988), however, noted that 
IgM RF suppressed the complement-activating effect of immune 
complexes. Doekes and co-workers have pointed out that only the 
1 staple 1 form of bound IgM activates complement; the star-like 
form does not. IgM RF bound to different com pl exes may assume 
different configurations and have different effects on 
complement activation. Indeed, Tesar and Schmid (1973) found 
that different RF-containing sera varied widely in their 
complement-activating potential. 
Shingu et al (1988) have suggested that lgG RF enhances the 
complement activation by immune complexes. However, using a 
different method to determine complement activity, Taylor-Upsahl 
et al (1977) were of the opinion that IgG RF was not involved in 
complement-mediated cell lysis. 
It is, therefore, unclear whether IgM RF is functioning in a 
protective manner to reduce the complement-activating behavior 
of immune complexes or is actually increasing complement 
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activation in some situations. In addition, the effect of RF on 
complement activation in local tissues, for example the 
synovium, may be different to that in the circulation (Doekes ~ 
tl 1985) . Indeed, Ford (1983) has noted that there is no~ 
vivo evidence to show that RF protects from immune complex 
mediated damage. 
3.8 PATHOLOGICAL EFFECTS OF RHEUMATOID FACTOR 
3.8.1 
It is equally difficult to establish whether RF is behaving in a 
physiological or pathological manner in disease states (Levinson 
and Martin 1988). 
The presence of RF in normal individuals as well as in a wide 
range of diseases suggests that RF production may be part of the 
normal immune response. 
However, there is evidence that RF has a role in the 
pathogenesis of RA and possibly in other conditions as well. 
In rheumatoid arthritis 
Increased production of RF: The levels of RF are higher in RA 
than other diseases and tend to be more persistently elevated 
(Williams 1983). Adults with the disease are more likely to have 
RF detected in their sera than children with the same condition. 
This is particularly evident when conventional tests are used 
for RF, as children may have hidden RF complexed to circulating 
IgG (Moore et al 1988) 
Enhanced synthesis of RF has been observed in vitro with 
peripheral blood mononuclear cells from patients with RA. 
Spontaneous IgM RF production occurred in patients with RA but 
not in normals. The patients demonstrating this had very active 
disease or vasculitis (Vaughan et al 1976). In addition, 
polyclonal stimulation by pokeweed mitogen resulted in a higher 
proportion of the IgM being IgM RF in supernatants from RA 
patients (Koopman and Schrohenloher 1980; Olsen et al 1982). 
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It has also been shown that immune complexes (in the form of 
HalgG), stimulated lgM RF · production by mononuclear cells in RA 
bu t no t no rm a l s ( Tao e t a l 1 9 8 4 ) • 
Association with disease activity 
The relationship betvJeen IgM RF concentrations and activity of 
the disease is controversial. Various workers have shown that 
the presence of IgM RF is associated with more severe, 
progressive and disabling forms of joint disease ( Franco and 
Schur 1971; Panush et al 1971; Ho 1 borow and Swannell 1983 pg 
24 7). Ernst et al (1988) found a correlation between disease 
activity and lgM RF levels in a group of patients with highly 
active RA. Other workers, however, have not found such a 
relationship (Withrington et al 1984; Lemm et al 1988), but have 
suggested that IgG RF levels may relate more closely to 
activity. 
Nevertheless, a reduction in IgM and IgG RF was shown to 
accompany clinical improvement in patients receiving non-
steroidal anti-inflammatory agents or gold therapy. IgM RF 
levels also decreased in patients treated with D penicillamine 
(Pope et al 1983). Olsen et al (1984) showed a fall in IgM RF 
production in vitro (which closely accompanied clinical 
improvement) following gold or D penicillamine therapy. 
Rheumatoid factors in synovial tissues and synovial fluid 
The presence of plasma cells containing IgM RFs in the synovia 
of patients with RA has been demonstrated in several studies 
(Mellors et al 1959; Munthe and Natvig 1972; Fehr et al 1981). 
Prior pepsin digestion of synovial membranes has demonstrated 
the frequent presence of lg G RF. Interce 11 ul a r and 
intracellular immune complex deposits containing IgG, IgM, c3 
and RF have also been shown (Fehr et al 1981). 
IgM and IgG RFs have been isolated from synovial fluid (Panush 
e~ 1971). IgG RF in synovial fluid appears to exist in self-
associating complexes (Winchester et al 1971; Mannik and 
Nardella 1985). Formation of large complexes in serum may be 
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pre v e n t e d by the pre s e n c e o f no rm a 1 I g G to w h i c h the I g G R F s 
attach (Mannik and Nardella 1985). The synovial fluid comple xes, 
however, may be large and are able to activate complement, 
although less efficiently than IgM RF (Sabharwal et al 1982) . 
Indeed, low levels of complement have been detected in the 
synovial fluid of patients with RA who have raised serum RF 
levels (Ruddy et al 1969; Winchester et al 1970 ) . Furthermore, 
Nardella et al (1983) have shown that IgG RFs indirectly cause 
synovial cells to release collagenase and prostaglandin. Thus 
IgG RFs may be responsible for tissue damage in RA synovial 
tissues. The role of IgM RF in synovial inflammation is less 
certain. It appears that IgM RF is necessary for complement 
fixation and phagocytosis of IgG complexes by neutrophils (Hurd 
et al 1970). This finding is supported by the fact that 
neutrophils from seronegative patients do not contain IgG and c3 inclusions (Britton and Schur 1971). 
Effects in tissues apart from the synovial membrane in 
rheumatoid arthritis 
There is a well known association between high titres of RF and 
extra-articular manifestations of RA such as vasculitis, 
multiple subcutaneous nodules and systemic organ involvement 
(Singer and Plotz 1956; Kunkel and Tan 1964; Mongan et al 1969; 
Holborow and Swannell 1983 pg 250; Gioud-Paquet et al 1987). 
IgG RF and a low molecular weight IgM RF appear to be involved 
in the development of vasculitis (Theofilopoulos et al 1974). In 
addition, Elson et al (1983) found that the presence of 
circulating immune complexes containing RF, IgG and complement 
showed a better correlation with the development of vascul itis 
than synovitis in RA. The discovery of IgM RF in the lungs of 
patients with RA and pulmonary involvement led DeHoratius et al 
(1972) to suggest that RF played a role in the pathogenesis of 
rheumatoid lung. 
Overall, these findings suggested that the presence of RFs 
including IgM RF may contribute to immune complex formation, 
complement fixation and chronic tissue damage in RA (Carson 1987 
pg 1205). 
3.8.2 
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Rheumatoid factor in other inflanmatory conditions 
There is work indicating that RF is associated with disease 
activity in a number of inflammatory conditions, both 
experimentally and in human disease. 
Liver Disease 
Dresner and Trombly ( 1959) detected RF in 71 % of 96 cases of 
hepatocellular disease. Remission of the liver disease resulted 
in the test becoming negative. Similarly, 19 cirrhotics with 
positive RF tests were studied. In 10 cases whose RF tests 
became negative there was clinical remission of disease. The 
remaining 9 cases whose tests stayed positive did not improve. 
Another patient in remission initially had a negative RF test. 
The patient relapsed and the RF test became positive prior to 
the development of clinical signs. From their work, Dresner and 
Trombly concluded that the measurement of RF levels appeared to 
reflect the patient's clinical condition more accurately than 
other tests of liver function. 
One possible drawback of the study, however, was that RF was 
measured using the euglobulin inhibition test. This test makes 
use of the fact that normal serum inhibits the agglutination of 
positive rheumatoid serum. Globulin (or Cohn Fraction II) from 
RF-containing serum does not, however, inhibit the agglutination 
(Ziff et al 1956). The problem with the method is not that it 
does not measure RF (indeed the test presumably detects hidden 
RF as well) but that it is technically difficult to perform and 
is not used today. 
investigators. 
The work has not been repeated by other 
Subacute bacterial endocarditis (SBE) 
Williams and Kunkel (1962) found RF in just over 50% of 51 
patients with SBE. Many patients showed a marked fall in the 
amount of RF following treatment (RF was quantitated using latex 
and sheep cell tests as well as precipitin curves obtained with 
heat-treated sera and aggregated gammaglobulin as antigen). The 
decrease in RF levels after treatment suggested that the 
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antigenic stimulus had been removed. 
thought to be one such stimulus. 
Immune complexes were 
The fact that not all patients with SBE produced RF was 
unexplained, although tests for 'hidden RF' were not in use at 
that time. Also unexplained was the fact that a few patients 
still had detectable RF after treatment (one such patient had 
chronic liver disease). 
Messner et al (1968) was able to correlate the presence of RFs 
in SBE with the duration of infection and raised immunoglobulin 
levels. 
In another study, Bacon et al (1974) confirmed the decline in RF 
levels (and other auto-antibodies) following cure of the 
disease. 
Carson et al (1978) also measured IgM RF levels in patients with 
SBE. The RF levels peaked approximately 9 days after the immune 
complex levels, and levels of both IgM RF and immune complexes 
fell after treatment 
Vasculitis 
A number of associations between RF and vasculitis have been 
described. In fact, RF may be instrumental in the induction of 
vascul itis. This has been shown by the infusion of RF and 
immune complexes into the mesenteric vessels of the rat (Baum~ 
_!l 1964). It appeared that immune complexes and the IgM RF-
containing fractions from patients with RA caused thrombosis and 
haemorrhage in the vessels. The injection of immune complexes 
alone, however, did not produce vascular damage. 
Likewise, IgM RF aggravated the vasculitis occurring as part of 
the Arthus reaction in rats. The Arthus reaction was produced by 
the intradermal administration of IgG antibody followed by 
intravenous antigen and was complement dependent (Floyd and 
Tesar 1979). The inflammatory reaction due to the antigen-
antibody deposition was not only augmented by IgM RF but 
vascular permeability was also increased. 
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Skin biopsies in renal transplant patients with CMV infection 
have shown the presence of perivascul ar IgM deposits. The 
finding of these deposits appeared to correlate with the RF 
concentration (Baldwin et al 1987). Similarly, IgM 
accumulations in the skin blood vessels have been noted in 
association with circulating RF in patients with RA. The 
presence of IgM and C3 in the vessels were shown to be related 
to a perivasular mononuclear infiltrate {Westedt et al 1984). 
These results provide circumstantial evidence that IgM RF may be 
linked with vascular damage in man. 
Lung disease 
Experiments using rats with diffuse proliferative lung disease 
have demonstrated that IgM RF attaches to the linings of alveoli 
and arterioles in areas of inflammation and accentuates the 
tissue damage and vasculitis (OeHoratius and Williams 1972). 
Renal disease 
Rheumatoid factor has been implicated in the pathogenesis of 
renal disease. In rats with nephrotoxic nephritis, it has been 
shown that the injection of RF-containing serum from RA patients 
resulted in worsening of the proteinuria (McCormick et al 1969). 
Deposits of RF have been found in the glomeruli in patients with 
glomerulonephritis. Rossen et al (1977) noted that RF was 
detected mainly in patients with severe glomerular damage. 
Rodriguez-Iturbe et al (1980) isolated IgG RF from the glomeruli 
in a patient with acute poststreptococcal glomerulonephritis. 
In addition, elevated levels of serum RF have been detected in 
90% of patients with the same condition, and appeared to be 
related to· the duration of the nephritis (McIntosh et al 1979) 
In rabbits with glomerulonephritis associated with SBE, the 
presence of RF in the glomeruli was closely related to the 
inflammatory changes (Sindrey et al 1981). 
Using a mouse model, other workers have shown that RF can bind 
to immune com pl exes located in gl omerul i and act as an 
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immunoabsor bent to bind f urther comple xes ( For d and Kosat ka 
1982) . 
Finally, Ford (1983) has postulated that RF may co ntribute t o 
ch r onicity in gl omerul onephritis. 
Lyme arthritis 
IgM RF levels appear to be related to disease activity in t his 
condition (Goebel et al 1988) . 
3.8.3 Summary 
In summary, the studies in RA and other inflammatory conditions 
have found relationships between RF concentrations and 
i. the age of the patient (onset of the disease in childhood 
is less'often associated with the presence of RF - Moore et 
~ 1988) 
ii. the severity and extent of the condition (Holborow and 
Swannell 1983 pg 247; Gioud-Paquet et al 1987; Carson 1987 
page 1205; Milgrom 1988) 
iii. the duration of the illness (Messner et al 1968, McIntosh 
et al 1979) 
iv. the disease pattern in terms of organ involvement (Singer 
and Plotz 1956, Holborow and Swannell 1983 pg _250) 
v. the activity of the disease following therapy (Bacon et al 
1974, Carson et al 1978, ) 
vi. immune complex levels (Carson et al 1978, Gioud-Paquet et 
~ 1987). 
These observations do not necessarily mean that RF has any 
causative role in the diseases mentioned. Nevertheless, the 
potential of RF to enhance tissue damage has been shown in a 
number of experimental situations. 
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3.9 RHEUMATOID FACTOR PRODUCTION IN CONGENITAL SYPHILIS 
3.9.1 
Rheumatoid factor production appears to be a consistent part of 
the immune response in congenital syphilis (Reimer et al 1975, 
Meyer and Malan 1987). 
It is possible that induction of RF synthesis is related to the 
presence of immune complexes in congenital syphilis in a manner 
similar to that which was described in section 3.4.2. 
It is, there fore, pertinent to discuss immune complex formation 
in congenital syphilis. 
I11111une complexes in congenital syphilis 
Concurrent with the development of the host immune response, 
immune complexes appear in the circulation. This has been 
demonstrated in acquired syphilis (S,.iflling et al 1978; Engel and 
Diezel 1980) and in congenital syphilis. Kaplan et al (1972) and 
Wi ggel i nkhui zen et al ( 1973) showed that the nephropathy of 
congenital syphilis was an immune complex gl omerul onephrit is. 
Few studies, however, have measured circulating immune complexes 
in congenital syphilis. The work of Dobson et al (1988b) showed 
the presence of immune complexes in all six symptomatic infants 
with congenital syphilis. The complexes, which were 
predominantly IgM-containing complexes, were measured using a 
Clq solid phase assay. 
Using a Clq binding assay, Samson et al (1990) also found raised 
levels of ClCS in 17 infants with congenital syphilis. 
In their preliminary studies, Dobson et al (1988b) were able to 
show the presence of treponemal antigens and anti-treponemal 
antibody in the immune complexes in congenital syphilis. This 
work has been confirmed by S'anchez et al (1989). 
In addition to finding treponemal antigens, endogenous host 
proteins in the form of creatine kinase and fibronectin 
degradation products were also detected in the immune complexes 
of infants with congenital syphilis (Dobson et al 1988b). 
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It is possible that the RF produced in congenital syphilis is 
induced by the immune complexes themselves . In particular, 
maternal IgG in the complexes may be altered, and the Fe region 
rendered immunogenic, resulting in RF production. A simila r 
mechanism for RF synthesis in other conditions has been 
suggested by other workers (Wi 11 iams and Kunkel 1963, Nemazee 
and Sato 1982). 
Whilst there is evidence to suggest a relationship between 
immune complexes and RF levels in several conditions (see 
section 3.7) there is another possible mechanism leading to RF 
production in infectious diseases. This has been outlined in 
section 3.4.3 and has recently been reviewed by Williams (1988). 
3.9.2 Antibodies mimicking the Fe portion of lgG 
A number of bacterial, viral and parasitic organisms have Fe 
receptors for IgG. In the presence of infection, the immune 
response may result in the formation of antibodies to the Fe 
receptors. These antibodies would have combining sites which 
were the mirror image of the Fe receptor. An anti-idiotypic 
response to these antibodies would result in molecules with a 
cross-reactivity for the Fe portion of IgG ie. the anti-
idiotypic antibody would be RF (Williams 1988). 
Although there is no work to indicate that treponemes are 
endowed with Fe receptors, the hypothesis is attractive and 
could, conceivably, be responsible for RF formation in 
congenital syphilis. 
Whatever the stimulus to RF induction in congenital syphilis, it 
is apparent that RF is found more often in the congenital than 
the acquired disease. Thus, in the former circumstance RF has 
been found in over 95% of cases in the 2 largest studies (Reimer 
et al 1975, Meyer and Malan 1987). Conversely, adults with 
syphilis have positive RF tests in 13-25% of cases, depending to 
some extent on the duration of the infection (Bartfeld 1969, 
Cerny et al 1985, Muller et al 1987). 
What are the pos~ible reasons for the difference in RF response? 
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3.9.3 Predisposition to RF production in early life 
Very recently, attention has been focussed on the CDS 
positive(+) subset of B ce~ls. It has become apparent that these 
RF-producing cells make up a substantial proportion of B 
lymphocytes in early life. Thus, up of 50% fetal spleen B cells 
belong to the CDS+ subpopulation (Antin et al 1986), compared to 
20% of adult spleen B lymphocytes (Gadol and Ault 1986). 
Furthermore, 75% of B cells in cord blood are CDS+ compared to 
20-30% adult peripheral blood B cells (Hardy et al 1987). 
Fong et al (1985) were able to demonstrate IgM RF production by 
B cells induced with Epstein-Barr virus in newborns. These 
workers found that the amount of IgM RF formed increased with 
age to young adulthood. 
Levinson et al (1987) reported somewhat different results when 
cord blood lymphocytes were stimulated with Staphylococcus 
aureus Cowan I. Although both cord blood and normal adult 
peripheral blood mononuclear cells were shown to produce IgM RF 
following Staphylococcal activation, the cord blood response was 
over 3 times greater. The cord blood cells produced IgM class 
immunoglobulin only. This latter finding is in keeping with work 
which indicates that IgA and lgG-producing plasma cells are not 
readily inducible, and that the IgM response is dominant in 
early life (Steele et al 1977, Cooper 1987). 
Nevertheless the results of Levinson et al appeared to differ 
from those of Fong et a 1 in terms of the magnitude of RF 
production. The nature of the stimulus used was different, 
however, and further studies are needed to clarify these 
results. 
In concl usion, the greater frequency with \'lhich RF is found in 
congenital (rather than acquired) syphilis may be due to larger 
numbers of readily inducible RF-producing B cells in newborns. 
There are other theoretical reasons for increased IgM RF 
synthesis in congenital syphilis, and these relate to the 
regulatory T cells and macrophages. 
3.9.4 
3.9.5 
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Possible role of regulatory T cells and macrophages in increased 
RF production in congenital syphilis 
Suppressor T cell function may be reduced in congenital 
syphilis. Evidence for this comes primarily from work in 
patients with acquired syphilis, although not all studies are in 
agreement (reviewed by Bos et al 1980). 
A striking feature of some studies has been the demonstration of 
a depression of cell mediated immunity including delayed 
hypersensitivity reactions in acquired syphilis. Not only is 
there an absolute reduction in T lymphocyte numbers, but the 
numbers of suppressor T cells may also be decreased in secondary 
syphilis (Fulford and Brostoff 1972; From et al 1976; Bos et al 
1980; Jensen and From 1982; Jensen et al 1982). 
Jensen et al (1982) have postulated that immune complexes may be 
responsible for the immunosuppression. 
If suppressor T cell function is 
syphilis,it might mean that there 
decreased 
is less 
production of RF and other immunoglobulins. 
in congenital 
control over 
Macrophage function is depressed in newborns (reviewed by Lu and 
Unanue 1985). Chen et al (1988) have suggested that CD5+ cells 
may be able to process anti gen-anti body complexes and present 
antigen to T cells. As this could occur independently of 
macrophages, CD5+ cells may have an advantage. 
Reimer et al (1975) proposed another reason for the RF 
production in congenital syphilis. 
RF fonnation against maternal IgG allotypes 
Reimer et al have correctly pointed out that anti-
immunoglobulins are often made against maternal IgG in the first 
year of 1 ife. These anti-immunoglobul ins are of the IgM class 
and may be directed against the Gm (genetic marker) antigen on 
the foreign maternal IgG molecules (Steinberg and Wilson 1963). 
3.9.6 
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It follows that this mode of response may be tri gg ered earl y by 
t he immune comple xes containin g forei gn IgG i n con gen ital 
syphilis. 
Nevertheless, the reas ons fo r finding relati vely more IgM RF in 
syphilis in early life remain speculative at present. 
What effects is this RF li kely to have? 
Effects of IgM RF in congenital syphilis 
Unfortunately, the effects of these antibodies in congenital 
syphilis are also hypothetical. 
Any or all of the physiological effects of RF described in 
section 3.6 may be operative. In particular, it is worth 
stressing the anti-infective properties of the antibody , which 
have been documented in trypanosomal infection in vivo and 
plasmodium infection in vitro (Clarkson et al 1981; Green and 
Pa.c ker 1984) • 
In addition, the "enhancing antibody " function of RF may be 
important in early life as anti gen responsiveness is impaired 
(Roper and Cooper 1983 pg 19). 
In spite of these potentially useful effects, there is evidence 
that RF plays a pathological role in RA and some inflammatory 
conditions (see section 3.8). 
Whilst untoward consequences due to the presence of RF have not 
been documented in congenital syphilis, it is clear that the 
overall immune response plays an important role in the 
pathogenesis of the condition. 
The effects of the immune response in congenital syphilis 
Initial work in support of this came from pathological studies. 
It was found that in the rare instances where spirochaetes were 
present in the fetus prior to 5 months gestation there were no 
inflammatory lesions and there was no evidence of a cytopathic 
effect due to the organisms (Stowens 1959 pg 187; Silverstein 
1962; Harter and Benirischke 1976). 
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Silverstein and Lukes (1962) noted that when the infected fetus 
was able to mount an immune response, plasma cells, inflammatory 
infiltrates and tissue damage were found in sites where t he 
pathogen was located. Such sites included lung, pancreas and 
periosteum. 
Certain lesions of early congenital syphilis may have an 
immunological pathogenesis. These include glomerulonephritis, 
placental vasculitis and haemolytic anaemia. 
In addition, the stigmata of late congenital syphilis such as 
interstitial keratitis, Clutton's joints and eighth nerve 
deafness appear to be mediated by a hypersensitivity response 
(King and Nicol 1975 pg 117, 120). These maninfestations do not 
respond to penicillin treatment but may be improved by steroid+ 
therapy. Indeed, Olansky (1971 pg 736) has suggested that these 
features of late congenital syphilis may be due to an autoimmune 
response which is triggered by T.pallidum. 
There is as yet little direct evidence of an autoimmune response 
in congenital syphilis. Recent data is available, however, to 
show that auto-antibodies are present in acquired syphilis and 
that autoimmune phenomena may be involved in the pathogenesis of 
some of the syphilitic lesions. Baughn et al (1986) have found 
immune complexes from patients with secondary syphilis to 
contain not only treponemal antigens, but also host proteins. 
These proteins were identified as fibronectin degradation 
products and anti-fibronectin antibodies. Immune complexes, of 
which these proteins are a part, have been demonstrated in renal 
and cutaneous lesions in patients with secondary syphilis 
(Tourville et al 1976; Jorizzo ·et al 1986). 
Experimental animals also appear to make auto-antibodies when 
infected with T.pallidum. Thus, antibodies to creatine kinase 
have been demonstrated in sera from infected rabbits. The 
antibodies were absent from pre-infection sera and creatine 
kinase was not present in sonicated or whole treponemal 
organisms (Strugnell et al 1986). These authors postulated that 
tissue destruction led to release of creatine kinase from 
damaged mitochondria. The same workers reported finding auto-
3.9.8 
86 
antibodies reactive with a soluble fraction of s keletal muscle 
in human syphilis. 
Similarly, guinea pigs infected with T.pallidum produce 
antibodies to treponemal antigens, creatine kinase and 
fibronectin. Auto-antibodies to the latter may be formed as a 
result of T.pallidum binding to fibronectin and inducing 
conformational changes leading to the molecule becoming 
immunogenic (Baughn et al 1987). 
The presence of other auto-antibodies in acquired syphilis has 
been proposed. In fact the nontreponemal antibody tests are 
reactive against cardiolipin which is a component of normal 
mitochondrial membranes. However, cardiolipin is also a 
component of T.pal 1 idum (Matthews et al 1979). Treponemes may 
incorporate mammalian cardiolipin (Ingall and Musher 1983 pg 
33?) and/or the VDRL may detect antibodies cross-reactive 
between T.pallidum and host cardiolipin (Doniach 1976 pg 210-
214). That similar phenomena may be involved in congenital 
syphilis has been suggested by the very recent finding of 
creatine kinase and fibronectin degradation products in immune 
complexes in congenital syphilis (Dobson et al 1988b). 
Overview of RF production in congenital syphilis 
The fundamental question raised by the various findings 
described is 'Does RF have a pathological role in congenital 
syphilis?' It is tempting to suggest that it may, in the light 
of the observations that: 
i. congeni ta 1 syphilis is the most severe form of syphilis 
(Handsfield and Lukehart 1984) 
ii. the host immune response takes part in the pathogenesis of 
the lesions of congenital syphilis 
iii. there is a propensity for patients with early congenital 
syphilis to form RF 
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iv. RF may have pathological effects in other conditions. 
However, essentially the same question has been investigated 
with regard to RA for almost 50 years and, as recently reviewed 
by Levinson and Martin (1988), is still unanswered. 
Nevertheless, it does appear that RF production in congenital 
syphilis merits further study. Potential benefits would include 
a better understanding of the immune response in the condition. 
This may ultimately lead to a reduction in the mortality rate. 
Furthermore, recent work has indicated that the RF autoantibody 
is encoded by germ line genes and that newborn cord blood cells 
are capable of producing more RF than adult peripheral blood 
mononuclears (Levinson et al 1987). It seems reasonable to 
expect that the study of RF antibodies early in the development 
of the immune system may help clarify their role in later life • . 
Which aspects of RF induction in congenital syphilis should be 
investigated to establish a platform from which further research 
might be launched? 
The classes of RF antibody produced could be determined and the 
percentage of IgM which is RF studied. 
In addition, it would be useful to know if the factors 
associated with RF production in congenital syphilis are the 
same as those operative in other conditions (see Section 3.8.3). 
If similar determinants were identified, this would facilitate 
comparisons between the diseases with the added advantage that 
information from an earlier stage of ontogenesis would be 
available. 
In some of the conditions where RF has been detected, it has 
been possible to show its presence at the site of the 
inflammatory lesions (in the synovium in RA and in the glomeruli 
in glomerulonephritis). Such findings have suggested at least a 
close association between the autoantibody and tissue damage, if 
not a direct relationship. It may be expedient to extend these 
observations to congenital syphilis where there is possibly a 
predisposition to RF formation. 
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It follows that, to investigate the RF response in congenital 
syphilis, reliable methods of measuring RF concentrations are 
needed. Some of the tests available are reviewed in Section 
3.10. 
3.10 DETECTION OF RHEUMATOID FACTOR 
There are numerous tests described for the detection of RFs of 
the various immunoglobulin classes. The early development of 
assays for RF has already been described with the history of the 
discovery of RF. 
Generally RFs in nonrheumatoid conditions are more reactive 
against human than rabbit IgG (Holborow and Swannell 1983 pg 
247). Tests employing human IgG are more sensitive for 
detection of RF but are less specific for RA than those using 
rabbit IgG (e.g. the Waaler-Rose test - Carson 1981 pg 677). It 
needs to be borne in mind that IgM RF activity can be hidden 
because of the tendency of IgM RF to form complexes with 
autologous IgG in the serum. Dissociation of these complexes 
(e.g. by acidic treatment) may be necessary before IgM RF can be 
detected (Allen and Kunkel 1966). 
3.10.1 Agglutination reactions 
These tests detect mainly IgM RF owing to the latter's 
polyvalency; IgG RFs are poor agglutinators (Stage and Mannik 
1972-73; Holborow and Swannell 1983 pg 248). 
Latex agglutination test 
The latex test is the most widely used test for the detection of 
IgM RF (Mannik 1979 pg 509). Singer and Plotz (1956) originally 
described a tube latex fixation test. The latex particles 
coated with Cohn fraction II human immunoglobulin were 
agglutinated in the presence of RF. 
The latex slide agglutination test which is simpler and quicker 
than the tube method is often used as a screening test for the 
presence of RF. Waller (1969) found that the slide and tube 
test for RF had equal sensitivity and specificity in the 
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diagnosis of RA. Singer (1973-74), however, noted that the 
slide tests were less sensitive and reproducible when compared 
to the tube test. The poorer performance of the slide tests 
could be partly attributable to a lack of standardization. 
Nevertheless, Cathcart (1975 pg 121) stated that the slide tests 
were useful, particularly when done in conjunction with a more 
reliable assay. False positive and false negative slide tests 
have been described. One possible cause of a false positive 
latex test is the presence of Clq component of complement. 
Latex particles coated with aggregated gammaglobul in can fix 
complement (Bernhard et al 1962) and this may result in non-
specific agglutination (Stage and Mannik 1973). The problem can 
be overcome by heat treatment (Stage and Mannik 1972-73) or by 
dilution of the serum (Singer 1973-74). Although the end point 
titre gives an indication of the amount of RF present, the latex 
tests are not truly quantitative (Mannik 1979 pg 509). 
Bentonite flocculation test 
This test is similar to the latex test but uses clay particles 
instead (Bozicevich et al 1958). The test is slightly more 
complicated to perform than the latex test but the titration end 
point can be more objectively read (Cathcart 1975 pg 115). 
Waaler-Rose test 
This is also known as the sensitized sheep cell agglutination 
test (SCAT) and has been previously described. The test is more 
difficult to carry out than those mentioned above but is more 
specific for RA (Waller 1969; Cathcart 1975 pg 119). 
Heterophile antibodies need to be absorbed prior to the test 
(Stage and Mannik 1972-73). For this reason the use of human O 
cells as an indicator system has been proposed (Cathcart 1975 pg 
119) • 
Tests using Cohn fraction II 
These include the FII sensitized sheep cell agglutination test, 
and the FII inhibition test (or euglobulin inhibition test), and 
have already been described. 
90 
The tests have an increased sensitivity but decreased 
specificity for RA (Waller 1969; Cathcart 1975 pg 107). 
Sensitized human D-Cell agglutination test 
In this test human red blood cells are coated with incomplete 
anti-Rhesus (anti-Rh) antibodies. The system can be used to 
detect complement-fixing and agglutinating IgM RF (Waller and 
Vaughan 1956). One of the difficulties is in obtaining 
sufficient anti-Rh sera. The sensitivity and specificity of the 
test are similar to that of the latex and bentonite methods 
(Cathcart 1975 pg 121). 
However, Mannik (1979 pg 509, 510) has pointed out that in the 
sensitized human D-cell agglutination test the IgG does not come 
from pooled sera so that some subclasses of IgG may not be 
represented. (This is in contrast to the latex test which uses 
pooled IgG). 
3.10.2 Complement fixation methods 
Rheumatoid factors can fix complement when reacting with IgG 
(Zwaifler and Schur 1968). This was shown by prior reduction 
and alkylation of the IgG to prevent its own complement 
activating effect. Tanimoto et al (1975) and Taylor-Upsahl ~ 
~ (1977) described haemolytic assay systems making use of this 
property. As stated by the latter authors, the test is subject 
to too many variables to be of use for routine purposes but does 
demonstrate the potential complement fixing ability of RF. 
3.10.3 Precipitation reactions 
The work of Epstein et al (1956) has already been mentioned. 
Winchester and Agnello (1970) quantified anti-immunoglobulins 
using a radial immunodiffusion method. Rheumatoid factors 
produced a precipitate in a gel containing IgG aggregates. 
The zone of precipitation was proportional to the RF 
concentration. Subsequently, Theofilopoulos et al (1974) have 
used the method to measure IgG and IgM RFs in RA patients with 
vasculitis. 
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3.10.4 Laser nephelometry 
This technique has recently been modified for the detecti on of 
IgM RF. The method is based on the fo rmation of com pl exes 
between HaigG and Ig M RF. The comple xes scatter light in 
ac cordance with the amount of antibody present ( Prentice ~ 
1987) . The place of the test in clinical practice has not yet 
been established, although in the prospective study of Prentice 
et al, it v,ias less sensitive for RF detection than the more 
conventional latex or haemagglutination tests. 
3.10.5 I111J1unosorbent procedures 
The basis of these procedures is that RF is removed from serum 
by absorption to IgG and subsequently eluted. IgG or gamma-
globulin is insolubilized by cross-lin king to glutaraldehyde or 
a similar substance. The preparation is washed several times to 
remove unbound immunoglobulin. Serum is added and incubated and 
unattached proteins are removed with the effluent. Absorbed 
proteins are eluted, usually with acidic treatment. The eluted 
fraction can then be analysed for immunoglobulins of different 
classes using a radial immunodiffusion method. Torrigiani and 
Roitt (1967) applied the method to patients with RA. Various 
workers have also detected anti-gammaglobulins (particularly in 
the IgG and IgA classes) in a high percentage of normal 
individuals (Panush et· al 197_1; Bianco et al 1974). 
Turner (1976 pg 417-420) found that a significantly greater 
percentage of patients with RA had antiglobulins than normals. 
However, the statistical difference was no longer apparent when 
corrected for the immunoglobulin levels in the patient's serum. 
Turner also demonstrated the likelihood of nonspecific protein 
uptake by the insolublized IgG since repeated absorptions 
resulted in some further immunoglobulin binding. Albumin was 
also shown to bind to the IgG. Nardella and Mannik (1978) 
confirmed the nonspecific binding of IgG in immunoabsorbent 
columns. 
Wernick et al (1981) used the method to prepare IgM and IgG RF 
standards. They found that 86% of the IgM RF was removed but no 
IgM was obtained from normal serum. 
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Other potential drawbacks include denaturation of the RF and a 
lac k of specificity of radial immunodiffusion methods in 
detecting the RF classes e.g. when measuring IgG RF, IgM RF can 
form a prec i pit in zone with the anti- IgG present in the agar 
(Lea and Ward 1972). 
In addition, IgG RF is likely to polymerize making radial 
immunodiffusion quantification difficult (Mannik and Nardella 
1985). 
Carson et al 1977 showed that normal IgG bound to IgM RF may be 
estimated as IgG RF, so that it may be necessary to remove the 
IgM before estimating IgG RF. A further problem with 
immunosorbent techniques is that Rf (of all classes) may be lost 
during washing steps, leading to underestimation of the RF 
present (Mannik 1979 pg 510). 
Nevertheless, not all the problems associated with the assay of 
IgG RF are specific to the immunoabsorbent method. 
3.10.6 Enzyme-Linked I11111unosorbent Assay (ELISA) 
In general ELISAs offer advantages over 
(RIAs) in that they are cheaper, do not 
equipment and are not medically hazardous. 
highly sensitive quantifiable method 
investigations, although their results are 
precise as RIA (Voller et al 1976). 
radioimmunoasssays 
require complex 
They provide a 
for serological 
not usually as 
The principle of RF ELISAs is that IgG is passively absorbed to 
a solid surface (e.g. polystyrene). Test serum is incubated 
with the antigen (IgG) and unbound substances are washed off. A 
class specific antibody (e.g. rabbit anti-human IgM) conjugated 
to a suitable enzyme (e.g. horseradish peroxidase) is added to 
the system. Bound RF (e.g. IgM RF) is detected by the anti-
human immunoglobulin (e.g. anti-human IgM). The enzyme coupled 
to the latter then reacts with a substrate to produce a colour 
change which can be measured spectrophotometrically. Willems and 
Klaassen de Kort (1978) found good correlation between the IgM 
RF ELISA and the Waaler-Rose test, but that the ELISA method was 
more sensitive. The correlation with the latex-fixation test 
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was less good (84%); the authors suggested that the latex test 
was less specific. Maiolini et al (1978) also found good 
agreement between IgM RF ELISA results and the Waaler-Rose test. 
Gripenberg et al (1979) noted good correlation between results 
of an ELISA for IgM RF and the latex-fixation and Waaler-Rose 
tests. These authors noted a significant association between RF 
titres using the agglutination tests and the RF ELISA readings. 
Methods have also been developed for measuring IgG and IgA RFs 
by ELISA (Palosuo and Milgrom 1981; Faith et al 1982; Procaccia 
et al 1987). In the IgG RF ELISA described by Faith et al 
(1982) microtitre plates were coated with rabbit IgG. Pepsin-
treated sera were then added and bound anti-globulins detected 
by rabbit anti-human Fab conjugated with alkaline phosphatase. 
Bampton et al 1985 used a similar method. The pepsin digestion 
step was utilized to destroy IgM RF which may interfere in the 
assay. lg G RF was converted to F( ab') 2 fragments by pepsin 
treatment but was still able to bind to the Fe fragment 
(Osterland et al 1963). The F(ab' )2 fragments of IgG RF are 
then detected by the rabbit anti-human Fab. Employing this 
method, Faith et al (1982) found that the IgG RF assay gave 
results which were reproducible, although less so that the IgM 
RF ELISA. A number of authors have described a somewhat simpler 
assay system where the antiserum used is an anti-human IgG 
rather than the anti-human Fab (Gioud-Paquet et al 1987; Stone 
et al 1987). The effect of this alteration has not been 
determined. Mannik and Nardella (1985) have noted, however, 
that the antiserum chosen must be highly specific and cross-
reactivity eliminated. Indeed the latter authors report that 
nonspecific binding of rabbit IgG to the solid phase may occur. 
The effect of IgA RF was not taken into account in the above 
method. Palosuo and Milgrom (1981) also developed a similar 
ELISA for lg G RF. Differences from the method of Faith et a 1 
(1982) were that immune complexes containing IgG were used as a 
solid-phase antigen. IgG RF was measured using a goat antihuman 
IgG. Interference from IgM RF was eliminated using 
dithiothreitol. 
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Proccacia et al (1987) utilized a similar method to that of 
Faith et al (1982) to detect IgA RF. Pepsin-digested sera were 
incubated with rabbit IgG. F(ab' )2 fragments of IgA RF were 
detected using a goat anti-human IgA conjugated to alkaline 
phosphatase. Potential problems with this assay are: 
i. pepsin digestion coverts variable amounts (from 6-40%) of 
IgA to F(ab' )2 fragments (LoSpalluto 1974; Calvani co and 
Tomasi 1974) 
ii. F(ab')2 fragments of the antiserum should probably be used 
(Elkon et al 1981), although Faith et al (1982) found this 
was unnecessary (possibly because IgM RF had been destroyed 
by the pepsin treatment). 
Measurement of the RF classes by ELISA has become popular. There 
is, however,' a lack of standardization in terms of the type of 
antigen used, the antiserum employed and the method of 
eliminating interference from IgM RF when measuring RFs of other 
classes (Kleveland et al 1988, Ruschen et al 1988, Grunnet and 
Espersen 1988). In fact, Milgrom (1988) has expressed the 
opinion that measuring IgG RF by ELISA is of limited diagnostic 
value. 
3.10.7 Radioi .. unoassay (RIA) 
The basis of the RIA tests for RF is as follows: IgG (human or 
rabbit) is bound to plastic tubes. Test serum ·is added and, 
after a period of incubation, unattached substances are washed 
off. Rheumatoid factors of different cl asses are detected by 
class-specific radiolabelled antibodies. The amount of 
radioactivity present is used to quantitatively estimate the RF 
level (Franchimont and Suteanu 1969). 
Hay et al (1975) found IgM and IgG RF in patients with RA using 
this method. Carson et al (1977) and Mannik and Nardella (1985) 
have pointed out some limitations of the method including: 
i. Underestimation of IgG RF 
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ii. IgM RF binding to the Fe portion of the anti-human IgG 
would .be estimated as IgG RF 
iii. IgG assayed may not be RF but simply IgG bound to the IgM 
RF. 
Carson and colleagues (1977) therefore used the Fe portion of 
human IgG to coat plastic tubes. Following a blocking step, 
serum was added (for measurement of IgG RF pepsin-treated sera 
were used). Rabbit antibody to the F(ab')2 portion of human IgG 
were subjected to pepsin digestion and radiolabelled to measure 
the F(ab' )2 portion of IgG RF. IgG RF is still underestimated 
by this method (Mannik and Nardella 1985). IgM RF was measured 
with the F(ab')2 segment of a rabbit anti-human IgM. 
Dunne et al (1979) and Elkon et al (1981) have measured IgA RFs 
using an extension of the technique of Carson et al (1977). 
While RIA methods have been developed for each of the RF 
classes, they are expensive and entail the use of radioactivity 
(Egeland and Munthe 1983). Therefore, they are not often used 
routinely (Holborow and Swannell 1983 p 248). 
3.10.8 Other methods 
The mixed reversed (solid-phase) passive anti-globulin 
haemadherence test (MRS PAH test) was described by March et al 
(1981). Using this test IgG and IgA RFs were found in many 
normal subjects although the levels were lower than in patients 
with RA. The test was subject to the same limitations as those 
mentioned in the RIA test of Hay et al (1975). 
Waller and Richard (1976) separated IgM and IgG by 
chromatography and assayed IgG RF using a sensitized D-cell 
assay system. 
A rheumatoid rosette assay and immunofluorescence techniques 
have also been described but are frequently associated with 
false positive reactions (Egeland and Munthe 1983). 
.. 
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Recently, a haemagglutination method using sheep erythrocytes t o 
which IgG is covalently bound has been described (Assimeh and 
Johnson 1980). 
Quin et al (1980) have developed a radioactive binding assay for 
detection of RF. Radiolabelled HalgG and test sera are 
incubated. RF and radioactive IgG are precipitated using 
polyethylene glycol and the radioactivity estimated. The test 
can be used for IgG RF determination. 
3.10.9 I1111unocytocheaical methods 
Immunocytochemical methods have been used to demonstrate RF and 
RF-producing cells in the tissues and the usual technique is 
based on the work of Mellors et al (1959) which has already been 
described. 
In 1963, Pernis et al used immunofluorescence to demonstrate RF 
-in vascular lesions in patients with RA. 
Munthe and Natvig (1972) determined the proportions of IgM and 
IgG RF producing plasma cells in rheumatoid synovial tissue. 
Cells and extracellular deposits containing RF were demonstrated 
with fluorescein-labelled HalgG. Cells with free RF activity 
always produced RF of IgM class, whilst pepsin digestion of 
tissues enabled plasma cells containing IgG RF to be more 
readily detected. 
3.10.10 Suaary 
The fact that there are so many tests to measure serum RF 
indicates, perhaps, that the ideal method has not been 
developed. Nevertheless, the trend appears to be to use 
agglutination tests, ELISAs, and, more recently, nephelometric 
techniques to identify and quantitate RF. 
To detect RF in congenita 1 syphilis, the RF 1 atex test would 
appear to be suitable as a screening test and the RF ELISA may 
be an appropriate method for measuring RF classes, in particular 
IgM RF. 
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PART II 
RHEUMATOID FACTOR ANO TESTING FOR CONGENITAL SYPHILIS 
CHAPTER 4 : INTRODUCTION AND AIMS 
4.1 INTRODUCTION 
It is possible to prevent congenital syphilis (Brown and Moore 
1963). However, there is a high incidence of congenital 
syphilis in developing countries (Larsson and Larsson 1970; Hira 
et al 1982). This suggests that failure of primary prevention 
is not infrequent. Early detection and treatment of congenital 
syphilis are therefore important if the effects of the disease 
are to be minimized. 
In general, there are 2 situations in which early diagnosis is 
attempted. The first of these is where the newborn infant is 
identified as being at risk of the disease due to the presence 
of maternal syphilis (Scotti et al 1969). The second instance 
is that where an infant demonstrates clinical signs compatible 
with the diagnosis of congenital syphilis (Pickering 1985). 
The diagnosis of congenital syphilis in these 2 settings usually 
requires the use of serological tests (Borobio et al 1980). The 
limitations of existing serological tests in the case of high 
risk newborn infants have been pointed out. In summary, 
however, tests such as the FTA-ABS (IgM) test lack sensitivity 
in asymptomatic patients (Kaufman et al 1974). Other tests, 
such as the VORL test, require a 3-4 months follow-up before 
final appraisal (Breasette 1979). Newer tests are still being 
evaluated and require laboratory-intensive methods. Tests in 
this category include Western blotting techniques (Dobson et al 
1988a). 
The usefulness of testing for RF (by means of the RF latex test). 
in situati ons where the newborn infant is at high risk of 
congenital syphilis has not been investigated. In particular, 
the sensitivity of th.e test would be the major consideration. 
If the sensitivity of the RF latex test in this context is 
established potential advantages would include its rapidity and 
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simplicity (Cathcart 1975 pg 121). A lack of specificity could 
be predicted from the studies of Bartfeld (1969) and Reimer et 
!l (1975). This would, however, be of lesser importance than a 
high sensitivity, as the consequences of overdiagnosis are 
likely to be far less serious than those of underdiagnosis 
( Go n i n 19 8 5) • 
The use of serological tests for congenital syphilis in 
symptomatic infants is more certain (Rathbun 1983a). The VDRL 
test and FTA-ABS ( IgM) test are often useful in this regard 
(Borobio et al 1980). However, in practice there is usually a 
delay of several days before the results of these tests are 
available. A test, which could be performed as a simple side-
room investigation would be useful. particularly in view of the 
fact that congenital syphilis may mimic a large variety of 
conditions (Alford et al 1975). 
It has been found that a high percentage of symptomatic infants 
with congenital syphilis have a positive RF latex test (Reimer 
et al 1975; Meyer and Malan 1987). However, there are no 
published studies that have investigated whether the RF latex 
test can distinguish between infants with congenital syphilis 
and those with similar clinical signs. If this is established, 
the characteristics of the RF latex test such as its rapidity 
and simplicity would clearly be advantageous. · 
As discussed above, testing for RF may have an unrealized value 
in the diagnosis of congenital syphilis. The presence of RF in 
congenital syphilis has, in the past, been regarded as an 
inconvenience, particularly in regard to the FTA-ABS (IgM) test 
(Ingall and Musher 1983 pg 359). Steps are usually taken to 
prevent interference by RF (Cerny et al 1985; Muller 1986). It 
is noteworthy, however, that the effect of abolishing RF 
activity has not been evaluated with respect to the FTA-ABS 
(IgM) test for congenital syphilis. 
4.2 AIMS 
The aims of the studies comprising Part Two were, therefore, to 
investigate these possibilities as follows. 
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Firstly to determine the usefulness of the RF latex test in the 
diagnosis of congenita 1 syph i1 is where the newborn infant is 
identified as being at risk of the disease. 
Secondly, to ascertain whether the RF latex test could 
distinguish between symptomatic infants with congenital syphilis 
and those whose clinical signs were due to other conditions. 
Thirdly, to demonstrate the effect on the FTA-ABS (IgM) test of 
RF removal. 
As these studies were to be carried out in the Peninsula 
Maternity and Neonatal Service in Cape Town some background 
information regarding this service is provided. 
4.3 THE PENINSULA MATERNITY AND NEONATAL SERVICE (PMNS) 
There are 5 maternity hospitals (Groote Schuur Hospital, Mowbray 
Maternity Hospital, Peninsula Maternity Hospital, Somerset 
Hospital, St Monica's Hospital) and 5 midwife obstetric units 
(Hanover Park, Heideveld, Khayelitsha, Mitchell's Plain and 
Retreat). High risk pregnancies are usually referred to the 
maternity hospitals for delivery. 
Altogether 25615 newborns were delivered in 1987. Forty percent 
of the women delivering in the PMNS were Africans, 59% were Cape 
Coloureds and 1% were of caucasian extraction (van Coeverden de 
Groot and van der Elst 1987). 
Of these patients, 94% received antenatal care prior to delivery 
(so called booked cases). According to hospital policy, 
serological tests for syphilis (STS) were performed on all 
patients who booked. The VDRL test was used as a screening test 
and the TPHA as a confirmatory test. A previous study found 
that 7.6% of booked mothers had serological evidence of active 
syphilis (Gonin 1985). 
The prevalence of syphilis is higher amongst unbooked pregnant 
women. These patients have STS performed on arrival to the 
labour ward and the percentage with positive VDRL and TPHA tests 
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was reported by Meyer and Woods ( 1989). It was found that 15% 
of 631 such women had positive tests. 
Once serological evidence of syphilis is obtained, treatment 
with benzathine penicillin 2,4 MU weekly for 3 weeks is 
commenced. 
The number of pregnant women who complete this therapy prior to 
delivery is unknown. A pilot study from Khayelitsha Midwife 
Obstetric Unit (MOU) was undertaken by Subotsky and Del port 
(1988). Of 52 pregnant women with syphilis who presented in 
labour and whose treatment status could be ascertained, 22 (42%) 
were fully treated whilst 30 (58%) were untreated or 
incompletely treated. A study from King Edward VIII Hospital in 
Durban indicated that fewer than 10% of patients received 
treatment in the prescribed manner (Manning et al 1985). 
The figures presented for the PMNS indicate that there are a 
1 a rge number of infants at risk of congeni ta 1 syphilis in that 
they are born to mothers who are unbooked or inadequately 
treated. 
How were these infants managed at the time the study was 
undertaken? 
Infants with definite clinical signs who had serological and/or 
radiological evidence of congenital syphilis were treated with 
intramuscular procaine penicillin 50 000 units per kilogram 
daily for 10 days. Newborn infants who were asymptomatic had a 
total IgM estimation performed on blood obtained from a heel-
prick. If the result was elevated, further investigations, in 
the form of the FTA-ABS (IgM) test and roentgenology of the long 
bones were carried out. If one or more of these tests were 
positive the infant was treated as already described. If the 
tests were negative a period of follow-up was arranged during 
which time the VDRL or RPR titre was monitored. Infants whose 
tests reverted to negative were discharged after 3 months. 
Infants whose tests showed rising titres or did not become 
negative during a 3-6 month follow-up were treated. 
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The overall prevalence of congenital syphilis in the PMNS is 
unknown, although Delport et al . (1989) estimated it to be 0,05 %. 
This is almost certainly an underestimation as stillbirths and 
asymptomatic cases were not included (Meyer 1990) 
Compared to congenital syphilis, clinical signs due to other 
congenitally acquired infections are relatively rare amongst 
infants in the PMNS. 
Congenital cytomegalovirus infection (CMV) was proven in only 5 
cases between 1972 and 1982. There were 11 'possible'. cases 
during this same period (Keen 1989). The prevalence of 
congenital CMV in the PMNS is not known. In similar 
populations elsewhere, however, 1.5% of infants are infected 
(Keen 1989). Of these only 5% will have the typical clinical 
signs at birth (Peckham et aljl983; Stagno et al 1984 pg 108). 
Congenital rubella was diagnosed in 6 cases between 1983 and 
1985 (Keen 1989). 
There were no cases of perinatally acquired human 
immunodeficiency virus (HIV) infection during the period in 
which the study on congeni ta 1 syphilis was performed ( February 
1987 to May 1988). Likewise a small pilot study of 1762 
antenatal sera in 1988 showed no positive tests for HIV (Keen 
1989, Spracklen 1989). 
There is little information regarding the prevalence of 
congenital toxoplasmosis in the PMNS. However, Jacobs (1978) 
obtained a figure of 0,003% in Johannesburg. 
Of the congenital infections described above, congenital 
syphilis is readily preventable by good antenatal care (Fiumara 
1951). Failing this the effects of the disease can be minimized 
by early diagnosis and treatment (Budell 1982 pg 936). The 
usefulness of the RF latex test in facilitating early diagnosis 
was evaluated in the studies which follow. 
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CHAPTER 5 
AN EVALUATION OF THE RHEUMATOID FACTOR LATEX TEST IN 
NEWBORN INFANTS AT HIGH-RISK OF CONGENITAL SYPHILIS 
The aim of this section was to determine the value of testing 
for RF in newborn infants at high-risk of congenital syphilis 
due to the presence of untreated or inadequately treated 
maternal syphilis. 
The value of measuring RF by means of a latex test was assessed. 
The sensitivity, specificity, and positive and negative 
predictive values of the test were determined. 
In addition, the usefulness of other diagnostic tests, which 
were also performed at birth, were compared to that of the RF 
latex test. 
5.1 STUDY DESIGN AND METHODS 
5.1.1 
In essence, a group of newborn infants at high-risk of 
congenital syphilis were prospectively selected. A variety of 
tests, including the RF latex test were performed at birth. The 
infants were then followed-up until they could either be 
pronounced free from infection with Treponema pallidum or they 
fulfilled a set of criteria, enabling the diagnosis of 
congenital syphilis to be made. 
Patient selection 
Groups of high-risk newborns and controls were studied. 
High-risk newborn infants 
Newborns were regarded as being at high-risk for contracting 
congenital syphilis if their mothers had positive reagin (e . g~ 
VDRL) and treponemal (e.g . TPHA) tests for syphilis and if their 
mothers were: 
i. untreated or 
ii. treated in the last month of pregnancy or 
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iii. treated with erythromycin 
That infants in these categories are at high-risk of congenital 
syphilis has been described in Chapter 2 {Fiumara 1951; Fiumara 
et al 1952; ~Joody et al 1964, South et al 1964). 
The method of patient selection was as follows. 
The labour ward delivery book at Groote Schuur Hospital was 
examined daily (Monday to Friday). Mothers with positive VDRL 
and TPHA tests were interviewed and their hospital folders 
inspected. Information was obtained regarding: 
i. the presence of signs or symptoms of syphilis in the mother 
ii. the date on which the VDRL and TPHA were done 
iii. the VDRL titres 
iv. treatment given during current and previous pregnancies. 
Details relating to treatment were also obtained from the cards 
of the local authority clinic responsible for treatment of 
sexually transmitted diseases. 
authority clinic was contacted. 
In uncertain cases the local 
Mothers who had previously been treated for syphilis and who had 
stable, low reagin antibody titres were excluded from the study. 
Mothers whose serology had been performed before the last 
trimester of pregnancy had repeat VDRL and TPHA tests at 
delivery. 
The mothers who were unbooked underwent serological testing on 
arrival to labour ward. Close liaison with the Microbiology 
Department at the University of Cape Town, Medical School 
enabled results to be obtained within 1 to 2 days of delivery. 
Mothers whose VDRL and TPHA tests were positive were considered 
for the study. 
The infants were then examined clinically. Those who \'Jere 
symptomatic and fulfilled the diagnostic criteria described by 
Kaufman et al (1977) entered the study and were treated. 
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A set of diagnostic criteria were used since there is no 'gold 
standard' test available for the diagnosis of congenital 
syphilis (Kaufman et al 1974). The reasons for chasing the 
criteria of Kaufman et al (1977) are discussed in Chapter 2. 
In addition to symptomatic patients, infants who were 
asymptomatic were included: 
i. if their mothers were to be resident at a contactable Cape 
Town address for at least four months after delivery 
ii. provided they did not receive treatment with antibiotics 
for coincidental reasons e.g. amniotic fluid infection 
syndrome. 
A nursing sister, with community health experience, visited th~ 
mothers and infants soon after discharge to check their 
addresses. 
An attempt was made to select 2 suitable cases per week. 
If two patients were not available at Groote Schuur Hospital in 
any one week then the labour ward registers in other parts of 
the PMNS were studied. The other units were contacted in the 
following order: 
Heideveld MOU, Khayelitsha MOU, Peninsula Maternity Hospital, 
New Somerset Hospital. 
The aim was to include 20 infants with congenital syphilis in 
the high-risk group. From the data quoted by Fiumara (1975) one 
would expect there to be 20 infants with congenital syphilis 
amongst 50 infants born to mothers with untreated early latent 
syphilis. 
The flow chart (Figure 5.1) summarizes the selection of infants 
for the study from the time that an expectant woman delivers in 
hospital. 
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Figure 5.1: Flow chart of patient entry into study 
WOMAN DELIVERS AT GROOTE SCHUUR HOSPITAL 
I Booked I Unbooked I -
STS negative 
Excluded 
.....__ from 
study 
STS positive STS negative 
Mother fully Mother treated 
treated inadequately 
Untraceable Traceable 
address address 
Excluded 
from 
study 
Ent High 
Risk 
Group 
Enters 
Control 
Group 
5.1.2 
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Controls 
It was anticipated that not all the high-risk infants would 
actually have congenital syphilis. The ones in whom the disease 
could be excluded would act as controls. 
In addition, however, a group of infants with negative serology 
for syphilis were also studied. Newborn infants whose mothers 
were unbooked on arrival to labour ward were considered for this 
group. 
Only mothers and their babies whose VDRL and TPHA tests were 
negative were included. An attempt was made to select 2 such 
newborn infants at Groote Schuur Hospital per week. The first 2 
suitable controls who presented after midnight on Sunday of any 
given week were entered into the study. 
As the aim was to compare the usefulness of the tests at birth 
the controls with negative STS were not followed-up. 
Ethics 
There is little doubt that symptomatic cases of congenital 
syphilis require appro priate therapy as soon as possible and 
this was adhered to throughout the study. At the time of 
commencement of the study ( 1937) the recommendations of the 
Centers for Disease Contra 1 ( USA) and the WHO regarding the 
management of asymptomatic newborn infants considered to be at 
high-risk of the disease, were similar (Kaufman et al 1977 and 
WHO 1982). Both authorities suggested that a period of clinical 
and serological surveillance was justified provided that 
adequate follow-up could be ensured. 
Hith re gard to the present study asymptomatic patients were only 
included if they were from traceable addresses; hence follow-up 
was likely to be complete. 
Parents were informed as to the nature of the study and their 
consent was obtained to perform the serological tests on the 
infants. 
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Approval for the project was obtained from the Ethics and 
Research Committee of the University of Cape Town. 
5.1.3 Procedure at birth 
The infants were examined clinically. Approximately 3 ml of 
venous blood was drawn into sterile plain glass tubes and 
allowed to clot at room temperature. The serum was removed and 
either tested immediately or aliquoted and frozen at -70°C. 
The following serological investigations were performed on all 
infants: RF latex test, total IgM level, VDRL and TPHA. 
Sera from infants born to mothers with positive STS were 
subjected to the FTA-ABS (IgM) test. 
Radiological examination of the long bones was also performed on 
the infants whose mothers had positive STS. 
The tests 1 i sted above were chosen for com pa ri son with the RF 
latex test because they were felt to be the most likely to be 
helpful in making the diagnosis of congenital syphilis (Kaufman 
et al 1974; Borobio et al 1980; Pickering 1985). Many authors 
recommend performing a CSF examination (e.g. Taber 1982; Rathbun 
1983a). However, Srinivasan et al (1983) could not demonstrate 
any benefit from carrying out the test in asymptomatic newborn 
infants and the Centers for Disease Control ( CDC 1988c) 
recognizes that the use of CSF examination in diagnosing 
congenital syphilis is debatable. 
All tests were done within the first 2 days of life. 
Infants with congenital syphilis were treated with procaine 
penicillin 50 000 u/kg daily for 10 days. 
Mothers were treated with benzathine penicillin and referred to 
the local authority clinic for further therapy and tracing of 
contacts. 
5.1.4 
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Follow-up procedure 
Mothers with positive serology whose infants were asymptomatic 
were given follow-up appointments for 6 weeks of age. A letter 
was attached to the infant's 'Road to Health' card. The letter 
stated that the infant was to be seen at Groote Schuur Hospital 
for follow-up. Health care personnel were requested not to 
treat the infant without first discussing the case with the 
researcher. 
The community worker visited the family prior to the follow-up 
appointment. 
At the 6 week visit the mother was questioned with regard to: 
i. health of the infant 
ii. whether the infant had received any medications or 
injections 
iii. whether she and her consort had received treatment. 
~lhere possible, clinic cards were checked to substantiate the 
history. 
The infant was examined. Venous blood was taken for repeat VDRL 
and RF latex titres. 
A return visit was scheduled for 4 months of age. Bus fare was 
provided. 
The procedure at the 4 month visit was the same as that 
described above. 
Any infant who developed features of congenital syphilis was 
treated as outlined previously. The diagnosis of congenital 
syphilis at follow-up was made according to the criteria of 
Kaufman et al (1977), except that, as discussed in Section 
2.4.1, 6 months was regarded as the limit by which passively 
transferred reagin antibodies should have disappeared in 
uninfected infants. 
5.1.5 Serolog;cal tests 
Rheumatoid factor 
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The presence of RF was determined using an RF latex slide 
agglutination test ('Ortho RA Test' produced by Ortho Diagnostic 
Systems, Belgium). Sera were tested at the Red Cross War 
Memorial Children's Hospital, Cape Town. The technologist 
performing the tests was not aware of the clinical or 
serolo gic al status of the patients. 
Sera, which had been collected from high-risk patients and 
controls, were either tested immediately or stored at -70°C. 
Frozen samples were thawed slowly at room temperature; they were 
then thoroughly mixed. 
The test procedure described in the diagnostic kit was followed. 
except that a serum dilution of 1:5 was used in addition to the 
recommended 1:40 dilution. 
This manipulation would enable the detection of 4 IU of RF/ml. 
(The sensitivity of the RF latex test was 0.8 IU/ml ). 
Further details about performing the test, and aspects of 
quality control are discussed in Appendix 2. 
Total serum IgM levels 
These were measured using a commercially available radial 
immunodiffusion assay (Immune-plate IV, Hyland Diagnostics, 
USA) • A 'Low 1 eve 1 human IgM Test Kit' ( ca ta 1 ogue number 085-
403) was used for the neonatal sera and a 'Human IgM test kit' 
(catalogue number 085-404) for the sera obtained at follow-up 
visits. Details of the actual procedure followed and the 
quality control determinations are given in Appendix 2. The 
upper limit of normal for this study was regarded as 42 IU/ml. 
This was the level 2 standard deviations above the mean obtained 
by testing 408 newborn 
syphilis ( see Appendix 
information) 
infants who did not have congenital 
2 and Figure A.2.1 for further 
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Venereal Disease Research Laboratory (VORL) test 
The VDRL antigen was obtained from Wellcome Diagnostics, England 
(catalogue number VD 02-03). The VDRL tube flocculation test 
(Harris et al 1948) was carried out by the Department of Medical 
Microbiology, University of Cape Town. 
Treponema Pallidum Haemagglutination (TPHA) test 
TPHA test kits were obtained from Fujirebio Incorporated, Japan 
(catalogue number FD 101). The test was performed according to 
the manufacturers instructions and was carried out in the same 
laboratory as the VDRL test. 
FTA-ABS (IgM) test 
The anti gen used was the FTA Treponema pa 11 i dum suspension, 
procured from Behring, West Germany (catalogue number ORMK 
04/05). The anti-human IgM was a product of Hel lcome 
Diagnostics, England (catalogue number MF 04). 
According to the manufacturer's recommendations possible 
interference from RF was eliminated using a sheep anti-human lgG 
(RF Absorbent, Behring, West Germany, catalogue number OUCG 
14/15). 
Serum was diluted 1:5 in FTA absorption medium from the FTA-ABS 
OS kit (Zeus Scientific, USA) and further diluted by a factor 
of 2 in the RF absorbent. This gave a final serum dilution of 
1: 10. 
Further details of the test are recorded in Appendix 2. Testing 
was performed in the laboratory described above (c and d). 
Radiography 
The long bones of the upper and lower extremities were subjected 
to standard radiological techniques. The tests were performed 
by the Radiology Department at Groote Schuur Hos pi ta 1. Once 
again, the radiologist giving the report did not know the 
clinical status of the pati·ents; all request forms simply stated 
that there was a maternal history of syphilis. 
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5.1.6 Statistical •ethods 
Statistical analysis was performed using the Student's t test, 
Chi-square test, the median test and Fisher's exact test {Bourke 
et al 1985 pg 113-122). The calculations were carried out using 
a computer programme {Epistat 1986). 
5.1.7 Costs 
The approximate costs of materials used to perform the various 
tests were obtained from the relevant hospital departments 
concerned. Technologist I s time and use of 1 aboratory equipment 
were not taken into account. 
5.2 RESULTS 
5.2.1 Mothers 
There were a total of 69 mothers of whom 42 {6U) were Blacks 
and 27 { 39%) were Cape Coloureds. None of the mothers had 
symptoms of syphilis either at antenatal clinic visits or at 
delivery. Sixty nine percent had received some antenatal care. 
The 69 mothers gave birth to a total of 15 infants with 
congenital syphilis {see Figure 5.2 and 5.3) 
Overal 1, 50 { 72%) of the mothers had not received any anti-
syphilitic therapy prior to delivery. This group of mothers 
with untreated syphilis gave birth to 14 infants with congenital 
syphilis. The majority of mothers (13/14) with infected 
children had VORL titres above 1:16. 
Nineteen mothers (28%) had obtained treatment for syphilis. 
Fourteen received benzathine penicillin in the last month of 
pregnancy, while 5 had been treated with erythromycin. The 
infant of one mother (no. 5.6) in the treated group had 
radiological features of congenital syphilis. The mother had 
received one injection of benzathine penicillin 11 days prior to 
delivery. None of the other infants of this group of mothers 
developed congenital syphilis. 
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The maternal VDRL titres were obtained in the last trimester of 
pregnancy and in 64/69 cases in the last month. The mothers of 
infants who developed congenital syphilis had higher VDRL titres 
(median 1:128; range 1:2-1:512) than the mothers of infants that 
were not affected (median 1:4; range 1:1-1:32). This difference 
was statistically significant as determined using the median 
test (p = 0.00017). 
Figure 5.2 shows the frequency distribution of the mothers' VDRL 
results in the treated and untreated groups. 
affected infants is also shown. 
The number of 
Further information concerning the mothers is given in the 
tables describing the results (see Tables 5.1 and 5.2) 
5.2.2 Infants 
Of the original 69 infants, one was lost to 4 month follow-up 
(no. 5.47). ~/hen she was seen at 3 months, however, her VDRL 
titre was declining (1:1) and she was clinically well. Two 
infants (nos 5.26 and 5.53) were treated for congenital syphilis 
by attendant doctors because of the maternal history although 
there were no clinical signs or serological changes compatible 
with the disease. The overall outcome of the infants is 
summarized in Figure 5.3, and the results are detailed in Tables 
5.1 and 5.2. 
Infants with congenital syphilis: There were 15 infants in whom 
a diagnosis of probable congenital syphilis was made on the 
basis of the criteria of Kaufman et al (1977). As soon as an 
infant fulfilled the criteria, therapy with procaine penicillin, 
50 000 u per kilogram per day for 10 days was commenced. Seven 
of the infants were treated at birth and the other 8 after a 
period of follow-up. The 7 cases treated at birth could be 
subdivided into 2 groups: those with clinical signs and those 
without. The infants without abnormal clinical findings .at birth 
fulfilled the diagnostic criteria by virtue of having 
radiological abnormalities of the long bones. Had it not been 
for this investigative procedure the diagnosis would only have 
become apparent at a later stage. 
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Figure 5.3: Schematic diagram: Outcome of infants at risk for congenital 
syphilis 
1: lost 
to fo 11 ow-up 
TOTAL: 69 
2: treated 
by other 
doctors 
Remi1nder: 66 
15: congenital 
syphilis 
51: normal 
7: diagnosed 
at birth 
8: diagnosed 
at fo 11 ow-up 
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Infants with definite clinical signs of congenital syphilis at 
birth 
Three of the 4 infants in this category had evidence of 
widespread disease (see Table 5.1). Case no. 5.2 died on day 1. 
The postmortem findings were consistent with the diagnosis of 
congenital syphilis although spirochaetes were not identified. 
Most of the infants mounted an immunological response. Three 
had positive RF latex tests while 4 had elevated total IgM 
levels. Only 2 patients had positive FTA-ABS (IgM) tests. Case 
no. 5.3 showed evidence of having produced IgM (total and anti-
treponemal IgM levels elevated; no IgM RF). The absence of free 
RF was confirmed with the RF ELISA. Techniques to detect hidden 
RF were also negative (see Chapter 9). 
None of the infants had significantly elevated VDRL titres i.e. 
4 times greater than those of their mothers ( Ingal l and Musher 
1983 pg 358). 
Infants with congenital syphilis who did not have definite 
clinical signs at birth 
Three infants (nos. 5.5-5.7) had metaphyseal dystrophy of the 
long bones demonstrated on roentgenology soon after birth. All 
three were term, appropriately grown infants. Two were noted to 
have minimal pretibial oedema. Two of these 3 infants had 
positive RF latex tests, elevated total IgM levels and positive 
FTA-ABS ( IgM) tests. In the third infant these test results 
were not abnormal. The 3 infants were treated soon after birth. 
Eight infants (nos. 5.8-5.15) had no evidence of congenital 
syphilis at birth but features of disease became apparent during 
fo 11 ow-up. 
Six of the 8 were term infants of normal birth weight; 2 who had 
low birth weights were preterm and small for gestational age 
(SGA)*. Two infants had positive RF latex tests at birth and 1 
had a ra i sect total IgM level. The other tests ( FT A-ABS ( IgM) 
* SGA - birthweight less than tenth percentile on the charts of 
Lubchenco et al (1966) 
118 
and roentgenograms of the long bones) were negative at birth in 
all 8 infants. 
Five of the 8 infants who were not treated at birth developed 
clinical signs of congenital syphilis at follow-up (nos. 5.8-
5.12). In addition the VDRL titres became diagnostically 
elevated (i.e. showed a four-fold rise in titre over the birth 
result ) . The other 3 infants (nos. 5.13-5.15 were well but had 
diagnostically raised VDRL titres. 
The RF latex results at follow-up are also given in Table 5.1. 
Of the 8 cases diagnosed at follow-up 1 was treated prior to the 
follow-up date. Six of the remaining 7 had positive RF latex 
tests at or prior to the time congenital syphilis was diagnosed. 
Infants not affected 
There were 51 infants who \-Jas asymptomatic at birth and who did 
not fulfil the diagnostic criteria for congenital syphilis 
during follo1t1-up. Table 5.2 sho1t1s the details of each patient 
in this group. 
Most of the infants were full-term with birth weights 
appropriate for gestational age. Sixteen infants were of low 
birth ~~eight: 7 were term and SGA; 7 were preterm; 2 were 
preterm and SGA. The proportion of low birth weight infants was 
similar to that of the infants with congenital syphilis (p > 
0,05 using Fisher's exact test). 
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The RF latex test was negative at birth in all 51 infants. 
Twenty nine of the infants had a positive VORL test (in 1 
patient serum was insufficient for a titre). Twenty one 
patients had negative tests (in 1 infant the specimen was 
lipaemic and the test could not be done). The median VORL titre 
in the unaffected infants \"as 1:1 (range 0-1:128), which was 
lower than in the infants with congenital syphilis (median 1:16; 
range 0-1:256). This difference in VORL titres was statistically 
significant (p=0.033 using the median test). The TPHA was 
positive in 49 infants, doubtful in 1 and nonspecific in another 
(the FTA-ABS IgG test was positive in these latter 2 infants). 
Forty nine of the infants had a normal total IgM level while 5 
had elevated levels(> 42 IU/ml). Of the 5 infants, 4 (nos. 
5.18, 5.41, 5.56 and 5.64) were well, appropriately grown 
infants, whose mothers had not received therapy for syphilis. 
The fifth infant (no. 5.33) was born at term but was somewhat 
lethargic on day 1. His mother had been treated for syphilis 
with erythromyci n during pregnancy. Blood cultures and a CSF 
examination were negative and by day 3 he appeared well and was 
discharged without treatment. Urine cultures for CMV were 
negative. All 5 infants had negative lgM antibody tests for 
toxoplasmosis, rubella and cytomegalovirus infections. Repeat 
serum samples tested for CMV IgM remained negative at the 6 week 
and 3 month follow-up. The cause for these elevated IgM levels 
was not determined. 
None of the 51 infants had abnormalities detected on radiography 
of the long bones and all had negative FTA-ABS ( IgM) tests. 
Considering all the asymptomatic infants at birth i.e. those 
shown to be unaffected as well as th'Jse who went on to develop 
features of congenital syphilis, it can be seen from Table 5.3 
that the RF latex test, radiography and the FTA-ABS ( IgM) test 
were able to identify a proportion of the infected infants. The 
total IgM test and the VDRL were less useful in this regard as 
positive results were also obtained in unaffected infants. 
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Results at follow-up 
During the follow-up period several infants had minor ailments 
such as upper respiratory tract infections and diarrhoeal 
disease (see Table 5.2). As far as could be ascertained from 
the mothers, none of the infants were given antibiotics. Case 
no. 5.20 had features of fetal alcohol syndrome and no. 5.55 
developed diarrhoeal disease with hypoalbuminaemia requiring 
admission at 4 months of age. Three other infants, nos. 5.30, 
5.39 and 5.62, had probable intercurrent viral infections, the 
clinical signs of which resolved spontaneously. 
Five patients developed a positive RF latex test on follow-up. 
In 4 cases (nos. 5.24, 5.39, 5.63 and 5.64) the test was 
positive between 4-8 weeks. Case tlo. 5.46 had developed a 
positive test by 4 months. One infant had an upper respirtory . 
tract infection at 'the time and another had recently had chicken 
pox. The remainder were well. 
Of the 30 infants who had a known positive VDRL titre at birth, 
12 patients had negative tests by 6 weeks, the majority of the 
remainder were negative by 4 months. 
Contro 1 infants 
Eighty five normal infants whose mothers had negative VDRL and 
TPHA tests were studied. The infants had no signs of congenital 
infection. Their findings are shown in Appendix 3. Fifteen 
were term and SGA, 4 preterm and SGA and 12 were preterrn. 
The RF latex test was negative in all cases at birth. The 
median total IgM level was 21 IU/ml with a range of 5-291 IU/ml. 
In 3 cases, the total IgM level was elevated. The cause of this 
elevati on was not apparent; the IgM antibody tests for 
rubella, toxoplamosis and cytomegalovirus were negative in all 
cases and the urine culture for cytomegalovirus, which was 
performed in 1 case, was negative. 
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5.2.3 Comparison of test results 
Usefulness of the various diagnostic tests 
A summary of the results obtained in the infants with congenital 
syphilis is shown below (Table 5.3). 
TABLE 5.3: 
SUMMARY OF TEST RESULTS AT BIRTH FOR INFANTS AT RISK OF 
CONGENITAL SYPHILIS 
Infant Affected Infant not 
Affected 
Clinical No clini-
signs present ca 1 signs 
No. 4 11 51 
+ve RF 1 a tex test 3 4 0 
Total lgM ( > 42 IU/ml) 4 3 5 
X-ray abnormality 2 3 0 
+ve FTA-ABS ( lgM) test 2 2 0 
+ve VDRL test 4 8 29 
The sensitivity, specificity and the positive and negative 
predictive values of the various tests in the diagnosis of 
congenital syphilis can be calculated. 
RF Latex Test 
A 2 x 2 contingency table (Table 5.4) to calculate the 
usefulness of the RF latex test in the diagnosis of congenital 
syphilis is shown below. 
133 
TABLE 5.4 
USE OF THE RF LATEX TEST IN THE DIAGNOSIS OF CONGENITAL SYPHILIS 
Infant Infant 
Affected Not Affected 
RF Latex Test: 
Positive 7 a b 0 7 a+b 
Negative 8 C d 51 59 c+d 
15 a+c b+d 51 66 a +b+c +d 
The sensitivity a x 100% was 46.7% 
---
( a + C) 
The specificity d x 100% was 100% 
---
(d + b) 
The positive predictive value a x 100% was 100% 
---
(a + b) 
The negative predictive value d x 100% was 86.9% 
---
( d + C) 
Similarly, the values for infants with congenital syphilis who 
were asymptomatic at birth were determined. The 2 x 2 
contingency table is not shown but the results appear in Table 
5.5. It was apparent that the sensitivity of the RF latex test 
was lower (36.4%) amongst this group of patients. 
Total IgM, FTA-ABS (IgM), X-Rays, qualitative VDRL 
The values for these tests also appear in Table 5.5. The 
sensitivity of the RF latex test was less than that of the VDRL, 
while the former was more sensitive than the FTA-ABS (IgM) test 
or radi ology of the long bones in the diagnosis of congenital 
syphilis. These differences were not statistically significant 
(p > 0,05 using Fisher's exact test). 
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The specificities of the various tests were similar, with the 
exception of the VDRL which was significantly less specific than 
the RF latex test in the diagnosis of congenital syphilis (p < 
0,01 using the Chi-square test). 
The positive predictive values of the total IgM test and the 
VDRL were less than that of the RF latex test although only the 
latter difference was statistically significant (p < 0,05 with 
Fisher's exact test). 
The different tests had comparable negative predictive values. 
When the tests were evaluated in the asymptomatic infants, the 
sensitivities were lower and the positive predictive values of 
the total IgM test and the VDRL were also reduced (Table 5.5). 
VDRL titre results 
The mothers' VDRL titres were generally higher in those infants 
who developed congenital syphilis (Figure 5.2). 
In the group of infants whose outcome is known the diagnostic 
value of a maternal VDRL titre of 1:32 or above can be construed 
from the following 2 x 2 table (Table 5.6). 
TABLE 5.6 
DIAGNOSTIC VALUE OF MATERNAL VDRL TITRE IN CONGENITAL SYPHILIS 
Infant Infant 
Affected not Affected 
VDRL 1/ 32 or more 14 a b 12 26 a+b 
VDRL 1/16 or less 1 C d 41 42 c+d 
15 a+c b+d 53 68 a +b+c +d 
The sensitivity was 93.3%, specificity 80.4%, positive 
predictive value 58.3% and negative predictive value 97.6%. 
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Similarly, for infants with 'JDRL titres of 1:16 or more, the 
results are shown in Table 5.7. (The total number of infants is 
64 as not all infants had known VDRL titres at birth) 
TABLE 5.7 
DIAGNOSTIC VALUE OF INFANTS VORL TITRE IN CONGENITAL SYPHILIS 
Infant Infant 
Affected not Affected 
VDRL 1:16 or more 10 a b 3 13 a+b 
VDRL l:8orbel0\'I 5 C d 46 51 c+d 
15 a+c b+d 49 64 a +b+c +d 
The sensitivity was 66.7%, specificity 93.9%, positive . 
predictive value 76.9% and negative predictive value 90.2% 
Costs 
The costs of the various tests were as follows: 
RF 1 atex test 
Total IgM test 
Radiography of long bones 
FTA-ABS (IgM) test 
VDRL test 
5.3 DISCUSSION 
R0.67 
R4.66 
R0.75 
RS .00 
RO.Cl 
In this prospective study various tests used in the diagnosis of 
congenital syphilis were compared. The aim was to ascertain the 
usefulness of the RF latex test in a group of high-risk 
newborns. 
136 
5.3.1 Usefulness of the RF Latex Test 
Sensitivity 
The overall sensitivity of the RF latex test (defined as its 
ability to be positive in persons with the disease) was 46.7% 
(see Table 5.4) 
Symptomatic infants 
Considering only the 4 symptomatic cases, the sensitivity was 
75%. This figure is within the range reported for other 
studies. Reimer et al (1975) detected RF in 26 (96.3%) of 27 
cases, while Meyer and Malan (1987) reported positive RF latex 
tests in all 14 infants with clinical signs of the disease. 
Dobson et al (1988a) found RF in 3 (50%) of 6 symptomatic 
infants and Pedersen et al (1989) detected RF in 7 of 9 such 
patients. Whilst all the studies report on infants with 
congenital syphilis, not all the patients were newborns. The 
ages of the subjects and therefore the results may not be 
comparable. Evidence in support of age-related changes in RF 
levels is presented in Chapter 9. 
Nevertheless, it is interesting to note that one of the 
symptomatic infants in the present study had no detectable RF at 
the time of diagnosis. This is in contrast to the 100% 
positivity found in the pilot study (Meyer and Malan 1987). The 
reason(s) for the negative result are unknown. Hidden RF (i.e. 
RF complexed to serum IgG and therefore not demonstrable in the 
latex test) was not detected (see Chapter 9). Overwhelming 
infection has also been suggested as an explanation for the lack 
of an IgM response in infants with congenital syphilis {Ackerman 
1969). The case in question, however, did not have severe life 
threatening disease and had an elevated total IgM level. 
Another explanation is that RF was produced, but became 
deposited in the tissues along with immune complexes. Tissue 
deposition of RF has been shown to occur in the kidney {Ford and 
Kosatka 1982), and it has been postulated that it could deplete 
the serum of free RF (Rossen et al 1977). These aspects of the 
RF response in infants with congenital syphilis are further 
discussed in Chapter 10. 
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Asymptomatic cases 
The RF latex test was positive in only 4 of the 11 infants 
without definite clinical signs of congenital syphilis 
(sensitivity 36.4%). 
Except for the VDRL tests, however, the other tests did not have 
a better sensitivity. This is disturbing as it is in the group 
of infants without clinical signs of disease that a sensitive 
diagnostic test is most needed (Kaufman et al 1974). The 
reason(s) for the low sensitivity of the RF latex test in this 
setting are unknown. It is likely, however, that some of these 
infants were infected late in pregnancy and that their disease 
was therefore of short duration. The absence of radiographic 
features of disease in 8 of the infants who lacked definite 
signs of congenital syphilis would be in keeping with this as 
bony lesions are usually apparent after approximately 5 weeks 
(Ingraham 1936). Two infants had negative VDRL tests at birth 
and this also suggests late infection (Boissiere 1967; Sparling 
1971) • 
It has even been described that infants may become infected 
during delivery (Stokes et al 1945 pg 1094). This is a rare 
event, however, and was considered unlikely in view of the 
absence of a primary site of innoculation being found in the 
asymptomatic cases in this study. 
Rheumatoid factor production can occur within 2 weeks in certain 
infectious diseases (Barfeld 1968), although work in patients 
with subacute bacterial endocarditis has shown that RF is more 
like 1 y to be present the 1 onger the duration of infect ion 
(Messner et al 1968; Bacon et al 1974). In additon, RF levels 
appear to be directly related to the antigenic load (Carson ~ 
2..l. 1978). The explanation for the absence of RF in some of the 
clinically well infants with congenital syphilis may, therefore, 
be recent infection and/or the presence of a low antigen load. 
Attempts were made to improve the sensitivity of the tests used 
in the present study to detect RF. The manufacturers recommend 
that a dilution of 1:40 be used for the RF latex test. In this 
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study. the test was performed at dilutions of 1:5 and \:40 (at a 
dilution of 1:5, a serum concentration of 4 IU/ml of RF would be 
detectable). There was no loss of specificity using the 1:5 
dilution when carrying out the tests on newborns. In addition. 
2 cases (nos. 5.6 and 5.10) had positive RF latex tests at a 
dilution of 1 :20 but negative tests at 1 :40. The recommended 
cut-off levels for adults may therefore not apply in newborns. 
Borobio et al (1980). using a commercial latex kit at a dilution 
0f 1: 25 reported negative RF tests in all 9 patients with 
suspected congenital syphilis. Of the cases described 2 were 
definitely asymptomatic and another 2 presumably asymptomatic at 
the time of testing. It would be interesting to know if the 
latex tests were repeated at other dilutions. 
Of the 26 patients with congenital syphilis described by Reimer 
et al (1975) who had positive RF latex tests. only 12/26 (46%) 
had positive tests at a dilution greater than 1:32. 
The rationale for performing the RF latex test at a dilution of 
1:40 as well as at 1:5 in the present study was to eliminate any 
prozone effect. 
The RF ELISA described in Chapter 8 was able to detect 0,025 -
0,05 IU/ml of RF. Using this more sensitive test. RF was 
detected in 9 of the 15 infants with congenital syphilis 
(sensitivity 60%). These results are presented in more detail 
in Chapter 9. The apparent improvement in sensitivity was not 
statistically significant (Fisher•s exact test p > 0,05) and was 
at the expense of using a more complicated test. Workers in 
other fields have not found a meaningful advantage when using 
the RF ELI SA to detect RF com pa red to the more conventional RF 
latex test (Stone et al 1987). This is further discussed at the 
end of this Chapter. 
Specificity 
The specificity of the RF latex test performed at birth was 
100%. That is, all the infants in the high-risk group who did 
not have congenital syphilis had negative RF tests at birth. No 
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previously reported study has determined the specificity of the 
RF latex test in congenital syphilis. It is known, however, 
that RF is produced in other congenital infections such as 
rubella, CMV and toxoplasmosis (Reimer et al 1975; Hyde et al 
1975; Stagno et al 1980). One would expect, therefore, that if 
a large enough population were tested, congenital infections 
other than syphilis would be detected using the RF latex test. 
Although the incidence of congenital CMV in the population 
studied is unknown, similar populations elsewhere have a 1.5% 
incidence (Keen 1989). 
Forty two percent of infants with congenital CMV have been shown 
to have positive RF latex tests (Griffiths et al 1982). 
Therefore, the 100% specificity found in the present study is 
almost certainly an overestimation due to the relatively small 
size of the high-risk group. 
Indeed, in a developed country, such as Britain, there is little 
congenital syphilis and proportionately more CMV (Peckham et al 
1983; Adler 1984). Using the RF latex test to diagnose 
congenital syphilis in such a situation would be likely to lead 
to many false positives. 
Less is known about the presence of RF in other congenital 
infections such as that caused by HIV. 
The cases with positive RF latex tests in the study had other 
strong supporting evidence for congenital syphilis e.g. positive 
maternal serology, characteristic radiological abnormalities, 
positive FTA-ABS (IgM) tests after RF removal or diagnostically 
rising VDRL titres. It is highly unlikely that any of the 
infants did not have congenital syphilis. 
Positive predictive value 
The positive predictive value of the RF latex test was also 100% 
in the study. For reasons similar to those mentioned concerning 
the specificity of the test, the positive predictive value would 
be expected to be lower if infants with other congenital 
infections were present in the population studied. 
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Nevertheless, it appears that the false-positive rate of the RF 
latex test in well infants at birth is low. In this study 53 
high-risk newborns and all 85 controls had negative tests. 
Stagno et al (1980) found negative tests in 676 well newborns. 
In the study reported by Meyer and Malan (1987), 80 neonatal 
controls had negative tests. 
In the current study, however, RF was detected in well infants 
outside the neonatal period. Thus 5/51 (9.8%) of the infants 
who did not have congenital syphilis developed positive RF tests 
at follow-up between 4 weeks and 4 months. Similarly, Stagno~ 
~ (1980) found that 12-14% of well infants had positive RF 
latex test between 1 and 3 months of age. Reimer et al (1975) 
fo·und positive tests in 6 (4.3% of 42) well infants; their age 
is not stated. The possible reasons for the presence of RF 
outside the neonata·l period are discussed in Chapter 9. 
Negative predictive value 
The negative predictive value of the RF latex test was 86.6%. 
Thi_s value would change depending on the prevalence of 
congenital syphilis in the population studied. The intention in 
the present study was to apply the test to a defined group of 
high-risk newborn infants. In this group the prevalence of 
disease was 22.7%. Studying a similar group, Larsson and 
Larsson (1970) obtained a prevalence of 21%, whilst Srinivasan 
et al (1983) reported a figure _of 12,7%. The prevalence of 
congenital syphilis in the present study and in the studies 
quoted above was lower than the figure of 40% for infants of 
mothers with untreated early latent syphilis reported by Fiumara 
(1975). 
If the RF latex test was applied to a group of infants with a 
lower prevalence of disease the negative predictive value would 
increase. For example, Delport et al (1989) reported that the 
prevalence of congenital syphilis in Cape Town was 0.05%. It is 
known that 7.6% of antenatal clinic attenders had positive 
serological tests for syphilis (Gonin 1985) and that there were 
25 030 live births in 1987 (van Coeverden de Groot and van der 
Elst 1987). If one assumes that 12 infants with congenital 
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syphilis (0.05% of 25 030) were born to the 1902 (7.6% of 25 
030) expectant mothers with positive serology the negative 
predictive value of the test is: 
1902 X 100 = 99.7% 
(1902 + 6) 
This calculation assumes that the sensitivity of RF latex test 
is unchanged and that there is no increase in false positives. 
The calculation is in fact incorrect because: 
i. the group of mothers at risk is increased by the 5% or so 
who are unbooked 
ii. the incidence of congenital syphilis may be higher than 
that quoted as asyptomatic infants were not followed-up to 
determine outcome (Meyer 1990). 
5.3.2 Total lgM 
Sensitivity 
The overall sensitivity of the total IgM test (46.7%) was the 
same as that of the RF latex test. 
Symptomatic infants 
Measuring total IgM levels was more sensitive in identifying 
infants with clinical signs of congenital syphilis 4/4 (100%), 
than those without signs (3/11 or 27.3%). 
Other studies report similar figures for symptomatic infants e.g 
Tan (1973) found raised levels in 5/6 cases: 83.3% 
Srinivasan et al (1983) found raised levels in 4/4 cases: 100% 
Ewing et al (1985) found raised levels in 3/3 cases: 100% 
Malan (1987 pg 628) found raised levels in 17/18 cases: 94.4% 
Meyer & Malan (1987) found raised levels in 10/12 cases: 83.3%. 
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Asymptomatic cases 
The sensitivity of the total IgM estimation in asymptomatic 
infants was 1 ow. It is difficult to compare this figure to 
those of other studies reporting IgM levels in asymptomatic 
infants because the fi na 1 diagnosis in these studies was not 
based on an acceptable 'gold standard' (Mamunes et al 1970, 
Borobio et al 1980; Srinivasan et al 1983) • In these studies 
infants were treated before the outcome was known and therefore 
the value of the test could not be determined. Alford et al 
(1969b) found normal IgM levels at birth in 2 infants who 
subsequently developed congenital syphilis. 
Specificity 
The specificity of the total IgM test in the diagnosis of 
congenital syphilis was 92%. This was somewhat lo\'1er than that 
of the RF latex test (100%). The presence of raised IgM levels 
in 5/53 (9.4%) of the group without congenital syphilis was 
responsible for the lower specificity. 
Increased lgM levels were also present in 3/85 (3.5%) of the 
controls. None of the total of 8 infants with elevated levels 
had congenital syphilis although in the case of one infant (no. 
5.33) the mother had been treated, so it is possible that the 
infant had been treated in utero and the raised IgM level was 
part of the immune response. This seems unlikely, however, as 
there were no other features of infection and the radiological 
examination of the long bones was normal. 
The presence of other infections in the infants with raised IgM 
levels could not be totally excluded. All 8 infants had 
negative IgM antibody tests for rubella, toxoplasmosis and CMV. 
The presence of negative tests does not completely exclude these 
diagnoses, however ( Stagno et a 1 1980; Griffiths et a 1 1982; 
Keen 1985). 
Virus isolation from urine culture is a more useful method for 
the diagnosis of CMV (reviewed by Keen 1985) and negative 
results were obtained in 3 patients. Attempts were made to 
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obtain urine samples in the other 5 patients, but problems were 
encountered. Owing to bed ' shortages in the hospital. these well 
babies had been discharged by the time the IgM result was 
obtained. Several patients did not attend early follow-up as 
requested. Urine was not always obtainable after a reasonable 
wait during the outpatient visit. 
contamination were also encountered. 
Urine 1 eakage and faecal 
One of the infants with an elevated IgM level (no. 5.33) had 
transient non-specific signs of an infection but the work-up did 
not demonstrate any organisms. 
Other studies have also demonstrated raised IgM levels in 
apparently well infants. Stiehm et al (1966) found increased 
levels in 7 (5.4%) of 129 cord sera from newborns whose mothers 
had had normal pregnancies. McCracken et al (1969) detected 
elevated cord IgM levels in 10% of 2600 controls. Stagno et al 
(1980) tested 676 cord sera whilst screening for sub-clinical 
CMV infection. Twenty one (3.1%) of the unaffected infants had 
raised concentrations of IgM. 
The fact that positive RF tests were not obtained in the 8 cases 
with high amounts of IgM in the current study may reflect the 
absence of infection. 
On the other hand, if early infection were present there may 
have been time to produce lgM (which can appear after 5 days -
Al ford et al 1967) but not RF. 
Positive predictive value 
The positive predictive value of the total IgM test (58%) was 
lower than that of the RF latex test, although this difference 
was not statistically significant (p > 0.05 using Fisher's exact 
test) The· finding of elevated levels of IgM in infants who did 
not have congenital syphilis was res pons i bl e for this. Five of 
51 controls had raised total IgM concentrations compared to none 
w i th po s i t i v e R F 1 a t ex t e s ts • The h i g her n um be r o f fa 1 s e 
positive IgM tests was not, however, statistically significant 
(p > 0,05 using Fisher's exact test). 
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Negative predictive value 
The negative predictive value of the total IgM test (85.7%) was 
similar to that of the RF latex test (86.9%). 
5.3.3 Fluorescent Treponemal Antibody Absorption Test 
The performance of the FTA-ABS ( IgM) test will now be 
considered. 
Sensitivity 
The overall sensitivity of the test was 26.6%. This was 
apparently lower than that of the RF latex test (46.7%) but this 
difference was not statistically significant (p > 0.05 using 
Fisher's exact test). Considering symptomatic cases only, the 
sensitivity of the fluorescent IgM test was 50%. Kaufman et al 
(1974) pooled the data from several studies. They found the 
sensitivity of the test in symptomatic infants to be 88.4%. 
However, infants were included if they developed signs of 
disease at any time within the first month of life. Thus, the 
age of the infants studied may not be comparable to those of the 
present study. Furthermore, the largest study considered by 
Kaufman (that of Scotti et al 1969), does not supply information 
as to when the symptoms became apparent. 
Rosen and Richardson (1975) found positive FTA-ABS ( IgM) tests 
in all 33 infants who were symptomatic with congenital syphilis 
within the first week of life. 
Borobio et al (1980) reported positive tests in 5/5 symptomatic 
newborns at birth. In a previous study from Groote Schuur 
Hospital, Meyer and Malan (1987) determined that sera from 12/12 
infected newborns were reactive in the FTA-ABS (IgM) test. 
The sensitivity of the FTA-ABS (IgM) test in the asymptomatic 
infants in the present study (2/11 or 18.2%) was also 
considerably lower than the 65% sensitivity for cases with 
delayed onset disease reported by Kaufman .et al (1974). 
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Rosen and Richardson (1975) found positive tests in 3/3 newborns 
in a similar category. 
One possible reason for the apparently low sensitivity in the 
present study is that the method of performing the tests 
differed. 
Subsequent to the work cited above, it has become commonplace 
for steps to be taken to prevent RF interference prior to 
testing for specific treponemal IgM (Cerny et al 1985; Muller~ 
~ 1987). Rheumatoid factor may, in fact, have been responsible 
for some of the positive FTA-ABS (IgM) tests (Reimer et al 
1975). Therefore, RF removal could have reduced the sensitivity 
of the test. This hypothesis was investigated in Chapter 7. It 
was found that if measures to remove RF were not employed, the 
FTA-ABS (IgM) test .was positive in 60% of asymptomatic infants. 
The specificity of the FTA-ABS (IgM) test was 100% in the study. 
That is to say, there were no false positive tests. Kaufman et 
~ (1974) reported 10% false positives. This difference could 
be . attributed to the presence of RF. The present study 
considered only newborn infants; there were no positive RF 
latex tests in the newborn controls. Conversely, approximately 
10% of the older controls had positive RF latex tests at follow-
up. As the studies reported by Kaufman et al (1974) considered 
older infants, RF may have been present in uninfected infants 
and have resulted in a positive s.pecific IgM test (Reimer et al 
1975). 
The positive predictive va 1 ue of the FTA-ABS ( IgM) test was 
100%. This would imply that the investigation may be a useful 
confirmatory test. Indeed, Kaufman et al (1974) suggested this 
but noted that there had been few studies which have looked at 
results in infants with similar clinical signs who did not have 
congenital syphilis. This is further explored in Chapter 6. 
The negative predictive value (82.8%) was similar to that of the 
other tests evaluated. 
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5.3.4 Radiography 
Radiological examination of the long bones was less sensitive 
(33.3%) than the RF latex test (46.7%). However, this 
difference was not statistically significant (p > 0.05 using 
Fisher's exact test). As with the other tests, symptomatic 
infants were more likely to have abnormal films (2/4 or 50%) 
than asymptomatic ones (3/11 or 27.3%). Higher sensitivity of 
radiological examination in infants with clinical signs has been 
previously reported e.g. Platou 1949 and Hira et al (1985) found 
sensitivities of 88 and 95% respectively. However, the 
sensitivity in asymptomatic infants has not been previously 
reported. 
The specificity of the roentgenograms was high (100%). All the 
infants with bony involvement had metaphyseal dystrophy or an 
'osteitis-like' dystrophy. Rarely, other infections, including 
septicaemia have been noted to give similar radiological 
changes. However, septicaemic infants without signs of 
congenital syphilis were not included in the high-risk group as 
they received antibiotics at birth and were excluded from the 
study. The presence of a periosteal reactfon alone would be 
expected to have a lower specificity as such changes have been 
reported in normal infants (Malmberg 1944; Shopfner 1966). 
The positive and negative predictive values of the radiological 
examination of long bones did not differ significantly from 
those of the RF latex test. 
5.3.5 VDRL 
The usefulness of the VDRL test to diagnose congenital syphilis 
was also determined in the study. 
Qualitative results 
Considering merely qualitative results, the sensitivity of a 
positive test in infants with congenital syphilis was higher 
than that of the RF latex test (80% compared to 46,7%). This 
difference was not statistically significant (p > 0,05 using 
Fisher's exact test). 
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The Centers for Disease Control (CDC 1986) have also reported a 
high sensitivity for the VDRL test in congenital syphilis (95%). 
The specificity of a positive VDRL result at birth was low 
(41.5%). This is presumably because of passive transfer of 
reagin antibodies from the mother to the fetus in the absence of 
i n f e c t i o n • F o r s i m i 1 a r re a s o n s , the po s i t i v e pre d i ct i v e v a 1 u e 
of the VDRL was only 28%. The specificity and positive 
predictive values of the RF latex test were significantly better 
than those of the VDRL (p < 0,05 using the Chi-square test and 
Fisher's exact test respectively). These results confirm the 
well-documented problem with the VDRL test, namely its inability 
to distinguish between active infection and passive transfer of 
maternal antibodies (Stokes et al 1945 pg 1096-1099; Brown and 
Moore 1963). It was for this reason that better tests were 
sought in the first place (Scotti and Logan 1968). The negative 
predictive value was 87.5%, confirming that a negative test 
cannot completely exclude congenital syphilis (Ingall and Musher 
1983 pg 365). 
Quantitative results 
Infants' VDRL titres 
The median VDRL titre of infants in the infected group in the 
study ( 1 :16; range 0-1 :256) was significantly higher than that 
from the non-infected group (1:1; range 0-1:128). The p value 
was 0.033 using the median test. 
Srinivasan et al (1983) also found higher reagin antibody titres 
amongst infected infants. Fifty eight of 61 unaffected infants 
born to mothers with untreated or inadequately treated syphilis 
had RPR titres below 1:4. Conversely the 4 infants who 
definitely had congenital syphilis had RPR titres of 1:8 or 
above. 
Mascola et al (1985) found that 66% of infected infants had a 
VDRL titre of 1:16 or above. Unfortunately, there was no 
control group with which to compare these titres. Three of 5 
infants with congenital syphilis described by Alford et al 
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(1969a) had VDRL titres at birth of 1 : 16 or above. 
Maternal VDRL titres 
From this data, it seems that infants born to mothers with 
syphilis with higher VDRL titres may be more likely to have 
congenital syphilis. A possible explanation for this is that 
the maternal VDRL titre in untreated cases rises to a peak at 
. 1 year after infection and then gradually declines (Hart 1986). 
Although high t itres do not always indicate early infection 
(Felman and Nikitas 1980), they may be found in the stage of 
secondary syphilis, a period during which the disease is highly 
infectious for the infant (Fiumara et al 1952). 
Consideration of the maternal VDRL titres in the current study 
would appear to support this. Figure 5.2 shows that 14/15 of 
the mothers with affected babies had VDRL tit res above 1: 16. 
Indeed, the sensitivity of a maternal VDRL titre of this level 
was 93.3% with a negative predictive value of 97.61. The 
sensitivity was significantly higher than that of the RF latex 
test (p < 0,05 with Fisher's exact test). 
Mascola et al (1985) found that the mean maternal VDRL titre 
amongst 50 mothers with infected babies was 1:64. 
Srinivasan et al (1983) do not give the maternal RPR titres in 
the group of high-risk unaffected infants they studied. 
However, 3/4 mothers whose infants had congenital syphilis had 
RPR titres of 1 :32 more. In another study the VDRL titres were 
known in 4 mothers whose infants were infected (Alford et a 1 
1969a). All 4 mothers had titres of 1:16 or above. 
Therefore, there appears to be an increased risk of congenital 
syphilis with higher VDRL titres. However, in the current study 
as well as those cited not all mothers whose infants developed 
the disease had high titres of reagin antibodies. In addition, 
it should be noted that serological testing in the mothers was 
performed in the last trimester and often at the time of 
delivery. Whether a VDRL titre obtained earlier in pregnancy 
would be as useful is unknown. Finally, two-fold changes in end 
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point dilutions are accepted as within the limits of 
reproducibility of the VDRL test ( Inga 11 and Musher 1983 pg 
358). 
The data does suggest, however, that measuring the VDRL titre is 
useful in the diagnosis of congenital syphilis and that other 
quantitative methods of detecting reaginic antibodies, such as a 
VDRL ELISA, would be worth evaluating. 
5.4 RECOtltENDATIONS AND CONCLUSIONS 
Some final comments can be made on the basis of the data 
obtained. 
None of the tests performed on high-risk infants or their 
mothers have sufficient sensitivity at birth to completely rule 
out a diagnosis of congenital syphilis. The fact that the 
disease is treatable means that a test with 100% sensitivity is 
needed. As adverse effects would be unlikely if unaffected 
infants were treated, a lower test specificity would be 
acceptable. 
The failure of the tests evaluated to meet these requirements 
means that in the absence of complete maternal treatment, the 
infant must either be followed-up for a per.iod of time or 
treated. The latter option is suggested by the Centers for 
Disease Control (CDC 1988c). 
If one considers the implications of this for a city such as 
Cape Town, one realizes that there are logistical problems. A 
study by Ganin (1985) indicated that 7.6% of pregnant women 
attending the antenatal clinics of the PMNS had positive 
serological tests for syphilis. Applying this percentage to the 
25 030 live-born infants in 1987 one obtains a figure of 1902 
(i.e. 190 2 infants were born to mothers with positive STS). 
Previous studies indicate that only a percentage (approximately 
40% at most) of these mothers \'lil l have been fully treated for 
syphilis antenatally (Manning et al 1985, Subotsky and Delport 
1988). This means that 60% of the newborns (1141 in the example 
above) will need treatment with 10 days of procaine penicillin. 
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Most of . these patients would be treated as outpatients which 
could be problematic as, in all likelihood, infants with 
congenital syphilis would default treatment, necessitating time-
consuming patient tracing. This state of affairs would best be 
avoided in the local situation where health facilities are 
already faced with coping with high morbidity and mortality 
rates due to conditions such as diarrhoeal disease, tuberculosis 
and measles (Yach et al 1989; Molteno et al 1989). Admittedly, 
however, the latter diseases are preventable and the 
circumstances may improve in time. 
The option of following-up the high-risk cases 1lso needs to be 
considered. The feasibility and cost of this procedure are 
difficult to estimate. It is noteworthy, however, that 72% of 
seropositive infants defaulted a follow-up progranvne in Durban 
(Naicker et al 1983). This implies that tracing of patients is 
likely to be necessary. In the present study the cost of this 
(in terms of the salary and travelling expenses of a community 
worker) was approximately Rl2 000 for 69 patients (or Rl73 per 
patient). Applying this figure to the 1141 newborns who may 
require treatment, the cost of follow-up may be Rl97 393. In 
fact, this could be an underestimate as the mothers in the 
present study were selected on the basis of residence at 
contactable Cape Town addresses. An unselected population would 
presum1bly be more difficult to trace. 
The maternal VDRL titre appeared to have the highest sensitivity 
of the tests evaluated and is relatively inexpensive. How useful 
would the test be in practice? 
There are a number of points to be considered: 
i. The VDRL tit res were obtained in the last trimester of 
pregnancy; in over 90% of cases in the last month. This 
means that, in most cases, the test would need to be 
performed between the mother's admission to labour ward and 
the infant's discharge. 
151 
ii. The VORL tube test was used in the present study. This test 
requires that VDRL antigen is prepared fresh daily, that 
prior heat-inactivation of the serum is performed and that 
strict quality control measures are practiced (Larsen et al 
1984 pg 876-880) .Such tests are best carried out in a 
central reference laboratory (WHO 1986). This may be 
particularly important as patient management would depend 
on the reagin titre. 
The main disadvantage of measuring the maternal VDRL titre is 
that testing at a central laboratory is necessary. ttow, 
populations where syphilis is common often have less well 
developed health-care systems (Ratnam et al 1982). In such 
situations there is likely to be a demand on hospital beds for 
maternity patients. Infants at risk of having congenital 
syphilis (e.g. those born to unbooked mothers or whose mothers 
have untreated syphilis) may be discharged within 1 or 2 days of 
delivery. Serological results may be unavailable by this time. A 
further disadvantage is the relatively low positive predictive 
value of the maternal VDRL titre (58%). 
Other measures of reaginic antibody with sensitivities and 
specificities similar to those of the VDRL flocculation tests 
are available (Larsen et al 1984 pg 876). Of these the RPR card 
test, although more expensive than the VDRL test (R0.75 compared 
to R0.01), is suitable for use in peripheral laboratories (WHO 
1986). The mechanical rotator necessary for the test would need 
to be obtained (approximate cost R2000). The main problem with 
using the card test as a side-room or peripheral laboratory test 
is that the actual reagin titre is required and not simply a 
positive or negative result. Wide variations in titre have been 
reported between peri phera 1 and centra 1 1 aboratori es (Delport 
1988).More accurate methods of quantitating the reagin response 
of the mother (e.g. the VORL ELISA described by Pedersen et al 
1987) would appear to be desirable. 
Apart from the delay in obtaining results, measurement of the 
maternal VDRL titre may be important in the management of high-
risk infants. Infants born to mothers with VDRL titres of 1 : 32 
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or above could be treated or followed-up. The risk of missing 
affected infants would only be 7% if this were done. The 
advantage would be that the number of infants requiring further 
management would be greatly decreased. This can be seen from the 
fact that 26% of antenatal patients with positive VDRL tests had 
titres of 1:32 or more (Ganin 1985). Assuming that 40% of these 
patients were treated (Manning et al 1985; Subotsky and Delport 
1988), a total of 179 infants would require follow-up and/or 
treatment (compared to 1141 if some form of selection were not 
attempted). These observations apply to the maternal VDRL titre. 
Somewhat similar interpretations are possible considering the 
VORL titre in the infant. Nevertheless, the sensitivity of the 
latter test in the infants was lower (67%) and the l-2ml of 
blood required for VDRL testing is more easily obtained from the 
mother. 
As the RF latex test is simple, can be rapidly performed and has 
a high positive predictive value (100%), it may have a role to 
play in patient management. Rheumatoid factor testing could be 
done as a side-room or peripheral laboratory test prior to 
discharge. Serum from a heel-prick could be used (Meyer and 
Malan 1987). The test is relatively cheap (it would cost R764 
to test the high-risk cases in the PMNS in the example cited). A 
positive RF latex test would indicate the need for particularly 
close evaluation of the infant prior to discharge. The high 
positive predictive value of the RF latex test obtained in the 
population studied, means that most of the infants with positive 
tests would be likely to have congenital syphilis. In this way 
nearly 50% of the affected infants would be detected prior to 
discharge. 
A negative RF latex test, however, would not exclude the 
diagnosis of congenital syphilis. In fact, when testing at-risk 
infants the RF latex test would most often be negative •. This can 
be deduced as follows: the prevalence of congenital syphilis in 
the high-risk group was 23%. Of the cases of congenital 
syphilis, 53% would have negative tests. Therefore 77% plus 12% 
(or a total of 89%) of the high-risk infants would be RF latex 
test negative. The problem of the further management of these 
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infants remains if the RF latex test alone is used. The 
concomitant use of the maternal VDRL titre, however, would be 
helpful if infants of mothers with VDRL titres of 1 :32 or more 
were followed-up or treated. This would enable the vast majority 
of the remaining infected infants to be accounted for. 
Other tests, such as detecting IgM antibody to a 47 kD antigen 
by Western blotting are being developed (Dobson et al 1988a; 
S 'anchez et a 1 1989). v/hether these techniques wil 1 detect a 11 
asymptomatic infants with disease and whether they will be cost-
effective tests, remains to be seen. 
In the meantime, the only definite way of not missing patients 
with congenital syphilis is to follow-up or treat those at risk. 
The load, this places on the community health services and the 
attendant risk of failure could be reduced by doing 2 relatively 
cheap and simple tests at the time of birth. A positive RF latex 
test would select out nearly half of the infants who need 
treatment. The VDRL titre obtained on the mothers of at-risk 
patients with negative RF latex tests would indicate which 
infants should undergo further follow-up or treatment. 
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CHAPTER 6 
THE VALUE OF THE RF LATEX TEST IN THE DIAGNOSIS OF 
CONGENITAL SYPHILIS IN SYMPTOMATIC INFANTS 
The diagnosis of congenital syphilis in infants with classical 
clinical signs may not be difficult, provided one is aware of 
the possibility (Kaufman et al 1974; Mascola et al 1985). Owing 
to the varied manifestations of the disease, however, sero-
logical testing is employed to confirm or refute the diagnosis 
(Borobio et al 1980; Krugman and Katz 1981 pg 398; Rathbun 
1983a). As stated in the criteria of Kaufman et al (1977), the 
diagnosis of congenital syphilis is unlikely in the presence of 
negative serological tests for syphilis. In fact, these workers 
never intended their criteria to be used in the absence of 
serological testing. Most of the tests employed take several 
days before the results are available. The RF latex test, 
however, can be rapidly performed on a small volume of serum and 
positive tests have been obtained in a high percentage of 
symptomatic infants with congenital syphilis (Reimer et al 1975; 
Meyer and Malan 1987). 
The aim of this part of the study was to determine if the RF 
latex test could be used to distinguish infants with congenital 
syphilis from those presenting with similar clinical signs. 
6.1 METHODS 
6.1.1 Study design 
The clinical signs of congenital syphilis are many (Krugman and 
Katz 1981 pg 396). However, the diagnosis is likely to be 
considered when certain physical findings are present (Alford~ 
~ 1975). Kaufman et al (1977) described clinical features 
which were useful pointers to the presence of congenital 
syphilis. These findings were: 
condylomata lata 
osteochondritis, periostitis 
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snuffles or haemorrhagic rhinitis 
fissures of 1 i ps 
cutaneous lesions 
mucous patches 
hepatomegaly, splenomegaly 
generalized lymphadenopathy 
central nervous system signs 
haemolytic anaemia 
elevated cells or protein in the CSF. 
The bony abnormalities associated with congenital syphilis are 
usually detected radiologically and not clinicaliy (Narbarro 
1951; Wilkinson and Heller 1971). Nevertheless, most authors 
describing criteria for the diagnosis of congenital syphilis 
have considered roentgenographic findings amongst the clinical 
criteria (Rathbun 1983b; Mascola et al 1985; CDC 1988c). This 
categorization was also used for this study. 
Kaufman et al (1977) did not specify the exact cutaneous lesions 
referred to. For the purposes of this study, typical 
dermatological manifestations were regarded as being: 
i. vesicular bullous eruptions 
ii. superficial desquamation of the palms and soles 
iii. an oval, symmetrical, hypopigmented maculopapular eruption 
affecting the buttocks, back, genitalia and extremities 
(King and nicol 1975 pg 109; Chawla et al 1988). 
Hepatomegaly was regarded as an enlargement of the organ of more 
than 2 cm bel ow the right subcostal margin in the mid-clavicular 
line in newborns and 1 cm below the rib margin in older infants 
(tlelson et al 1979 pg 1110). Splenomegaly was said to be 
present if the inferior margin was more than 1 cm below the left 
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subcostal margin (Gandy and Robertson 1987 pg 56). 
The central nervous system signs. were not elaborated by Kaufman 
et al (1977). As reviewed by Ingall and Musher (1983 pg 348), 
however, pathological features in the central nervouse system 
in infants with early congenital syphilis are: 
i. acute syphilitic leptomeningitis which presents with signs 
of meningitis and/or raised intracranial pressure with an 
abnormal cerebrospinal fluid, and a positive serological 
test for syphilis 
ii. chronic meningovascular syphilis with hydrocephalus, 
cranial nerve involvement and vascular lesions 
iii. cerebral infarction with acute hemiplegia and convulsions. 
In considering the usefulness of these features in the diagnosis 
of congenital syphilis, Ingall and Musher (1983 pg 347) stated 
that other common conditions need to be exclude. For practical 
purposes infants presenting with only a CSF picture of aseptic 
meningitis (Nelson et al 1979 pg 727) or isolated CSF changes 
were not considered for the study unless the STS were known to 
be positive. 
Haemolytic anaemia in newborns is often due to blood group 
incompatibility (Oski 1981 pg 551). Congenital syphilis ~sually 
forms part of the differential diagnosis when a patient has 
unexplained haemo 1 yt i c anaemia ( Inga 11 and Musher 1983 pg 34 7). 
For this reason, cases with haemolytic anaemia where the cause 
was readily apparent were not considered for the study. 
Infants with one or more of the clinical criteria listed below 
were included in the study: 
condylomata lata 
metaphyseal dystrophy, periosteal dystrophy 
snuffles or haemorrhagi~ rhinitis 
fissures of lips 
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cutaneous lesions 
mucous patches 
hepatomegaly, splenomegaly 
generalized lymphadenopathy 
unexplained hydrocephalus with cranial nerve involvement 
unexplained cerebral infarction with acute hemiplegia 
unexplained haemolytic anaemia. 
Study infants consisted of newborn infants delivered in the PMNS 
and infants presenting to the Red Cross War Memorial Children's 
Hospital (RCWMCH) under the age of 4 months. 
Doctors working in the PMNS or the admitting room at the RCWMCH 
were asked to inform the author of the arrival of patients 
meeting the criteria previously laid down. Frequent, regu 1 a r 
contact helped to ensure that as many cases as possible 1-1ere 
included. The ward admission records were also frequently 
checked. 
Infants were entered into the study before the final diagnosis 
was known. They were examined by the author and thejr findings 
recorded. 
The diagnosis of congenital syphilis was based on the criteria 
suggested by Kaufman et al (1977). As previously stated on page 
48, however, these criteria require that serological testing be 
carried out. This point should be stressed as the diagnosis of 
probable congenital syphilis on the basis of 1 'major' and 1 
'minor' clinical sign can only be made in the presence of 
positive serol ogical tests for syphilis and not in isolation 
(see point 5 in the section 'Certainty of diagnosis' in Table 
2.1 on page 54). 
The clinical case study and the study of high-risk infants 
described in Chapter 5 were carried out at the same time. To 
avoid confusi on, infants from Groote Schuur Hospital (GSH) were 
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not considered for the clinical case study whilst the study of 
high-risk cases was in progress. 
6.1.2 Controls 
6.1.3 
Infants who did not have congenital syphilis but who were 
included in the high risk study (Chapter 5) because their 
mothers had positive serological tests for syphilis were used as 
controls. As described in Chapter 5, the infants were seen at 
birth, 6 weeks and 4 months. 
Apart from serological tests for syphilis, RF and total IgM \~ere 
determined. Radiological examination of the long bones ·was also 
undertaken at birth. 
Investigations 
After obtaining informed parental consent, the followin·g 
investigations were performed. 
Infants with clinical signs 
Venous blood was drawn within 48 hours of presentati on. The 
blood was collected in sterile glass tubes and allowed to clot 
at room temperature. The serum obtained was either tested 
immediately or aliquoted and stored at -70°C. The following 
tests were performed on each infant: VDRL, TPHA, RF latex test, 
RF ELISA and total IgM levels. Roentgenograms of the long bones 
were obtained. 
The sequence of investigations was as outlined in Figure 6.1. 
The tests for other infections carried out in the cases where 
STSs were ne gative, were those that were appropriate for making 
a diagnosis (e.g. blood culture, serological tests for other 
intrauterine infections, viral isolation from urine samples). 
Control infants 
As described in Chapter 5. the VDRL and TPHA tests, RF 1 a tex 
test, total IgM test and radiological examination of long bones 
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Figure 6.1: Procedure in infants with clinical signs of 
congenital syphilis 
Patient with 1 or more clinical 
or radiological signs of congenital syphilis 
VDRL, 
~ 
Serological Tests 
for Syphi 1 is 
POSITIVE 
f 
FTA-ABS (IgM) test 
t 
Fulfilled criteria of 
Kaufman et al ( 1977) 
+ Congenital syphilis 
diagnosed 
t 
Treatment commenced 
t 
TPHA performed 
~ 
Serological tests 
for Syphilis 
NEGATIVE 
t 
Tests for other 
infections carried out 
(see below) 
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were undertaken at birth in these infants. In addition, with 
the exception of the roentgenology, the investigations were 
repeated at the follow-up visits. 
Mothers 
Serological tests for syphilis (VORL and TPHA) were performed on 
the mother's serum obtained as near to the date of delivery as 
possible. 
6.2 RESULTS 
A total of 49 patients with one or more clinical signs 
compatible with congenital syphilis entered the study over an 18 
month period. Thirty four patients fulfilled the criteria of 
Kaufman et al (1977) and were diagnosed as having probable 
congenital syphilis. A further 15 patients had . one or more 
clinical signs suggestive of congenital syphilis but the 
serological tests for syphilis (VDRL and TPHA) were negative. 
Of these patients, 7 had suspected or proven septicaemia, 5 had 
CMV infection, 1 rubella, 1 hereditary spherocytosis and 1 
trisomy 13. 
The details for each patient are given in the tables which 
follow. Tables 6.1 and 6.2 show the data for infants with 
probable congenital syphilis while Table 6.3 gives the details 
for patients with other conditions. 
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Infants with congenital syphilis 
Maternal characteristics 
The mothers of 31 of the 34 infants in this group had positive 
STSs for syphilis (the remaining 3 delivered in outlying areas 
and did not accompany their infants to hospital). The 
serological tests of the mothers were obtained either at the 
time of presentation or within the last trimester of pregnancy. 
None of the women were symptomatic. Twenty eight (90%) of the 
31 mothers with known VDRL results had titres of 1:32 or above. 
Nineteen (56%) of the women whose infants had probable 
congenital syphilis were unbooked or the results of their 
serological tests were not available at presentation. 
None of the mothers had received any treatment for syphilis 
prior to delivery. Fourteen of the 15 booked cases did not 
return to the antenatal clinics after the initial visit. One 
patient was referred to a clinic for sexually transmitted 
diseases but did not attend for treatment. 
Infants with congenital syphilis - clinical data 
Nineteen (56%) of the 34 patients with probable congenital 
syphilis presented in the first 3 days of life (these were 
recorded as presenting at 'birth' in the tables), the remaining 
15 patients were older. Three days was taken as the dividing 
line because the total IgM levels start to rise soon after birth 
(Alford 1971), making it difficult to evaluate the usefulness of 
this test without establishing different control values. 
Of the 34 patients 7 were preterm, 7 were preterm and SGA and 7 
were SGA (3 infants had unknown birth weights and gestational 
ages). 
Thirteen patients were Cape Coloureds and 21 were Blacks. 
Overall, 15 of the mothers were booked and had VDRL titres 
obtained antenatally. Therefore, when these mothers presented to 
hospital with their infants the maternal serology result was 
available from the 'Road to health card'.According to the 
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criteria of Kaufman et al (1977), a diagnosis of probable 
congenital syphilis can be based on the presence of 1 'major• 
clinical sign and positive maternal serology or 2 'minor• 
clinical signs with positive serology. At presentation to 
hospital an immediate or pretest diagnosis could have been made 
in 15/ 34 or 441 of cases (presuming the mothers brought the 
'Road to health card' with them). 
Once the result of the STS was obtained from the laboratory the 
diagnosis could be made in all 34 patients. Thirty one of these 
patients had features (including abnormal radiological 
appearances of the long bones) compatible with the 'major• 
clinical signs of congenital syphilis listed by Kaufman et al 
(1977). Apart from the bony abnormalities, only 3 patients had 
•major• clinical features in the form of snuffles or 
haemorrhagic rhinitis. 
Two or more of the clinical signs described as 1minor 1 by 
Kaufman et al were present in 19 of the infants with probable 
congenital syphilis. 
Infants with congenital syphilis - serological results 
Thirty two (94%) of the 34 infants with probable congenital 
syphilis had positive RF latex tests at a dilution of 1 :5 (31 
tests were positive at 1:40). Eighteen of 19 newborns and 14 of 
15 older infants had positive RF latex tests. Total IgM levels 
were elevat"'1 in all 19 newborns presenting with probable 
congenital syphilis at birth and in 14 of 15 infants who 
presented later. 
The VORL results were positive in all 34 cases. Six of the 
infants diagnosed at birth as having probable congenital 
syphilis had a VORL titre which was at least 4 times greater 
than that of the mother. In addition a 11 infants had positive 
treponemal tests for syphilis (TPHA or FTA-ABS IgG). The · FTA-
ABS (lgM) results were positive in 28 (82%) of 34 cases at 
presentation. FHteen of the patients with positive tests were 
newborns and 13 were older infants. 
6.2.2 
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Infants with clinical signs who did not have congenital syphilis 
There were 15 infants in this ,group. Overall, 7 infants had 
septicaemia, 5 had CMV infection, l had congenital rubella, 1 
had hereditary spherocytosis and 1 had trisomy 13. 
The clinical and laboratory features of each infant as shown in 
the Table 6.3 will be described in more detail. However, it 
should be noted that each of the infants had negative 
nontreponemal and treponemal tests for syphilis. 
Septicaemia 
Altogether 7 patients (nos. 6.39-6.45) were diagnosed as having 
septicaemia. In 4 the blood cultures were confirmatory and 
yielded Escherichia coli in 3 cases and Staphylococcus aureus in 
1 case. Another patient (no. 6.42) had gonococcal ophthalmia 
and hepatomegaly. The blood culture was negative but the 
symptoms resolved following antibiotic treatment. Serological 
tests for CMV, toxoplasmosis, rubella and a urine test for CMV 
were negative. This patient may have had systemic gonococcal 
disease (Fanaroff and Martin 1987 pg 790). 
Patient no. 6.41 presented soon after birth with lethargy and 
oedema which were thought to represent non-specific signs of 
infection. Mo organisms were isolated from cultures of the 
blood or cerebrospinal fluid. Serological tests for chronic 
intrauterine infections were negative. The symptoms rapidly 
disappeared on antibiotic therapy. 
The other patient with a final diagnosis of suspected 
septicaemia had a diffuse eczematous rash, irritability and 
thrombocytopenia. Blood and CSF cultures were negative but the 
irritability and low platelet count resolved following treatment 
with antibiotics. 
All these patients had negative RF latex tests while 1 had a 
raised total IgM level at birth. 
Cytomegalovirus infection 
Five patients (nos. 6.35, 6.36, 6.46, 6.47, 6.48) had 
176 
cytomegalovirus infection. In 4 patients the virus was isolated 
from the urine. In a fifth patient (no. 6.48) the CMV ELISA for 
IgM was positive. Two of these patients had positive RF latex 
tests and 2 had elevated total IgM levels. A lack of serum 
prevented the IgM concentration from being determined in 1 case 
(no. 6.47). 
Other conditions 
One patient (no. 6.37) had congenital rubella. This was 
suggested by the spectrum of clinical signs and the rubella IgM 
ELISA which was positive. 
Case no. 6. 38 had some clinical features of a chronic 
intrauterine infection but in addition had a cleft palate. At 
postmortem additional findings were those of congenital heart 
disease and the cause of the hepatosplenomegaly was found to be 
extramedullary haematopoiesis. The final diagnosis of trisomy 
13 was confirmed by chromosomal analysis. 
The presenting features of pallor and hepatosplenomegaly in case 
no. 6.49 were subsequently ascribed to hereditary spherocytosis. 
6.2.3 Controls 
These consisted of the 51 infants who were at risk of congenital 
syphilis but who were shown to be unaffected (see Chapter 5). 
The mothers of these infants had positive STS for syphilis and 
were either untreated or inadequately treated. The infants were 
examined at birth and followed up at the ages of approximately 6 
weeks and 4 months. 
The details of each case are given in Table 5.2. 
The important results for this Chapter are as follows. tlone of 
the infants had congenital syphilis, as judged by the absence of 
clinical si gns of disease as well as the negative serology for 
syphilis at 3 t o 4 months of age. 
Rheumatoid fact or latex tests were negative . at birth in all 
cases. Res ults of RF latex tests were available in 46 cases at 
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follow-up between 4 - 8 weeks and in 50 cases at 3 to 4 months. 
Altogether 5 patients (approximately 10%), had positive RF latex 
tests at some stage during follow-up. 
In contrast to the negative RF latex results at birth, 5 
patients (9.8%) had elevated total IgM levels at birth but did 
not have congenital syphilis. 
From the sera obtained at follow-up, the distribution of the 
total IgM levels .,.,as determined. At 4-6 .,.,eeks the mean was 100 
+ 104 IU/ml and at 3-4 months 175 + 180 IU/ml (see Appendix 4) 
6.2.4 Analysis of results 
To determine the usefulness of the RF latex test in the 
diagnosis of congenital syphilis when a patient presented with 
clinical signs of the disease, Table 6.4 was constructed. 
From the results obtained in the infants with clinical signs the 
sensitivity, specificity and positive and negative predictive 
values of the RF latex test and the total IgM test were 
determined. The calculations were performed as described in 
Chapter 5. Results are summarized in Table 6.5 
The overall performance of each test is shown, and in addition, 
a separate column shows the values at birth. 
There were no statistically significant differences between 
these tests (p > 0.05, Fisher's exact ~est). 
6.3 DISCUSSION 
The aim of the study was to ascertain whether the RF latex test 
gave a useful initial indication that an infant's clinical signs 
\-Jere due to congenital syphilis, whilst the results of other 
investigations were awaited. 
Overall, relatively small numbers of patients with clinical 
signs due t o conditions other than congenital syphilis were 
included in the study. There are several possible reasons for 
this: 
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TABLE 6.4 
THE USEFULNESS OF THE RF LATEX TEST AND THE TOTAL lgM LEVEL IN 
INFANTS WITH CLINICAL SIGNS SUGGESTIVE OF CONGENITAL SYPHILIS 
FINAL DIAGtlOSIS RF LATEX TEST TOTAL lgM LEVEL 
Positive tlegative Elevated No rma 1 
Congenital syphilis 32 2 33 1 
Other condition 3 12 4 11 
(with similar 
clinical signs ) 
TABLE 6.5: 
SUMMARY OF THE PERFORMANCE OF THE RF LATEX TEST AHO TOTAL IgM 
TEST IN THE DIAGNOSIS OF CONGENITAL SYPHILIS IN SYMPTOMATIC 
HIFANTS 
RF LATEX TEST TOTAL IgM TEST 
Overa 11 At birth Overall At birth 
(%) ( % ) (%) ( % ) 
Sensitivity 94.l 94.7 97 100 
Specificity 80 77 . 8 73.3 55.6 
Positive pre- 91.4 90 89.2 82 .6 
dictive value 
tlegative pre- 85 .7 97.8 91. 7 100 
dictive value 
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i. the clinical signs elaborated in the study design led to 
the selection of infants with congenital syphilis 
ii. other congenital infections are relatively rare in the 
population studied (see Chapter 4). 
iii. It is possible that more cases of congenital syphilis were 
referred to the author than cases with other diagnoses. 
Frequent communication with colleagues was used in an 
attempt to overcome this. The fact that over 50% of cases 
of congenital syphilis had insufficient criteria to make 
such a diagnosis at the time of entry into the study, makes 
this possibility unlikely. 
The sensitivity of the RF latex test at birth (94.7%) as well as . 
amongst infants aged 0-4 months (94.1 %) was high. Reimer et · a1 
(1975) and Meyer and Malan (1987) noted similar results, 
although only 50% of the patients described by Dobson et al 
(1988a) had positive RF latex tests. 
It should be considered, however, that a pre-test diagnosis of 
congenital syphilis could be made in 44% of cases in the current 
study. The pre-test diagnosis could be achieved by considering 
the known results of the maternal VDRL (done at the antenatal 
booking visit) and the clinical presentation of the infant. 
The specificity of the RF latex test performed on the tnfants 
with clinical signs of congenital syphilis was 80%. Positive 
RF latex tests were obtained in 2 (40%) of the 5 patients with 
CtW. This is similar to the 7/20 (35%) incidence of positive 
tests in CMV noted by Stagno et a 1 (1980) but lower than the 
13/16 (81%) reported by Reimer et al (1975). 
The one patient in the study with congenital rubella also had a 
positive RF latex test. Reimer et al (1975) found positive RF 
latex tests i n 4/6 {67%) of infants with congenital rubella. 
tlone of the other patients who did not have congenital syphilis 
had positive RF latex tests. The majority of these infants had 
suspected or co nfirmed septicaemia. 
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The results obtained in the controls demonstrated that 
asymptomatic infants did not h~ve positive RF latex tests at 
birth. However, 5/46 (10.9%) had positive tests between 1 and 4 
months. This indicates that if larger numbers of infants were 
tested outside the neonatal period more false positive tests may 
be obtained and the specificity of the RF latex test could be 
lower. 
The positive and negative predictive values of the RF latex test 
(91.4% and 85.7 % respectively) were high. One needs to bear in 
mind, however, that these figures would change depending on the 
prevalence of congenital syphilis in the study group. 
Congenital syphilis was relatively common in the group selected. 
Studying a different population, e.g. that of a developed 
country where congenital syphilis is rare and congenital CMV 
with clinical signs commoner, the positive predictive value 
would probably be lower. However, the prevalence of congenital 
syphilis is generally much higher in developing countries (Hira 
et al 1982) and the test is likely to be more valuable in such 
situations. 
The total IgM test gave similar results to that of the RF latex 
test although the sensitivity was slightly higher as one of the 
infants with congenital syphilis had a raised total IgM level 
but a negative RF latex test. In addition, another patient with 
presumed septicaemia had an elevated IgM level. The RF latex 
test was negative in this case and this may simply reflect that 
the total IgM rises within a few days of the onset of infection 
whilst RF takes several weeks to appear (Bartfeld 1969, Jawetz 
et al 1980 pg 162). 
The total IgM was measured by radial immunodiffusion. Results 
were obtainable after 24 hours which was a considerable 
disadvantage when considering the test as a side-room 
investigation. The RF latex test result was available in a 
matter of minutes. Total IgM can also be measured by a latex 
test (Tympner and Neuhaus 1972). This is likely to give rapid 
results but this method was not evaluated in the study. 
The radiological changes in the long bones were used as a 
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criterion for entry into the study, so that their diagnostic 
value could not be independently determined. It is noteworthy, 
however, that the changes of periosteal dystrophy and 
metaphyseal dystrophy were not specific for congenitally 
infected infants but were also present in 3 infants with 
septicaemia and 1 with haemolytic anaemia. Caffey (1939), 
reported similar findings, while Shopfner (1966) noted that 
periosteal reactions could be found in up to 35% of normal term 
infants. 
The VDRL test enabled the diagnosis of congenital syphilis to be 
made in all the affected infants. At the same time the test was 
negative in all the infants without the disease. As the VDRL 
tube test is inexpensive, does the RF latex test have any 
advantage? The usefulness of the latter test lies in the fact 
that it can be performed as a side-room investigation. The VDRL 
test, however, is best carried out in a central laboratory (WHO 
1986}. As has been discussed elsewhere, this is because of the 
need for fresh antigen on a daily basis as well as the fact that 
heat inactivation of the serum is required. In addition, strict 
quality control is advisable (Larsen et al 1984 pg 875-879). The 
RPR test is recommended for peripheral laboratories (WHO 1986) 
and may also be suitable as a side-room test. The cost of this 
test, however, is approximately R0.75. This is simnar to that 
of the RF latex test (R0.67). The disadvantage of the RPR is 
that a mechanical rotator (at a cost of R2000} is needed at each 
locality where the test is to be offered. The RF latex test 
would appear to be technically easier to carry out and requires 
a minimum of equipment. 
In summary, al 1 the patients with positive RF latex tests at 
birth had a congenital infection. The RF latex test was not 
able to distinguish, however, between the various types of 
chronic intrauterine infection at birth. Therefore, the 
prevalence of other congenital infections in the populati_on 
influences the value of the test for congenital syphilis. 
In a developing country such as South Afric~, where maternal 
syhphilis is still relatively common, a positive RF latex test 
appears to provide useful confirmatory evidence of a diagnosis 
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of congenital syphilis in a symptomatic infant. Even in more 
developed communities it is of value to indicate that symptoms 
in a neonate are likely to be due to a congenital infection. 
Measuring the total IgM levels gave similar results, the 
advantages of the RF latex test being its rapidity and lower 
cost (see Chapter 5). 
In the older age group (4 days to 4 months) positive RF latex 
tests were encountered in well infants in the control group (see 
Chapter 5). As suggested by Stagno et al (1980), this phenomenon 
may occur predominantly outside the neonatal period. This 
reduces the value of a positive test in older patients although 
the results of the more specific serological tests would 
indicate that the RF latex test result was positive in the 
absence of congenital infection. 
In conclusion, the sensitivity of the RF latex test in the 
diagnosis of congenital syphilis was found to be high in infants 
presenting with one or more clinical signs of the disease. In 
the setting in which it was investigated, the technique would 
appear to have value as a rapid side-room test for congenital 
syphilis. 
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CHAPTER 7 
RHEUMATOID FACTOR AND THE FTA-ABS (IGM) TEST FOR CONGENITAL SYPHILIS 
It has been suggested that the presence of serum RF may result 
in the FTA-ABS ( IgM) test being non-specific for congenital 
syphilis (Reimer et al 1975). 
It follows, therefore, that RF interference should be eliminated 
prior to the test being performed. Muller and Sinzi g (1982 ) 
separated the IgM and IgG fractions and carried out the FTA-ABS 
( IgM ) test on the former fraction. Removal of the IgG prevents 
any RF interaction, although fractionation procedures do not 
always remove all the IgG and can be time consuming and 
complicated (Sever 1969; Muller et al 1987). A more convenient 
method has been found to be that of removing the IgG by 
immunopreci pitation (Gispen et al 1975). This not only 
abolishes the effect of RF, but has also been shown to improve 
the sensiti vity of testing for anti-treponemal IgM (Cerny et al 
198 5) • 
Be fore this technique can be recommended, however, it is 
important t hat the effect on the FTA-ABS ( IgM) test of 
eradicating RF interference be determined. 
7.1 METHODS 
7.1.1 Patient selection 
Sera from patients described in Chapters 5 and 6 were used. The 
study groups are outlined below: 
i. Infants having congenital syphilis with clinical signs at 
present ati on 
ii. In fan t s with congenital syphilis without clinical si gns at 
presentati on 
iii. Infants without congenital syphilis but with similar 
clini cal signs at presentation 
7.1.2 
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iv. Control infants: newborn infants at high-risk of 
congenital syphilis who did not, in fact, develop the 
disease were considered as controls. The features which 
resulted in the infants being high-risk are described in 
Chapter 5. In brief, however, the mothers had positive 
serological tests for syphilis and were either untreated or 
inadequately treated. 
Sera was obtained from the controls as follows: 
i. within 3 days of birth 
ii. at follow-up visits in the first 4 months of life. 
The older control group was considered necessary since not all 
the patients with congenital syphilis were newborn infants. 
Each of the 15 older patients with congenital syphilis \'1as 
matched ~~ith a randomly selected control infant of a similar 
age. 
Serological tests 
The FTA-ABS (IgM) test was performed as described in Appendix 2. 
Al 1 sera were pretreated with sorbent to remove antibodies to 
nonpathogenic treponemes and tested at a final dilution of 1:10. 
Rheumatoid factor activity was removed by precipitating the IgG 
vlith a sheep anti-human IgG (Behring, Hest Germany, catalogue 
number OUCG 14/15). For this procedure 10 ul of serum was added 
to 40 ul of the anti-human IgG. After being allowed to stand 
for 15 minutes at room temperature the precipitate was removed 
by centrifugation at 300 G for 10 minutes. 
Completeness of RF removal was checked by means of an RF EL ISA 
(see Chapter 8). Ten microlitres of serum in 40 ul of PBS pH 
7, 2 was mixed with 50 ul of anti-human IgG. After incubati on 
and removal of the precipitate PBS pH 7, 2 was added to reach a 
final dil uti on of 1: 200. 
Radial immunodiffusion plates (LC Partigen immunodiffusi on 
plates, Behring, ~/est Germany, catalogue number OTCR 03) \'/ere 
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used to measure the IgG concentration following treatment of the 
sera with the anti-human IgG . 
The FTA-ABS (IgM) test was carried out before and after the IgG 
immunoprecipitation step. 
7.2 RESULTS 
7.2.1 
7.2.2 
Patients having congenital syphilis with clinical signs at 
presentation 
There were 37 cases in this category, 22 of whom presented in 
the first few days of 1 i fe ( see Table 7 .1) and 15 presented 
later (Table 7.2). The RF ELISA which was positive in 35 of 37 
cases prior to IgG removal became negative in 32 ( IgG was not 
detected in any of the sera following treatment with the anti-
human IgG) . 
The FTA-ABS (IgM) test was positive in 34 (92%) of the 37 cases 
prior to abolishing RF interference and in 29 (78,4%) of the 37 
cases afterwards . This difference was not statistically 
significant (Chi-square test p > 0.05 ) . 
The immuno f luorescence was brighter in 8 cases before treatment 
with the anti-human IgG and brighter after removal of IgG in one 
case. 
These results are summarized in Tables 7.1 and 7.2. 
Patients with congenital syphilis without clinical signs at 
presentation 
Three newborn infants (nos. 5.5 - 5.7) (as described in Chapter 
5) had no definite clinical signs of congenital syphilis but the 
diagnosis could be made on the basis of the serological and 
radiol og ical features. A further 8 newborn infants developed 
features of congenital syphilis during follow-up (cases 5.8 -
5.15 re po rted in Chapter 5). These 11 infants v1ere considered 
together with 1 infant from the study group in Chapter 6 (no. 
6.7) wh o had no abnormal clinical signs but metaphyseal 
dysplasia v,as noted on radiographic examination of the long 
bones. 
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TABLE 7.1 
EFFECT OF RF REMOVAL Ot4 THE FTA-ABS { IgM) TEST IN NEWBORN 
INFANTS WITH CLINICAL SIGNS OF CONGENITAL SYPHILIS 
BEFORE TREATMEtlT AFTER TREATMENT 
WITH ANTI-IgG HITH AtHI-IgG 
* ** PATIENT AGE RF LEVEL FTA-ABS RF LEVEL FT A-ABS CODE AT IU/ml ( IgM) IU/ml ( I gM) 
NO. PRESEtlTA-
TIOM 
5.1 Birth 24 + ve 0 + ve 
5.2 Birth 4 + ve 0 - ve 
5.3 Birth 0 + (brighter) 0 + ve 
5.4 Birth 21 + ve 0 - ve 
6.1 Birth 152 + (brighter) 0 + ve 
6.2 Birth 205 + ve 0 + ve 
6.3 Birth 156 + (brighter) 0 + ve 
6.4 Birth 90 + ve 0 + ve 
6.5 Birth 92 + ve 6 - ve 
6.6 Birth 50 + ve 0 + ve 
6.8 Birth 27 + ve 0 - ve 
6.9 Birth 165 + ve 0 + ve 
6.10 Birth 32 + ve 0 + ve 
6.11 Birth 11 + (brighter) 0 + ve 
6.12 Birth 788 + ve 60 + ve 
6.13 Birth 34 + ve 0 - ve 
6 .14 Birth 165 + ve 0 + ve 
6.15 Birth 21 + (brighter) 0 + ve 
6.16 Birth 850 + ve 34 + ve 
6.17 Birth 3 - ve 0 - ve 
6 . 18 Birth 24 + ve 0 + ve 
6 .19 Birth 6 + ve 0 + ve 
tlo . of positive tests 21/22 (95,5%) 16/22 (72 . 7%) 
* Tests performed at 1: 10 dilution 
** ) 
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TABLE 7.2 
EFFECT OF RF REMOVAL ON THE FTA-ABS (lgH) TEST IN OLDER INFANTS 
WITH CONGENITAL SYPHILIS 
BEFORE TREATMENT AFTER TREATMEtlT 
~JITH ANTI-IgG WITH AtlTI-IgG 
* ** PAT I HIT AGE RF LEVEL FTA-ABS RF LEVEL FTA-ABS 
CODE AT IU/ml (IgM) IU/ml ( I gM) 
rw PRE SENTA-
TICN 
6.20 6 \~ 38 + (brighter) 0 + ve 
6.21 2 mo 30 + (brighter) 0 + ve 
6.22 10 w 520 + (brighter} 7 + ve 
6.23 3 mo 0 ve 0 + ve 
6.24 2 w 32 + ve 0 + ve 
6.25 2 Vi 238 + ve 0 + ve 
6.26 4 mo 500 + ve 5 + ve 
6.27 6 \'I 80 - ve 0 - ve 
6.28 ? mo 160 + ve 0 + ve 
6.29 1 mo 113 + ve 0 + ve 
(brighter) 
6.30 3 mo 38 + ve 0 + ve 
6.31 10 .... , 54 + ve 0 + ve 
6.32 14 w 6 + ve 0 + ve 
6.33 2 w 96 + ve 0 - ve 
6.34 2 mo 14 + ve 0 + ve 
No .of po sitive tests 13/15 (86,7%) 13/15 (86,7%) 
* Tests performed at 1:10 dilution 
** 
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Using the sera obtained at birth, RF was removed from 7 cases by 
the addition of the anti-human IgG. Results are shown in Table 
7. 3. 
The FTA-ABS (IgM) test was positive in 10 of the 12 cases prior 
to RF removal and in 3 cases afterwards. This difference was 
statistically significant (Fisher's exact test p < 0,05). 
7.2.3 Patients without congenital syphilis but with similar clinical 
signs at presentation 
There were 15 cases in this category who \'/ere described in 
Chapter 6. There was sufficient serum for FTA-ABS (IgM) testing 
in all but 1 patient (no. 6.43). Three of the infants (nos. 
6.35, 6.37 and 6.47) had positive tests for RF. The RF 
activity was eliminated by IgG removal. All 14 cases had 
negative FTA-ABS ( IgM) tests before and after the steps to 
eradicate RF. 
7.2.4 Control infants 
At birth: all 51 newborn infants had negative tests for RF using 
the latex and ELISA methods (see Chapters 5 and 9). One of the 
infants (no. 5.65) had a positive FTA-ABS (IgM) test prior to 
IgG removal. None of the control patients had a positive test 
after steps to eliminate IgG. 
Older infants: of the 15 age-matched older controls, 2 had 
positive FTA-ABS (IgM) tests prior to the use of the anti-human 
lgG ( see Table 7 .4). The RF ELISA demonstrated the presence of 
RF in 4 cases altogether, 1 of whom (no. 5.49) was FTA-ABS (lgM) 
positive. 
Following the addition of the anti-human lgG, the FTA-ABS (IgM) 
test was negative in all cases. 
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TABLE 7.4 
EFFECT OF RF REMOVAL ON FTA-ABS ( IgM} TEST IN CONTROL ItlFANTS 
BETWEEN 1 MONTH AND 4 MONTHS OF AGE 
PATIENT 
CODE 110 
5.19 
5.25 
5.28 
5.34 
5.36 
5.40 
5.46 
5.49 
5.50 
5.58 
5.63 
5.65 
5.67 
5. 68 
5.69 
* 
** 
RF CONCENTRATION FTA-ABS (IgM) TEST 
( IU/m1) 
* ** BEFORE AFTER 
0 
-ve -ve 
0 
-ve -ve 
0 -ve -ve 
0 -ve -ve 
0 -ve -ve 
0 -ve -ve 
7,6 
-ve -ve 
4 ,2 +ve 
-ve 
0 -ve -ve 
0 -ve -ve 
7,5 
-ve -ve 
2,8 
-ve -ve 
0 -ve -v e 
0 +ve 
- ve 
0 -ve -ve 
samples tested before and after elimination of RF 
effect at 1:10 dilution 
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7.3 DISCUSSION 
The aim of this study was to determine the effect on the 
sensitivity and specificity of the FTA-ABS (IgM) test of 
eliminating RF interference. The method chosen to prevent the 
latter was that of IgG removal by precipitation. As IgM RF in 
the serum is associated with Ig G (Egeland and Munt he 1983), it 
follows that precipitation of the latter should extract the RF 
(Gispen et al 1975). In addition, as IgM RF binds more avidly to 
aggregated than native IgG (Chen et al 1987), it is likely that 
the IgG-ant i IgG com pl exes form a suitable substrate for RF 
attachment. The technique of RF removal proved to be simple and 
effective. Rheumatoid factor activity was not detected in 89% 
of RF positive sera following the procedure. The treated sera 
with residual RF had no IgG antibody indicating that RF 
interference could no longer take pl ace. The effects of the 
steps to prevent RF activity are discussed below. 
7 .3.1 Effect of RF removal on the sensitivity of the FTA-ABS ( IgM) 
test in the diagnosis of congenital syphilis 
The sensitivity of a test has been defined as its ability to be 
positive in patients with the disease (Jaffe 1975). Two groups 
of patients with congenital syphilis were studied. 
Symptomatic patients with congenital syphilis 
In symptomatic infants in the present study, the sens it iv it i es 
of the test before (92%) and after (78.4%) RF removal were not 
significantly different (Chi-square test p > 0.05). However, 
tests in 6 patients which were positive before RF removal became 
negative a fterna rds. Rheumatoid factor was demonstrated in the 
sera of these patients. It is possible that RF was responsible 
for the positive tests. This could occur in 2 ways: 
i. The IgM RF may bind directly to the treponemes. The anti-
human IgM conjugated antibody would then attach to the RF 
giving a positive test (which would revert t o negative 
after RF extraction). 
ii. The RF, by attaching to IgG bound to the treponemes, would 
be detected by the anti-human IgM conjugate in the same way 
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as specific IgM. 
The first postulate appeared to be unlikely because a number of 
patients (e.g. numbers 6.17 and 6.27), had detectable IgM RF but 
a negative FTA-ABS (IgM) test, In addition, the IgM RF extracted 
from patient 6.12 (see Section 9.3) gave a negative result when 
tested in the FTA-ABS (IgM) test. These findings indicate that 
IgM RF does not attach to the spirochaetes directly. In contast 
to this, the addition of IgM RF to serum containing pathogen-
specific IgG has been shown to give rise to falsely positive IgM 
immunofluorescence tests, suggesting that the second mechanism 
is the correct one (Shirodaria et al 1973). 
Another patient (no. 6.23), whose serum tested negative for RF, 
had a positive FTA-ABS (IgM) test after IgG precipitation. This 
phenomenon may have been due to competitive inhibition between 
IgG and IgM treponemal antibodies. IgG extraction vmuld then 
have eliminated the competition for binding sites (Cohen et al 
1967). 
Steps to remove IgG (and hence RF) from the sera could, 
therefore, have had different effects on the sensitivity of the 
FTA-ABS ( Igt1) test in different patients. It was apparent, 
however, that the sensitivity of the FTA-ABS (IgM) test after RF 
removal in the symptomatic infants in the present study (78,4%) 
\'las lower than that in various other studies. Thus, Kaufman et 
~ (1974) quoted a sensitivity of approximately 96%. Similarly, 
Rosen and Richardson (1975) found that 100% of symptomatic 
infants with congenital syphilis had positive tests. A previous 
study from the PMNS (Meyer and Malan 1987) also demonstrated a 
high sensitivity (100%). 
The FTA-ABS (IgM) in the study reported in 1987 was performed in 
exactly the same way as in the present study except that the 
anti-human IgG was not used. It appears that the use of the 
anti-human IgG to remove RF may have had the effect of reducing 
the sensitivity of the test. 
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Patients with congenital syphilis without clinical signs at 
presentation 
Extraction of RF by means of IgG removal resulted in a 
significant reduction in the sensitivity of the FTA-ABS ( IgM) 
test in this group of patients. The reason for this may be 
that, as suggested by Reimer et al (1975), infants with 
congenital syphilis produce relatively large amounts of lgM 
anti-lgG (RF) and less lgM directed against . Treponema pallidum 
(specific IgM). This may be particularly true in early disease 
as nonspecific lgM (e.g.RF) is produced before specific IgM 
{Alford et al 1969). 
These findings could explain the observation in the present 
study that RF removal had a greater effect on the sensitivity 
of the FTA-ABS (IgM) test in the asymptomatic patients than in 
the symptomatic ones. The former group probably had earlier 
disease and could have produced more IgM RF than specific IgM. 
The lgM RF may have been largely responsible for the reactive 
FTA-ABS (lgM) results as indicated by the fact that most of the 
tests became negative after RF removal. In the symptomatic group 
with more advanced disease, however, the FTA-ABS (IgM) test may 
have been positive because of the presence of specific IgM; the 
extraction of RF would not have altered this result. 
The presence of RF alone, however, does not explain the positive 
FTA-ABS ( IgM) tests before IgG removal in all cases. Patients 
5.12 and 5.14 had negative RF tests. This means that 
antiglobulins could not have caused these results unless hidden 
RF was present. (This is RF that is not detected by the usual 
tests because it is bound to IgG - Allen and Kunkel 1966). · 
Tests to detect hidden RF were carried out as described in 
Chapter 9, but were negative. 
Another explanation for the different FTA-ABS ( IgM) results in 
the patients without RF, is that treatment of the sera with the 
anti-human IgG may have removed some of the specific IgM. This 
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hypothes h could not be directly tested but was thought to be 
unlikely because of results obtained in 5 control patients who 
were RF negative. In these patients the total IgM 
concentrations before and after lgG precipitation gave almost 
identical results (see Appendix 5). 
Finally, it is possible that the RF was so closely associated 
with immune complexes in the patients with congenital syphilis 
that its removal resulted in precipitation and loss of the 
immune complexes (and therefore of the specific IgM also). 
The sensitivity of the FTA-ABS ( IgM) test before IgG removal 
(88%) was greater than the 65% described by Kaufman et al (1974) 
for a similar group of patients. The latter authors, however, 
considered delayed onset cases only. If patients without 
clinical signs who had abnormal roentgenograms are excluded from 
the analysis of the present study, . the sensitivity becomes 75% 
( 6/ 8). 
7.3.2 Specificity 
The specificity of a test is defined as its ability to be 
negative in persons without the disease (Jaffe 1975). Several 
groups of patients without congenital syphilis were studied, and 
the effect of RF removal on the specificity of the FTA-ABS (IgM) 
test investigated. 
Patients without congenital syphilis but with similar clinical 
signs at presentation 
None of the patients with conditions mimicking congenital 
syphilis had false-positive FTA-ABS ( IgM) tests. Reimer et al 
(1975) argued that RF in the sera of such patients may make the 
FTA-ABS (IgM) test nonspecific. The reason put forward was that 
IgM RF would be detected as specific IgM. The events would be 
as follows: maternal IgG directed towards T.pallidum would bind 
to treponemal antigens. lgM RF would then bind to the maternal 
IgG; the anti-human IgM fl uorescei n-1 a belled conjugate would 
then identify the bound RF in the same _way as anti-treponemal 
IgM. 
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Studies have demonstrated that this occurs, for example, v1hen 
testing for IgM antibodies to rubella, toxoplamosis and CMV 
(Gispen et al 1975; Hyde et al 1975; Stagno et al 1980). Reimer 
et al (1975) demonstrated that the phenomenon could occur in 
congenital syphilis. It appeared that both anti- treponemal IgG 
and IgM RF were necessary to obtain a false-positive test. 
This leads one to question the likelihood of fulfilling these 2 
conditions in infants with diseases other than ccngenital 
syphilis. 
Apart from congenital syphilis, the most likely reason for a 
symptomatic infant to have RF present in the serum is probably 
CMV infection. 
The probabi 1 i ty of a fa 1 se positive FT A-ABS ( IgM) test due to 
symptomatic CMV can be calculated. 
Approximately 8 percent of expectant women had positive 
treponema 1 lgG antibody tests in the PMNS (Gonin 1985) 
Therefore, if one studied 100/8 = 12 cases of CMV, each of whom 
had produced RF, one could expect one false positive FTA-ABS 
(lgM) test. Considering that: 
i. the prevalence of symptomatic CMV may be approximately 
0.08% (see Chapter 4) 
ii. 42% of infants with CMV produce RF (Griffiths~ 1982) 
iii. 26 000 newborn infants are Aelivered annually in the PMNS 
(see Chapter 4). 
One could expect 9 cases of symptomatic CMV with positive RF 
tests every year. 
The 12 cases of CMV would, therefore, be seen over 15 months. 
It is therefore, perhaps not surprising, that none of the 
symptomatic patients in the present study had false-positive 
FTA-ABS ( IgM) tests due to RF activity. A larger study would be 
necessary to demonstrate enhanced FTA-ABS (IgM) specificity 
following RF removal in symptomatic infants with other 
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congenital infections (the commonest of which would presumably 
be CMV). 
tl ewborn infants at high risk of congenital syphilis who were 
unaffected 
These infants had positive treponemal tests for syphilis but all 
had negative tests for RF. Only 1 patient was found to have a 
positive FTA-ABS (IgM) test prior to IgG removal. It is 
possible that a lack of conjugate specificity was responsible 
for the result (Alford et al 1969a). 
There was no significant increase in FTA-ABS (IgM) specificity 
observed following steps to eliminate RF interference. tlewborn 
infants have not been shown to make RF in the absence of a 
congenital infection (Stagno et al 1980, Meyer and Malan 1987). 
The probabi 1 i ty of a mother having ant i-treponema l IgG and the 
infant having RF due to a congenital infection other than 
congenital syphilis is likely to be low as previously discussed. 
On the other hand a high percentage of asymptomatic mothers ,,.,;i l 
have IgG antibodies to rubella and CMV (Chonmaitree et al 198:?; 
Keen 1985 ) . If congenital syphilis develops in this setting and 
the infant produces RF, the IgM antibody tests for rubella or 
CMV may be falsely positive (Gispen et al 1975; Stagno et al 
1980). 
Specificity in older infants outside the neonatal period 
Here a different situation prevails. More infants are likely to 
be RF positive al though they a re othenli se we 11. Percentages 
range from 10-15% (Reimer et al 1975; Stagno et al 1980). 
Therefore, the older infants who had passively transferred 
maternal anti-treponemal IgG could be expected to have a higher 
incidence of false positive FTA-ABS (IgM) tests due to the 
effect of RF. 
The results of the present study confirmed the higher incidence 
of fals.e positive FTA-ABS (IgH) tests prior to IgG removal( :? 
tests were positive before and all were negative afterwards ) . 
Surprisingly, the improved specificity was not always due to RF 
removal as one patient (no. · 5.68) had negative RF tests. Hidden 
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RF may have played a part. Al though this substance was not 
directly sought, it v1as not found in a group of infants with 
congenital syphilis (see Chapter 9), Furthermore, 2 other 
patients who had RF present had negative FTA-ABS (IgM) tests. 
It appears that RF is not the only cause of the false positive 
FTA-ABS (IgM) tests seen prior to IgG removal. 
As an alternative explanation, it is possible that the conjugate 
specificity is deficient. Removing the IgG from the serum would 
then remove anti-treponemal IgG which, if the postulate is 
correct, could be identified as anti-treponemal IgM. 
This hypothesis could be tested by removing the IgM RF but not 
the anti-treponemal IgG (e.g. by mercaptoethanol or pepsin 
treatment) and repeating the FTA-ABS (IgM) test on the group of 
high-risk controls. 
That anti-treponemal IgG is necessary for a false positive test 
to occur is suggested by the lack of false positives in the 
group of infants who were symptomatic but who did not have 
congenital syphilis. These infants all had negative anti-
treponemal IgG tests (see Chapter 6). 
7.4 SUMMARY 
In summary, the following points can be made. 
i. The use of the anti-human IgG preparation to eliminate RF 
interference in the FTA-ABS ( IgM) test was simple and 
effective. 
ii. There was no observed increase in the sensitivity of the 
FTA-ABS ( IgM) test fol 1 owing steps to remove RF from the 
sera to be tested. There was, in fact, a reduction in 
sensitivity of the test for both symptomatic and 
asymptomatic infants ·~ith congenital syphilis. The loss in 
sensitivity was more marked in asymptomatic infants, the 
very group where a sensitive test is most needed (Kaufman 
~ 1974). 
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iii. The specificity of the FTA-ABS (IgM) test appeared to be 
somewhat improved fol.lowing IgG precipitation. This was 
noted mostly for infants outside the neonatal period. The 
cause of the reduced specificity was unclear but did not 
appear to be entirely due to the presence of RF. 
7.5 CONCLUSIONS AND RECOMMENDATIONS 
The recommendations to be made apply solely to the population 
studied and are not necessarily applicable to communities where 
other congenital infections e.g. CMV are commoner than 
congenital syphilis. 
In newborn infants the prevention of RF interference reduced the 
sensitivity of the FTA-ABS (IgM) test. This finding was 
particularly marked in the asymptomatic cases where a sensitive 
test is essential. It seems important not to extract RF in these 
patients. 
A low incidence of false positives (2%) was found amon gst high-
risk newborns and fa 1 se pos i. ti ve FTA-ABS ( IgM) tests v,ere not 
seen amongst a group of infants with clinical signs who did not 
have congenital syphilis (even though some had positive RF 
tests). Prevention of RF interference did not seem to be of 
value in this group either. 
The older high-risk infants had a greater incidence of false 
positive FTA-ABS ( IgM) tests. The danger of over-diagnosis, 
however, is much less than the problem of under-diagnosis in 
congenital syphilis. 
The findings suggest that,in the context in which the FTA-ABS 
(IgM) test was studied, it is immaterial whether the test was 
positive du e to the presence of specific IgM or IgM RF. In both 
instances the patient is likely to have congenital syphilis. 
Hence it seems advisable that no steps be undertaken to prevent· 
RF interference; this is most important when testing newborns. 
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PART II I 
RHEUf~ATOID FACTOR AND THE IMMUNE RESPONSE IN CONGENITAL SYPHILIS 
As pointed out in Chapter 3, there are a number of aspects of RF 
production in congenital syphilis which merit further study. 
i. How much IgM RF is produced and are other RF classes 
present? 
ii. What factors are associated with RF synthesis in congenital 
syph i1 is? 
iii. Is tissue-bound RF present at sites of inflammation in 
congerrital syphilis? 
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CHAPTER 8 
MEASUREMENT OF RHEUMATOID FACTOR CONCENTRATIONS USING 
AN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
8.1 INTRODUCTION 
In order to determine if there were associations between the RF 
levels and various clinical and laboratory findings in 
congenital syphilis it was necessary to measure the RF 
concentration.It would, for example, be possible to compare the 
RF levels with the severity and extent of the disease. A 
similar approach in patients with RA has demonstrated an 
association between the RF titre, clinical activity and extra-
articular manifestations of the disease as well as a higher 
mortality (Gordon et al 1973; Holborow and Swannell 1983 pg 247; 
Gioud-Paquet et al 1987; Carson 1987 pg 1204). 
The ELISA technique provides a more sensitive estimate of the 
serum RF concentration than the conventional tests (such as the 
latex agglutination tests), which are difficult to quantify 
(Bampton et al 1985; Gioud-Paquet et al 1987). It also allows 
specific classes of RFs to be measured and this has provided 
useful information regarding the pathogenesis of rheumatoid 
vasculitis (Stone et al 1987). 
The quantitation of RF by means of an ELISA has been described 
by severa 1 workers ( Wil 1 ems and Klaassen de Kort 1978, 
Gripenberg et al 1979, Faith et al 1982). These methods were 
adopted with minor modifications. 
The establishment of the ELISA is described in: 
Section 8.2: reagents used and technique followed. 
Section 8.3: evaluation of the RF ELISA. 
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8.2 MATERIALS AND METHODS 
8.2.1 Materials 
Carrier surface 
The assays were performed on 96 well, flat bottomed polystyrene 
microtitre plates. Greiner (West Germany, catalogue number 
655001) and Nunc (Denmark, catalogue number 4-42404) plates 
were evaluated. 
Human IgG was used to coat the plates (some workers have used 
rabbit IgG; human IgG was chosen here because binding of RF from 
non-RA patients appears to be better - Bartfeld 1969; Egeland 
and Munthe 1983. 
Purified IgG was obtained from ICN Immunobiologicals (USA, 
catalogue number 64-145). Immunodiffusion was carried out by 
the manufacturers to demonstrate the presence of IgG and the 
absence of IgM and IgA. The IgG was heat-aggregated by heating 
it to 63°C for 20 minutes in a waterbath (Gripenberg et al 1979) 
Peroxidase-conjugated antibody, enzyme and substrate 
The conjugated detection antibody was a goat anti-human IgM 
coupled to peroxidase. The F(ab')2 fragment, which was u-chain 
specific, was used (obtained from Cappel Products, USA. 
catalogue number 33010201). 
The substrate was 2,2'-azinobis (3-ethylbenzthiazoline sulphonic 
acid diammonium salt) acquired from the Sigma Chemical Company, 
USA (catalogue number Al888). One hundred microl itres of a 40 
mM solution of 2,2'-azinobis in 10 ml of 0.05 M citric acid at 
pH 4 was used. One hundred microlitres of 3% hydrogen peroxide 
was added to 10 ml of substrate just before use. 
Buffers 
The antigen coating buffer used was a carbonate-bicarbonate 
buffer at pH 9.6. Sera were diluted in Dulbecco's phosphate-
buffered saline (PBS) pH 7.2 obtained from Highveld Biologicals 
200 
Plates were washed with a PBS-Tween solution (0.05% Tween- 20) at 
pH 7.2. The Tween- 20 was supplied by Merck, West Germany. 
Blocking of nonspecific binding sites 
These were blocked with a solution of either i) 1% goat serum 
with 1% bovine serum albumin (BSA, from Boehringer Mannheim, 
West Germany) and 0,75 g glycine in 100 ml PBS pH 7,2 or ii) the 
same solution containing 2,5% BSA. The effectiveness of these 2 
solutions was compared by assaying 5 sera in duplicate with each 
of the blockers. 
Measurement of optical density 
This was performed using an SLT 210 photometer (SLT-
Labinstruments, Austria) at a wavelength of 405 nm and using a 
reference wavelength of 620 nm. 
8.2.2 Serum samples and methods 
During the establishment of the RF ELISA serum samples were 
obtained as follows. 
Positive control sera 
i. an external (or primary) standard, the International 
Reference Preparation of RA serum obtained from the WHO. 
The characteristics of this preparation have been reported 
by Anderson et al (1970). 
ii. an internal (or in-house) standard obtained from an adult 
patient with RA. This patient had a positive RF latex test 
(titre 1:160) and, apart from being the internal standard, 
the serum was also used as a high-titre positive control 
serum during the establishment of the RF ELISA. 
iii. sera from 2 infants with congenital syphilis who had 
positive RF latex tests.These sera were used as mid- and 
low-titre positive control sera. 
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Negative control serum 
This was obtained from a normal term newborn infant whose serum 
was RF latex test negative. 
Heat inactivation of the sera was not carried out ( Carson et al 
1977; Gripenberg et al 1979). 
All sera were aliquoted in 100 ul amounts and stored at -70°C. 
Method for the RF ELISA 
Checkerboard titrations were performed to ascertain the optimum 
concentrations of reagents (Voller et al 1980 pg 367-371). The 
plates were coated with 100 ul of HaigG at concentrations 
ranging from 0.25 - 2.0 mg/100 ml in coating buffer. Rows A, C, 
E and G of each plate were coated with antigen whilst rows B, D 
F and H received coating buffer only. After being left 
overnight at 4°C, the plates were washed once with PBS pH 7,2. 
The plates were then blocked with the solutions previously 
described. Greiner plates were blocked with 250 ul per well and 
the Nunc plates with 450 ul per well. After 1 hour the plates 
were washed with PBS pH 7,2. 
The sera were assayed in duplicate (100 ul serum per well). 
Serum dilutions of 1:100 to 1:4000 in PBS-Tween were added to 
antigen-coated wells and to uncoated wells. Four wells on each 
plate had no sera added. After overnight incubation at 4°C, the 
plates were washed 6 times with PBS-Tween. 
Conjugate dilutions of 1:800 to 1:3200 in PBS-Tween were tested 
to determine the optimum conjugate concentration. One hundred 
microlitres of conjugate was placed in each well and left for 1 
hour at room temperature. Following this the plates were washed 
10 times with PBS-Tween and 100 ul of substrate added. The 
optical density was read at 405 nm after 1 hour. 
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8.2.3 Results of checkerboard titrations 
Effect of different polystyrene plates 
The use of the Greiner and Nunc plates were compared with 
respect to nonspecific binding and the strength of the antibody 
signal obtained. 
Optical density readings were measured in each experiment to 
determine nonspecific (background) binding. The background 
readings were obtained from wells in which either the coating 
antigen (IgG) and/or the test serum were omitted. 
The background values obtained from wells with antigen but no 
serum were very similar to those obtained with no antigen and no 
serum. The effect of the antigen on the background optical 
density readings obtained with both plates was of the order of 
0.003 - 0.007. The major portion of the background measurements 
was due to non-specific binding of serum to the wells. 
Consequently, in the results which follow only the backgrounds 
due to the serum were taken into account. 
During the establishment of the ELISA, the mean optical density 
of 200 background values due to nonspecific binding of serum to 
the Greiner plates was 0.075 with a standard deviation of 0.029. 
The Nunc pl ates gave lower background readings (mean of 200 
tests 0.055 with a standard deviation of 0.019). 
In Figure 8.1, graphs 1-8 (obtained with Greiner plates) can be 
compared with graphs 9-12 (obtained with Nunc plates). It can 
be seen that, apart from the background values, the positive and 
negative control sera gave similar results on the different 
plates. 
Blocking buffers 
The background values obtained when the solution containing 1% 
BSA was used were very similar to those observed with the 2.5% 
solution. The difference in the mean backgrounds obtained was 
0.001; the 2.5% solution giving slightly lower results. Bovine 
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serum albumin at a concentration of 1% was used in the 
subsequent assays. 
IgG coating antigen concentration 
As shown in Figure 8.1 graphs 1-4 and 9 and 10, IgG 
concentrations below 0.5 mg 100 ml resulted in a fall in the 
optical density readings measured with the positive control 
sera. Higher IgG concentrations did not have a marked effect 
on the values obtained with these sera, although the backgrounds 
were slightly higher (backgrounds here were calculated from 
wells coated with antigen but to which no serum was added). A 
coating antigen concentration of 0.5 mg/100 ml was therefore 
chosen for future assays. 
Peroxidase-conjugated antibody dilutions 
Graphs 5-8 and 11 and 12 . in Figure 8.1 show the effect of 
varying conjugate and serum dilutions. Although the highest 
optical density readings were obtained with the more 
concentrated conjugates, the background values were also 
highest. 
An acceptable distinction between positive and negative control 
sera and a reduction in background readings could be achieved 
with conjugate dilutions between 1:1600 and 1:3200. A final 
conjugate dilution of 1:2000 was used (Figure 8.1, graphs 11 and 
12) • 
Serum Concentrations 
Figure 8.1, graph 11 shows the effect of using different serum 
concentrations whilst maintaining the IgG strength of 0.5 mg/100 
ml and the conjugate strength at 1:2000. Again, higher 
backgrounds were a feature of sera tested at higher concentra-
tions (e.g. 1:100). A serum dilution of 1:500 allowed a good 
distinction to be made between positive control sera containing 
high, intermediate and low amounts of RF. 
Figure 8: 1 
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Graphs 1-12 showing the results of checkerboard 
titrations obtained during the establishment of 
the IgM RF ELISA 
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8.3 EVALUATION OF THE RF ELISA 
Once the working strengths of the reagents had been determined 
the following steps were carried out to validate the ELISA. 
8.3.1 Determination of the specificity of the RF ELISA 
The specificity of the ELISA for RF 
This was checked by comparing the results of the RF ELISA and 
the RF latex tests and by investigating the effect of RF 
removal. 
Comparison of RF ELISA and RF latex test results 
The RF ELISA was performed on the 34 patients with congenital 
syphilis who had positive RF latex tests and were described in 
Chapter 6 (patients 6.1 to 6. 34). The RF ELISA results are 
recorded in Chapter 9. The important results for this section 
are that all the patients who had positive latex tests had a 
positive RF ELISA reading. Two patients were RF latex test 
negative, 1 of these (no. 6.6) gave a positive result with the 
RF ELISA, the other (no. 6.23) was nega t ive. 
Similar results were obtained with the two tests in the control 
patients at birth. All these patients were RF latex test 
negative (see Chapter 5) and, as described in Chapter 9, their 
sera gave insignificant readings with the RF ELISA. 
Effect of RF removal 
Rheumatoid factor was removed by 2 methods. 
i. by addition of a sheep anti-human IgG: this precipitated 
IgG and RF with it (further described in Chapter 7) • Ten 
micro lit res of serum in 40 ul of PBS pH 7. 2 were added to 
50 ul of sheep anti-human IgG. After incubating for 15 
minutes at room temperature the solution was centrifuged at 
300 G for 10 minutes. The supernatants obtained from 2 
sera which were RF latex positive were tested in the RF 
ELISA at a dilution of 1:200. 
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ii. by addition of a HaigG absorbent prepared from Cohn 
Fraction II by sodium sulphate precipitation using the 
method of Christian (1958). This technique is outlined in 
Chapter 9. Rheumatoid factor was removed by adding 80 ul 
of this sodium sulphate fraction 1 (containing 1.26 mg of 
protein per ml) to 250 ul of serum. After incubation for 
30 minutes at room temperature the precipitate was removed 
by centrifugation at 1500 G for 10 minutes. Two sera, 
which were RF latex positive (from different patients to 
those above) were treated with the HaigG and tested in the 
RF ELISA at dilutions of 1:4000 and 1:500 respectively. 
When RF was removed from the 2 sera by means of IgG 
immunoprecipitation the results shown in Table 8.1 were 
obtained. 
TABLE 8.1 
SPECIFICITY OF THE RF ELISA AS DEMONSTRATED BY RF REMOVAL 
USING IgG IMMUNOPRECIPITATION 
* 
** 
SERUM 
1 
2 
** 
* OPTICAL DENSITY READING 
Before IgG After IgG 
Immunoprecipitation Immunoprecipitation 
0.479 
0.138 
0.05 
0.010 
the mean of duplicates after subtraction of 
backgrounds 
serum was diluted 1:200 
The optical density values were shown to be markedly lower 
after the immunoprecipitation technique to eliminate RF. 
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Extracting RF by adding HaigG also reduced the opti cal 
density readings in t he RF EL ISA. The details are shown in 
Table 8.2 
TABLE 8.2 
SPECIFICITY OF THE RF ELISA DEMONSTRATED BY RF REMOVAL 
USING HEAT-AGGREGATED IgG 
·* OPTICAL DENSITY READING 
** SERUM 
Before addition of After addition of 
heat-aggregated lg G heat-aggregated IgG 
3 0.21 0.10 
4 0.24 0.01 
* mean of duplicates after subtraction of backgrounds 
** serum no. 3 was diluted 1:4000 
serum no. 4 was diluted 1:500 
Specificity of the ELISA for IgM RF 
The ELISA method described is likely to detect mainly IgM RF 
(Faith et al 1982). The specificity of the ELISA for IgM class 
antibodies depends on the specificity of the goat anti-human IgM 
conjugate. The specificity of the conjugate was determined by 
an ELISA similar to that reported by Faith et al (1982). The 
procedure for the ELISA was the same as that detailed previously 
with some modifications. 
The coating antigens were anti-human IgM, anti-human IgG and 
anti-human IgA. The first 2 antibodies were obtained from 
Dakopatts, Denmark (catalogue numbers A091, A090) and the anti-
human IgA from Behring, West Germany (catalogue number ORCI 
04,05). One hundred microlitres of the coating antigen at a 
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dilution of 1:100 in coating buffer was added and left at 4° C 
overnight . The plate was washed and blocked as previously 
described. Human serum from a normal adult control was added 
after being diluted 1:500 in PBS-Tween and the plate was again 
incubated at 4°C overnight. Following a washing step the goat 
anti-human IgM conjugate at a dilution of 1:500 in PBS-Tween was 
applied (for 1 hour). The plates were washed and substrate 
added for 1 hour after which the optical density was read at 405 
nm. 
The results are shown in Table 8.3 
TABLE 8.3 
THE SPECIFICITY OF THE GOAT ANTI-HUMAN IgM PEROXIDASE-LABELLED 
CONJUGATE FOR IgM CLASS ANTIBODIES · 
* ** COATING ANTIGEN OPTICAL DENSITY READING 
Anti-human IgM 0.51 
Anti-human IgG 0.025 
Anti-human IgA 0.025 
* Coating antigen used at 1:100 dilution 
** Mean of duplicates after background values subtracted 
It was demonstrated that very low readings were obtained with 
the anti-human IgG and anti-human IgA coating antigens. 
To further examine the specificity of the RF ELISA for IgM class 
antibodies a pepsin digestion step was carried out. Pepsin 
digestion destroys IgM RF (Theofilopoulos et al 1974). The 
method of pepsin digestion is outlined in Chapter 9. The RF 
ELISA was performed on 5 RF latex positive sera (obtained from 
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infants with congenital syphilis) before and after treatment of 
the sera with pepsin. The final serum dilution after pepsin 
di gestion was 1: 200. Table 8 .4 shows that pepsin digesti on of 
the sera practically abolished the readings obtained in the 
ELISA. 
TABLE 8.4 
THE EFFECT OF PEPSIN DIGESTION ON THE OPTICAL DENSITY READINGS 
OBTAINED WITH THE RF ELISA 
BEFORE PEPSitl AFTER PEPS IN 
DIGESTIO N 
SER UM 
SERUM OPTICAL OEtlSITY SERUM OPTICAL DENSITY 
* * DILUTION READING DIL UTIO N REA DrnG 
1 1: 200 0.177 1: 200 0.0 18 
') 1: 200 0.100 1 : 200 0. 030 
3 1 :1000 0.1 80 1 :200 0. 00 9 
4 1: 2000 0. 44 1 1: 200 C. 013 
5 1:1000 0.400 1: 200 0. 008 
* Mean of duplicates after background val ues subtracted 
8.3.2 Standardization of the RF ELISA 
This wa s do ne usin g the external (W HO ) reference ser um fo r RF 
and t he internal standard (see Section 8 .1 ) . The ELISA wa s 
per fo rmed on the standards at dilutions from 1 : 100 - 1 : 32000 . 
The gr ap h i n Figure 8 . 2 is representative of t he re sults 
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obtained. The 2 standards gave very similar results over a 
range of dilutions. 
For standardization of the RF ELISA it was also necessary to 
show that parallelism existed between the test sera and the 
standard (Hamilton and Adkinson 1988 pg 66-69). This was 
achieved by assaying 2 sera over a range of different dilutions. 
The results shor1ed that below a reading of 0.6, the optical 
densities of the test sera were parallel to those of the 
internal standard (see Figure 8. 2) . 
Determining the cut-off values for the RF ELISA 
The upper limit was determined by measuring dilutions of the 
external standard from 1 :200 to 1 :500. The point at which the 
graph of optical density versus concentration demonstrated a 
plateau effect was regarded as the upper limit of the ELISA. 
It can be seen that above an optical density of 0.4 (background 
reading subtracted) the graph became definitely sigmoid in shape 
(see Figure 8. 2). 
The lower cut-off was also determined. The lov1est optical 
density reading which was on the linear portion of the graph was 
determined using serial dilutions of the WHO standard. 
The results obtained in 4 assays are shown in Table 8. 5. It can 
be seen that very low concentrations of RF could be detected. 
The lowest optical density readings on the linear portion of the 
curve were between 0. 032 and 0.053 with a mean of 0.042 
(background values subtracted). 
For practical purposes the lower cut-off value r1as regarded as 
an optical density of 0. 05 . 
Reproducibility of the RF ELISA 
Inter-assay variation 
This \'las determined by measuring the RF content of 3 sera on 
different occasions . The sera chosen had high, intermediate and 
low RF concentrations respectively. 
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TABLE 8.5 
THE LOWEST OPTICAL DENSITY READINGS FALLING ON THE LINEAR 
PORTION OF THE GRAPH OBTAINED BY PLOTTING OPTICAL DENSITY VERSUS 
SERIAL DILUTIONS OF THE WHO STANDARD 
ASSAY 
1 
2 
3 
4 
RF CONTENT OF WHO 
STANDARD ( IU/ml) 
0.05 
0.031 
0.05 
0.024 
LOWEST OPTICAL DENSITY 
ON LINEAR PORTION OF GRAPH 
0.045 
0.032 
0.038 
0.053 
* Optical density after background values subtracted 
* 
The inter-assay variation was as follows (values given are the 
means of duplicate samples). 
High-titre serum: Values (in IU/ml) of 390, 360, 400, 380, 340, 
370, 390, 360, 375 were obtained in different assays. The mean 
was 374 with a standard deviatibn of 18.7. The coefficient of 
variation was 5%. 
Mid-titre serum: The concentration of RF (in IU/ml) obtained in 
different tests was 160, 150, 190, 160, 155, 140, 180, 200, 150, 
190, 165, 155. 
The mean was 167.3 with a standard deviation of 19.67. The 
coefficient of variation was 11.75%. 
Low-titre serum: The amount of RF (in IU/ml) present in this 
serum when it was assayed on different occasions was 14, 15.3, 
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12.5, 12.5. The mean was 13.56 IU/ml with a standard deviation 
of 1.35. The coefficient of variation was 9.9%. 
Intra-assay variation 
This was measured by assaying the same serum on 12 occasions. 
The intra-assay variation was obtained for a high, intermediate 
and low titred sera. 
The intra-assay variation is given below (results expressed in 
IU/ml). 
High-titre serum: The results obtained in the same ELISA were 
360, 400, 370, 380, 340, 370, 375, 390, 360, 400, 360, 390. The 
mean was 374.6 The standard deviation was 18.27 with a 
coefficient of variation of 4.87%. 
Mid-titre serum: The RF concentrations measured when the sample 
was analysed 12 times were 156, 160, 156, 146, 142, 155, 150, 
144, 152, 146, 134, 147. The mean was 149 with a standard 
deviation of 7.3 and a coefficient of variation of 4.9%. 
Low-titre serum: When the serum was assayed 12 times the RF 
concentrations were 11.6, 12.6, 12.0, 11.5, 13.0, 12.6, 11.6, 
14.6, 12.6, 12.6, 12.5, 11.3. 
The mean was 12.36 with a standard deviation of 0.873 and a 
coefficient of variation of 7%. 
8.3.5 Effect of storage of serum 
Fresh WHO reference serum was obtained 1 year after the initial 
batch and the RF concentrations of the internal standard re-
determined. 
The mean RF concentration was 360 IU/ml compared to 370 IU/ml 
after storage. This difference was within the 1 imits of the 
inter-assay variation for the ELISA. 
Similarly, mean values of 147 IU/ml and 155 IU/ml after storage 
for 1 year (at -70°C) were obtained with another serum sample. 
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8.4 DISCUSSION 
The RF ELISA was established with the aim of providing a 
sensitive, reproducible and quantitative test for RF. A number 
of variables which could affect the assay were examined. 
8.4.1 Reagents and methods 
Carrier surface 
The Nunc and Greiner microtitre plates appeared to have a 
similar sensitivity for the detection of RF. However, the 
background readings were considerably lower with the Nunc 
plates. Nunc plates were used for subsequent assays. 
Bampton et al (1985) compared the use of various microtitre 
plates for the detection of IgM RF in patients with RA. 
Although no significant differences were found with regard to 
the overall sensitivity, Linbro plates (Flow Laboratories Ltd, 
Scotland) were chosen as they were cheaper than the other plates 
(including Nunc plates). 
Likewise, Stone et al (1987) evaluated the use of different 
types of plates (Linbro, Nunc, Falcon and Dynotec). These 
workers also chose Linbro plates, having found that background 
values were higher and/or reproducibility between wells was 
lower with other plates. The authors do not specify which 
plates were responsible for the problems, or the magnitude of 
the difficulty encountered. 
Although Li nbro pl ates were not tested in the present study, 
neither high backgrounds nor a lack of reproducibility were 
observed. 
Human IgG was used for the RF ELISA. Whilst IgG from different 
sources has been studied, most workers have used human or rabbit 
material. Gripenberg et al (1979) compared human and rabbit IgG 
as coating antigen for an RF ELISA in patients with RA. 
Stronger reactions were found with the human IgG. In addition, 
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Bartfeld (1969) stated that binding of RFs from patients with 
nonrheumatoid conditions was more pronounced with human IgG. 
Heat aggregation of the IgG increases the avidity of the latter 
for IgM RF (Egeland and Munthe 1983). Hence this procedure was 
employed in the assay. The human IgG was a pooled preparation, 
the reason being that this source would be likely to contain 
many of the IgG antigens recognized by RFs (Egeland and Munthe 
1983). 
The working concentration of IgG employed as a coating antigen 
was 0.5 mg/100 ml. Gripenberg et al (1979), Faith et al (1982), 
Procaccia et al (1987) and Moore et al (1988) all used the same 
IgG concentration. 
Peroxidase-conjugated antibody, enzyme and substrate 
The goat anti-human IgM conjugate utilized was found to be 
highly specific for IgM. Although Faith et al (1982) and 
Procaccia et al (1987) determined the specificity of the 
conjugate used, few other authors describing RF ELISAs state 
that t .his was done. For example, Gripenberg et al (1979), 
Bampton et al (1985), Gioud-Paquet et al (1987) and Stone et al 
(1987) do not mention that conjugate specificity was checked. 
The F(ab' )2 fragment of the conjugate was used in the present 
study. This was to prevent non-specific binding of RFs to the 
Fe portion of the conjugate (Carson et al 1977). 
The conjugate strength chosen was 1 :2000 which provided a low 
background value but a reasonable signal and was the most 
economical in terms of the use of reagents. The enzyme used in 
the ELISA was peroxidase. Peroxidase was chosen in preference 
to alkaline phosphatase as it was cheaper and readily available 
(Voller et al 1976). 
The substrate employed was 2.2' azinobis. Bampton et al (1985) 
compared 2.2' azinobis and orthophenyl-diamine as substrates. 
It was found that the latter substance was more sensitive. 
However, the former substrate was selected for the present study 
because of local availability and experience with its use. 
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Buffers 
In order to block nonspecific antibody absorption after the IgG 
coating step, solutions containing 1% and 2.5% BSA were 
evaluated. There was no significant difference observed in the 
background readings and a 1% solution was chosen. Stone et al 
(1987) also used 1% BSA. Bampton et al (1985), however, found 
that the blocking step could be omitted altogether. This may be 
worth further study because of the potential savings in terms of 
time and cost. 
Incubation times 
Voller et al (1980 pg 370) recommended 18 hour incubation 
periods at 4°C for both antigen coating and conjugate binding. 
For convenience, these time periods were chosen for the present 
ELISA. 
Few workers have reported the effects of different incubation 
times on the RF ELISA. However, Bampton et al (1985) found that 
maximal binding of rabbit IgG to the polystyrene plates occurred 
after overnight incubation at 37°C. Whether the improved 
binding altered the sensitivity of the assay is not stated. 
Heat inactivation of sera 
This appears to be unnecessary (Carson et al 1977; Gripenberg et 
~ 1979). With the exception of Bampton et al (1985) none of 
the authors quoted in this chapter used heat inactivated sera. 
8.4.2 Evaluation of the RF ELISA 
Having established the protocol for the RF ELISA the technique 
was evaluated and the results of this will be discussed. 
Specificity of the ELISA for RF 
The RF ELISA appeared to be measuring RF. This was concluded 
from the following findings: 
i. the 1 inear dose-response curve obtained with the external 
(WHO) standard 
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ii. the fact that all the patients with positive RF latex tests 
had a positive RF ELISA and vice versa. 
iii. the reduction in optical density readings obtained with the 
ELISA following removal of RF. 
Gripenberg et al (1979) and Faith et al (1982) reached similar 
conclusions in studies designed to test points ii) and iii) 
above. Neither of these authors used an external standard, 
however. 
Specificity of the ELISA for IgM RF 
That the RF measured was of the IgM class was suggested by a 
number of findings. 
i. The peroxidase-conjugate was highly specific for IgM. 
This, however, only provides indirect evidence that the 
ELISA is measuring IgM RF. 
ii. RF activity was lost following pepsin digestion. This step 
is known to destroy IgM RFs but not IgG or IgA RFs to the 
same extent (Theofilopoulos et al 1974). 
iii. Tests employed to detect other classes of RF were 
consistently negative. These tests are described in 
Chapter 9 and included an immunoabsorbent column and an IgA 
ELI SA. 
iv. The RF latex test detects IgM RF predominantly (Stage and 
Mannik 1972-73). 
As noted previously, there was a close association between the 
results of the latex tests and the RF ELISA results. 
Faith et al (1982), Procaccia et al (1987), Stone et al (1987) 
and others h~ve employed a similar RF ELISA to detect IgM RF. 
Standardization of the RF ELISA 
This was achieved using the WHO reference preparation. 
Subsequent ELISA results were expressed in terms of IU/ml. 
Klein and Janssens ( 1987) have reported on the use of the WHO 
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standard and have demonstrated that the use of international 
units improves the comparison of data between laboratories. 
The internal standard chosen was shown to reflect the RF 
concentration over a wide range of dilutions. 
Furthermore, it could be shown that the 1 inear portion of the 
curves obtained with the internal standard and the sera of 2 
positive control patients, were parallel. This is important as 
it means that the sera could be tested at any dilution within 
the upper and lower ranges of the ELISA (Hamilton and Adkinson 
1988 pg 66-69). 
Upper and lower cut-off values of RF ELISA 
The upper limit was chosen as an optical density of 0.4 and the 
lower cut-off limit as 0.05 (after the background readings were 
subtracted). Other workers do not appear to have reported the 
upper and lower cut-off limits. Nevertheless, the ELISA 
evaluated in the present study was able to detect less than 0.05 
IU/ml of RF. This can be contrasted to the sensitivity of the 
RF latex test which is 0.7 IU/ml (Orthodiagnostics package 
insert). The ELISA has previously been reported to be a more 
sensitive test for the measurement of RF than the latex test 
(Gioud-Paquet et al 1987). 
Reproducibility of the RF ELISA 
The results obtained in the present study were compared to those 
obtained by other workers. Gripenberg et al (1979) found an 
inter-assay coefficient of variation of 20% and an intra-assay 
coefficient of variation of 11% at a serum dilution of 1:500. 
Faith et al (1982) reported that the inter-assay coefficient of 
variation (15 sera tested on 2 occasions) was 'less than 10%'. 
A similar value was obtained for the intra-assay coefficient of 
variation (sera tested in triplicate). Stone et al (1987) 
reported inter and intra-assay coefficients of variation of 8% 
and 6% respectively. Procaccia et al (1987) do not state the 
reproducibility of their RF ELISA. Kemeny and Chantler (1988 pg 
22) recommended that the upper, middle and lower ranges of the 
curve be tested. Unfortunately, none of the authors quoted 
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state which portion of the curve was tested. This makes if 
difficult to compare results. Neverthel ess, the inter-assay 
coefficient of variation of bet~1een 5% and 11.7% and the intra-
assay coeffi c ient of variation between 4.9% and 7% obtained in 
the current study were thought to be acceptable. 
Effect of storage of serum 
The effect of the RF concentration of storage for one year at 
-7 0°C ,.,as demonstrated, by means of the use of fresh external 
standard, to be minimal. This does assume that the external 
(WHO) standard maintains its potency. Some workers have 
questioned this (Klein and Janssens 1987). Nevertheless , 
Wernick et al (1981) showed that repeated freezing and thawing 
of sera (on 1 occasions) had no effect on the RF levels. 
8.5 CONCLUSIONS 
This chapter describes the establishment of an RF ELISA. It was 
sho\•m that the technique was specific for RF of the IgM class 
and gave reproducible results. In addition, the test 
sensitivity was higher than that expected for the RF latex test 
(according to the package insert). In the work v1hich follows, 
the ELISA was used to quantitate RF concentrations in patients 
with congenital syphilis and to establish a normal range amongst 
controls. 
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CHAPTER 9 
RHEUMATOID FACTORS IN CONGENITAL SYPHILIS 
QUANTITATION AND CHARACTERIZATION 
Infants with congenital syphilis frequently have RF in their 
sera as demonstrated by the use of the RF latex test (Reimer et 
~ 1975; Meyer and Malan 1987). 
The results of studies described in Chapters 5 and 6 support 
these fJndings. The IgM RF response in infants with congenital 
syphilis was further investigated by performing a number of 
experiments: 
i. RF was q·uantitated more accurately using the IgM RF ELISA 
which was described in Chapter 8. The IgM RF 
concentrations in patients with congenital syphilis were 
compared to those of controls. 
ii. The presence of hidden IgM RFs was sought. 
iii. The contribution made by IgM RF to the tot a 1 lgM response 
was determined. 
In addition, techniques were used to measure RFs of the IgA and 
I g G i mm u no g l o bu l i n c l a s s e s • / 
9.1 IGM RF CONCENTRATIONS IN INFANTS WITH CONGENITAL SYPHILIS AND 
CONTROLS 
9.1.1 Study outline 
Three groups of patients and controls were considered . The 
groupings were made on the basis of age because IgM anti-IgG is 
more likely to be found in the serum of normal infants as they 
grow older (Wilson and Steinberg 1965; Speiser 1966). 
The age categories were: 
i. within 3 days of birth 
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ii. between the ages of 4 days and 2 months 
iii. older than 2 months but less than 4 months of age. 
These groups wee chosen because the control infants (previously 
described in Chapter 5) were followed-up at these ages. 
9.1.2 Materials and methods 
Serum samples were obtained as follows: 
Sera from infants within 3 days of birth 
There were 26 newborns with congenital syphilis in this group. 
These infants have previously been described in Chapter 5 (nos. 
5.1-5.7) and Chapter 6 (nos. 6.1-6.19). 
Controls: The sera from 96 normal newborn infants were randomly 
selected using random number tables. The infants were selected 
from those described in Chapter 5. They did not have congenital 
syphilis. This was demonstrated either by the results of 
extended follow-up or by the fact that the STS in mother and 
baby were negative at birth. 
Sera from infants aged 4 days - 2 months 
There were 9 infants with congenital syphilis in this age group 
(nos 6.20 - 6.29). Their clinical features have been described 
in Chapter 6. 
Controls: Sera from 39 infants described in Chapter 5 were used 
as controls. These infants had all been followed-up between the 
ages of 1 and 2 months and did not have congenital syphilis. 
Sera from infants over the age of 2 months but less than 4 
· months old 
Six of the infants with congenital syphilis were in this age 
group at presentation (nos 6.30 - 6.36). 
Controls: Forty-one of the infants followed-up between the ages 
of 3 and 4 months were selected as controls. 
9.1.3 
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The sera from infants in the groups above were thawed by 
allowing them to come to room temperature . They were then 
vigorously mixed and tested in duplicate in the IgH RF ELISA. 
Sera from patients with congenital syphilis were initially 
tested at a dilution of 1 :500. Sam pl es from the controls and 
from infants with congenital syphilis whose ELISA was negative 
at 1:500 were re-tested at a dilution of 1:100. 
Results 
Within 3 days of birth 
The IgM RF concentrations in the patients with congenital 
syphilis in this age group a re shown in Appendix 6 (Table 
A.6.1). The median RF concentration was 29 .5 IU/ml with a range 
of 0-850 IU/ml . 
When the 96 sera from the control patients were tested in the RF 
ELISA the results shown in Appendix 6 (Table A.6.2) were 
obtained . It was found that the optical density readings (after 
the background ·values were subtracted) \<Jere below the lower 
limit of sensitivity for the RF ELISA. This was apparent even 
when the sera were analysed at a dilution of 1:10 . For this 
reason the optical density readings are shown rather than the RF 
concentration in IU/ml. 
The median optical density was 0.016 and the 95th percentile was 
0.039 which , at a dilution of 1:100, corresponded to an RF 
concentration of 2.5 IU/ml. 
Infants a~ed 4 days - 2 months 
The RF concentrations in the sera of the 9 infants with 
congenital syphilis in this age group are also sho\m in the 
Appendix 6 (Table A.6.3). The median RF level v,as 80 IU/ml v1ith 
a range of 14- 238 IU/ml. 
~Ihen tt1e RF concentration was measured in the 39 controls the 
median was 3. 2 IU/ml and the 95th percentile was 17 .5 IlJ/ml . 
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Infants over the age of 2 months but less than 4 months old 
The 6 infants in this group with congenital syphilis had a 
median serum RF value of 46 IU/ml; the range was 0-520 IU/ml. 
The median RF concentration in the 41 control sera was 5.0 IU/ml 
and the 95th percentile was 29.5 IU/ml (see Appendix 6, Table 
A.6.4). 
The 'results are summarized in Figure 9.1. Between birth and 3 
days of age, 24 (92%) of the 26 infants had RF levels above the 
95th percentile of the controls. Infants with congenital 
syphilis aged 4 days - 2 months had elevated RF levels in 8 out 
of 9 (89%) of cases. In the oldest group (over 2 months - 4 
months) 4 of the 6 infants had RF levels which were raised with 
respect to the controls. 
It can also be se·en from Figure 9.1 that the upper limit of 
normal increased with increasing age of the controls. 
9.1.4 Discussion 
Patients with congenital syphilis 
Most of the patients with congenital syphilis described in this 
chapter had serum RF concentrations which were above the upper 
limit of age-matched control infants. 
This trend was particularly noticeable among the newborn infants 
with congenital syphilis. Of those presenting at birth 24/26 
had elevated IgM RF levels as measured with the IgM RF ELISA. 
All except one (no. 6.6) of the 24 with elevated RF 
concentrations had positive RF latex tests. The 2 patients who 
had no detectable RF by ELISA were also latex test negative. 
Of the older patients with congenital syphilis, 14 out of 15 had 
IgM RF detectable with the ELISA. However, 2 of the 14 (nos. 
6.32, 6.34) had a RF level within the normal range for age. The 
RF latex test was positive in the 14 infants where RF was 
detected by ELISA. It should be noted, however, that the RF 
latex test was positive in 10% of control infants who were 
tested between 1 and 4 months of age (see Chapter 5) 
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Figure 9·1 lgM Rheumatoid factor levels in infants with congenital syphilis 
at different ages compared to the upper limits of normal 
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It is interesting to speculate why serum RF was not detected in 
some patients. 
It is possible, as suggested by Rossen et al {1977) that the RF 
was deposited in tissues. Another explanation· may be that low 
levels of immune complexes were present in these patients. This 
was established to be the case in 2 instances (patients 5.3 and 
5.7 had levels of 6% and 0% respectively). There was 
insufficient serum to measure immune complex levels in patient 
6.23 (see Chapter 10 for details of immune complex 
measurements). 
Controls 
Using the RF ELISA different normal ranges were obtained at 
various ages. The - newborn infants had the lowest values and 
infants from 2 - 4 months the highest. However, the fact that 
the control infants were sampled at 2 distinct ages prevents a 
true longitudinal assessment from being made. 
Stagno et al (1980) have described that the prevalence of 
positive RF latex tests increases with age in early infancy. 
They found negative tests in all 676 normal newborns studied but 
positive tests in 1 out of 7 (14%) infants at 1 month and in 4 
out of 32 (12%) at 3 months. 
the reason for the normal infants having demonstrable RF (or IgM 
anti-IgG antibody) is unclear. However, Steinberg and Wilson 
(1963) and Wilson and Steinberg (1965) have described that 
normal infants may produce IgM antibodies against maternal IgG 
allotypes. Allotypic markers on IgG may be of the Gm 
specificity and these Gm markers are genetically determined 
(Egeland and Munthe 1983). Presumably the infant may recognize 
the maternal allotypes as foreign. Speiser (1966) reported that 
anti-Gm antibodies appear at 6 months of age and pea~ at 12-18 
months. 
Rheumatoid factors may be directed against Gm antigens on IgG 
(Mannik 1979 pg 504). Therefore as suggested by Reimer et al 
(1975) the IgM RF found in some normal infants after birth may 
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represent the presence of anti-allotypic antibodies. 
If this is so, the present study indicates that these antibodies 
may be measurable before 6 months of age. Indeed, Steinberg and 
Wilson (1963) reported anti-allotypic antibodies in an infant 
aged 7 weeks and suggested that the antibody may be present from 
birth but undetectable by the methods then in use. 
The demonstrated rise in IgM RF levels between birth and 4 
months in the present study may be in keeping with the rise in 
anti-Gm antibodies noted by others (e.g. Wilson and Steinberg 
1965, Speiser 1966), the earlier onset in this study reflecting 
the use of the more sensitive ELISA detection system. 
Whatever the cause of the raised IgM RF levels in normals, their 
presence limits the usefulness of measuring RF levels by ELISA 
to diagnose congenital syphilis beyond the first 2 months of 
life. Regarding the diagnosis of congenital syphilis in the 
infants described, it was apparent that the ELISA did not have 
substantial advantages over the simpler RF latex test • . The lack 
of significant diagnostic benefit achieved using the RF ELISA 
instead of the RF latex test has also been reported in RA (Stone 
etal 1987) . 
The purpose of accurately quantitating the IgM RF levels in the 
i n fa n t s w i t h c o n g e n i ta l s y p h i l i s 1·1 a s to de t e rm i n e i f 
associations existed between RF levels and clinical and 
laboratory findings. This is further investigated in Chapter 
10. 
9.2 TESTIHG FOR HIDDEN IGM RF IN INFANTS WITH CONGENITAL SYPHILIS 
The reactivity of serum IgM RF may be concealed by the formation 
of comple xe s with circulating IgG. The conventional methods 
used to detect RF may then be inadequate (Allen and Kunkel 
1966). This has been shown to occur in juvenile chronic 
arthritis, for example, where only 5-10% of patients have 
positive RF latex tests but over 60% are reported to have hidden 
RF (rloore et al 1988) . 
The aim of this section v1as to determine the concentration of 
9.2.1 
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hidden RF amongst infants with congenital syphilis. It would 
then be apparent if steps to measure hidden RFs were necessary 
to obtain an accurate estimate of the total serum RF 
concentration. 
Allen and Kunkel (1966) described a method of acid treatment and 
exclusion chromatography to detect hidden RF. However, this is 
time consuming. Dorner et al ( 1983 ) found that ion exchange 
chromatography gave comparable results. The latter meth od 1·1as 
therefore chosen for this study. 
Materials and methods 
Sera 
Latex test negative sera: Sera from 9 patients with congenital 
syphilis wh ose RF latex tests were negative were studied. The 
patient code numbers are shown in Table 9.1. In addition, sera 
from 2 normal ne\~borns (5.68 and 5.69) were used as negative 
controls. 
Latex test positive sera: Sera from 7 infants with congenita l 
syphilis wh ose RF latex tests were positive were also tested for 
hidden RF. The first 7 patients with sufficient serum (200 ul) 
\'Jere ch osen. 
Methods 
Commercially prepared ion exchan.ge columns (Quick-Sep, System 
II, obtained from Isolab, USA) were used. These columns were 
designed t o separate IgM from IgG ( Johnson and Libby 1980) and 
were found t o be suitable for detecting hidden RF (Dorner et al 
1983). The manufacturers instructions v1ere followed. Briefly, 
the serum was diluted in the IgG ,,.,ash buffer and applied t o the 
column. Further wash buffer was added to remove unb ound 
material. An IgM elution buffer was added and the IgM el uate 
(at a dil uti on of 1: 20) was collected. 
The RF late x test and RF ELISA were used to detect RF in the 
sera and I9M eluate. The RF ELISA v1as carried out at a final 
dil uti on of 1:100 and the latex test at a dilution of 1:20 . 
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TABLE 9.1 
RHEUMATOID FACTOR LEVELS IN SERA AND IgM FRACTIONS IN INFANTS 
WITH CONGENITAL SYPHILIS 
SERUM IgM FRACTIO~l 
PAT! ENT RF LATEX RF ELISA RF LATEX RF ELI SA 
CODE NO. TITRE (IU/ml) TITRE ( IU/ml) 
5.1 1:160 24 1:80 0 
5.3 < 1: 5 0 < 1: 20 0 
5.7 < 1 :5 0 < 1: 20 0 
5.8 < 1: 5 12 <1:20 0 
5 .11 < 1: 5 3 <1:20 0 
5.12 < 1: 5 0 < 1: 20 0 
5.13 < 1 :5 0 <l :20 0 
5.14 < 1 :5 0 1 :80 0 
5.15 < 1: 5 0 <1:20 0 
5.68 < 1 :5 0 < 1: 20 0 
5.69 <l :5 0 <1:20 0 
6.6 <1.5 50 < 1 :20 5 
6.9 1:80 165 <1:20 76 
6.13 1:160 34 1 :80 3 
6.17 1:320 3 1:20 0 
6.20 1 :80 38 1:80 10 
* 6.26 1:160 500 ND 106 
6.33 1:160 96 1:80 22 
*NO - not done 
In addition, the RF ELISA was used to determine the RF 
concentration in the IgG fraction obtained from 2 sera. This 
was done to obtain an estimate of RF losses in this fraction. 
9.2.2 
9.2.3 
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Results 
The table shows the RF val -ues in t he sera and t he IgM f ra cti ons. 
It can be seen that the RF concentrati ons obtained with t he 
ELISA were generally lower foll owing passa ge through the ion 
exchange columns. 
It could be shown that RF was lost in the IgG fracti on. The RF 
concentrations in this fraction of patients 6.9 and 6.26 were 8 
and 15 IU/ml respectively. 
Hidden RF was only detected in the IgM fraction using the RF 
late x test in one case (5.14). The RF ELISA in this case 
remained negative following the ion exchange procedure. 
Discussion 
The method was easy to carry out. It was apparent, however, 
that substantial losses of RF occurred. Some of the RF was 
present in the IgG fraction. Presumably the remainder was not 
eluted from the column. 
Dorner et al (1983) were able to recover over 60% of the total 
serum IgM in the IgM fraction. However, it was not shown that 
RF recovery was similar. Moore et al (1988) used an RF ELISA to 
measure RF concentrations in the IgM fractions obtained from 30 
patients with juvenile chronic arthritis using an ion exchange 
co 1 umn. In 15 cases 1 ower RF va 1 ues were noted in the IgM 
fraction following the procedure. In 10 cases the RF values 
were the same while in 5 cases they were higher. It is 
apparent, therefore, that RF losses were also experienced by 
these workers. 
Hidden IgM RF was only detected in 1 case in the present study. 
One of the limitations of the method was that the RF latex test 
had to be carried out at a dilution of 1:20 on the IgM fraction. 
Nevertheless, even the more sensitive RF ELISA did not detect 
hidden RF in the IgM fraction. 
It was evident that no significant benefit was experienced using 
the ion exchange method to measure hidden RF. The procedure was 
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not carr ied out in subsequen t tests. Indeed , r1oore et al ( 1988) 
have proposed that the IgM · RF ELISA measures hidden and 
clas sical RF without the need for IgM separation. 
9.3 RHEUMATOID FACTOR LEVELS AND THE TOTAL IGM RESPONSE 
It is known that infants with congenital syphilis may have 
elevated levels of serum IgM (Alford et al 1967). It is not 
known, however, what proportion of the tota 1 IgM response in 
co ngenital syphilis is . IgM RF. 
Results of in vitro experiments showed that newborn unibil ical 
cord blood cells were capable of producing large amounts of IgM 
RF when stimulated with Staphylococcus aureus Cowan 1 (Levinson 
et al 1987). It could be hypothesized, therefore, that a high 
percentage of the IgM produced in congeni ta 1 syphi 1 is would be 
IgM RF. 
The most direct way of determining the amount of IgM that was RF 
would be to measure RF concentrations using the RF ELISA and 
then to relate these to the total IgM levels, Ho.,.,ever, the WHO 
standard measures RF in IU/ml (Anderson et al 1970). This 
cannot be directly converted to IU/ml of IgM-. Wernick et al 
(1981) overcame this problem by preparing a purified RF 
standard. This work cannot be extrapol-ated to other studies, 
however, as these workers:--·did not com .are their standard with an 
international standard. 
In order to repeat this work ·-.a similar method was used to 
isolate IgM RF from the serum of an inf~t with congenital 
syphilis. The RF and IgM concentrations of this purified 
standard were then determined simU:lt-aneOlrsly. 
9.3.1 Materials and Methods 
An immunoabsorbent method, based on the batchwise procedure 
described by Avrameas and Ternynck (1969), was followed. 
Insolubilized gammaglobulin cross-linked to glutaraldehyde was 
used to absorb RF from test sera. The RF was subsequently 
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eluted under acidic conditions (Torrigiani and Raitt 1967; 
Wernick et al 1981). 
Preparation of insolubilized gammaglobulin 
The method of Avrameas and Ternyck (1969) was used to cross-link 
gammaglobulin and glutaraldehyde. Human Cohn Fraction II (1.5 g 
in 30 ml 0.1 M phosphate buffer pH 7) was added to 
glutaraldehyde (6 ml of a 2.5% solu.tion). The gammaglobulin 
(obtained from ICN Immunologicals, Lot no 50) was added drop-
wise to the glutaraldehyde (obtained from BDH Chemicals, 
England). The resulting gel was allowed to stand for 3 hours at 
room temperature. The gel was then mixed with 400 ml of 0.2 M 
phosphate buffer pH 7.3 and homogenized. 
The mixture was placed in a beaker, stirred, and allowed to 
settle at 4°C overnight. The supernatant was decanted and the 
precipitate mixed with 100 ml of Tris-saline pH 7 .4. After a 
period of 30 minutes the supernatant was again discarded. This 
procedure was repeated 4 times with the intervals between 
stirring and decanting being decreased to 15 minutes, 10 
minutes, 5 minutes and 2 minutes. In this way fine particles 
were removed. The remaining insolubilized protein was then 
washed twice in 200 ml of 0.1 M glycine-HCl buffer. The 
immunoabsorbent was finally washed twice with Tris-saline pH 7.4 
and the optical density of the supernatant was found to be Oat 
280 nm (a Beckman spectrophotometer, model 25, was used). 
Serum samples: these were obtained from: 
i. A patient with congenital syphilis whose RF latex test and 
IgM RF ELISA tests were positive. The patient has been 
described in Chapter 6 (patient code number 6.12). The 
serum RF concentration was 788 IU/ml and the serum was 
shown to contain only IgM RF (see Sections 9.4, 9.5 and 
9.6). 
ii. A control patient (no. 5.120) whose RF latex and RF IgM 
ELISA tests were negative. 
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Prior to immunoabsorption, the sera (2 ml from each patient ) 
were heated to 56°C for 30 minutes to inactivate complement. 
Batchwise procedure of immunoabsorption 
Avrameas and Ternynck (1969) used approximately 60 mg of 
insolublized protein per ml of serum. The immunoabsorbent 
prepared as described above contained 41 mg of gammaglobulin per 
ml. Therefore, 1.5 ml of immunoabsorbent was used per ml of 
serum. 
The immunoabsorbent was placed in glass test tubes (12 x 75 mm) 
and serum added. The samples were incubated for 1 hour at 37°C 
in a waterbath (a mechanical shaker was used to ensure thorough 
mixing). They were then left at 4°C overnight (Wernick et al 
1981). They were allowed to return to room temperature 
(Nardella and Mannik 1979 noted less non-immunospecific protein-
protein binding at this temperature) and centrifuged at 350 G 
for 15 minutes. The supernatant was carefully removed, and 
analysed with the RF ELISA to detect unbound RF. The 
immunoabsorbent and bound material were then washed with Tris-
saline pH 7.4 (Wernick et al 1981). Repeated washing followed 
by centrifugation at 350 G for 5 minutes was carried out until 
the opt i ca 1 density of the supernatant at 280 nm was 1 ess than 
0.035. 
Elution 
The immunoabsorbed protein was then eluted with 0.1 M glycine 
HCl at pH 2.8. One millilitre of the latter was added to the 
immunoabsorbent and the solution agitated with a vortex mixer. 
Following centrifugation at 350 G for 5 minutes the eluate was 
obtained. The procedure was repeated following the addition of 
1 ml of Tris-saline 7.4. This buffer was used rather than 
glycine -HCl to obtain a second eluate as more than 1 exposure 
to the latter has been shown to destroy RF (Wernick et al 1981). 
The eluates were neutralized with 1 or 2 drops of 0.1 M sodium 
hydroxide to obtain a pH of 7.2 - 7.4. 
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Analysis of eluates 
The eluates were concentrated approximately 20 times using a 
Centricon 30 microconcentrator (Amicon, USA, catalogue number 
4208). The IgM RF levels of the eluates were measured before 
and after concentration to assess whether RF was lost during 
this step. 
The IgM and IgM RF concentrations were then measured and the 
means obtained. IgM levels were determined on radial 
immunodiffusion plates (Immuno-plate IV, Hyland Diagnostics, 
USA). The IgM RF levels were measured using the RF ELISA, the 
preparation being tested at a dilution of 1:50. 
9.3.2 Results 
The supernatant obtained following exposure of the serum 
containing RF to the immunoabsorbent contained 65 IU/ml of RF. 
This indicated incomplete absorption. 
The concentration step d i_d not result in further loss of RF, 
however. This was demonstrated by finding 3.8 IU/ml of RF in 
the eluate before concentration and a mean of 77.5 IU/ml 
afterwards. 
When the concentrated eluate from the patient with congenital 
syphilis was assayed with the IgM RF ELISA the following RF 
concentrations were obtained: 72.5, 72.5, 85, 80 IU/ml. The 
mean was 77.5 IU/ml with a standard deviation of 6.1. The IgM 
levels were 19.0, 19.0, 20.5 IU/ml. The mean was 19.5 IU/ml 
with a standard deviation of 0.87. It was evident, therefore, 
that 1 IU of IgM corresponded to 4 IU of RF. 
The eluates from the control patient contained no RF or IgM. 
Percentage of IgM which is RF in infants with congenital 
syphilis 
Using the conversion factor obtained from the purified IgM RF 
standard, the percentage of the IgM response which was RF was 
9.3.3 
237 
calc ulated for ea ch of th e pa tients wi th co ngeni t a l syph il i s who 
were des cri bed in secti on 9. 1. 
The data is shown i n the ta ble in Appendi x 6 (Tab l e A. 6. 5) and 
summari zed in Fi gu re 9. 2. The mean amount of IgM wh ic h was IgM 
RF was 4% with a range O - 29% and a median value of 3% . 
Discussion 
Preparation of the IgM RF standard 
It was demonstrated that not all the IgM RF was removed from t he 
test serum fol 1 owing exposure to the immunoabsorbent. Other 
wor kers have obtained similar results (Lea and Ward 197 2; 
Wernick et al 1981), although Torrigiani and Raitt (1967) 
reported minimal RF losses during this step. 
The reason for the variable RF absorption is unknown, but may be 
explained by the fact that different RFs have different 
affinities for IgG (Egeland and Munthe 1983). Thus, higher 
affinity RFs would tend to be absorbed whilst lower affinity 
ones may not attach to the immunoabsorbent. 
This is one of the disadvantages of the method in that the RFs 
in the sample chosen to make a standard may have stronger or 
weaker binding constants than the RFs in the test sera. 
This would effect the estimation of IgM RF levels. Wernic k et 
~ (1981) appear to have ignored this, as Mannik and Nardella 
( 1985) have pointed out. To overcome this prob 1 em in future, 
another method of standardizing the RF ELISA to allow 
quantitation of the amount of IgM which is RF, would be needed. 
Relationship between IgM RF and total IgM levels 
The circulating IgM RF accounted for a variable amount of the 
IgM response in the infants with congenital syphilis with a mean 
of 4%. Al though, in some cases, a high percentage of the IgM 
was RF (up to 29%), the median value was 3% . There was a 
statistically significant correlation between the total IgM 
levels and the amount of IgM which was RF. Spearman's Ran k 
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Co rrelation Coeffi c ient v,as 0.66 v1hic h v1as si gnifi cant at the 
0 , 1% 1eve1 ( p < 0. 00 1) . 
It might have been predicted that a greater amo unt of t he Igf.1 
would be RF. Possible reasons for this being: 
i. up to 75 % of the B lymphocytes in cord blood bel ong t o the 
Leu 1+ subset which are the RF producing ce11s (Hardy~ 
198 7). 
ii. the IgM RF secreted by cord mononuclear ce11s i n response 
to stimulation with Staphylococc us aureus Co wan I acc ou nted 
for 16,7% of the total IgM produced (Levinson et a1 1987). 
There are several explanations for the seemingly sma11 
percentage of IgM RF in the infants with congenital syphilis. 
Firstly, the results of Levinson et a1 (1987) were obtained in 
vitro, not in vivo. It is conceivable that the infants with 
congenital syphilis did, in fact, produce larger amounts of RF 
but the latter may have been deposited in the tissues. Indeed, 
Ford and Kosatka (1982) have shown experimentally that RF 
attaches to the tissue-bound immune complexes. Such complexes 
have been demonstrated in the kidney and placenta in congenital 
syphilis {Wigge1inkhuizen et a1 1973, Samson 1989) and may be 
present at other sites. 
Secondly, different agents may have differing abilities to 
induce RF synthesis. For example, when stimulated with Ebstein-
Barr virus, few RF producing cells were found in neonates (Fong 
et al 1985). The stimulatory effect of immune complexes 
containing treponema1 antigens may, therefore, be less than that 
of the Staphylococcus aureus used by Levinson et al (1987). 
Thirdly, as discussed previously, the standard used in the 
present study to determine the amount of IgM which was RF may 
have had an affinity for IgG which was different to that of the 
other RFs in the patients with congenital syphilis. Indeed, the 
same criticism could be applied to the work of Levinson et a1 
(1987). These authors used a monoclonal RF from a patient with 
Waldenstrom's macroglobu1inaemia and assumed that the RFs found 
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in the cultures from the cord blood cells all had the same 
affinity for IgG. 
Interestingly, in 17 adult patients with RA, Wernick et al 
(1981) found that an average of 6% of the total IgM was RF. 
Patients with RA also have large numbers of Leu-1+ B cells 
(Plater-Zyberk et al 1985). There are, therefore, similarities 
in the IgH RF responses seen in RA and congenital syphilis. 
What of the remainder of the IgM produced in congenital 
syphilis? A percentage is undoubtedly IgM directed against 
T.pallid um itself (Scotti and Logan 1968). Ho\'1ever, Reimer et 
~ (1975) found that some infants with congenital syphilis did 
not make a significant amount of IgM against the spirochaete, 
but made more IgM RF. However, these \'1orkers did not directly 
measure the concentrations of either of these IgM antibodies. 
Therefore, an effort was made in the pre.sent study, to measure 
the amount of anti-treponemal (or specific) IgM using the method 
descri bed by Altemeier et al (1969). The amount of specific IgM 
would then be compared with the concentration of IgM RF. 
A treponemal suspension (Behring, catalogue no. ORMK 04/05) •,vas 
inc ubated with serum from which RF and IgG had been removed 
using sheep anti-human IgG (as described in Chapter 7). After 
overni ght incubation at 37°C the suspension was centrifuged and 
the su pernatant tested for the presence of specific IgM using 
the FTA-ABS ( IgM) test. The purpose was to measure t otal IgM 
levels be fo re and after removal ·of specific Ig M. HovJever, in 
spite of repeated attempts made under a variety of co nditions 
and with different sera, the specific IgM could not be removed. 
The reas on f or this failure to remove the IgM in ~vhat was 
presumab 1 y an excess amount of anti gen, is unkn own. However, 
there is still much to be learnt regarding anti gen-anti body 
interacti ons in syphilis (reviewed by Musher 1984 pg 296) . 
It is c lear, however, that the IgM response in congenital 
syphil i s has different components. This indicates that the RF 
produc t i on in congenital syphilis is part of a polyc l ona l B 
lymphocyt e response. The stimulus for this response may be the 
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presence of immune comple xes as has been s hown by Pi s ko et a l 
(198 2). Using mononuclear cells from healthy adults these 
wor kers were able to show that under certain conditions, i mmu ne 
com plexes composed of Ha ig G l ed to a pol yclonal Ig M response 
which included IgM RF production in vitro. 
9.4 IgG AND IgA RFS IN CONGENITAL SYPHILIS 
Rheumatoid factors in these immunoglobulin classes have been 
detected in low concentration in normal individuals but hi gh 
levels occur in patients with a wide variety of infections and 
autoimmune diseases (Gharavi et al 1985). 
High levels of IgG RF have been associated with vasculitis, 
subcutaneous nodules and more severe forms of RA (Scott et al 
1981). 
Concentrations of IgA RF have been found to correlate with the 
severity and activity of the disease and also with the presence 
of systemic symptoms in patients with RA (Gioud-Paquet et al 
1987 ) . In addition, the presence of bone erosions have been 
linked to the finding of IgA RF in patients with rheumatic 
diseases (Arnason et al 1987). 
Whether IgG or IgA RFs are present in congenital syphilis has 
not been extensively investigated, although Dobson et al (1988a) 
reported the absence of IgG RF in 5 infants with congen ita 1 
syphilis. 
9.4.1 Measurement of IgG RF using radial i1111unodiffusion 
There are many techniques described for the measurement of IgG 
RF. Mannik and Nardella (1985) have pointed out the pitfalls 
associated with some of the methods. In their review, the 
authors favour the use of radioimmunoassay or an ELISA based on 
similar principles. Because of the cost of the reagents and the 
difficulty of obtainuig highly purified anti-human Fab, another 
method, based on reverse radial immunodiffusion on agar plates 
impregnated with aggregated gammaglobin, was used. This 
procedure has been described by Theofilopoulos et al (1974). 
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9.4.2 Materials and methods 
Sera from patients with congenital syphilis 
Five infants with congenital syphilis were studied. They were 
selected using random number tables; patients being inclu ded if 
they had sufficient serum available (300 - 500 ul ). The infants 
are described in more detail elsewhere and included the patients 
coded 6.6, 6.12, 6.18, 6.28 and 11.5. All these infants had 
elevated IgM RF levels as measured using the RF ELISA. 
Sera from patients with rheumatoid arthritis 
The sera of 4 adults with RA were tested for IgG RF in an effort 
to find a positive control serum. These patients attended the 
outpatient RA clinic at ·Groote Schuur Hospital and had active 
disease with positive RF latex tests. 
Normal newborn serum 
Serum from a normal newborn was used as a negative control. The 
serum tested negative for RF using both the RF latex test and 
the RF ELISA. The patient code number was 5.120. 
Pepsin digestion of sera 
This was carried out to destroy IgM RF (Theofilopoulos et al 
1974) and was necessary because IgM RF may give a false positive 
reaction for IgG RF (Lea and Ward 1972). 
To each serum an equal volume of 0.1 M sodium acetate buffer (pH 
4.1) was added. (The pH of the mixture was checked and found to 
be below 4.5). Pepsin obtained from the Sigma Chemical Company 
was used. A freshly prepared solution containing 10 mg/ml in 
the sodium acetate buffer was then added (0.2 ul of pepsin per 
ul of serum). The sera were allowed to digest overnight in a 
waterbath at 37°C. Mixing was facilitated by means of a 
mechanical shaker. The samples were then dialysed overnight 
against 3 changes of Tris-buffered saline pH 7.5 (0.05 M Tris in 
0.2 M sodium chloride). To determine the completeness of 
digestion, the dialysates were then added to agar 
immunodiffusion plates (made according to the method described 
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by Rose and Friedman 1980 pg 5-6). Fifteen microlitres of anti-
human IgM (obtained from Oakopatts, Denmark, catalogue number 
A.091) was placed in the centre well. Ten microlitres of the 
pepsin-digested sera were then added to the surrounding wells. 
After an incubation period of 48 hours at room temperature, the 
immunodiffusion plates were examined for precipitin lines. Sera 
which reacted with the anti-human IgM were re-treated with 
pepsin and used only after demonstrating the absence of IgM. 
Preparation of immunodiffusion plates for IgG RF detection 
The technique of reverse immunodiffusion was used 
(Theofilopoulos et al 1974). The antigen used was heat-
aggregated Cohn Fraction II (ICN Immunologicals) which was 
prepared according to the method of Christian (1958). Two grams 
of gammaglobulin were dissolved in 100 ml of Tris-buffered 
saline pH 8.0 and aggregated by heating to 63°C for 10 minutes 
in a waterbath. Tv,enty ml of 2.18 M sodium sulphate was then 
added and the cloudy suspension obtained centrifuged for 20 
minutes at 1000 g. The precipitate was re-suspended in 5 ml of 
buffer at pH 8.0 and dialysed at 4°C overnight against 3 changes 
of Tris-buffered saline (0.05 M Tris HCl _\•iith 0.2 ~I sodium 
chloride pH 7.5). The protein concentration of the dialysate 
was determined by measuring the optical density at 260 and 280 
nm and applying a standard formula (Richterich 1969) 
Three ml of a solution containing 1. 3 mg of gammaglobulin per ml 
\'las then added to · 9 ml of molten 1% agar at 60°C. Agar plates 
were prepared and l'lells 4 mm in diameter and 1 cm apart were 
cut. 
The sera which had previously been digested with pepsin were 
added to the wells ( 20 ul of serum per well) and read at 24 
hours and again at 48 hours. 
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9.4.3 Results 
None of the 10 sera tested in v1hich IgM was removed by pepsin 
digestion and IgG RF measured by radial immunodiffusion showed 
any precipitation rings. 
9.4.4 Discussion 
The technique described by Theofilopoulos et al (1974) has not 
been used to measure IgG RF in congenital syphilis by other 
workers. Whilst this study was in progress, the results of wor k 
by Dobson et al (1988a) became available. Using a 
radioimmunoassay they were unable to detect IgG RF in the · serum 
of 5 infants with congenital syphilis. 
The apparent failure of infants with congenital syphilis to make 
IgG RF is not unexpected. This is because, although class-
switching is likely to occur in RF-producing plasma cells in 
adults {Gharavi et al 1985), B cells synthesizing IgG and IgA 
are not readily inducible in infants (Roper and Cooper 1983 pg 
19). IgM antibodies are the predominant antibody response early 
in life {Alford 1971) and therefore IgM RF is likely to be the 
major RF class produced in infants with congenital syphilis. 
Nevertheless, the technique used by Theofilopoulos et al (1974) 
has been regarded by some workers as being relatively 
insensitive for the detection of IgG RF {Wernick et al 1981). 
For this reason an immunoabsorbent method was also set up in the 
present study. This method was used to detect RFs of the IgG 
and IgA classes simultaneously. 
9.5 DETECTION OF IgG AND IgA RFS USING AN I"'1UNOABSORBENT METHOD 
The batchwise procedure of immunoabsorption as described by 
Avrameas and Ternynck (1969) was used. This method was outlined 
in the section dealing with the preparation of an IgM RF 
standard. Essentially, the only difference was that pepsin-
digested sera were used (Wernick et al 1981, Faith et al 1982, 
Procaccia et al 1987). The reason for this was that pepsin 
digestion destroys IgM RF (Theofilopoulos et al 1974). IgM RF, 
9.5.1 
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if present in the test sera, can result in the isolation of 
normal IgG from the immunoabsorbent (Mannik and Nardella 1985) . 
Materials and methods 
Serum sampl es 
Sera from the patients with congenital syphilis that were tested 
for the presence of IgG RF using the reverse radial 
immunodiffusion technique were used. The patient code numbers 
were 6.6, 6.12, 6.18 and 6.28. 
The serum of a patient with seropositive RA was used as a 
positive control and that of a normal newborn infant (no. 5.120) 
as a negative control. 
Pepsin digestion of sera 
This was carried out as previously described (Section 9.4.2). 
The IgM RF ELISA was performed on the sera before and after 
exposure to the pepsin to ensure complete destruction of IgM RF. 
Batchwise procedure of immunoabsorption 
The method has been previously elaborated (Section 9.3.1). 
Analysis of eluates 
The neutralized eluates were concentrated as described (Section 
9.3.1). Levels of IgM, IgG and IgA were then measured on radial 
immunodiffusion plates. 
Plates obtained from Hyland Diagnostics, USA (Immuno-plate IV) 
were used to quantitate IgM. IgG and IgA concentrations were 
determined on plates supplied by Behring (LC Partigen 
immunodiffusion plates OTCR 03 and OTCP 03). 
In addition, the eluates were tested for IgM, IgG and IgA using 
turbidimetry. This was performed in the Chemical Pathology 
laboratory, Red Cross War Memorial Children's Hospital. 
The reason for including turbidimetry in addition to radial 
immunodiffusion was that the latter may underestimate IgG RF 
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because of the tendency of this substance to und ergo self-
polymerization (Mannik and Nardella 1985). 
9.5.2 Results 
The results are shown in Table 9. 2 below . The IgM RF ELISA 
values before and after pepsin digestion are given . Sera had no 
measurable IgM after pepsin digestion. The results shovm are 
for the pooled first and second eluates. 
TABLE 9.2 
IgG AND IgA RHEUMATOID FACTORS ISOLATED USING AN IMMUNOABSORBENT 
METHOD 
IgM RF ELISA *ELUATE IMMUNOGLOBULIN 
IU/ml LEVELS 
PATIENT 
NO . BEFORE AFTER IgM IgG lg A 
PEPSIN PEPSIN IU/ml IU/ml IU/ml 
DIGESTION DIGESTION 
6.6 50 0 0 0 0 
6.12 788 0 0 0 0 
6.18 24 0 0 0 0 
6.28 160 0 0 0 0 
** RA 380 0 0 0 2. 3 
5.120 0 0 0 0 0 
* Measured by radial immunodiffusion 
** Adult patient with rheumatoid arthritis 
9.5.3 
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None of the sera had detectable IgG RF levels _ as measured y1ith 
either immunodiffusion or turbidimetry. The patient with RA had 
measurable IgA in the eluted fraction. 
Discuss ion 
The results were similar to those obtained with the reverse 
immunodiffusion method in that IgG RF was not isolated. 
The use of an immunoabsorbent technique to measure IgG RF has 
been s ubj ect to some criticism. One of the reported problems is 
t hat of nonspecific protein-protein interaction (Turner 1976 pg 
417- 420) . This non-specific binding \•1as noted to be less at 
room temperat ure ( Nardella and Mannik 1978 ). When the 
immunoa bsorbent method was carried out at this temper·ature the 
phenomenon was not observed in the present study as indicated by 
the absence of IgG in the eluate from the normal newborn infant 
(no. 5. 120) . 
The use of the pepsin digestion step to destroy IgM RF prevented 
isolati on of normal IgG from the immunoabsorbent, thus 
circ umventin g an other problem cited by Mannik and Nardella 
( 198 5 ) 
The possible pitfalls of quantitating RFs using immunodiffusion 
have been noted by Lea and Hard (1972) and Mannik and tlardella 
(1985). Hence the technique of turbidimetry was employed in 
additi on t o that of immunodiffusion, although without noticeably 
affectin g t he results. 
When th e ne gative results obtained are considered with those of 
Dobson e t al (1988a) it appears that IgG RF is not present. 
This wor k co uld be confirmed with larger numbers of infants with 
congen ital syphilis using an IgG RF ELISA or radio-immunoassay 
method . The IgG RF ELISA was not used in the present study. 
This \·1as because of the expense and diffic ulty of .o btaining 
hi ghly pu rified rabbit anti-human Fab conjugate used as a second 
antibody ( Faith et al 1982, Bampton et al 1985) . 
The i mmu noabsorbent meth od detected IgA R~ in the serum of an 
adult \vit h RA but not in the infants with congenital syphilis. 
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To verify these negative results in the infants an IgA ~F ~LI SA 
was established. Compared to the IgG RF ELISA, the second 
antibody conjugate used for this procedure (a goat anti-human 
lgA wh ich was alpha-chain specific) was readily available. 
9.6 IGA RF ELISA 
The method of Procaccia et al (1987) was used with minor 
modifications. 
9.6.1 Materials and Methods 
The same materials described for the IgM RF ELISA were used, 
with the some exceptions. 
Peroxidase-conjugated antibody 
A peroxidase-labelled goat anti-human IgA was used. The F(ab' )2 
fragment of this alpha chain specific antibody was obtained from 
Cappel Products, USA (catalogue number 33010021). 
TABLE 9.3: 
THE SPECIFICITY OF THE GOAT ANTI-HUMAN IgA ANTIBODY FOR lgA 
CLASS IMMUNOGLOBULINS 
* 
COATING ANTIGEN 
Anti-human IgA 
Anti-human IgG 
Anti-human IgM 
* OPTICAL DENS I TY 
0.63 
0.25 
0.32 
Mean of duplicates after background values subtracted 
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Specificity of the conjugate 
This was determined in the same vJ ay as that of the co njugated 
antibody used in the IgM RF ELISA ( see Chap ter 8) . 
It was shown that, although the conjugate detected mainly IgA 
class antibodies, there was considerable cross-reactivity for 
other immunoglobulin classes. In an effort to improve conjugate 
specificity, the latter was absorbed with human IgG. (Although 
the conjugate demonstrated a lack of specificity for IgM in 
addition to IgG it was not absorbed with the former because the 
pepsin digestion step destroyed IgM antibodies) 
Absorption of the anti-human IgA conjugate 
The absorption was carried out in a polystyrene Falcon tube. 
Five hund.red microl itres of purified human IgG ( from ICN 
Immunobiologicals) at a concentration of 4 mg/ml in coating 
buffer was added. The IgG was allowed to bind to the tube at 
4°C overnight. The tube was then washed 3 times with PBS pH 
7.2. Ten percent foetal calf serum (from Centrolab, Cape Town) 
in PBS pH 7 .2 was added for 2 hours at room temperature as a 
blocking agent. 
After 3 washes with PBS pH 7.2, 500 ul of the anti-IgA conjugate 
at a dilution of 1:50 in PBS was added. This was incubated at 
37°C for 30 minutes and then overnight at 4°C. The absorbance 
of the conjugate as measured at 280 nm was 0.89 before addition 
to the plastic tube and 0.89 afterwards. 
This indicated that an insignificant amount of protein had been 
removed. 
Serum samples 
Infants with congenital syphilis: Sera from the same 4 infants 
used for the batchwise immunoabsorbent procedure were studied 
(patient code numbers 6.6, 6.12, 6.18. 6.28). In addition, sera 
from another 2 patients with congenital syphilis (patient code 
numbers 5.5 and 11.5 were tested in the IgA RF ELISA. 
9.6.3 
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Positive control serum: the serum from the patient with RA 
whi ch was shown to contain IgA RF using the immunoabsorbent 
procedure was used. 
Negative control serum: this was obtained from a normal newborn 
infant (patient code number 5.120). 
The sera were all subjected to pepsin digestion as previously 
described and contained no IgM. A serum dilution of 1:50 in PBS 
Tween was used in the ELISA. 
Checkerboard titrations The optimum conditions for the assay 
were determined. 
IgG concentration: concentrations from 0.5 - 3 mg per 100 ml 
were evaluated as the coating antigen. 
Blocking solutions: to determine the optimum blocking 
conditions, different solutions were tested. One percent bovine 
serum albumin (BSA) with 1% goat serum, 4% BSA and 4% BSA with 
0.25% BSA added to the serum and conjugate were assessed. 
Peroxidase-conjugated antibody: the absorbed conjugate was 
employed at dilutions from 1:500 - 1:2000. 
Incubation times: the conjugate was left on the plates for a 
period of 1 hour as for the IgM RF ELISA or 2 hours as suggested 
by Procaccia et al (1987). 
Results 
Checkerboard titrations: The results obtained during the 
establishment of the IgA RF ELISA are shown in Figure 9.3 and 
Figure 9.4. From Figure 9.3 it can be seen that even when no 
serum was added, the conjugated antibody bound to the IgG 
coating antigen. Several steps were taken in an effort to 
minimize this. 
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Reduction of nonspecifi c binding of peroxidase con j ugate to IgG 
i. Decreasing the strength of the IgG coatin g antigen l owe red 
the bac kground optical density readings ob tained ( Figure 
9. 3). The use of a solution containing 0.5 mg of Ig G per 
100 ml resulted in the lowest val ues. 
ii. Using a more dilute conjugate resulted in less binding t o 
the IgG. This is shown in Figure 9. 4 where it can be seen 
that the lowest nonspecific con j ugate reaction with the IgG 
was encountered at a conjugate strength of 1: 2000. 
iii. Applying the conjugate for 1 hour instead of 2 also reduced 
conjugate binding to the coating IgG. In one experiment, 
the optical density obtained from wells containing only 
coating antigen, conjugate and substrate was 0.60 after 2 
hours, while after 1 hour it was 0. 38. 
In addition, during the development of the IgA RF ELISA it was 
evident that there was conjugate binding to the polystyrene 
plates. 
Nonspecific binding of peroxidase conjugate to the polystyrene 
plates 
That this binding occurred was shown from the background 
readings obtained from wells containing no coating IgG but to 
which conjugate and substrate were added. Figure 9.4 
demonstrates that the reaction was lessened by using more dilute 
conjugates. Thus, an optical density of 0.062 was obtained at a 
conjugate strength of 1:2000. 
The blocking solutions also had -some effect on the binding of 
the conjugate to the polystyrene. The mean background value 
from 6 wells was 0.078 when 4% BSA was used, 0.078 with the 4% 
BSA with 0.25% BSA added to the serum and conjugate and 0.10 
with the 1% BSA and 1% goat serum. 
From these results, the fi na 1 working strength of the reagents 
used were determined. 
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Optimum concentration of reagents 
In the absence df positive control sera from patients with 
congenita 1 syphilis, the conditions chosen for the performa nee 
of the IgA RF ELISA were those which gave the lowest background 
values. These were: 
a coating antigen concentration of 0.5 mg/ 100 ml 
a conjugated antibody dilution of 1:2000 
a blocking step with 4% BSA 
applying the conjugated antibody to the polystyrene plates 
for 1 hour. 
Serum samples 
The samples were tested at a dilution of 1:50. The results were 
negative in all cases except for the adult patient with RA. The 
optical density obtained in this cise after the background 
values were subtracted was 0.186. 
9.6.3 Discussion 
The method 
The goat anti-human lgA conjugated antibody clearly lacked 
specificity for lgA: significant cross-reaction with lgM and IgG 
was noted. The lgM binding was considered unimportant because 
pepsin-digested sera were used, hence destroying the IgM 
{Theofilopoulos et al 1974). The lgG reactivity of the 
conjugate was not abolished by an absorption step. 
Nevertheless, by using low concentrations of the IgG coating 
antigen and the anti-human IgA conjugate, relatively low 
background values were obtained. Ideally, if the method were 
to be repeated the effect of using an affinity purified 
conjugate should be assessed. 
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The results 
The immunoabsorbent method and the ELISA for the detection of 
IgA RF gave identical results, both in terms of the negative 
findings in the patients with congenital syphilis and the 
positive results in the patient with RA. 
IgA RFs have not previously been studied in congenital syphilis. 
In general, IgA production occurs much later in childhood 
(Allansmith et al 1968). 
Nevertheless, Tan (1973) has reported raised IgA levels in 
newborns with congenital syphilis. It is possible that these 
results were due to the presence of IgM RF which could produce a 
false positive result for IgA using radial immunodiffusion 
plates (Lea and Ward 1972). 
IgA RFs have been reported in 88% of adults with active RA 
(Bampton et al 1985), so that it was not surprising to find this 
substance in the adult control patient. 
9.7 SUtltARY AND CONCLUSIONS 
The IgM RF levels were strikingly higher in most of the patients 
with congenital syphilis compared to the controls. There was 
some overlap, however, particularly in infants over the age of 2 
months. The mean IgM RF levels increased in the control 
patients from birth to 4 months. Hidden RF was only detected in 
the serum of 1 patient with congenital syphilis. Measuring 
total IgM levels and the concentration of IgM RF showed that 
some infants with congenital syphilis had produced large amounts 
of IgM RF and that there was a significant correlation between 
the tota 1 IgM and IgM RF. 
IgG and IgA RF were not found in the · infants with congenital 
syphilis who were studied. This suggested that there was little 
or no class switching amongst RF-producing plasma cells in these 
patients. 
Overall, the results of these studies are in keeping with 
observations on normal newborn infants which have shown that IgM 
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is the predominant immunoglobulin class produced. The IgG and 
IgA producing plasma cells appear to be less readily inducible 
(Cooper 1987). The IgM response is a polyclonal one, perhaps 
• stimulated by the presence of immune complexes containing 
treponemal antigens and maternal IgG. 
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CHAPTER 10 
ASSOCIATIONS BETWEEN THE SERUM RHEUMATOID FACTOR CONCENTRATION AtlD 
VARIOUS CLINICAL AND LABORATORY FINDINGS IN CONGENITAL SYPHILIS 
10.1 INTRODUCTION 
In the previous chapters the frequent occurrence of RF in 
patients with congenital syphilis has been demonstrated. 
As described in Chapter 3, infants with congenital syphilis have 
a tendency to produce RF more often than adults with acquired 
syphilis. 
This raises the question as to whether RF is implicated in the 
disease process and might even be partly responsible for the 
greater severity of congenital syphilis compared to the acquired 
form of the disease. 
That RF plays a role in the pathogenesis of RA and other 
inflammatory conditions such as glomerulonephritis has been 
suggested (Ford 1983; Chen et al 1988). It has not been 
possible to determine for certain, however, that RF has a 
pathological rather than a physiological role in these 
conditions (Olsen and Jasin 1985; Levinson and Martin 1988). 
The same difficulty of separating cause from effect arises in 
congenital syphilis. 
Whilst it may not be possible to ascribe a definite role to RF 
in congenital syphilis, it would appear that the variables 
associated with the presence of RF in congenital syphilis merit 
further study. In particular, it would be useful to ascertain 
whether factors similar to those which have been identified in 
RA and other inflammatory conditions, are related to RF levels 
in congenital syphilis. Not only would such investigation 
facilitate comparison between RF formation in different diseases 
but it would allow RF production to be investigated during an 
early stage in the development of the immune response. 
In this study the factors considered were those outlined in 
Chapter 3, Section 3.7.3 and included: 
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i. the age of patient 
ii. the severity and extent of disease 
iii. the duration of the illness 
iv. the disease pattern in terms of which organs were involved 
v. the activity of the disease following therapy 
vi. immune complex levels. 
10.2 STUDY DESIGN AND METHODS 
10.2.1 Patient selection 
Patients with definite clinical and/or radiological signs of 
congeni ta 1 syphilis whose disease was confirmed by the results 
of serological tests were studied. These infants all fulfilled 
the criteria of Kaufman et al (1977) and included: 
a. patients outlined in Chapter 5 who presented and were 
diagnosed and treated at birth 
b. the patients described in Chapter 6. 
Control sera were obtained as outlined in Chapter 9, Section 
9.1. 
10.2.2 Quantitation of RF levels 
This was achieved using the RF ELISA set up as described in 
Chapter 8. The RF levels were determined on the patients with 
congenital syphilis using sera obtained at the initial 
presentation. The RF levels obtained in control infants have 
already been presented in Chapter 9. 
10.2.3 Factors influencing RF production 
Age of patients 
The RF levels in infants with congenital syphilis at different 
ages have already been compared {Chapter 9). In this section, 
the relationship between gestational age and RF concentration 
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was investigated. 
The gestational age in completed weeks was assessed according to 
the method of Ballard et al (1979) and collated with the RF 
concentration. In addition, RF levels in preterm newborn 
infants (less than 37 weeks gestation) were contrasted with 
those of term newborns (37-42 weeks gestation). The RF levels 
of patients who presented after the age of 3 days were not 
considered in this analysis. 
Severity and extent of disease 
Infants were divided into those who had severe disease and those 
who did not. The criteria for these groupings were based on 
reports in the literature outlining prognostic features for 
infants with congenital syphilis. Infants with widespread signs 
at or soon after birth have a worse prognosis than those whose 
i 11 ness starts over 1 month of age ( Stokes et a 1 1945 pg 1100; 
Brown and Moore 1963; Ingall and Musher 1983 pg 362; Krugman and 
Katz 1981 pg 396; Chawla et al 1988). 
In addition, newborn infants with non-immune hydrops are likely 
to have a poorer outcome (Tan 1973; Chawla et al 1988). 
Renal involvement may, on occasion, be associated with severe 
renal damage (Wiggelinkhuizen et al 1973). 
For the purposes of the study, severe disease was identified 
when: 
i. there were 2 or more organ systems i nvo 1 ved in the first 
month of life, or 
ii. non-immune hydrops was noted, or 
iii. life-threatening complications were present. 
Milder disease was said to be present in infants who developed 
clinical signs after the first month of life or when the 
diagnosis was made earlier but there were fewer than 2 organ 
systems involved. 
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The systems considered for this analysis were the liver, 
reticulo-endothelial system, the haematological system, the 
musculoskeletal system, the kidneys, the skin, the respiratory 
tract and the central nervous system. 
From the description of the severity it is apparent that this is 
partly related to the extent of the disease. Nevertheless, the 
latter was also analysed separately. 
Extent of the disease The extent of the disease was scored 
according to the number of the following signs that were 
present : 
liver involvement 
reticule-endothelial involvement 
haematological involvement 
bony disease 
skin signs 
oedema. 
The maximum score was therefore 6. Involvement of other systems 
e.g. the renal tract were not added to the list because very few 
of the patients demonstrated disease in these systems. The 
score obtained was then correlated with the RF concentration. 
VDRL titres were also correlated with the severity and extent of 
the disease. 
Duration of infection 
As most women with syphilis in pregnancy are asymptomatic 
(Kaufman et al 1977; Wendel 1988), the timing of fetal infection 
is usually unknown. 
Careful studies by Ingraham (1936) indicated that the 
characteristic metaphyseal dystrophy took approximately 5 weeks 
to develop, whilst the periosteal changes were evident by 16 
weeks. 
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It follows that radiological evidence of a periosteal dystrophy 
may indicate that the disease has been present for at least 16 
weeks. 
The usefulness of the periosteal dystrophy in determining 
duration of infection is limited, however, by the finding of 
such changes in 47% of normal preterms (Malmberg 1944) and 35% 
of normal term infants (Shopfner 1966). 
Another assessment of the duration of infection may be possible 
in some infants who develop clinical signs after birth. The 
clinical features indicating recent onset are reported to be 
snuffles and skin manifestations (Stokes et al 1945 pg 1100; 
Budell 1982 pg 924). On the other hand, renal involvement 
points to a longer period of infection. 
For the purposes of this study, recent onset disease was said to 
be present in the following circumstances: 
i. infants presenting at birth without evidence of periosteal 
dystrophy on radiography of the long bones. 
ii. infants presenting after birth who had the early clinical 
features described above in the absence of periosteal 
changes on roentgenogram. 
Tardy disease was diagnosed if a periosteal dystrophy was 
present at the time of diagnosis, or if renal disease was 
evident. 
(The division of cases into those of recent onset and those with 
a tardier course should not be confused with 'early' and 'late' 
congenital syphilis. The latter categorization is based on the 
age of the patient, 'late' disease occurring over the age of 2 
years). 
Disease pattern 
The presence of certain clinical signs or the involvement of 
certain organs may be associated with the induction of RF 
synthesis. For example, active liver disease was found to 
correlate with the presence of RF in adults with cirrhosis 
(Dresner and Trombly 1959). 
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For the purpose of the present study, the liver was regarded as 
being involved if there were clinical signs of liver disease 
(e.g. jaundice or hepatomegaly as defined in Chapter 6) and/or 
if there were abnormal liver function tests. The liver function 
tests were carried out by the Chemistry Laboratory at the Red 
Cross War Memorial Children's Hospital and consisted of the 
measurement of serum bilirubin, alkaline phosphatase and alanine 
aminotransferase (ALT) concentrations. The following normal 
ranges were adopted {Nelson et al 1979 pg 2076-2090): 
Conjugated bilirubin 
Alkaline phosphatase 
ALT 
0 - 4 umol/L 
newborns 50 - 165 U/L 
older 20 - 150 U/1 
5 - 28 U/L 
The concentrations of ALT and conjugated bilirubin were compared 
to the RF levels. 
The reticulo-endothelial system was considered to be affected if 
there was splenomegaly (as defined in Chapter 6.1.1) or 
generalized lymphadenopathy. 
Haematological involvement was diagnosed if there was anaemia 
(haemoglobin level below the accepted normal for age (Oski 1981 
pg 545-547)) or thrombocytopenia {platelet count below 150 000 
per mm 3 (Nelson et al 1979 pg 2090)). 
Bony i nvo 1 vement was considered to be present if there were 
typical roentogenographic findings (Cremin and Fisher 1970). 
Skin lesions (including mucocutaneous manifestations) were 
eva 1 uated separately. A petechia l rash due to thrombocytopeni a 
was assessed with the haematological manifestations. 
The respiratory system was adjudged diseased if there was 
respiratory distress with radiological evidence of pneumonitis 
(Malan 1987 pg 627). 
263 
An indication of placental involvement in congenital syphilis is 
an increase in placental weight relative to that of the infant 
(Budell 1982 pg 923-924). A percentile chart for gross 
placental weight at various infant weights has been established 
(Malan et al 1990) and is shown in Appendix 8. Using this chart 
it was possible to calculate a ratio of observed to expected 
(50th percentile) placental weights. The ratio obtained was 
compared with the RF levels. 
Generalized oedema was categorized separately. The aetiology of 
the oedema is multifactorial. Anaemia, liver disease and renal 
disease may be contributory (Tan 1973). 
Evidence of other organ involvement was obtained in some 
instances (e.g. syphilitic meningitis, pancreatitis). As few 
infants demonstrated these findings they were not analysed 
separately. 
Immune complexes The RF levels at the time of diagnosis were 
compared to the levels of circulating immune complexes (CIC). 
The latter were measured by a Clq binding assay performed 
according to the method of Zubler et al (1976). The CIC assays 
were done in the Renal Laboratory , Groote Schuur Hospital. The 
normal range for this laboratory is 0-7%. To determine the CIC 
levels in infants with congenital syphilis the first 25 patients 
who had sufficient serum available (200 ul) were chosen. In 
addition, serum samples from 13 control infants (described in 
Chapter 9) were randomly selected using random number tables and 
the Clq binding assay was carried out. 
Effect of treatment The effect of treatment was assessed by 
measuring RF levels before and at intervals after treatment. 
The RF Levels were compared with VDRL titres. A steady decline 
in the latter signifies successful therapy (Felman and Nikitas 
1980) • 
A group of 10 infants with congenital syphilis whose families 
were resident at fixed addresses were selected. Serum was 
' 
obtained at the start of treatment, on the day treatment was 
completed (day 10) and at monthly intervals for 3 months. The 
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RF concentration and VORL titres in these infants were compared 
to those obtained at follow-up from the 51 infants at risk of 
congenital syphilis who were unaffected. Details of the control 
infants and their VORL titres at follow-up are shown in Table 
5.2. The RF concentrations in the controls at follow-up have 
been reported in Chapter 9. 
10.2.4 Analysis of data 
The RF values in the infants with congenital syphilis were 
analysed by non-parametric statistical tests involving ranking 
the data. This method was chosen in preference to the use of 
parametric tests because the RF va~ues were not normally 
distributed (see Figure 10.1). The non-parametric tests used 
were the Mann-Whitney test and Spearman•s Rank Order Correlation 
Coefficient (Conover 1971 pg 224-236; Bourke et al 1985 pg 156-
157). 
The principle behind the use of the Mann-Whitney test is 
illustrated in the example which follows. 
According to the Null hypothesis one would assume that patients 
with evidence of liver involvement would have RF levels which 
were no different to those without liver disease. In other 
words, any arrangement of the patients with and without 1 iver 
disease would be equally possible when their RF values were 
ranked. 
The sample size of patients without liver disease was denoted n, 
and the sample size of infants with liver disease m. The RF 
values of all the patients were ranked. The patient with the 
lowest RF value was given rank 1. If the ranks were tied the 
average rank was assigned. 
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The test statistic, T, was determined as foll ows: 
T = S - n (n + 1) 
2 
\·/here S is the score of the ranks assigned to n patients (the 
patients without liver disease in the example). 
The critical regions at which T attained statistical 
significance (at the probability (p) value of 0.05), are 
available from standard tables. 
To simplify the recording of results a O was used to denote 
patients who did not have a particular variable and a 1 to 
indicate those who did. If the variable was not applicable in a 
specific case, a blank -..,as left. 
designation of the patients. 
Table 10.1 summarizes the 
TABLE 10.1: 
DESIGNATION OF PATIENTS INTO THOSE WITH OR WITHOUT DIFFERENT 
VARIABLES 
VARIABLE 
DESIGNATION 
* AGE SEVERITY DURATION DISEASE PATTERN 
0 Preterm Mild Recent Absent 
1 Term Severe Tardy Present 
* Absence or presence of a particular finding 
Spearman's Rank Correlation Coefficient was used to assess 
concordance, for example between the levels of RF and CIC. 
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Unless otherwise specified, 2-tailed tests were carried out. The 
Mann-Whitney results were calculated by hand, whereas Spearman's 
Rank Correlation Coefficient was determined using a computer 
programme (Epistat,1986). 
10.3 RESULTS 
The 41 patients included in the study are described in Chapters 
5 and 6. Overall, 30 cases were less than 1 month of age at 
presentation. 
Details of each patient are shown in Appendix 7 (Tables A.7.1, 
A.7.2, A.7.3) and the results are sunvnarized in Figure 10.2. 
(The patient code numbers correspond to those in Chapters 5 and 
6.) 
The T values, together with the critical regions for each 
variable, are shown in Tables 10.2 and 10.3. 
10.3.1 Age of patients 
In Chapter 9 it was shown that in infants with congenital 
syphilis the RF concentrations of those presenting at birth were 
similar to those who presented between 2 and 4 months of age. 
The levels of RF in controls, however, increased between birth 
and 4 months of age. 
The RF concentrations of infants with congenital syphilis were 
considered in relation to gestational age. The overall results 
are shown in the scatter diagram (Figure 10.3). A significant 
correlation between the variables was not found using Spearman•s 
Rank Correlation Coefficient (p > 0,05). 
In addition, comparing the RF levels of preterm infants (under 
37 weeks gestation) with term infants ( 37 weeks and above) a 
statistically significant relationship between gestational age 
and RF levels was not apparent (p > 0.05}. 
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10.3.2 Severity of disease 
J The severity of the disease was determined according to the 
criteria in the methods section. According to these criteria 
the severity could not be determined in 1 patient (no. 6.26). 
He had late onset disease (usually associated with a good 
prognosis) but had renal involvement at the age of 4 months. 
Renal biopsy showed membranous glomerulonephritis with 
epithelial crescent formation. The reversibility of the changes 
was uncertain as some of the features were similar to those of a 
patient with the same condition who developed glomerulosclerosis 
with marked loss of glomeruli (Wiggelinkhuizen et al 1973). 
Because of the uncertainty of the outcome, the results of this 
patient were not considered in the analysis. 
The calculated T value was statistically significant (p < 0.05), 
leading to the Null hypothesis being rejected. That is, an 
association between RF levels and the severity of the disease 
could be shown. 
When the RF concentrations in the 5 newborns who died shortly 
after birth were compared with those who survived, however, 
there was no significant difference in the rankings (p > 0.05) 
using the Mann-Whitney test). 
The VDRL titre did not correlate with the severity of the 
disease (p > 0.05 using the Mann-Whitney test). 
10.3.3 Extent of the disease 
When the extent of the disease was scored using the procedure 
described in the methods section, a statistically significant 
association between RF levels and higher scores was found (p < 
0.05 using Spearman's Rank Correlation Coefficient). The 
results are shown in Figure 10.4. The score of the extent did 
not correlate with the VDRL titre (Spearman's r = 0.26; p > 
O.OS). 
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10.3.4 Duration of infection 
A statistically significant relationship between the RF 
concentration and the chronicity of infection (as previously 
defined) was not demonstrated (p > 0.05). 
10.3.5 Disease pattern 
A statistically significant association (p < 0.05) was found 
between RF levels and the presence of the following: 
liver involvement, 
renal disease, 
oedema. 
Statistically significant correlations (p > 0.05) were not 
observed with the other variables; these included: 
reticulo-endothelial system involvement, 
haematological involvement, 
bone involvement, 
skin involvement, 
respiratory system involvement. 
Bone and skin involvement showed a trend towards being 
associated with higher RF concentrations. The results are 
summarized in Table 10.3. 
The relative placental weight was statistically significantly 
higher in newborn infants with higher RF levels. The results are 
tabulated in Appendix 7 (Tables A.7.4) and shown in Figure 10.5. 
The p value for Spearman's Rank Correlation Coefficient was < 
0.05 for a 1-tailed test. 
The RF levels were compared to the ALT and conjugated bilirubin 
concentrations where the latter were available. A statistically 
significant correlation was not observed (p > 0.05 using 
Spearman's Rank Correlation Coefficient). The actual values are 
shown in Appendix 7 (Table A.7.5) and in Figures 10.6 and 10.7. 
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TABLE 10.2 
THE TEST STATISTIC (T) AND THE CRITICAL REGIONS FOR THE MANN-
WHITNEY TEST CALCULATED FOR DIFFERENT VARIABLES 
VARIABLE T CRITICAL REG IONS p VALUE 
* Gestational age 93 56 109 N/ S 
( ~ 37 corn pl eted weeks) 
Disease severity 257 113 251 < 0.05 
Duration of infection 214 123 267 N/ S 
* N/S - p value not significant at 5% level 
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TABLE 10.3 
THE TEST STATISTIC (T) ANO THE CRITICAL REGIONS FOR THE MANN-
WHITNEY TEST CALCULATED FOR DIFFERENT DISEASE PATTERNS 
DISEASE PATTERtl T CRITIC IAL REG IO NS P VAL UE 
Liver involvement 196 72 192 < o. 05 
* Reticule-endothelial 230 113 251 N/ S 
involvement 
Haematological involvement 239 130 278 N/ S 
Bone involvement 138 41 139 N/ S 
Renal involvement 76 7 71 < 0.05 
Skin involvement 273 135 285 tl/ s 
Respiratory involvement 139 62 176 N/ S 
Oedema 289 127 273 < o. 05 
* N/S - p value not significant at 5% level 
10.3.6 Immune complexes 
The RF levels showed a statistically significant correlation 
with the CIC levels (p < 0.000001 using Spearman's Rank 
Correlation Coefficient). The CIC levels measured in the normal 
infants had a mean value of 3.8% with a standard deviation of 
1.2%. Figure 10.8 shows the results and the actual values are 
given in Appendix 7 (Table A.7.4). 
I 
: 
; 
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10.3.7 Effect of treatment 
When the median RF levels obtained at diagnosis, and then at 
monthly i nterva 1 s for 3 months after treatment were compared 
with the VDRL titres done at the same time a statistically 
significant correlation was observed (p < 0.001) with Spearman's 
Rank Correlation Coefficient. In general, the RF levels had 
decreased one month following treatment. One patient (no. 5.3), 
however, had no detectable RF at delivery but the concentration 
increased in the first 2 months after treatment. In addition, 
the RF level in patient no. 6.34 was higher 1 month after 
treatment than at the commencement of therapy, but then declined 
steadily. 
Figure 10.9 shows that changes in the median RF values in 
infants with congenital syphilis closely followed those of the 
VDRL titres. In add it ion. a peak in both 1 eve ls was observed 
after completion of therapy on day 10. (The actual RF levels 
and VDRL titres obtained in each patient are shown in Appendix 7 
(Table A.7.6) the RF concentration and VDRL titres in the 
control patients are shown in Figure 10.10. 
10.4 DISCUSSION 
As shown by the results obtained, associations between a number 
of variables and RF levels in congenital syphilis were 
demonstrated. Each of the variables will be considered in turn. 
l0.4.1 Age of the ~tient 
It was shown in Chapter 9 that the RF concentrations in infants 
with congenital syphilis were similar at different ages from 
birth to 4 months. During this same period however, the RF 
levels in control infants increased. It was postulated that the 
anti-immunoglobulins detected might have Qn specificity. 
The results analysed in this chapter indicated that the amount 
of RF in newborn infants with congenital syphilis did not appear 
to be related to the presence or absence of prematurity. It is 
apparent, however, that the CD 5+ subset of B lymphocytes res-
ponsible for RF production accounts for a substantial proportion 
of B lymphocytes from early fetal 1 i fe (Antin et al 1986). The 
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present study would suggest that these cells are functionally · 
capable of producing anti-gammaglobulins as early as 29 wee ks 
gestation and that neither gestational age nor postnatal age 
affect the amount of RF induced by the infection. 
10.4.2 Severity and extent of disease 
Infants who were judged to have more severe congenital syphilis 
had significantly higher RF levels than those with a milder 
illness. 
The assessment of the severity depended partly on the extent of 
the condition and, in addition, there was a direct correlation 
between the number of organ systems involved and the RF 
activity. 
These findings have not previously been reported in congenital 
syphilis and, in fact, the severity of the disease has not been 
related to the results of serological tests. 
Work in other conditions has demonstrated similar findings: e.g. 
higher RF levels are associated with more severe RA (Carson 
1987 pg 1204; Milgrom 1988) as well as more severe vasculitis in 
experimental animals (Floyd and Tesar 1979). In addition, the 
presence of RF in renal tissue has been found to correlate with / 
more severe kidney disease (Rossen et al 1977). 
A possible explanation for the findings in congenital syphilis 
relates to the effects of immune complexes. If, as appears 
likely, the latter mediate some of the tissue damage in 
congenital syphilis, it is possible that there is a quantitative 
effect. Higher levels of immune complexes could then lead to 
more severe disease, extensive clinical signs and higher RF 
levels. In the light of experimental animal studies such as 
those of Baum et al (1964), McCormick et al (1969), and 
DeHoratius and Williams (1972), which have been reviewed in 
Section 3.8.2, it may be that RF actually exacerbates tissue 
damage in congenital syphilis. 
Fi
g.
10
.5
: 
Sc
at
te
r 
di
ag
ra
m
 o
f 
R
F 
le
ve
ls
 
an
d 
pl
ac
en
ta
l 
w
e
ig
ht
 r
a
tio
s 
# 
in
 i
nf
an
ts
 w
ith
 c
o
n
ge
ni
ta
l 
s
yp
hi
lis
 
P
la
ce
nt
al
 w
e
ig
ht
 r
a
tio
 
2.
25
 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
,
 
1.
75
 t-
•
 
.
 
•
 
•
 
1.
25
1"
 • • 
•
 
.
 
.
 .
 
•
 
•
 
0.
75
 I 
.
 
I 
I 
I 
I 
I 
I 
0 
10
0 
20
0 
30
0 
40
0 
50
0 
60
0 
R
F 
c
o
n
c
e
n
tr
at
io
n 
(IU
/m
l) 
# 
R
at
 i o
 
o
f 
o
b
se
rv
e
d
/e
x 
p e
 c
t e
 d 
p I
 a
c
e
 n
 ta
 I 
w
e
ig
ht
 
I 
70
0 
80
0 
N
 
-
.
.
.
J 
·
-
1
 
Fi
g.
10
.6
: 
Sc
at
te
r 
di
ag
ra
m
 s
ho
w
in
g 
RF
 
an
d 
a
la
ni
ne
 a
m
in
ot
ra
ns
fe
ra
se
 l
ev
el
s 
in 
13
 i
nf
an
ts
 w
ith
 c
o
n
ge
ni
ta
l 
s
yp
hi
lis
 
A
la
ni
ne
 a
m
in
ot
ra
ns
fe
ra
se
 l
ev
el
 (
U/
L)
 
3
0
0
.
-
-
-
-
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
 
25
0 
.
_
 
ii
 
20
0 
~ 
II
 
15
0 
.
_
 
1 o
o 
r 
ii
 
II
 
II
 
II
 
II 
50
 r 
II
 
II 
ii
 
ii
 
"
 
I 
0 
ii
 
I 
I 
I 
0 
20
0 
40
0 
60
0 
80
0 
RF
 c
o
n
c
e
n
tr
at
io
n 
(IU
/m
l) 
N
 
-
.
.
J 
0:
:, 
Fi
g.
10
.7
: 
Sc
at
te
r 
di
ag
ra
m
 s
ho
w
in
g 
R
F 
an
d 
c
o
n
ju
ga
te
d 
bi
lir
ub
in
 l
ev
el
s 
in
 1
6 
in
fa
nt
s 
w
ith
 c
o
n
ge
ni
ta
l 
s
yp
hi
lis
 
C
on
ju
ga
te
d 
bi
lir
ub
in
 le
ve
l 
(u
m
ol/
L)
 
5
0
0
.
-
-
-
-
-
-
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
~
-
-
-
,
 
40
0 
,_
 
30
0 
,_
 
..
 
20
0 
f-
II
 
10
0 
~
II
 
II 
II
 
0
~
 
0 
..
 
II
 
"
 
..
 
II
 
ii
 
ii
 
..
 
I 
J 
l 
20
0 
40
0 
60
0 
80
0 
RF
 c
o
n
c
e
n
tr
at
io
n 
(IU
/ m
l) 
r 
N
 
-
.
J 
'°
 
Fi
g.
10
.8
: 
Sc
at
te
rg
ra
m
 o
f 
im
m
un
e 
c
o
m
pl
ex
 
le
ve
ls
 (0
/o 
bi
nd
in
g)
 a
n
d 
RF
 c
o
n
c
e
n
tr
at
io
ns
 
in 
in
fa
nt
s 
w
ith
 c
o
n
ge
ni
ta
l 
s
yp
hi
lis
 
Im
m
un
e 
c
o
m
p
le
x 
le
ve
ls
(%
 b
in
di
ng
) 
10
0 
~
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
~
 
80
 ~
 
60
 ~
 
•
 
40
1 . 
20
 r 
.
 
.
 
.
 
.
 
•
 
••
 .
 
•
 •
 
•
 
•
 
.
 
01
 
I 
0 
10
0 
•
 
•
 
•
 
•
 
I 
I 
I 
I 
I 
20
0 
30
0 
40
0 
50
0 
60
0 
R
F 
c
o
n
c
e
n
tr
at
io
n 
(IU
/m
l) 
l 
I 
70
0 
80
0 
N
 
CX
l 
0 
Fi
g.
 1
0.
9 
E
ff
ec
t 
o
f 
tr
e
a
tm
e
n
t 
o
n
 
m
e
d
ia
n
 
R
F 
le
ve
ls
 a
n
d 
V
D
RL
 t
it
re
s 
in
 i
n
fa
n
ts
 
w
it
h 
c
o
n
ge
ni
ta
l 
s
yp
hi
li
s 
RF
 l
ev
el
s 
a
n
d 
re
c
ip
ro
ca
l 
VD
RL
 t
it
re
s 
20
0 
,
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
~
 
15
0 
10
0 50
 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
·
 
0'
--
--
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
~
 
0 
0.
5 
1 
1.
5 
2 
2.
5 
T
im
e 
a
ft
er
 c
o
m
m
e
n
c
in
g 
th
er
ap
y
 (
m
on
th
s)
 
-
-
-
-
-
-
M
ed
ia
n 
RF
 l
ev
el
 
IV
/m
l 
-
-
M
ed
ia
n 
VD
RL
 t
it
re
 
(r
ec
ip
ro
ca
l) 
3 
3.
5 
N
 
co
 
~
 
281a 
Fig 1 o. 1 O Rheumatoid factor levels and VDRL titres in 
10 
8 
Rheumatoid 6 
factor levels 
and 
Reciprocal VDRL 
titres 
4 
2 
0 
control infants 
RF level 
\ 
\ 
\ 
\ 
\ 
\ 
\ 
\ 
\ 
\ 
Reciprocal 
VDRL 
titre 
--
---
1 2 
Age ( months) 
RF level (1u/m1) 
Reciprocal VDRL titre 
D 
fill 
3 4 
282 
The RF concentrations in the 5 newborns who died soon after 
birth were not higher than· those of the newborns who survived. 
It was also evident that not all those who demised had the most 
extensive disease. These findings appeared to be contradictory 
to those just discussed and remain unexplained, although the 
numbers are probably too small to draw any conclusions. 
There was no statistically significant relationship between VORL 
titres and the severity or extent of the disease. A similar 
lack of relationship has also been noted in adult disease 
(Felman and Nikitas 1980). 
10.4.3 Duration of infection 
Messner et al (1968) and Bacon et al (1974) were able to show an 
association between RF levels and the duration of infection in 
SBE. Unfortunately, the chronicity of congenital syphilis is 
difficult to ascertain. It was thought that the simplest 
measure of duration would be the bony lesions, in particular the 
periosteal dystrophy (Ingraham 1936). 
Using this criterion, there was no association between RF levels 
and the duration of infection. It is possible, however, that 
the older infants (who were more likely to have periosteal 
dystrophy Hira et al 1985) were also more likely to have milder 
disease (and lower RF levels). There were insufficient numbers 
of infants presenting after birth with early features of 
congenital syphilis (e.g. snuffles, skin rash) who did not also 
have i nvo 1 vement of other systems. On the other hand, rena 1 
involvement is thought to occur relatively late in the course of 
the disease (Ingall and Musher 1983 pg 348). The two infants 
with renal disease had very high RF levels. However, it is 
uncertain whether the elevated RF levels were associated with 
the renal pathology itself or the chronicity. 
No other assessment of chronicity was possible, so that its role 
in determining RF levels in congenital syphilis remains 
uncertain, but from other literature cited, likely. 
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10.4.4 Disease pattern 
Liver involvement: Infants with clinical or laboratory evidence 
of liver involvement had higher RF levels than those who did not 
(p < 0.05). 
The effect of RF in aggravating inflammatory damage in the 
kidney and lung of experimental animals has been established 
(McCormick et al 1969, DeHoratius and Williams 1972). It 
remains a possibility, therefore, that RF had some potentiating 
effect on the 1 iver damage. However, no correlation could be 
shown between the level of RF and the concentrations of ALT or 
conjugated bilirubin in the present study. 
There are alternative explanations for the raised RF levels seen 
with liver disease. It is known that the liver is involved in 
the stripping of immune complexes from the circulation (Williams 
1982). Liver disease could interfere with this process and 
result in higher levels of CICS which could in turn induce more 
RF synthesis (Nemazee 1985). 
Another possibility is that the increase in RF parallels that of 
other gammaglobul ins which are frequently elevated in chronic 
liver disease (Nelson 1979 et al pg 1149). 
It is unknown if any of these mechanisms are responsible for the 
observed association between RF levels and liver disease. 
Reticulo-endothelial involvement: The features of splenic and 
lymph node enlargement were not linked to higher RF levels (p > 
0.05). Signs of RES involvement may be explained by lymphoid 
hyperplasia. Alternatively, extramedullary haematopoiesis 
related to anaemia and/or chronic hypoxic stress as wel 1 as 
prematurity may produce evidence of RES involvement (Fanaroff 
and Martin 1987 pg 836). Such involvement may, therefore, be 
allied to the haematological findings. Even when the variables 
of haematological and RES involvement were considered together, 
however, a significant association was not established. 
Haematological system: The presence of anaemia and 
thrombocytopenia were not associated with higher RF levels in 
infants with congenital syphilis. 
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Anaemia in patients with RA has been related to the finding of 
RF in the serum (Harvey et al 1983). These workers put forward 
evidence that IgM antibodies and/or RF was capable of directly 
suppressing erythropoeisis. 
Rheumatoid factor has also been proposed as a cause of 
haemolytic anaemia (Goldberg and Barnett 1969). In the present 
study only 2 infants with congenital syphilis (nos. 6.17 and 
6.19) had definite evidence of haemolysis. These infants did 
not have RF levels which were significantly higher than those 
without haemolysis (p > 0.05). 
The observations made in the study do not exclude any 
association between RF and anaemia or thrombocytopenia but 
simply indicate that a quantitative relationship was not 
demonstrated. 
Bone disease: A statistically significant relationship between 
higher RF levels and bony lesions was not demonstrated in the 
present study (p > 0.05). The pathophysiology of the bony 
changes in congenital syphilis has not been established. In 
patients with RA a correlation has been noted between bony 
erosions and RF levels determined by agglutination tests, 
although a closer association has been shown with IgA RF 
(Arnason et al 1987). The periarticular lesions seen in RA have 
a different distribution to those of congenital syphilis. It 
seems unlikely, therefore, that RF is directly causitive of the 
symmetrical metaphyseal dysplasia of congenital syphilis. 
Nevertheless, higher RF levels have been related to the presence 
of vasculitis in RA (Singer and Plotz 1956; Gordon et al 1973). 
It is conceivable that a vascul itis could affect the actively 
growing bones indirectly in congenital syphilis. This awaits 
further study. 
Renal disease: Although only 2 infants with congenital syphilis 
had documented renal disease, the RF levels in these patients 
were significantly elevated compared to those who did not have 
renal disease (p <0.05). 
In general, the effect of RF in glomerulonephritis is unclear. 
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Rheumatoid factor has been demonstrated, however, in the blood 
and glomeruli in patients with post-streptococcal 
glomerulonephritis (McIntosh et al 1979; Rodriguez-Iturbe et al 
1980)). In addition, RF was present in the glomeruli in 
transplant kidney rejection, systemic lupus erythematosis and 
polyarteritis nodosa (Rossen et al 1977). In these conditions 
the finding of RF was related to more severe renal damage. 
However, the effect of the kidney damage itself on the RF levels 
is unknown. The concentrations of various proteins are altered 
in nephrotic syndrome; in general gammaglobulins are decreased 
but some macroglobulins e.g. alpha 2 globulin are increased 
(Pesce and First 1979 pg 38-39). lgM levels have been reported 
to be increased in 6/7 studies of children with minimal change 
nephrotic syndrome (Meadow et al 1981; Chan et al 1987). Two 
studies have reported persistently elevated IgM levels after 
remission in minimal change nephropathy and normal IgM 
concentrations in patients with nephrotic syndrome due to other 
causes (Giangiacomo et al 1975; Meadow et al 1981). A third, 
albeit smaller, study reported increased amounts of IgM in all 
patients with nephrotic syndrome. The IgM levels decreased on 
recovery (Chan et al 1987). The relationship between IgM levels 
and nephrotic syndrome is, therefore, unclear. In the present 
study the IgM levels in the patients with nephrotic syndrome due 
to congenital syphilis were not significantly higher than those 
without renal involvement (p = 0.22 using the Mann-Whitney 
test). These findings suggest that rena 1 disease does not 
increase IgM concentrations in patients with congenital syphilis 
and, by inference, increased levels of IgM RF would not be 
expected in these cases. 
In experimental animals, RF resulted in increased glomerular 
damage in nephrotoxic serum nephritis (McCormick et al 1969). 
Similarly, in the glomerul i of mice given intravenous immune 
complexes, RF not only attached to trapped complexes, but also 
allowed the binding of unrelated immune complexes. This 
immunoabsorbent effect of RF was thought to be related to its 
multivalency and could increase the pathogenicity of immune 
complexes (Ford and Kosatka 1982). 
286 
To demonstrate a direct pathological effect due to RF in 
congenital syphilis, however, an animal model would need to be 
found. In the meantime, other experimental work seems to 
support the concept that RF may augment renal damage due to 
immune complexes (Ford 1983). 
Skin i nvo 1 vement: Concentrations of RF tended to be higher in 
patients with skin involvement but this relationship was not 
significant at the 5% level. Although the cause of skin lesions 
in congenital syphilis has not been documented, immune complexes 
have been associated with vasculitis and skin damage in acquired 
syphilis (Jorizzo et al 1986). 
That RF may play a role in vasculitis in the skin has been 
suggested in transplant patients with CMV and in patients with 
RA (Westedt et al 1984; Baldwin et al 1987). The findings of 
the present study are not at variance with this hypothesis. 
Lung involvement: This study did not find a statistically 
significant association between RF levels and lung disease in 
congenital syphilis (p > 0.05). 
Rheumatoid factor has been demonstrated in the lungs of patients 
with RA who have rheumatoid lung (DeHoratius et al 1972). In 
addition, experimental animals develop more severe 
perigranulomatous pneumonitis and vasculitis in the presence of 
RF (DeHoratius and Williams 1972). On the basis of these 
experimental findings, an association between lung involvement 
in congenital syphilis and RF levels may have been expected. 
This was not the case, however. 
The radiographic features used to define the presence of lung 
involvement in the infants are nonspecific (Malan 1987 pg 627). 
It is possible that the lung involvement in some of the infants 
with congenital syphilis was caused by other conditions e.g. 
chorioamnionitis. This may have masked any association between 
RF levels and lung disease. 
Placental involvement: The enlargement of the placenta seen in 
congenital syphilis may be due to the presence of oedema (Budell 
1982 pg 924). Congenital syphilis is associated with a 
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placental vasculitis (Russel and Altshuler 1974) and the latter 
may produce oedema. As RF can cause a vasculitis in 
experimental animals (Floyd and Tesar 1979) it was postulated 
that higher RF levels would be associated with a heavier, more 
oedematous placenta. The statistically significant correlation 
between RF levels and the placental weight ratio would provide 
some support for this postulate (p < 0.05 using Spearman•s Rank 
Correlation Coefficient for a 1-tailed test). 
Oedema: Infants with congenital syphilis with generalized 
oedema had higher RF levels than those who did not (p < 0.05). 
Oedema in congenital syphilis has been attributed to anaemia, 
cardiac failure, liver involvement and nephrotic syndrome 
(Ingall and Musher 1983 pg 345-349). A vasculitis, as observed 
in the placenta, could presumably occur in the skin and lead to 
oedema. It is also noteworthy that hydrops is associated with a 
poor prognosis (Tan 1973; Chawla et al 1988). 
Both liver and kidney involvement have been shown to be related 
to RF levels in the present study. Furthermore, the severity 
appeared to correlate with RF levels. These factors may be the 
reason for the association demonstrated between RF levels and 
oedema. 
Interrelationships between the variables, as implied above were 
considered likely. For this reason the statistical analysis was 
not extended to cover the large number of combinations that were 
possible. 
10.4.5 1 .. une coaplexes 
The demonstrated association between RF levels and levels of 
CICs was not unexpected. Experimental evidence exists which 
indicates that CICs give rise to RF production (Nemazee 1985; 
Coulie and Van Snick 1985). 
Whilst Dobson et al (1988b) and Samson et al (1990) have 
reported finding elevated levels of CICs in infants with 
congenital syphilis there have been no published studies 
relating RF production in newborns with the presence of C !Cs. 
Several workers have compared RF levels and CIC levels in adults 
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with various conditions and using a number of CIC assays. 
Thus, Carson et al (1978) showed a temporal relationship between 
CIC levels and RF concentrations in patients with SBE. The CIC 
levels did not correlate with the actual amount of RF (the Raji 
cell assay and conglutinin radioimmunoassay were used to assay 
CICs). 
Elkon et al (1983), using a staphylococcal binding assay, were 
also unable to find an association between CIC levels and RF 
concentrations in SBE. 
A similar lack of correlation between amounts of CIC and RF has 
been noted in acute post streptococcal glomerulonephritis 
{McIntosh et al 1979) and HIV infection {Procaccia et al 1987). 
The CIC levels in these 2 studies were determined using the Clq 
binding assay. 
The findings in patients with RA appear to differ from those in 
the infectious diseases above in regard to CIC levels and RF 
concentrations. Thus, for example, both Pope et al {1981) and 
Gioud-Paquet et al (1987) found significant correlations between 
concentrat i ans of CI Cs and RF in RA ( Clq binding assays were 
used for detection of CICs). 
The reason for this difference may be related to the fact that 
CICs in RA are composed primarily of IgG-IgG RF complexes or 
lgG-lgM RF complexes (Theofilopoulos and Dixon 1979). It 
follows, then, that CIC and RF concentrations would correlate. 
It may be that a similar situation prevails in congenital 
syphilis (i.e. that the CICs are composed partly of RF). This 
has been suggested by Dobson et al (1988b) and the striking 
correlation observed between CIC levels and IgM RF 
concentrations would tend to support the idea. 
It is also interesting that the CICs found in acquired syphilis 
in adults have a similar composition to those in infants with 
congenital syphilis (Baughn et al 1986; Dobson et al 1988b). 
Nevertheless, RF is found in only 13-251 of adults with acquired 
syphilis (Bartfeld 1969; Cerny et al 1985; Muller et al 1987) 
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compared to over 95i of infants with congenital · infection 
(Reimer et al 1975; Meyer and Malan 1987). 
These differences may indicate that infants produce RF more 
readily.This has been discussed in Sections 3.8.3.- 3.8.5. 
10.4.6 Effect of treatment on RF levels and relationship to VDRL titres 
The decline in the RF levels in the months following therapy in 
the infants with congenita 1 syphilis was unlike the pattern 
observed in the controls. 
The drop in RF levels in the infected infants was not 
unexpected, however. Similar observations have been made in SBE 
(Williams and Kunkel 1962; Bacon et al 1974). In addition, in 
RA effective therapy is followed by a decline in RF 
concentrations (Olsen and Jasin 1985). 
A likely explanation for the findings in congenital syphilis is 
that treatment with penicillin reduced the levels of CICs by 
destroying the treponemal antigen. 
It .was interesting to note that the VDRL titre declined in a 
similar fashion to the RF concentration. Rheumatoid factor and 
anti-cardiolipin antibodies (which are measured by the VDRL 
test) are both auto-antibodies (Doniach 1976 pg 210). The close 
relationship between RF levels and the VDRL titres, and the fact 
that both declined following therapy, lends support to the idea 
that autoimmune phenomena may be involved in the pathogenesis of 
congenital syphilis. 
Another noteworthy feature was that the RF level and the VDRL 
titre both increased initially following treatment. This was 
reminiscent of the rise in liver enzymes s~en immediately after 
therapy (Long et al 1984), and may be akin to the Jarisch-
Herxheimer reaction • A possible explanation for these events 
is that death of treponemes released new antigens which in turn 
invoked antibody production and immune complex formation (Ingall 
and Musher 1983 pg 363). The latter could lead to enhanced RF 
synthesis and raised RF levels within 2 weeks (McIntosh et al 
1979). Furthermore, as CICs are cleared by the liver (Williams 
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1982). damage to the organ could result and lead to raised liver 
enzymes. Finally, cardio1ipin is one of the antigenic 
components of T.pa1lidum (Musher 1984 pg 294). Release of this 
substance may not only result in elevation of the VDRL titre but 
could cause immune complex formation (and in turn stimulate RF 
production). 
The rise in RF concentration observed 1 month after completion 
of treatment in patient no. 5.3 was difficult to explain. It 
was also uncertain why the RF level at diagnosis was not 
increased. The levels of CICs in this patient, although 
elevated (6,0%). were not as high as in most of the other 
patients. Possibly the stimulus was insufficient to produce 
circulating RF (it is conceivable that RF was present but had 
been deposited in the tissues). The fact that RF was detected 
after treatment (and presumably after clearance of the 
treponemal antigen) may indicate that the RF had been formed in 
response to other causes such as the Qn antigens on maternal IgG 
(Steinberg and Wilson 1965). 
10.5 SUtltARY 
Various clinical and laboratory findings were correlated with RF 
levels in congenital syphilis. The ranked RF levels were found 
to be associated with the severity and extent of the disease, 
involvement of the liver and kidney and with the presence of 
oedema. In addition, a close relationship between RF 
concentrations and levels of CICs as wel1 as the VDRL titres 
were found. 
Essentially the relationship was between RF, CICs and the 
severity and extent of the disease. The separate relationship 
with liver and kidney disease may simply reflect that disease of 
these organs is part of the definition of the severity and 
extent of the condition. The oedema may be exacerbated by liver 
or renal disease. 
Taken together, these findings suggest that RF is related in 
some way to the disease process. Work in experimental animals 
indicates that RF can exace·rbate tissue damage (DeHoratius and 
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Williams 1972; Floyd and Tesar 1979). The results of this study 
would appear to support the suggestion that RF may assume a 
pathological role in certain circumstances. 
Having demonstrated that similar factors are operative in the RF 
production in congenital syphilis and other conditions it would 
appear to be worth investigating congenital syphilis as a 
possible model for the induction of RF synthesis. This would 
have the advantage that a germ-1 i ne response could be studied 
early in life when the RF-manufacturing CD5+ cells are known to 
be plentiful (Hardy et al 1987; Levinson et al 1987). 
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CHAPTER 11 
DEMONSTRATION OF TISSUE-BOUND RHEUMATOID FACTOR IN 
CONGENITAL SYPHILIS USING IIIIUNOFLUORESCENCE 
The demonstrated association between RF levels, the severity and 
extent of the disease and the concentrations of circulating 
immune complexes (CICs) in infants with congenital syphilis 
implies that RFs and CICs may be mediators of tissue 
inflammation and damage in this condition. This hypothesis 
would be strengthened by finding these entities at the sites of 
tissue damage. 
Indeed, Samson (1989) has demonstrated components of immune 
complexes (i.e. IgG, IgM and complement) in the placentae of 5 
infants with congenital syphilis. Similar complexes were not 
found in the placentae of controls. The presence of RF has not 
been documented in any of the organs of infants with congenital 
syphilis but RF has been detected by means of fluorescein-
labelled IgG in other inflammatory conditiqns (Mellors et al 
1959, Rossen et al 1977). 
The aim of this section was to use immunocytochemistry to show 
the presence of RF in tissues from patients with congenital 
syphilis. At the same time it was planned to confirm that 
immune complexes were deposited in the same vicinity as the RF. 
11.1 METHODS 
11.1.1 Preparation of fluorescein-labelled IgG 
Materials 
The following materials were used: 
IgG: this was a commercially obtained purified human IgG from a 
pooled source (ICN Immunobiologicals USA, catalogue no 64-145. 
Fluorescein isothiocya.nate (FITC) - this was supplied by Sigma 
Chemicals, USA. 
Buffers and solutions: Phosphate buffered saline pH 7.2 was 
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made up as described in Chapter 8. 
In addition, a solution of 0.25 M sodium carbonate pH 9.0 in 0.1 
M sodium chloride was prepared. 
Sephadex G-25 column: The column was 1.5 cm in diameter and 30 
cm long (Biorad, Econo-column USA). The Sephadex G-25 was a 
product of Pharmacia Fine Chemicals, USA. Medium particle size 
(50 - 150 u) was used. 
Spectrophotometer: A Beckman spectrophotometer, model 25 was 
used. 
Methods: 
The IgG was dissolved in the carbonate buffer (20 mg in 2 ml). 
The fluorescein was added at a concentration of 0.03 mg per mg 
of IgG (Johnson and Holborow 1986 pg 28.4). The mixture was 
left for 22 hours at 4°C. 
The Sephadex column was used to separate bound from unbound 
fluorescein by means of gel filtration. The column was prepared 
according to the method described by Johnstone and Thorpe 
(1982). Air bubbles were removed from 75 ml of the swollen 
Sephadex particles in PBS pH 7.2 by applying a vacuum. The 
slurry was suspended in 250 ml of buffer and a 11 owed to stand 
for 20 minutes. Fine particles were then aspirated and a final 
volume of approximately 100 ml obtained. 
The column outlet was closed and 10 ml of PBS pH 7.2 added. The 
gel slurry was stirred and poured into the column until the 
latter was filled to within 2 cm of the top. The particles were 
allowed to settle for 2 hours. Excess buffer was passed through 
the column and the column was packed with the Sephadex gel. The 
fl uorescei n and IgG mixture was added to the column and a fl ow 
rate of 100 ml/hr was used. The column was eluted with PBS (pH 
7.2)and the first coloured fraction was collected~ The 
fluorescein/protein ratio was calculated after measuring the 
absorbance of the conjugated fraction at 280 and 495 nm. 
The following formula was applied (Johnstone and Thorpe 1982 pg 
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259): Molar ratio= 
2.87 x absorbance at 495 nm 
absorbance at 280 nm -0.35 x absorbance at 495 nm 
The molar fluorescein/protein ratios were 2.33 - 2.89. The 
protein concentration of the fluorochrome IgG conjugate was 
measured according to the formula: mg/ml protein= 
{1.55 x absorbance at 280 nm)-(0.76 x absorbance at 260 nm) 
(Richterich 1969 pg 241). 
A po.rtion of the FITC-labelled IgG was heat-aggregated (Ha) 
before use as this preparation has been shown to be more 
reactive (Mellors et al 1959). The heat-aggregation was carried 
out by heating in a waterbath to 63°C for 10 minutes (Gripenberg 
et al 1979, Fehr et al 1981). 
11.1.2 Other fluorescein-labelled conjugates 
Fluorescein-labelled anti-human lgG was acquired from Behring, 
Wes-t Germany (catalogue number OTKB04/05). Fluorescein-labelled 
rabbit anti-human IgM and anti-human C3 were obtained from the 
same source (catalogue numbers OTKC04/05 and OTKD 04/05) 
11.1.3 I1111unohistocheaical method 
Frozen tissue sections were air dried and then fixed with 
anhydrous acetone for 10 minutes at 4°C. The sections were 
washed with water followed by 0.05 M PBS pH 7 .2. Excess water 
was removed from the slides and the tissues were then stained. 
Protein concentrations of FITC-labelled IgG of 2.8 mg/ml, 1.4 
mg/ml, 0.7 mg/ml and 0.35 mg/ml were used initially to determine 
the optimum dilution. Sufficient fluorochrome conjugate was 
placed on the slides to cover the tissue and the sections were 
stained for 1 hour at room temperature. 
The specificity of the immunohistochemical procedure was checked 
by inhibition tests. These were carried out by reacting the 
tissues with non-labelled IgG for 30 minutes. This was followed 
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by washing with PBS pH 7.2, and addition of the FITC-labelled 
IgG for 1 hour. 
Following the staining procedure, slides were washed with PBS pH 
7.2 and cover-slips applied. 
The stairring procedure for the other fluorochromes was identical 
to that described above for the FITC- IgG. Protein 
concentrations of 1.2 mg/ml were used. 
Fresh section were examined with a fluorescence microscope 
(Nikon Optiphot) which employed epi-fluorescent illumination. 
Microscopy was performed using objectives with magnifications of 
10-60 times. 
Photography was carried out with a Nikon camera attachment (FX-
35A) Fujichrome and Konica film (400 ASA) were used. 
11.1.4 Patient Selection 
Patients with congenital syphilis: Tissues from patients with 
congenital syphilis were available as follows: 
Postmortem Specimens: Specimens were obtained (with parental 
consent) from 3 newborn infants with congenital syphilis. 
Patient 1: this patient was described in Chapter 6 (code no. 
6.1). This postmortem interval was 2 days 
Patient 2: This preterm infant has also been described in 
Chapter 6 (code no. 6.15}. The cause of death was probably a 
secondary septicaemia (Escherichia coli} and the postmortem 
interval was also 2 days. 
Patient 3: (code no. 11.1) This male infant, whose gestational 
age was 34 weeks died 20 minutes after birth. The infant was 
under weight for gestational age (1990 g}, pale and oedematous. 
The placenta weighed 970 g and was pale. The infant's mother 
had a positive VDRL (titre 1: 2048) and TPHA. She had received 
1 dose of 2.4 megaunits of long-acting benzathine penicillin 1 
week prior to delivery. 
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Apart from the postmortem results to be described, other 
investigations were as follows: radiographs of the long bones 
demonstrated a marked metaphyseal dysplasia and periosteal 
reaction. The FTA-ABs (IgM} test was positive and the RF latex 
test was positive at a dilution of 1:40. 
Placentae: In addition to the placentae from the 3 infants who 
died, placentae were available from 2 other infants with 
·congenital syphilis. The placentae from patients 11.1,11.2 and 
11.3 were obtained at birth and frozen immediately. 
Patient 11.2: She was a preterm infant (30 weeks gestation} 
weighing 1100 g, who was found to have hepatoslenomegaly. The 
placenta weighed 300g and was friable and oedematous. The 
maternal VDRL was positive to a titre of 1:512 and the TPHA was 
positive. Radiographs of the long bones showed metaphyseal 
dystophy and the serum RF concentration was 24 IU/ml. 
Patient 11.3: This infant was 30 weeks gestation and weighed 
1450g at birth. The infant had clinical features of pallor, 
oedema and hepatosplenomegaly. The placenta weighed 700g and was 
pale. The maternal VDRL titre was 1:256 and the TPHA was 
positive. The patient demised shortly after birth. 
Control patients 
Postmortem specimens: 
Patient no 11.4: This infant was a newborn of 33 weeks 
gestation. He died 6 hours after birth primarily as a result of 
hyaline membrane disease. The mother had negative serological 
tests for syphilis. The consent of the parents was obtained and 
sections of the liver and spleen were stained with the 
fluorescein-IgG conjugate. Tissue from this patient was used as 
a negative control for patient no. 11.1. 
Placentae: Placental tissue was obtained from 4 control 
stillborn infants whose gestational 11ge had been matched with 
that of the test patients. The mothers gave informed consent 
for the placentae to be examined. The stillbirths were fresh 
and the placentae had no macroscopical evidence of 
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chorioamnionitis. All 4 stillbirths were due to abruptio 
placentae. The gestational age was assessed by means of the 
maternal history, ultrasonic findings and the external 
characteristics of the infants. The tissue for microscopic 
examination was obtained from areas of the placenta which were 
not haemorrhagic and frozen immediately. Table 11.1 shows the 
clinical details for the control patients. 
After obtaining the tissues they were frozen with liquid 
nitrogen and stored at -70°C until used. 
11. 2 RE SUL TS 
11.2.1 Optimum FITC-IgG concentrations 
The best contrast between tissue fluorescence and backgrounds 
was obtained with 0.35-0.7 mg/ml of the protein-conjugate. 
11.2.2. Inhibition experi•ents 
The use of aggregated-IgG at a concentration of 0.7-1.4 mg/ml 
was found to completely prevent binding of the FITC-labelled 
IgG. 
11.2.3 Tissue sections 
The tissues obtained from patients 1 and 2 were autolytic and 
unsuitable for further study. The results obtained with the 
remaining patients will be described under the headings of the 
organ studied. 
Placenta: Placentae which were appropriate for histological 
study were obtained from 3 patients with congenital syphilis 
{11.1, 11.2 and 11,3). 
The findings on 1 ight microscopy were those of a mild chronic 
inflammatory infiltrate in case no. 11.1 and blunting and 
enlargement of the villi in case no. 11.2. Case no. 11.3 showed 
the same features as 11.2 except that patchy inflammatory 
changes and a vasculitis were also present. 
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Using the Ha fluorescein-labelled IgG to detect RF, positive 
immunofluorescence was demonstrated in the placentae of all the 
infants with congenital syphilis. 
The main regions of positivity were the inner lining of small 
blood vessels within the placental villi. As shown in the 
photographs which follow, many vessels appeared to be involved. 
The fluorescence was regular and the vessel lining was smooth. 
There were, in addition, granular deposits in the stroma of some 
of the villi. It was not possible to determine if these 
accumulations were intracellular (photographs lla, llc, lle and 
1 lm). 
The positive staining was completely inhibited by the use of 
non-labelled IgG (photographs llb, lld and llf). 
The native i.e. non-heat aggregated IgG-fluorochrome conjugate 
produced far less fluorescence than the Ha preparation. 
Staining was present in the lining of some of the small blood 
vessels in patients with congenital syphilis. 
Unstained placental tissue from the patients with congenital 
syphilis did not demonstrate autofluorescence 
The immunohistochemical staining with fluorescein-labelled anti-
human IgM, anti-human IgG and anti-C3 was also positive in the 
placentae of patients with congenital syphilis. Positivity was 
most marked along the cours.e of small blood vessels. 
Photographs llk, lln and llp demonstrate these findings. 
The placentae of the 4 controls had a different histological 
appearance to that described above. 
Light microscopy revealed that the placentae were normal; there 
was no inflammatory cell infiltrate. 
There was minimal staining with the Ha fluorescein-labelled IgG 
(photographs llg, llh, 111, 110). No fluorescence was observed 
in control placentae using non-aggragated IgG. 
In addition, the use of the anti-human IgM, anti-human IgG and 
anti-CJ indicated that positive fluorescence was not present in 
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11a Placenta of pateint no 11.1 stained with FITC-IgG. (Magnification x20, 
Fuji film 400 ASA). Note RF deposits in blood vessels and villi. 
11b Same placenta stained with FITC-IgG after an inhibition step using non-
labelled heat-aggregated IgG (Magnification x20, Fuji film 400 ASA, neutral 
density filter ND4). Note absence of fluorescence. 
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11c Placenta of patient no 11 .2 stained with FITC-IgG. (Magnification x40, Fuji 
film 400 ASA, neutral density filter ND2). Granular deposits of RF along walls 
of small blood vessels and in the stroma of the villi. 
11d · Placenta of patient no 11.2 stained with FITC-IgG after an inhibition step 
using non-labelled heat-aggregated IgG. (Magnification x40, Fuji film 400 ASA 
neutral density filter ND4). A lack of immunofluorescence is present. 
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1e Placenta of patient no 11 . 3 stained with FITC-IgG . (Magnification x40, Fuji film, neutral density filter ND2). Fine and coarsely granular RF deposits in a placental villus . Some of the larger deposits may be intracellular. 
f Placenta of patient no 11 . 3 stained with FITC-IgG after an inhibition step using non-labelled heat-aggregated IgG. (Magnification 40x, Fuji film 400 ASA, neutral density filter ND4) . Irrununofluorescence is absent. 
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11g Placenta of control patient no 11 .5 stained with FITC-IgG. (Magnification x20, 
Fuji film 400 ASA). No RF was demonstrated. 
1h Placenta of control patient no 11,7 stained with FITC-IgG. (Magnification x40, 
Fuji film 400 ASA). No RF was localized, 
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11i Liver of patient no 11.1 with congenital syphilis stained with FITC-IgG. Positive immunofluorescent staining in Kuppfer cells adjacent to a portal tract. (Magnification x40, Fuji film 400 ASA) 
lj Spleen of patient no 11.1 with congenital syphilis stained with FITC-IgG. Bright irnmunofluorescence in macrophages, lesser fluorescence in cells amongst splenic pulp. (Magnification x40 , Fuji film 400 ASA, neutral density filter ND4) . 
111 Placenta of control patient no 11 .5 
stained with fluorescein-labelled 
rabbit anti-human IgM. No IgM 
staining noted. (Magnification 
x20 Konica film 400 ASA). 
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11k Placenta of patient no 11.1 with 
congenital syphilis stained with 
fluorescein-labelled rabbit anti-
human IgM. Note the localization 
of IgM to the walls of blood vessel R 
(Magnification x20 Konica film 
400 ASA) 
11m Placenta of patient no 11 .1 
with congenital syphilis 
stained with fluorescein-
labelled lgG. Note the 
presence ·of RF in a simila r 
location to the IgM in 
photograph 11k. In 
addition, extravascular RF 
is present, (Magnification 
x20, Konica film 400 ASA). 
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11n Placenta of patient no 11.2 with congenital syphilis stained with fluorescein-labelled rabbit anti-human IgG. Note extensive IgG depostis in walls of blood 
vessels. (Magnification x20, Konica film ASA 400) 
110 Placenta of control patient no 11.5 stained with fluorescein-labelled 
rabbit anti-human IgG. No positive tissue fluorescence is seen. (Magnification x20, Konica film ASA 400). 
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11p Placenta of patient no 11.1 with congenital syphilis stained with fluorescein-labelled rabbit anti-human CJ. Complement deposits are localized around blood vessels. (Magnification x20, Konica film ASA 400). 
11q Placenta of control patient no 11.5 stained with fluorescein-labelled rabbit anti-human CJ. Trophoblast-lining cells have taken up the stain. (Magnification x20, Konica film ASA 400). 
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the fetal blood vessels of the controls. There was, however, a 
1 inear deposit of C3 detected on the maternal surface of some 
villi (photograph llq). 
Liver: The light microscopic findings in patient no. 11.1 were 
those of a mild periportal inflammation and a mild inflammatory 
cell infiltrate extending into the parenchyma. Using Ha 
fluorescein-labelled IgG, positive fluorescence was demonstrated 
in the portal tracts (photograph lli). 
The fluorescence was most marked in Kuppfer cells and not 
blocked by the use of non-labelled IgG. Positive staining was 
not seen in chronic inflammatory cells or in the liver 
parenchyma. 
The liver from the patient who served as a control (no. 11.4) 
was normal by 1 ight microscopy. The sections stained with Ha 
fluorescein-labelled IgG had a pattern of immunofluorescence 
similar to that described above (most marked in Kuppfer cells). 
Again, the fluorescence was not inhibited by the use of non-
labelled IgG. 
Spleen: The presence of an inflammatdry infiltrate and 
congestion was noted on light microcopy in patient no. 11.1. 
Positive fluorescence was noted following staining with Hag 
fluorescein-labelled IgG. The fluorescence was not inhibited by 
non-1 abel 1 ed IgG and was observed in macrophages and cel 1 s in 
the splenic pulp (photograph llj). 
Similar findings were present in the spleen of the control 
patient (no. 11.4). 
Kidneys: Tissue obtained from patient no. 11.1 at autopsy 
showed mild i nfl amma tory changes only. Immunofl uorescent 
staining was negative. 
No abnormalities were demonstrated in the kidneys of the control 
patient. 
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Lungs: A marked inflammatory infiltrate was noted with the 
presence of plasma cells, lymphocytes and fibrosis in the lungs 
of the patient with congenital syphilis. In spite of numerous 
attempts, for technical reasons frozen sections of the lung 
could not be cut. 
Other Findings: The patient with congenital syphilis (Ho. 11.1) 
had fibrotic changes in the pancreas and extramedul lary 
haematopoiesis in many organs. The brain and pancreas were not 
further examined because of the presence of autolysis. 
Summary of results 
Positive immunofluorescence was observed using both non-
aggregated and ~tat aggregated fluorescein-labelled lgG to 
detect RF in the placentae of all 3 patients with congenital 
syphilis studied. The changes were most marked in small blood 
vessels. 
In addition, using fluorescein-labelled anti-human IgM, IgG and 
C3 fluorescence was noted in the placentae of these same 
patients. These phenomena were not seen in unstained placentae 
or to the same degree in the placentae of control infants. 
Non-specific positive fluorescence was noted in the 1 i ver and 
spleen of both the patient with congenital syphilis and in the 
control patient. 
11.3 DISCUSSION 
There was a marked difference demonstrated in the staining of 
the placentae from patients with congenital syphilis and 
controls. The staining with heat aggregated FlTC-IgG in the 
patients appeared to be specific for antibodies to IgG (i.e. 
RF) or Fe receptors in that it was inhibited by prior treatment 
with non-labelled IgG. 
Using t i ssues derived from patients with RA, various workers 
(e.g. Mellors et al 1959; Hijmans et al 1969; Munthe and Natvig 
1971; Fehr et al 1981) have put forward evidence th J ~ · 1 - .. ~ ~ '.' f 
fluorescein-labelled lgG detects RF. It may be that the 
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fluorescent deposits observed with the FITC-IgG in patients with 
congenital syphilis in this study were due to RF. 
Nevertheless, the placenta contains Fe receptors which could 
bind the aggregated IgG (Burton and Gregory 1986 pg 11). Indeed, 
such receptors have been shown to be present on endothelial 
cells in the apical aspect of fetal stem vessels (Johnson et al 
1976). In addition, lgG coated red blood cells have been 
successfully used as indicators to detect Fe receptors on 
trophoblastic tissue (Page Faulk and Johnson 1980 pg 12-14). 
Receptors in the latter site are not demonstrated when aggegated 
IgG is used (Johnson et al 1976). 
Three types of Fe receptor are known to exist. Of these, only 
type II receptors (Fe -'t RII) have been found in the placenta. 
Type II receptors bind aggregated IgG and immune complexes, but 
have no affinity for native IgG (Tax and van der Winkel 1990). 
In the light of these findings, the FITC-IgG staining observed 
in the placentae with the heat aggregated preparation could be 
due to Fe receptors. However, Fe o RII have no a ffi ni ty for 
non-aggregated lgG so that the use of this substance would not 
detect these receptors. Rheumatoid factors, although having 
greater a ffi ni ty for aggregated IgG wi 11 bind to non-aggregated 
IgG (Rossen et al 1977). The demonstration of placental 
immunofluorescence using non-aggregated IgG in the present study 
is likely to be due to the presence of RF. 
As both Fe receptors and RF recognize the same epitope(s) on IgG 
(Mouritsen 1986), blocking experiments would not be expected to 
allow differentiation between Fe a RII and RF. In keeping with 
this, unlabelled heat aggregated IgG prevented all fluorochrome 
staining in the present study. 
There was a striking difference between the fluorescence · 
observed in the placentae of patients and controls using the 
labelled HalgG. This could indicate increased numbers or 
affinity of the Fe receptors in response to disease, the 
presence of RF or both. 
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The effect of congenital syphilis and the immune complexes found 
therein on Fe receptor expression are unknown. In acute 
mastitis, however, immune complexes can block Fe receptors on 
phagocytic cells (Targowski and Klucinski 1985). In addition,in 
a number of diseases associated with the presence of immune 
complexes (e.g. systemic lupus erythematosis, Sjogren's syndrome 
and dermatitis herpetiformis) there is decreased clearance of 
IgG-coated erythrocytes. In the case of systemic lupus 
erythematosis, the clearance returns to normal with remission of 
the disease (Unkeless et al 1988). In other diseases such as 
malaria, there is an increased expression of monocyte Fe 
receptors (Ward et al 1984). Proteolysis, such as may occur in 
sites of inflammation, can increase the affinity of type II Fe 
receptors for IgG (Tax and Van der Winkel 1990). Although the 
effects of infection and inflammation on Fe receptor expression 
appear to be variable, the possibility of increased affinity in 
congenital syphilis cannot be excluded. 
The positive staining of trophoblast observed with heat 
aggregated FITC-IgG in the placentae of patients with congenital 
syphilis is unlikely to be due to Fe receptors. In contrast to 
the endothelial cells Fe'! RII have not been demonstrated in 
trophoblastic tissue using fluorescein-labelled IgG (Johnson et 
,!l 1976). The positive staining in the present study may have 
been due to deposits of RF. 
Utilizing other fluorochromes (anti-human IgG, IgM and C3) 
components of immune complexes, particularly IgM, were 
demonstrated in the placentae, thus confirming the work of 
Samson ( 1989). The pattern of immune complex localization 
appeared to be similar to that of heat aggregated FITC-IgG 
accumulation. 
Taken together, these findings suggest the presence of RF in the 
placentae of infants with congenital syphilis. 
While there have been no previous reports of RF deposits in the 
blood vessels of patients with congenital syphilis, a placental 
vasculitis has been well described (Russell and Altshuler 1974). 
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Similarly, other workers have shown a relationship between RF 
and vasculitis in various conditions apart from congenital 
syphilis. In RA there is an association between vasculitis (and 
other systemic manifestations of RA) and RF levels (Epstein and 
Engleman 1957; Gordon et al 1973; Theofilopoulos et al 1974; 
Gi cud-Paquet et al 1987). 
DeHoratius et al (1972) observed extensive pulmonary capillary 
RF deposition in patients with rheumatoid lung. In order to 
investigate the role of RF in the pulmonary lesions of RA, an 
animal model was developed (DeHoratius and Williams 1972 ) . 
these workers found that after inducing a diffuse proliferative 
lung disease in rabbits, the intravenous injection of RF 
resulted in arteriolar RF deposition. In addition, some of the 
animals developed segmental haemorrhagic lung infarction 
following the injection. The RF was also deposited in alveolar 
walls and appeared to cause an increase in inflammation around 
existing granulomas. 
Other work in experimental animals appears to confirm the 
relationship between RF and vasculitis. 
Experiments performed by Baum et al ( 1964) demonstrated that 
infusion of RF and immune complexes into rat mesenteric vessels 
caused vasculitis. Thrombosis was also observed. The pattern 
of RF deposition was linear in nature, similar to that found in 
the placentae of the 3 infants with congenital syphilis. 
Floyd and Tesar (1979), using an experimental model, put forward 
evidence that RF was linked with inflammation and vasculitis. 
These workers studied the cutaneous Arthus reaction in rats. 
Injection of immune complexes and normal IgM resulted in only 
mild inflammatory changes. However, injecting IgM RF and immune 
complexes caused the Arthus reacticn and a vasculitis to 
develop. 
DeHoratius and Williams (1972) proposed that immune complex 
deposition resulted in the RF localization in the same area. 
Ford and Kosatka (1982) found that injecting RF into mice who 
had deposited immune complexes in their glomeruli resulted in RF 
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accumulation in the same site. The RF then acted as an 
immunoabsorbent for the deposition of further immune complexes. 
This could result in chronic ongoing damage. 
These findings, together with those of this study, suggest that 
RF, together with immune complexes may induce a vasculitis in 
the placentae of infants with congenital syphilis. The 
experimental evidence cited above indicates that RF may 
aggravate the vascular and tissue damage. 
No attempt was made in the present study to relate the serum RF 
levels to the degree of RF deposition in the placentae. 
Nevertheless, the association demonstrated between more severe 
and extensive disease and RF levels indicates that higher RF 
levels may cause more severe placental damage. 
The increased placental size in congenital syphilis has been 
well described (McKelvey and Turner 1934, Russell and Altshuler 
1974, Budell 1982 pg 923-924). 
It is conceivable that RF together with immune complexes causes 
vasculitis, increased capillary permeability and oedema which in 
turn results in enlargement of the placenta. · It may be possible 
to correlate the amount of oedema with the quantity of RF and 
immune complex deposition. This is an area for future research. 
Preliminary findings were presented in Chapter 10.2 where an 
association between RF levels and a greater placental weight was 
documented. 
The heat-aggregated IgG appeared to bind avidly to the normal 
macrophages of the liver and spleen. The uptake by these cells 
was not prevented by the prior inhibition step. Macrophages, 
including Kuppfer cells are capable of removing circulating 
immune complexes (Mannik 1982). Heat-aggregated IgG has been 
used to simulate an immune complex (Pisko et al 1982) and this 
may explain the macrophage staining in the normal control as 
well as the patient with congenital syphilis. 
Discrete RF deposits were not found in the· liver or spleen. 
This is, perhaps, surprising but it may be that the Kuppfer 
cells and macrophages had ingested immune complexes (Mannik 
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1982). 
The kidney did not appear to be affected in the patient 11.1 
with congenita 1 syphilis. Other authors have reported immune 
complex deposition in the glomeruli of infants with nephrotic 
syndrome due to congenital syphilis (Wiggelinkhuizen et al 
1973). However, renal disease in congenital syphilis usually 
develops at 2-3 months of age (Ingall and Musher 1983 pg 349) 
One of the limitations of the current study was a lack of 
suitable fresh tissue (apart from the placentae) for 
immunofl uorescence. De 1 ayed contact between parents and the 
medical staff meant that pennission for a postmortem examination 
was not immediately forthcoming. 
The findings are - based on placentae from 3 patients and 4 
controls, and the kidney, liver and spleen from 1 patient and 1 
control. The conclusions should, therefore, be regarded as of a 
preliminary nature. 
To extend this study a method of detecting RF in formalin-fixed 
tissue would allow use of specimens obtained over the years. It 
is conceivable that the peroxidase-antiperioxidase system could 
be used (Johnstone and Thorpe 1982 275-276). Whilst the method 
is attractive it does not appear to have been used to detect 
tissue RF and would need to be compared to the conventional 
method used in this study. 
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CHAPTER 12 
CONCLUSIONS. RECOtltENDATIONS AND FUTURE RESEARCH 
12.1 CONCLUSIONS AND RECOtltENDATIONS FROM PART II 
Rheumatoid factor and testing for congenital syphilis 
The RF latex test was shown to lack sensitivity in asymptomatic 
patients when applied as a screening test to a group of infants 
at high-risk of congenital syphilis i.e. a negative test could 
not be used to rule out the diagnosis. In busy and overcrowded 
newborn nurseries such as may be found in developing countries, 
the RF latex test may be of value. This is because its high 
predictive value and rapidity of performance on a serum sample 
collected in a capillary tube could help to identify a 
percentage of the infected newborns prior to hospital discharge. 
For example, a positive RF latex test in the presence of 
serological evidence of maternal syphilis is likely to be due to 
congenital syphilis. Early diagnosis would allow treatment to 
be quickly instituted without having to await the results of 
more complex investigations (e.g. the FTA-ABS (IgM) test). This 
would reduce the time of hospital admission and/or detect 
patients who should not be discharged before full evaluation. 
Although the RF ELISA appeared to be somewhat more sensitive, 
the RF latex test was a far simpler and quicker test for the 
presence of RF. The total IgM test had similar sensitivity to 
the Rf latex test, but a lower specificity. The sensitivities 
of the other tests performed on the infants were, unfortunately, 
no better. Therefore, one is left with the options of prolonged 
follow-up of high-risk infants or that of treating such cases. 
The selection of infants requiring further management could be 
made on the basis of those whose mothers have been inadequately 
treated and who have a VDRL titre of 1 :32 or more in the last 
month of pregnancy. 
In a different study it was found that the RF latex test was 
useful in determining which infants with one or more of the many 
signs and symptoms of congenital syphilis actually had the 
disease (sensitivity 94%, specificity 80%). The results were 
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rapidly available and the test could be used as a side-room 
screening test whilst awaiting the results of more definitive 
laboratory tests. 
In the population attending the PMNS, the majority of 
symptomatic infants with positive RF latex tests had congenital 
syphilis (positive predictive value 911). In other communities 
the value of the test would be determined by the prevalence of 
the disease. 
The sensitivity of the fractionated FTA-ABS (IgM} test was shown 
to be adversely affected by IgG and RF removal. It would seem 
to be unnecessary and indeed deleterious to the sensitivity of 
the specific IgM test to attempt RF extraction in newborns. As 
pointed out, both anti-treponemal IgG and RF are needed to 
obtain a false positive FTA-ABS (IgM) test and these 
circumstances are unlikely to occur in the absence of congenital 
syphilis. 
Eliminating RF interference in older infants appeared to reduce 
the number of false positive tests but at the expense of a 
reduced sensitivity. As the effect of unnecessary treatment is 
unlikely to be significant (Gon1n 1985), it may be advisable to 
ignore the RF activity completely when using the FTA-ABS ( IgM) 
test. 
12.2 CONCLUSIONS FROM PART III - RHEUMATOID FACTOR ANO THE IMMUNE 
RESPONSE IN CONGENITAL SYPHILIS 
In summary, the following features were demonstrated: 
1. Rheumatoid factor was present in the sera of a greater 
percentage of symptomatic infants with congenital syphilis 
(921) than has been reported for adults with acquired 
syphilis (13-25% - Barfeld 1969; Muller et al (1987). 
2. IgM RF was the only class of RF detected in the infants 
with congenital syphilis. It appeared that the IgM RF 
accounted for 4% of the total IgM produced (mean value). 
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3. An association could be demonstrated between RF levels and 
more severe and extensive disease (p < 0.05). The RF 
levels also correlated with liver and kidney involvement 
as well as oedema ( p < 0.05). Levels of RF and CI Cs were 
closely related (p < 0.000001). 
4. Using immunohistochemical methods, positive fluorescence 
1 ikely to be due to RF, was found in the placentae of 3 
infants with congenital syphilis, but not in controls. 
Deposition of RF was noted in blood vessels and 
extracellularly in placental villi. 
5. Rheumatoid factor was not detected in the sera of newborn 
controls using the RF latex test and very low levels of RF 
were observed in these infants using the RF ELISA. It was 
apparent, however, that levels of anti-IgG increased in 
normal infants after birth. 
These findings have already been discussed. Some conclusions 
will now be made under the following headings: 
i. RF · synthesis as part of the tota 1 IgM product ion in 
congenital syphilis 
ii. RF and the pathogenesis of congenital syphilis. 
The possible direction of future research will also be 
discussed. 
12.2.1 RF synthesis as part of the total IgM production 1n congenital 
syphilis 
It was evident that IgM RF and anti-treponemal (or specific) IgM 
were synthesized as part of the total IgM production. This 
indicated that a polyclonal response was in progress. It was 
found that 41 of the IgM produced was IgM RF; it should be borne 
in mind, however, that this figure reflects RF levels after 
tissue deposition. It was apparent that RF was found more often 
in congenital than acquired syphilis, suggesting that activation 
of CDS+ cells occurs more readily in the younger patients. 
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The elevated levels of anti-IgG noted in the older controls may 
be due to the production of IgM antibodies to foreign maternal 
Qn allotypes. The early onset of anti-IgG production 
demonstrated in the present study may reflect the use of a 
sensitive detection system. 
That lgG and IgA RF were not detected implied that cl ass-
switching did not readily occur in the infants. This may be in 
keeping with observations that B lymphocytes produce 
predominantly IgM in early life (Steele et al 1977). 
12.2.2 RF and the pathogenesis of congenital syphilis 
The findings that RF levels were related to multisystem 
involvement and more severe disease and that RF may be deposited 
in the placental blood vessels suggested that RF may be involved 
in the pathogenesis of congenital syphilis. 
It was likely that the presence of RF was related to the 
deposition of immune complexes. Whether the RF bound to immune 
complexes in the circulation or whether it attached to tissue-
bound complexes was unknown, although its ability to do both has 
been established (Ford and Kosatka 1982). 
Presumably RF may aggravate tissue damage by the following 
mechanisms: 
i. by acting as an immunoabsorbent to bind more immune 
complexes 
ii. complement activation: animal experiments have shown that 
complement is needed for the full effect of RF to be 
manifest {Floyd and Tesar 1979). 
This leads one to question why a potentially physiological 
immunoglobulin (i.e. RF) should be associated with pathological 
effects? 
Possibly there is excessive production of RF in congenital 
syphilis. Given suitable stimuli, RF manufacture, being part of 
a germ-line response, may be greater in early infancy. In 
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addition, it appears that in early life a mechanism exists 
whereby the normal infant begins to make anti-al lotypic 
antibodies. As suggested by Reimer et al (1975) this could be 
exaggerated in infants with immune complex disease (e.g. 
congenital syphilis) because the IgG in the complexes is of 
maternal origin (and presumably allotypically different). The 
maternal IgG may assume a more antigenic nature because of 
configurational changes induced by the formation of immune 
complexes. The immune response of the young infant which is 
geared, for reasons previously set out, to make anti-
immunogl obul in may produce 1 arge amounts of RF which exert a 
pathological effect. 
12.3 DIRECTIONS OF FUTURE RESEARCH 
12.3.1 Tests for the di1gnosis of congenital syphilis 
The results obtafoed in Chapter 5 indicated that the maternal 
VDRL titre near the time of delivery was a good predictor of 
whether an infant would develop congenital syphilis. 
It may be worthwhile to establish an ELISA for VDRL antibody and 
determine if a reliable cut-off level can be identified. This 
would require a similar study to that described in Chapter 5. 
Whilst there are a number of new techniques available to 
diagnose congenital syphilis it should be emphasized that none 
have been thoroughly tested in asymptomatic patients (Dobson!!_ 
!l. 1988; S'anchez et al 1989; Pedersen et al 1989; Ijsselmuiden 
et al 1989). It would seem to be wise to await further studies 
before introducing these newer tests. 
One of the reasons that establishing a diagnosis is so important 
in congenital syphilis is because of the prolonged nature of the 
treatment which is difficult to carry out in developing 
countries. It has been pointed out that the treatment regime 
was empirically derived. It is important that studies are 
performed to determine the efficacy of a shorter course of 
therapy. The possibility of using different agents (e.g. the 
newer cephalosporins) should be considered. 
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12.3.2 RF and the i1111111ne response in congenital syphilis 
Could RF production in congeni'tal syphilis be used as a model 
for other diseases? 
suggesting this: 
There are a number of reasons for 
i. similar factors correlate with Rf levels fo congenital 
syphilis, RA, SBE and other conditions. 
ii. RF synthesis is part of a germ-line response to and it may 
be advantageous to study the latter at an early stage of 
development. 
Further studies on CDS+ cells in newborns in general and those 
with congenital syphilis in particular, appear to be warranted. 
The numbers of such cells could be quantitated and the stimulus 
for RF production in congen i ta 1 syph i1 is sought ( i • e. is the 
treponemal antigen important, or is complexed maternal IgG alone 
sufficient?). 
The development of an animal model (e.g. the rabbit - Fitzgerald 
1985 or the hamster - Kajdacsy-Balla et al 1987) would allow 
further investigation of the importance of RF in the development 
of the lesions of congenital syphilis. One would be able to 
compare, for example, the effects of injected immune complexes 
(containing treponemal antigens) with the same complexes and RF. 
The study of Dresner and Trombly (1959) indicated that 
monitoring RF levels could be a useful way of assessing the 
activity of liver disease. This finding appears to be worthy of 
further study. 
The above areas would seem to merit further research. 
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APPENDIX 1 TABLE A.1.2 
*CRITERIA FOR THE DIAGNOSIS OF NEONATAL AND EARLY CONGENITAL SYPHILIS - MASCOLA ET AL 1985 
CLINI L 
Absolute 
1. Specimen from 1 es ions showing presence of Treponema pa 11 i dum by dark-field examination, or by histologic exam1nat1on Major 
2. Condyloma lata 
3. Osteochondritis, periostitis 
4. Snuffles or hemorrhagic rhinitis 
Minor 
5. Fissures of lips 
6. Cutaneous lesions 
7. Mucous patches 
8. Hepatomegaly, splenomegaly 9. Generalized lymhadenopathy 
10. Central nervous system signs 
11. Hemolytic anemia 
12. Elevated no. of cells or protein level in cerebrospinal fluid 
SEROLOGIC 
A. 
B. 
C. 
D. 
E. 
Reactive STS (VDRL or FTA-ABS) 
Reactive FTA-ABS (IgM) test 
Nonreactive STS (VDRL or FTA-ABS) 
Reactive STS (VDRL or FTA-ABS) 
nonreactive within 4 mo 
Rising VDRL titer over 3 mo 
MATERNAL HISTORY 
that does not revert to 
AA-documented history of adequately treated syphilis during pregnancy 
CERTAINTY OF DIAGNOSIS 
Definite: Absolute clinical criterion Probable: Any of the following: (1) serologic criterion E; (2) serologic criterion D; (3) one major clinical criterion and serologic criterion A or B; (4) two or more minor clinical criteria and serologic criterion A or B; (5) one major and one minor clinical criterion 
Possible: Serologic criterion A or B with only one minor criterion, or no criterion 
Unlikely: (1) serologic criterion C with any other criterion; (2) serologic criterion A or B with maternal history AA 
* Reproduced with permission 
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APPENDIX 2 
TEST PROCEDURES ANO QUALITY CONTROL 
RHEUMATOID FACTOR LATEX TEST 
The 'Ortho RA Test' produced by Ortho Diagnostics, Belgium was used. 
Procedure 
Twenty microlitres of serum was mixed with 80 ul of 'Ortho RA Glycine 
Buffer' in a 10 x 75 mm clean glass test tube. Twenty microlitres of 
this mixture was then transferred to a second test tube containing 140 
ul of buffer to give a final dilution of 1:40. 
The positive and negative control sera were diluted in the same way. 
The glass slide provided was placed on a bench-top beneath a white light 
source. Using a Pasteur pipette, 1 drop of each serum dilution was 
placed in the centre of a square on the glass slide. 
One drop of 'Ortho RA latex antigen' was placed next to each serum to be 
tested. The antigen and serum were mixed with the plastic rod provided, 
taking care to cover the entire surface of the glass square. A timer 
was started after completion of the mixing and the slide tilted back and 
forth for one minute. If agglutination was present at 1 in 5, doubling 
dilutions were prepared as follows: 
Tube Composition Dilution 
1 20 ul serum + 80 ul buffer 1:5 
2 20 ul tube I + 20 ul buffer 1: 10 
3 20 ul tube 2 + 20 ul buffer 1:20 
4 20 ul tube 3 + 20 ul buffer 1:40 
The highest dilution at which visible agglutination was detected was 
regarded as the end-point. As the Ortho RA test has been standardized 
against the WHO Rheumatoid Arthritis Reference Serum, an approximation 
of the RF concentration could be obtained. 
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Quality Control 
In addition to using the positive and negative control sera provided, 
the withi n- and bet\veen-observer variation (Barker 1982 pg 19,20) were 
determined. Qualitative results only were considered because the RF 
concentrations were measured with the RF ELISA . 
a. Within-observer variation 
A random selection of 50 patients who formed part of the study 
groups of Chapters 5 and 6 was made using a random number table. 
The RF latex test, at a dilution of 1:5, was performed on two 
occasions (Run 1 and Run 2) . The technologist was unav,are of the 
results of Run 1 when performing Run 2. The results are shown in 
Tables A.2.1 and A.2.2. 
TABLE A.2.1: 
WITHIN-OBSERVER VARIATION USING THE RF LATEX TEST 
PATIENT CODE NO. RUN 1 RUN 2 
5.2 +ve +ve 
5.3 
-ve 
-ve 
5.7 
-ve 
-ve 
5.15 
-ve 
-ve 
5.16 
-ve 
-ve 
5.23 
-ve 
-ve 
5.25 
-ve 
-ve 
5.30 
-ve 
-ve 
5.35 
-ve 
-ve 
5.36 
-ve 
-ve 
5.42 
-ve 
-ve 
5.44 
-ve 
-ve 
5.50 
-ve 
-ve 
5.53 
-ve 
-ve 
5.54 
-ve 
-ve 
5.59 
-ve 
-ve 
5.60 
-ve 
-ve 
5.72 
-ve 
-ve 
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Table A.2.1 continued 
-
PAT! ENT CODE NO. RUN 1 RUN 2 
5.76 
-ve 
-ve 
5.85 
-ve 
-ve 
5.86 
-ve 
-ve 
5.87 
-ve 
-ve 
5.92 
-ve 
-ve 
5.97 
-ve 
-ve 
5.98 
-ve 
-ve 
5.102 
-ve 
-ve 
5.104 
-ve 
-ve 
5.109 
-ve 
-ve 
5 .111 
-ve 
-ve 
5.113 
-ve 
-ve 
5 .115 
-ve 
-ve 
5 .116 
-ve 
-ve 
5.124 
-ve 
-ve 
5.127 
-ve 
-ve 
5.139 
-ve 
-ve 
5.140 
-ve 
-ve 
5.142 
-ve 
-ve 
5.147 
-ve 
-ve 
6.3 +ve +ve 
6.6 
-ve 
-ve 
6.8 +ve +ve 
6.9 +ve +ve 
6.12 +ve +ve 
6.14 +ve +ve 
6.20 +ve +ve 
6.24 +ve +ve 
6.25 +ve +ve 
6.28 +ve +ve 
6.33 +ve +ve 
The within-observer repeatibility was calculated from Table A.2.2. 
325 
TABLE A.2.2 
WITHIN-OBSERVER VARIATION WITH THE. RF LATEX TEST 
RUN 2 · Positive 
Negative 
Positive 
12 
0 
The within-observer repeatability was a 
(a+b+c) 
b. Between-observer variation 
RUN 1 
a b 
C d 
= 100% 
Negative 
0 
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A further 50 patients were randomly selected and the RF latex test 
was performed independently by 2 technologists. The results are 
given in Table A.2.3. 
TABLE A.2.3: 
BETWEEN-OBSERVER VARIATION USING THE RF LATEX TEST 
PATIENT CODE NO. TECHNOLOGIST 1 TECHNOLOGIST 2 
5.6 
- ve 
- ve 
5.9 
- ve 
- ve 
5.12 
- ve 
- ve 
5.13 
- ve 
- ve 
5.16 
- ve 
- ve 
5.18 
- ve 
- ve . 
5.20 
- ve 
- ve 
5.21 
- ve 
- ve 
5.22 
- ve 
- ve 
5.27 - ·ve 
- ve 
5.30 
- ve 
- ve 
5.32 
- ve 
- ve 
5.36 
- ve 
- ve 
5.37 
- ve 
- ve 
5.38 
- ve 
- ve 
5.40 
- ve 
- ve 
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Table A.2.3 continued 
PA TI ENT CODE NO. TECHNOLOGIST 1 TECHNOLOGI ST 2 
5.41 
- ve 
- ve 
5.42 
- ve 
- ve 
5.45 
- ve 
- ve 
5.46 
- ve 
- ve 
5.48 
- ve 
- ve 
' 
5.49 
- ve 
- ve 
5.52 
- ve 
- ve 
5.54 
- ve 
- ve 
5.59 
- ve 
- ve 
5.60 
- ve 
- ve 
5.61 
- ve 
- ve 
5.63 - ve 
- ve 
5.65 
- ve 
- ve 
5.67 
- ve 
- ve 
5.71 
- ve 
- ve 
5.76 
- ve 
- ve 
5.78 
- ve 
- ve 
5.85 
- ve 
- ve 
5.86 
- ve 
- ve 
5.87 
- ve 
- ve 
5.88 
- ve 
- ve 
5.92 
- ve 
- ve 
5.95 
- ve 
- ve 
5.101 
- ve 
- ve 
6.7 + ve + ve 
6.13 + ve + ve 
6.14 + ve + ve 
6.17 + ve + ve 
6.19 + ve + ve 
6.24 + ve + ve 
6.27 + ve + ve 
6.28 + ve + ve 
6.30 + ve + ve 
6.47 + ve + ve 
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The between-observer repeatability was calculated from Table A.2.4. 
TABLE A.2.4 
BETWEEN-OBSERVER ~ARIATION WITH THE RF LATEX TEST 
Technologist 1 
Technologist 2 Positive 
Negative 
Positive 
10 
0 
The between-observer repeatability was a 
(a+b+c) 
TOTAL IgM TEST 
a b 
C d 
= 100% 
Negative 
0 
40 
The 'Low level human IgM Test Kit' and the 'Human IgM Test Kit' obtained 
from Hyland Diagnostics, USA (catalogue numbers 085-403 and 085-404) 
were used. 
Procedure 
A Hamilton micropipette was used to delivery 5 ul of serum to each well. 
Care was taken not to introduce bubbles or damage the walls of the well. 
The first 4 wells of one plate from each batch were used for the 
reference standards provided. Thereafter, only 1 reference serum was 
used per plate of the same lot number. 
After the dilution of sera the plate cover was firmly replaced and the 
plate kept at room temperature for 24 hours. The diameter of the 
precipitin zone was measured using a calibrated measuring device. 
Reference curves were constructed and the IgM values of the samples 
determined. 
The procedure for the 'Human IgM' kits was similar except that 3 
reference sera were used. 
Quality Control 
The inter-assay variation for the 'Low level' plates was determined by 
measuring IgM concentrations on 3 known standards. 
shown in Table A.2.5. 
The results are 
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TABLE A.2.5 
INTER-ASSAY VARIATION OF TOTAL IgM LEVELS 
STANDARD · KNOWN IgM TEST RESULTS MEA N STANDARD COEF FICIENT 
CONCENTRA- DE VIA TION OF 
TION VAR IATI ON 
( IU/ml) (%) 
1 65 65,65,64,69,61 64.8 2.86 4.4 
2 42 44,44,48,44,40 44 2. 8 6.4 
3 32 32,29,28,28,25 28.4 2.5 8.8 
The inter-assay variation of the 'Human IgM' kit was not determined 
because all the sera were stored and tested on one occasion. 
The intra-assay variation was determined for the 'Low level' and 'Human 
IgM' plates. Two sera were tested with each plate. The results are 
shown in Table A.2.6. 
TABLE A.2.6 
INTRA-ASSAY VARIATION OF TOTAL lgM LEVELS 
PLATE TYPE SAMPLE IgM RESULTS (IU/ml) MEAN STANDARD COEFFICIENl 
DEVIATION VARIATION 
'Low level' 1 . 38,38,38,38,38,36,41.5 38.2 1. 73 4.5 
40,36 
2 17,16,17,20,19,17,20, 17.7 1.58 8.9 
16,17 
'Human IgM' 3 112,108,112,112,120, 112 .4 4.2 3.7 
110,110,110,110,120 
4 252,252,252,252,252, 259 11.44 4.4 
260,260,252,280,280 
' IgM Concentrations in 408 newborn infants 
Total IgM levels were estimated by radial immunodiffusion in 408 normal 
newborn infants. The IgM determinations were performed as part of the 
Groote Schuur Hos pi ta l screening programme for congenital syphilis in 
32 9 
1985 and 1986. During this period , it wa s the hospital policy t o test 
all infants born to unbooked mothers in this way . The VDR L and TPHA 
test s were also carried out on the mother s. From this informati on it 
vJas po ssible to analy ze th e IgM results of well babies born to mo ther s 
whose STS were negative at de li ve ry. The results are s how n in Fig ure 
A.2.1. 
The mean IgM concentration was 20 .1 8 IU/ml with a standard deviation of 
11.12. The upper limit of normal was, therefore, regarded as 42 IU/ml (mean+ 2 standard deviations). 
PROCEDURE FOR THE FTA-ABS (lgM) TEST 
The FTA-Treponema pallidum suspension (Behring catalogue number ORMK 
04/05) was used to prepare antigen-coated glass slides. The slides were 
fixed in acetone for 10 minutes and air dried before use. Three wells 
were used for each test or control serum. 
Ten microlitres of heat-inactivated serum was placed in a clean glass 
tube and 40 ul of FTA absorption medium from the FTA-ABS 
, OS kit (Zeus Scientific, USA) was added. After thorough mixing, 10 ul 
of the solution was transferred to the first well of the slide for a 
Forty microl itres of 
number OUCG 14/ 15) was 
and 
pre-IgG precipitation FTA test. 
(Behring, ~~est Germany, catalogue 
remaining 40 ul of test serum 
incubation for 15 minutes at 
centrifuged at 300 g for 10 minutes. 
absorption medium. 
room temperature, the 
RF absorbent 
added to the 
Following 
solution was 
Ten microl itres of supernatant was then added to the second and third 
wells of the slide for post IgG precipitation FTA-ABS IgG and IgM 
testing. Following incubation in a moist chamber at 37°C for 3 hours, 
PBS (pH 7.6) was used to rinse and then soak the slides. After the 
slides had air dried, 10 ul of fluorescein-labelled anti-human IgG (Wellcome Diagnostics, England, catalogue number MF03) was added to the first and second wells and anti-human IgM (Wellcome Diagnostics, 
England, catalogue number MF04) to the third well. 
The material was incubated for 40 minutes at 37°C, washed, dried and 
examined for fluorescence. 
Positive and negative controls were set-up with each batch tested. 
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APPENDIX 4 
TOTAL IgM LEVELS AT FOLLOW-UP 
The total IgM concentration was measured in 43 infants without 
congenital syphilis who were between 4 and 6 weeks of age. The 
results are shown in Figure A.4.1, The mean IgM value was 100 JU/ml 
with a standard deviation of 64 JU/ml; median was 104 JU/ml (range 0-
274 IU/ml). 
Similarly, the mean IgM level of 45 infants between the ages of 3 to 
4 months was 175 JU/ml with a standard deviation of 69 JU/ml; the 
median was 180 IU/ml (range 62-330 IU/ml). Figure A.4.2 shows the 
results. 
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APPENDIX 5 
THE EFFECT OF IgG PRECIPITATION ON THE TOTAL IgM LEVEL 
To determine whether IgG precipitation resulted in a decrease in the 
total IgM concentration, 5 normal infants who were RF negative, v1ere 
studied and their IgM levels measured. 
Ten microlitres of serum was ' diluted with 40 ul of PBS pH 7.2 and 50 ul 
of the RF absorbent (anti-human IgG) was added. 
After incubation (15 ·minutes at room temperature) and centrifugation (300 G for 10 minutes), total IgM levels were quantified using radial 
immunodiffusion plates (Immunoplate IV, Hyland Diagnostics, catalogue 
numbers 085-403 and 085-404). Taking into account the dilutions 
employed, the total IgM levels shown in Table A.5.1. 
TABLE A.5.1 
THE EFFECT OF IgG PRECIPITATION ON TOTAL IgM LEVELS 
PATIENT AGE TOTAL IgM VALUE { IU/ml) 
CODE (MONTHS) BEFORE IgG AFTER IgG 
NO. PRECIPITATION PREC IP !TAT ION 
5.22 4 274 263 
5.25 4 160 160 
5.41 4 180 185 
5.55 4 270 268 
5.62 4 201 204 
It was observed that the IgG precipitation step did not 
alter the IgM concentration in these normal infants. 
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APPENDIX 6 
TABLE A.6.1 
SERUM RF CONCENTRATIONS IN INFANTS WITH CONGENITAL SYPHILIS 
WHO PRESENTED WITHIN 3 DAYS OF BIRTH 
PA TI EMT CODE 
MUMBER 
5.1 
5.2 
5.3 
5.4 
5.5 
5.6 
5.7 
6.1 
6.2 
6.3 
6.4 
6.5 
6.6 
RF COMCENTRATION 
IU/ml 
24 
4 
0 
21 
35 
27 
0 
152 
205 
156 
90 
92 
50 
PA TI ENT CODE 
NUMBER 
6.7 
6.8 
6.9 
6.10 
6.11 
6.12 
6.13 
6.14 
6.15 
6.16 
6.17 
6.18 
6.19 
RF CONCEflTRATION 
IU/ml 
15 
27 
165 
32 
11 
788 
34 
165 
21 
850 
3 
24 
6 
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TABLE A.6.2 
* OPTICAL DENSITY READINGS (BACKGROUND VALUES SUBTRACTED) 
OBTAINED WITH THE RF ELISA IN 96 NORMAL NEWBORN INFANTS 
PATIE NT 
CODE rrn. 
5.18 
5.19 . 
5.20 
5.24 
5.25 
5. 34 
5.35 
5.36 
5.38 
5.39 
5.42 
5.45 
5.47 
5.49 
5.50 
5.51 
5.52 
5.54 
5.55 
OPTICAL 
DENS ITV 
0.017 
0.022 
0.029 
0.023 
0.039 
0 
0 
0.037 
0.032 
0.013 
0 
0.028 
0 
0.039 
0.019 
0.038 
0.037 
0.023 
0.011 
PATIENT OPTICAL 
CODE NO DENSITY 
5. 77 0.002 
5.79 0.013 
5 .80 0.003 
5.81 0.015 
5.82 0.006 
5.83 0.044 
5.85 0 
5.86 0.010 
5 .87 0.032 
5 .89 0.015 
5.90 0.008 
5.91 0.016 
5.92 0.007 
5.93 0.015 
5.94 0 
5.95 0.006 
5.96 0.011 
5.97 0.011 
5.98 0.039 
PATIE NT OPTICAL 
CODE NO DEflSITY 
5.115 0.015 
5.116 0.018 
5.117 0.017 
5 .118 0.013 
5.119 0.030 
5.120 0 
5.122 0.001 
5.124 0.017 
5.125 0.028 
5.126 0.019 
5.127 0.021 
5 .128 0.011 
5.129 0 
5.130 0.033 
5.131 0 
5.132 0.006 
5 .134 0.032 
5.135 0.030 
5.136 0.027 
Table A.6.2 continued 
PATIENT 
CODE NO 
5.56 
5.58 
5.62 
5.65 
5.66 
5.67 
5.69 
5. 71 
5.72 
5.73 
5.74 
5.75 
5.76 
OPTICAL 
DENSITY 
0.010 
0.018 
0.005 
0.017 
0 
0.046 
0 
0.070 
0.002 
0.013 
0.019 
0.029 
0.004 
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PATIENT OPTICAL 
CODE NO DENSITY 
5.99 0.031 
5.101 0.016 
5.102 0.038 
5.104 0 
5.105 0.022 
5.106 0 
5.107 0.024 
5.109 0.012 
5 .110 0.009 
5 .111 0.035 
5 .112 0.003 
5 .113 0.039 
5 .114 0.040 
PATIENT OPTICAL 
CODE NO DENSITY 
5.137 0.019 
5.139 0.013 
5.140 0.020 
5 .• 141 0.014 
5.142 0.003 
5.144 0.016 
5.146 0.021 
5.147 0.001 
5.148 0.025 
5.149 0.032 
5.150 0.023 
5.152 0.009 
5.154 0.016 
* Optical density reading after background value subtracted 
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TABLE A.6.3 
RHEUMATOID FACTOR CONCENTRATIONS IN 39 NORMAL INFANTS AGED 4 DAYS - 2 
MONTHS 
PATIENT 
CODE NO 
5.16 
5 .17 
5.18 
5.19 
5.20 
5.22 
5.23 
5.24 
5.25 
5.26 
5.27 
5.33 
5.35 
5.36 
5.37 
5.38 
5.39 
5.41 
5.42 
5.46 
RF CONCENTRATION 
IU/ml 
3.3 
10.3 
6.2 
0 
3.8 
3.2 
5.1 
18 
0 
0 
0 
4.5 
0 
0 
2.9 
4.2 
78 
0 
5.1 
7.6 
PATIENT 
CODE NO 
5.47 
5.48 
5.49 
5.50 
5.52 
5.53 
5.54 
5.55 
5.57 
5.58 
5.59 
5.60 
5.62 
5.63 
5.64 
5.65 
5.67 
5.68 
5.69 
RF CONCENTRATION 
IU/ml 
6 
5.1 
4.2 
0 
3.4 
0 
0 
9.2 
0 
0 
3.3 
0 
3.7 
7.5 
17 
0 
0 
0 
0 
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TABLE A.6.4 
RHEUMATOID FACTOR CONCENTRATIONS IN INFANTS WITH CONGENITAL SYPHILIS 
OLDER THAN 4 DAYS BUT LESS THAN 2 MONTHS OF AGE 
PATIENT 
CODE NO 
6.20 
6.21 
6.24 
6.25 
6.27 
RF CONCENTRATION 
IU/ml 
38 
30 
32 
238 
80 
PATIENT 
CODE NO 
6.28 
6.29 
6.33 
6.34 
RF CONCENTRATION 
IU/ml 
160 
118 
96 
14 
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TABLE A.6.5 
RHEUMATOID FACTOR CONCENTRATIONS IN 41 NORMAL INFANTS OLDER THAN 2 
MONTHS BUT LESS THAN 4 MONTHS OF AGE 
PATIENT 
CODE NO 
5.16 
5.17 
5.19 
5.20 
5.22 
5.23 
5.24 
5.25 
5.26 
5.27 
5.32 
5.33 
5.34 
5.35 
5.36 
5.37 
5.38 
5.39 
5.40 
5.41 
5.42 
RF CONCENTRATION 
IU/ml 
4.8 
4.5 
14.5 
3.9 
6 
5.1 
0 
0 
5.8 
9 
10.5 
5 
0 
12.8 
0 
25 
6.4 
115 
0 
9.1 
5.6 
PATIENT 
CODE NO 
5.43 
5.44 
5.46 
5.47 
5.48 
5.49 
5.50 
5.51 
5.52 
5.54 
5.55 
5.57 
5.58 
5.59 
5.60 
5.62 
5.64 
5.65 
5.68 
5.69 
RF CONCENTRATION 
IU/ml 
0 
6.4 
22.5 
0 
3.3 
5.8 
4.2 
3.2 
13 
4.6 
12.5 
6.4 
7.2 
4 
2.8 
0 
35 
2.8 
3.2 
0 
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TABLE A.6.6 
RHEUMATOID FACTOR CONCENTRATIONS IN INFANTS WITH CONGENITAL SYPHILIS 
OLDER THAN 2 MONTHS BUT LESS THAN 4 MONTHS OF AGE 
PATIENT 
CODE NO 
6.22 
6.23 
6.26 
6.30 
RF CONCENTRATION 
IU/ml 
520 
0 
500 
38 
PATIENT 
CODE NO 
6.31 
6.32 
RF CONCENTRATION 
IU/ml 
54 
6 
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TABLE A.6.7 
SHOVING TOTAL IgM LEVELS, AMOUNT OF lgM WHICH IS RF AND PERCENTAGE OF 
TOTAL IgM WHICH IS RF IN INFANTS WITH CONGENITAL SYPHILIS 
PATIENT 
CODE NO 
5.1 
5.2 
5.3 
5.4 
5.5 
5.6 
5.7 
6.1 
6.2 
6.3 
6.4 
6.5 
6.6 
6.7 
6.8 
6.9 
6.10 
6.11 
6.12 
6.13 
TOTAL IgM 
( IU/ml) 
301 
97 
0 
126 
426 
186 
0 
764 
1500 
600 
284 
726 
348 
255 
1124 
633 
195 
484 
1200 
504 
*IgM WHICH IS 
RF (IU/ml) 
6 
1 
0 
5 
9 
7 
0 
38 
51 
39 
23 
23 
12 
4 
7 
41 
8 
4 
197 
9 
**% IgM WHICH 
IS RF 
2 
1 
0 
4 
2 
3 
0 
5 
3 
7 
8 
3 
3 
2 
1 
6 
4 
1 
16 
2 
Table A.6.7 continued 
PATIENT 
CODE NO 
6.14 
6.15 
6.16 
6.17 
6.18 
6.19 
6.20 
6.21 
6.22 
6.23 
6.24 
6.25 
6.26 
6.27 
6.28 
6.29 
6.30 
6.31 
6.32 
6.33 
6.34 
TOTAL lgM 
( IU/ml) 
1080 
732 
732 
156 
375 
935 
270 
785 
1380 
340 
471 
1490 
1117 
521 
1000 
1210 
525 
227 
520 
255 
675 
* to nearest IU/ml 
** to nearest percent 
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*lgM WHICH IS 
RF ( IU/ml) 
41 
5 
213 
1 
6 
2 
10 
8 
130 
0 
8 
58 
125 
20 
40 
28 
10 
14 
2 
24 
4 
**% lgM WHICH 
IS RF 
4 
1 
29 
1 
2 
0 
4 
1 
9 
0 
2 
4 
11 
5 
4 
2 
2 
6 
0 
9 
1 
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APPENDIX 7 
TABLE A.7.1 
RHEUMATOID FACTOR LEVEL COMPARED TO GESTATIONAL AGE,SEVERITY OF DISEASE 
AND DURATION OF INFECTION IN PATIENTS WITH CONGENITAL SYPHILIS 
* * PATIENT RF LEVEL GESTATIONAL GESTATIONAL DISEASE DURATION 
CODE IU/ml AGE AGE ~ 37 WEEKS SEVERITY OF 
NUMBER (NEWBORNS ( NEWBORNS IM FE CT ION 
ONLY) ONLY) 
6.16 830 37 1 1 1 
6.12 788 40 1 1 0 
6.22 520 1 1 
6.26 500 1 
6.25 238 1 0 
6.2 205 40 1 l** 0 
6.14 165 34 0 1 0 
6.9 165 35 0 1 0 
6. 28 160 0 1 
6.3 156 33 0 1 0 
6.1 152 36 0 l** 0 
6.29 118 1 0 
6.33 96 1 0 
6.5 92 36 1 0 
6.4 90 37 1 1 1 
6.27 80 0 1 
6.31 54 0 1 
6.6 50 36 0 1 1 
6.30 38 0 1 
6.20 38 0 1 
5.5 35 40 1 0 0 
6.13 34 34 0 1 0 
6.24 32 1 0 
6.10 32 29 0 l** 0 
6.21 30 0 0 
5.6 27 40 1 0 0 
6.8 27 34 0 1 0 
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Table A.7.1 continued 
* 
* PATI ENT RF LEVEL GESTATIONAL GESTATIONAL DISEASE DURATION 
CODE IU/ml AGE AGE) 37 WEEKS SEVERITY OF 
MU MBER (NEWBORNS (NEWBORNS INFECTIO N 
ONLY) ONLY) 
5.1 24 37 1 1 0 
6.18 24 40 1 1 0 
6.15 22 34 0 1 1 
5.4 21 40 1 0 0 
6.7 15 40 1 0 0 
6.34 14 0 1 
6.11 11 33 0 1 1 
6.19 6 35 0 1 0 
6.32 6 0 1 
5.2 4 30 0 1** 0 
6.17 3 32 0 1** 0 
5.3 0 36 0 1 0 
5.7 0 42 1 0 0 
6.23 0 0 1 
* Gestational age in completed weeks 
** Died shortly after birth 
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TABLE A.7.2 
RHEUMATOID FACTOR LEVELS RELATED TO INVOLVEMENT OF THE LIVER, RETICULO-
ENDOTHELIAL SYSTEM, HAEMATOLOGICAL SYSTEM AND RENAL SYSTEM 
PATIENT'S RF LEVEL INVOLVEMENT OF 
CODE IU/ml 
NUMBER LIVER RES HAEMATOLOGICAL BONES RENAL 
SYSTEM SYSTEM 
6.16 830 1 1 1 1 1 
6.12 788 1 1 1 1 0 
6.22 520 1 1 1 1 0 
6.26 500 1 1 1 1 1 
6.25 238 1 0 0 1 0 
6.2 205 1 1 0 1 0 
6.14 165 1 . 1 1 1 0 
6.9 165 1 1 0 1 0 
6.28 160 1 1 1 1 0 
6.3 156 1 1 1 1 0 
6.1 152 1 1 1 1 0 
6.29 118 1 1 1 0 0 
6.33 96 1 1 1 1 0 
6.5 92 1 1 0 1 0 
6.4 90 1 0 0 1 0 
6.27 80 1 1 1 1 0 
6.31 54 1 1 1 1 0 
6.6 50 1 1 0 1 0 
6.30 38 1 1 1 1 0 
6.20 38 1 1 1 1 0 
5.5 35 0 0 0 1 0 
6.13 34 0 0 0 1 0 
6.24 32 1 0 1 1 0 
6.10 32 0 0 0 1 0 
6.21 30 1 0 1 1 0 
5.6 27 0 0 0 1 0 
6.8 27 1 1 1 1 0 
35 2 
Table A.7.2 continued 
PATI EN T'S RF LE VEL INVOLVEME NT OF 
CODE IU/ml 
NU MBER LIVER RES HAEMATOLOGICAL BO NES RENAL 
SYSTEM SYSTEM 
5.1 24 1 0 0 1 0 
6.18 24 1 0 0 1 0 
6.15 21 1 1 0 1 0 
5.4 21 0 0 0 0 0 
6.7 15 0 0 0 1 0 
6.34 14 1 1 0 1 0 
6.11 11 1 1 0 1 0 
6.19 6 1 1 1 0 0 
6.32 6 0 1 1 1 0 
5.2 4 1 1 1 0 0 
6.17 3 1 1 1 0 0 
5.3 0 1 1 1 1 0 
5.7 0 0 0 0 1 0 
6.23 0 1 1 1 1 0 
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TABLE A.7.3 
RHEUMATOID FACTOR LEVELS RELATED TO INVOLVEMENT OF SKIN, RESPIRATORY 
SYSTEM AND OTHER SYSTEMS 
PATIENT RF LEVEL INVOLVEMENT OF EXTENT 
CODE IU/ml OF 
NUMBER SKIN RESPIRATORY OEDEMA DISEASE 
6.16 830 0 1 1 5 
6.12 788 1 0 0 5 
6.22 520 1 0 1 6 
6.26 500 1 0 1 6 
6.25 238 0 0 1 3 
6.2 205 1 0 1 5 
6.14 165 1 0 1 6 
6.9 165 1 0 1 5 
6.28 160 1 0 1 6 
6.3 156 0 1 0 4 
6.1 152 0 1 0 4 
6.29 118 1 0 1 5 
6.33 96 1 0 1 6 
6.5 92 1 1 0 5 
6.4 90 . 0 0 0 2 
6.27 80 1 0 1 6 
6.31 54 1 0 0 5 
6.6 50 0 0 0 3 
6.30 38 1 0 0 5 
6.20 38 0 0 0 4 
5.5 35 0 0 0 1 
6.13 34 0 0 1 2 
6.24 32 0 0 0 3 
6.10 32 0 1 0 2 
6.21 30 0 0 0 3 
5.6 27 0 0 0 1 
6.8 27 1 0 0 5 
5.1 24 1 0 0 3 
6.18 24 0 0 0 2 
6.15 21 1 1 1 5 
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Table A.7.3 continued 
PATI EtlT RF LEVEL HIVOLVEMENT OF EXTENT 
CODE IU/ml OF 
tlUf.H3 ER SKIN RESPIRATORY OEDEMA DISEASE 
5.4 21 1 0 0 1 
6.7 15 0 0 0 1 
6.34 14 0 0 0 3 
6 .11 11 1 0 0 4 
6.19 6 0 0 1 4 
6.32 6 1 0 0 4 
5.2 4 0 1 1 4 
6.17 3 0 0 0 3 
5.3 0 0 0 1 5 
5.7 0 0 0 0 1 
6.23 0 1 0 0 5 
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TABLE A.7.4 
RHEUMATOID FACTOR LEVELS COMPARED TO PLACENTAL WEIGHT RATIO AND H1MUUE 
COMPLEX LEVELS 
PATIENT RF LEVEL INVOLVEflENT IMMUNE COMPLEX 
CODE IU/ml OF PLACrnTA * BINDitJG 
NUf.1BER (%) 
6.16 850 84 .9 
6.12 788 1.56 67 
6.22 520 83.2 
6.26 500 75 
6.25 238 92.5 
6.2 205 1.59 92 
6.14 165 1. 38 
6.9 165 1.32 53 
6.28 160 
6.3 156 1.46 
6.1 152 14.1 
6.29 118 54 
6.33 96 18 
6.5 92 0.91 
6.4 90 1.24 21 
6.27 80 19.2 
6.31 54 8 
6.6 50 1. 51 5.2 
6.30 38 18 
6.20 38 9.2 
5.5 35 0.93 
6.13 34 0.76 11 
6.24 32 6.7 
6.10 32 1.02 
6.21 30 14.7 
5.6 27 0.95 11.4 
6.8 27 1. 38 12.4 
5.1 24 2.18 3.6 
6.18 24 1.29 6. 2 
6.15 21 0.86 
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Table A.7.4 continued 
PATI Etn RF LEVEL It!VOLVEMENT H1MUME COMPLEX 
* CODE IU/ml OF PLACENTA BIMOING 
NUMBER (%) 
5. 4 21 1.11 
6. 7 15 1.02 
6.34 14 
6.11 11 
6. 19 6 35 .5 
6. 32 6 
5. 2 4 0.97 
6.17 3 1.19 
5.3 0 1.01 6 
5.7 0 1.16 
6.23 0 
* Ratio of observed:expected palcental weight 
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TABLE A.7.5 
RHEUMATOID FACTOR LEVELS AND LIVER FUtlCTION TESTS IN INFANTS WITH 
CONGENITAL SYPHILIS 
PATIENT CODE RF LEVEL ALT COtlJ UGATED 
tlUMB ER (IU/ml) ( u/ L) BILIRUBIN 
( umo 1 / L) 
6.12 788 93 99 
6.25 238 ~ID 70 
6.14 165 52 39 
6.9 165 18 72 
6.1 152 6 190 
6.29 118 75 55 
6.33 96 ND 478 
6.27 80 52 39 
6.20 38 18 72 
6.24 32 256 238 
6.21 30 82 8 
6.8 27 177 149 
6.15 21 ND 12 
6.11 11 76 105 
6.19 6 12 62 
6.32 6 84 2 
ND - not done 
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TABLE A.7.6 
RHEUMATOID FACTOR LEVELS Arm VDRL TEST RESULTS HI HI F Arns w ITH 
CO"GEHITAL SYPHILIS FOLLOWING THERAPY WITH PROCAitlE PENICILLHI 
TEST RESULTS 
PAT! ENT TEST AT AT AT 1 MO AT 2 t10 AT 3 MO 
CODE DIAGNOSIS COMPLETION AFTER AFTER AFTER 
NO . OF TREATMENT TREATMEtlT TREATMENT TREATMENT 
* 5. 3 RF 0 0 14 68 14 
** V DR 64 64 16 8 1 
5. 10 RF 33 30 8 9 11 
VDRL 64 128 16 4 4 
6.9 RF 165 342 95 15 0 
VDRL 256 1024 1024 256 4 
6. 13 RF 35 29 4 0 14 
VDRL 16 16 16 16 8 
6. 18 RF 24 rw 5 ND 0 
VDRL 128 ND 32 tlD 2 
6.29 RF 118 320 240 113 36 
VDRL 256 256 256 128 16 
6. 30 RF 38 36 17 ND 10 
VDRL 256 256 64 MD 128 
6.31 RF 54 52 17 6 10 
VDRL _ 128 256 64 8 4 
6. 33 RF 96 380 30 11 7 
VDRL 128 128 128 32 8 
6. 34 *RF 14 ND 43 33 0 
** VDRL 128 MD 8 2 0 
MO - Month 
rw - not done 
* RF level in IU/ml 
** Reciprocal of VDRL titre 
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APPENDIX 8 
Relative placental weight in congenital 
syphilis (from Malan et al (1990)* 
• 
• 
• • • 
• • 
••• 
• 
• 
• 
2000 3000 4000 
Birthweight {g) 
* reproduced with permission 
90th 
50th 
10th 
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APPENDIX 9 
The RF latex test was carried out by technologists (Mrs S 
Rousseau, and Mrs K Judge}. 
Total serum IgM estimates were performed by Mrs N Mallick and 
the author. 
The VDRL, TPHA, FTA-ABS ( IgM} and the RF removal for the FTA 
test were cartied out by Mrs S Louw. 
The optimal conditions for the RF ELISA, its validation, 
standardization and quality control were carried out by the 
author. 
Measurement of the RF levels in patients and controls was 
performed by the author, Mrs S Rousseau and Mrs K Judge. 
Hidden RF was detected by the author. 
The amount of RF which was IgM was determined by the author. 
IgG and IgA RFs were measured by the author. 
The preparation of fluorochromes and the histological 
examination of the sections were performed by the author. 
Immunocytochemical staining was carried out by Mrs D Blake. 
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